000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|þpakki||N05AX08|01.04.2000||R|1|0|0|0|0|0|JAS|0|0|0|100|SEK|1030|2823|lyfalmen|||1|20|0|2,0000|Vistor hf|Janssen-Cilag AB|Risperídón||1030||1030|2823||1 000018|G01AF0501|Pevaryl|krem/sti|||15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|0|0|0|0|0|0|TRI|0|0|0|100|IKR|||lyflausa|||0|15|0|4,5000|Vistor hf|Trimb Healthcare AB|Ekónazól|||||||1 000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|RRG|0|0|0|100|DKK|23999|33424|lyfsjukr|||1|1,8|0|24,0000|Icepharma hf|Roche Registration GmbH|Epóetín||23999||23999|33424||2 000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|5951|9596|lyfalmen|V0457|8667|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||5951||5951|9596||2 000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|18272|26555|lyfalmen|V0475|9359|1|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||18272||18272|26555||2 000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|0|0|0|0|G|0|NED|0|0|0|100|XEU|23602|32922|lyfalmen|V0540|20531|1|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||23602||23602|32922||2 000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|0|0|1|FER|0|0|0|100|DKK|3653|6433|lyfsjukr|||1|0,9|0|0,0400|Vistor hf|Ferring|Atosíban||3653||3653|6433||1 000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|3558|6921|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|Meloxícam||3558||3558|6921||1 000237|G02CX0101|Tractocile|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|0|0|1|FER|0|0|0|100|DKK|9785|14873|lyfsjukr|||1|5|0|0,2300|Vistor hf|Ferring|Atosíban||9785||9785|14873||1 000299|N06AB0311|Fluoxetin Mylan|hylki|20|mg|250|stk|1|glas||N06AB03|01.11.2015||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2641|5040|lyfalmen|||2|250|0|250,0000|Icepharma hf|Mylan AB|Flúoxetín||2641||2641|5040||2 000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|0|0|0|0|0|1|GPH|0|0|0|100|DKK|2243|4492|lyfsjukr|||1|5|0|1,6700|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill ||2243||2243|4492||1 000546|G03DA0406|Crinone|sk-hlaup|8|%|6|stk|1|sk-ílá||G03DA04|01.02.2018||R|0|0|0|1|G|0|MEC|0|0|0|100|SEK|2297|4567|lyfalmen|V0942|4062|1|6|0||Icepharma hf|Merck AB|Prógesterón||2297||2297|4567||2 000552|G04BE0105|Caverject Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|3743|6557|lyfalmen|||1|2|0|2,0000|Icepharma hf|Pfizer ApS|Alprostadíl||3743||3743|6557||1 000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|2184|4411|lyfalmen|||1|60|0|3,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||2184||2184|4411||1 000613|G03DA0406|Crinone|sk-hlaup|8|%|15|stk|1|sk-ílá||G03DA04|01.02.2018||R|0|0|0|1|G|0|MEC|0|0|0|100|SEK|6357|10155|lyfalmen|V0942|10155|1|15|0||Icepharma hf|Merck AB|Prógesterón||6357||6357|10155||2 000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|pokar||B05BA02|01.04.2004||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|8965|13744|lyfsjukr|||1|1000|0||Vistor hf|Fresenius Kabi AB|Fitusambönd||8965||8965|13744||1 000663|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|500|ml|12|pokar||B05BA02|01.12.2014||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|28988|39734|lyfsjukr|||1|6000|0||Vistor hf|Fresenius Kabi AB|Fitusambönd||28988||28988|39734||1 000784|G04BE0105|Caverject Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|2783|5235|lyfalmen|||1|2|0|1,0000|Icepharma hf|Pfizer ApS|Alprostadíl||2783||2783|5235||1 000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|1,7500|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1 000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|0,8750|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1 000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|0|0|0|1|0|1|MRP|0|0|0|100|SEK|71957|94081|lyfsjukr|||1|6|0|122,7907|Icepharma hf|Merck Europe B.V.|Interferón beta-1a||71957||71957|94081||2 001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|þpakki||C10AA05|01.06.2002||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|12327|18372|lyfalmen|V0115|8149|1|100|0|400,0000|Icepharma hf|Pfizer ApS|Atorvastatín||12327||12327|18372||1 001291|C07AB0206|Seloken ZOC|forðatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1472|3431|lyfalmen|V0050|2079|1|100|0|15,8300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1472||1472|3431||1 001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4686|7855|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||4686||4686|7855||1 001512|C04AD0301|Trental|forðatfl|400|mg|100|stk|1|þpakki||C04AD03|01.05.2002||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|2189|4418|lyfalmen|||1|100|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||2189||2189|4418||1 001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|16922|24696|lyfsjukr|||1|4104|0||Vistor hf|Fresenius Kabi AB|Blöndur||16922||16922|24696||1 001599|B03AC0002|Venofer|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.07.2005||R|0|1|0|0|G|0|VIF|0|0|1|100|CHF|11376|17063|lyfalmen|V0637|16196|1|25|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||11376||11376|17063||1 001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|23181|32390|lyfsjukr|||1|6160|0||Vistor hf|Fresenius Kabi AB|Blöndur||23181||23181|32390||1 001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|1866|3973|lyfsjukr|||1|10|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlergómetrín||1866||1866|3973||1 001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|3808|6646|lyfalmen|||1|15|0|75,0000|Vistor hf|Novartis Europharm Ltd|Brinzólamíð||3808||3808|6646||1 001954|N05AX0802|Rison|filmhtfl|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1416|2662|lyfalmen|V0291|2231|2|60|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Risperídón||913||913|2662||1 001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|0|0|0|0|0|0|BIG|0|0|1|100|SEK|2672|5083|lyfalmen|||1|45|0||Icepharma hf|Bioglan AB|Capsaicin||2672||2672|5083||2 001965|N05AX0802|Rison|filmhtfl|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2407|4130|lyfalmen|V0292|3057|2|60|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Risperídón||1980||1980|4130||1 001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|1353|3267|lyfalmen|V0004|2769|1|28|0|18,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1353||1353|3267||1 002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|2757|5200|lyfalmen|V0005|1953|1|28|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||2757||2757|5200||1 002194|B05BA1010|Kabiven Peripheral|irl|1000|kcal|1440|ml|4|pokar|fleyti|B05BA10|01.02.2002||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|19763|28607|lyfsjukr|||1|5760|0||Vistor hf|Fresenius Kabi AB|Blöndur||19763||19763|28607||2 002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2401|4710|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||2401||2401|4710||1 002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.08.2002||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|10738|16185|lyfalmen|V0492|7880|1|98|0|39,2000|Vistor hf|M.S.D.|Montelúkast||10738||10738|16185||1 002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Lóratadín|||||||1 002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Lóratadín|||||||1 002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|G|0|GPA|0|0|1|100|IKR|||lyfalmen|V0362|1858|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Lóratadín|||||2635||1 002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|6,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|818|2531|lyfalmen|||1|5|0|28,0000|Icepharma hf|Santen Oy|Tímólól||818||818|2531||2 002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|0|0|0|1|0|1|IRE|0|0|0|100|XEU|22272|31240|lyfsjukr|||1|1|0||Actavis ehf|Allergan Pharmaceuticals Ireland|Clostridium botulinum toxín-A||22272||22272|31240||1 003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.06.2007||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|10152|12572|lyfalmen|V0089|2492|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||8113||8113|12572||1 003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|6487|10334|lyfalmen|V0515|3607|1|100|0|16,6700|Vistor hf|U.C.B|Levetíracetam||6487||6487|10334||1 003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|9893|15022|lyfalmen|V0253|5534|1|100|0|33,3300|Vistor hf|U.C.B|Levetíracetam||9893||9893|15022||1 003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|19034|27603|lyfalmen|V0516|5259|1|100|0|66,6700|Vistor hf|U.C.B|Levetíracetam||19034||19034|27603||1 003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|G|0|PFP|0|0|0|100|SEK|6601|10491|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||6601||6601|10491||1 003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|G|0|PFP|0|0|0|100|SEK|9748|14822|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||9748||9748|14822||1 003192|QM01AX9001|Cartrophen vet.|stl|100|mg/ml|10|ml|1|hgl|lausn f.hunda|QM01AX90|01.08.2015||R|0|0|0|0|0|0|AEL|1|0|0|100|XEU|6359|12235|vetalmen|||0|10|0||Icepharma hf|Arthropharm Europe Limited|Pentosan Polysulfate Sodium||6359||6359|12235||2 003310|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|120|skammtar|1|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|4703|7878|lyfalmen|||1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||4703||4703|7878||1 003325|R03AK0702|Symbicort mite Turbuhaler|innönddu|84,5|mcg/sk|120|skammtar|1|innö.t|80+4,5 mcg/sk|R03AK07|01.08.2002||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|4410|7475|lyfalmen|||1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||4410||4410|7475||1 003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|þpakki||A02BB01|01.08.2002||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|2404|4714|lyfalmen|||1|60|0|15,0000|Icepharma hf|Pfizer ApS|Mísóprostól||2404||2404|4714||1 003775|V03AF0701|Fasturtec|st/irþ|1,5|mg/ml|1,5|mg|3|hgl|+leysir|V03AF07|01.12.2015||R|0|0|0|0|0|1|SGB|0|0|0|100|XEU|27610|37991|lyfsjukr|||1|4,5|0|0,1500|Vistor hf|Sanofi-aventis groupe|Rasburicase||27610||27610|37991||1 003859|N05AH0205|Clozapine Actavis|töflur|25|mg|100|stk|1|glas||N05AH02|01.10.2014||R|2|0|0|0|G|0|GRP|0|0|0|100|XEU|1707|3754|lyfalmen|||2|100|0|8,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Klózapín||1707||1707|3754||1 003880|N05AH0205|Clozapine Actavis|töflur|100|mg|500|stk|1|glas||N05AH02|01.06.2015||R|2|0|0|0|G|0|GRP|0|0|0|100|XEU|23216|28422|lyfalmen|||2|500|0|166,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Klózapín||20044||20044|28422||1 003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.11.2000||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|840|2367|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Sertralín||699||699|2367||1 003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.11.2000||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2426|2911|lyfalmen|V0322|2456|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Sertralín||1094||1094|2911||1 004002|L04AD0101|Sandimmun|irþ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|14685|21617|lyfsjukr|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||14685||14685|21617||1 004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|6140|9856|lyfalmen|||1|250|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||6140||6140|9856||1 004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|þpakki|hart hylki|N05AE04|01.03.2003||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|3536|6272|lyfalmen|||1|14|0|7,0000|Icepharma hf|Pfizer ApS|Ziprasidon||3536||3536|6272||1 004282|R03AK0601|Seretide|innúðal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|4625|7771|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||4625||4625|7771||1 004293|R03AK0601|Seretide|innúðal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|6459|10295|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||6459||6459|10295||1 004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|0|1|0|0|0|1|PHH|0|0|0|100|DKK|16343|23899|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer Limited|Voricónazól||16343||16343|23899||1 004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|þpakki||A04AA01|01.01.2009||R|1|0|0|0|G|0|NAA|0|0|1|100|DKK|5037|4996|lyfalmen|V0381|4144|1|10|0|2,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||2609||2609|4996||1 004388|QJ51RC2501|Benestermycin, vet.|spenalyf|||5|ml|20|spr||QJ51RC25|01.12.1978||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|5970|11497|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||5970||5970|11497||1 004455|N02AX0208|Zytram|forðatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|2519|4872|lyfalmen|||1|56|0|14,0000|Icepharma hf|Norpharma |Tramadól||2519||2519|4872||2 004478|N02AX0208|Zytram|forðatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|3360|6030|lyfalmen|V0226|2510|1|56|0|18,6667|Icepharma hf|Norpharma |Tramadól||3360||3360|6030||2 004502|J07BC0101|Engerix-B|stl|20|mcg/ml|0,5|ml|1|dæla|einnota dæla|J07BC01|01.01.1990||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|1603|3611|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-B, hreinsaðir mótefnavakar||1603||1603|3611||1 004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.06.2005||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|2254|2600|lyfalmen|V0494|2093|1|90|0|180,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||868||868|2600||1 004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2359|4652|lyfalmen|V0318|3470|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Cítalópram||2359||2359|4652||1 004613|J07BC0101|Engerix-B|stl|20|mcg/ml|1|ml|1|áfspr||J07BC01|01.01.1990||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|2368|4664|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-B, hreinsaðir mótefnavakar||2368||2368|4664||1 004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|4200|4767|lyfalmen|V0320|2781|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Cítalópram||2443||2443|4767||1 004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1557|3548|lyfalmen|V0317|2781|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Cítalópram||1557||1557|3548||1 004676|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|200|stk|1|glas||A02AA04|01.03.2018||L|1|0|0|0|0|0|MEA|0|0|0|100|IKR|||lyfalmen|||0|200|0|33,3333|Icepharma hf|Meda AB|Magnesíum hýdroxíð|||||3087||2 004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|1|0|0|0|0|0|MEA|0|0|0|100|IKR|||lyfalmen|||0|100|0|16,6700|Icepharma hf|Meda AB|Magnesíum hýdroxíð|||||2206||2 004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|0|1|0|1|0|1|BIO|0|0|0|100|DKK|29008|39760|lyfsjukr|||1|4,69|0|7,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||29008||29008|39760||3 004746|A10AE0405|Lantus [Clikstar]|stl|100|ein/ml|3|ml|5|rörlyk|Clikstar/JuniorStar pennar|A10AE04|01.06.2004||R|0|0|0|0|G|0|SDH|0|0|0|100|XEU|6685|10606|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||6685||6685|10606||1 004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|þpakki||P01AB01|01.12.1972||R|1|0|0|0|0|0|GRP|0|0|1|100|DKK|652|2302|lyfalmen|||2|24|0|3,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metrónídazól||652||652|2302||1 004880|J01FA1001|Zitromax|irs|500|mg|10|ml|1|hgl||J01FA10|01.05.2003||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|4202|7189|lyfsjukr|||1|10|0|1,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||4202||4202|7189||1 004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|1|0|0|0|0|0|GRP|0|0|1|100|DKK|277|1786|lyfalmen|||2|8|0|2,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metrónídazól||277||277|1786|30.6.2018|1 004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|GRP|0|0|1|100|DKK|716|2390|lyfalmen|||2|14|0|3,5000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metrónídazól||716||716|2390||1 004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|GRP|0|0|1|100|DKK|1226|3092|lyfalmen|||2|30|0|7,5000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metrónídazól||1226||1226|3092||1 005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|36|0|2,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 005085|J07AJ5205|Boostrix|stl|||0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|1998|4155|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Kíghósti, í blöndum með öðrum toxóíðum||1998||1998|4155||1 005108|G04CA0201|Omnic|hylki|0,4|mg|90|stk|1|þpakki|með br.losunarhraða|G04CA02|01.08.1998||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|6809|6177|lyfalmen|V0148|3023|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||3467||3467|6177||1 005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|TCA|0|0|1|100|DKK|2569|4188|lyfalmen|V0353|2593|2|30|0|3,7500|Actavis Group hf|Actavis hf|Díkloxacillín||2022||2022|4188||1 005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|TCA|0|0|1|100|DKK|1980|4130|lyfalmen|||2|20|0|5,0000|Actavis Group hf|Actavis hf|Díkloxacillín||1980||1980|4130||1 005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|TCA|0|0|1|100|DKK|2223|3647|lyfalmen|V0337|3470|2|30|0|7,5000|Actavis Group hf|Actavis hf|Díkloxacillín||1629||1629|3647||1 005241|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|14108|20823|lyfalmen|V0356|20823|1|360|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||14108||14108|20823||1 005303|N02CC0303|Zomig Nasal|nefúði|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003|31.08.2018|R|0|0|0|0|G|0|ASZ|0|0|0|100|SEK|2257|4511|lyfalmen|||1|10|0|4,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||2257||2257|4511||1 005330|D08AG0201|Betadine|húðlausn|100|mg/ml|500|ml|1|fl|sprittlausn|D08AG02|01.09.1982||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2 005336|R01AA0704|Otrivin ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.07.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.04.1996||R|0|0|0|1|G|0|AZA|0|0|0|100|SEK|39591|52017|lyfalmen|V0451|44152|1|1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||38699||38699|52017||1 005390|R03BB0101|Atrovent|innúðal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|1388|3315|lyfalmen|||1|200|0|33,3300|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||1388||1388|3315||1 005576|R05CA0301|Tussol|mixtúra|||150|ml|1|glas||R05CA03|01.10.2001||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||0|150|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Slímlosandi lyf nema slímþynnir (mucolytica)- guaifenesin|||||||1 005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|4500|7599|lyfalmen|||1|30|0|54,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||4500||4500|7599||1 005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|4564|7687|lyfalmen|||1|30|0|54,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||4564||4564|7687||1 005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|1450|3401|lyfalmen|||1|30|0|15,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||1450||1450|3401||2 005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|þpakki||A10BB09|01.04.2002|30.06.2018|R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|2858|5339|lyfalmen|||1|60|0|30,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||2858||2858|5339||2 005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|4562|7684|lyfalmen|V0020|7684|1|180|0|90,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||4562||4562|7684||2 005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|3332|5991|lyfalmen|V0020|3842|1|90|0|45,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||3332||3332|5991||2 005766|H01CC0201|Cetrotide|sts|0,25|mg|1|hgl|1|pakki||H01CC02|01.12.2016||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|3578|6330|lyfalmen|||1|1|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Cetrorelix||3578||3578|6330||2 005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|4222|7216|lyfalmen|V0324|2838|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||4222||4222|7216||1 005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|13937|24022|vetorma|||0|5|0||Vistor hf|Merial (MSD)|Ivermectinum||13937||13937|24022||1 005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6776|10731|lyfalmen|V0325|2698|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||6776||6776|10731||1 005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|0|0|0|0|G|0|NED|0|0|0|100|XEU|2132|4339|lyfalmen|||1|1|0|1,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||2132||2132|4339||2 005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|11913|16989|lyfalmen|V0326|5102|1|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||11322||11322|16989||1 005963|J01CR0204|Amoxin comp|filmhtfl|875|mg|14|stk|1|þpakki|875+125 mg|J01CR02|01.02.2013||R|0|0|0|0|0|0|RHA|0|0|1|100|IKR|1816|2231|lyfalmen|V0169|2231|2|14|0|12,2500|Alvogen|ratiopharm Oy|Amoxicillín og beta-laktamasa hemill ||600||600|2231||2 006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4479|7570|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||4479||4479|7570||1 006079|J02AX0403|Cancidas|irþ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|0|0|1|MSD|0|0|0|100|DKK|77802|101474|lyfsjukr|||1|1|0|1,4000|Vistor hf|M.S.D.|Caspofungin||77802||77802|101474||1 006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4289|7308|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||4289||4289|7308||1 006115|J02AX0403|Cancidas|irþ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|0|0|1|MSD|0|0|0|100|DKK|59439|78249|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Caspofungin||59439||59439|78249||1 006239|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1995||R|0|0|0|0|0|0|MEA|0|0|1|100|SEK|2241|4489|lyfalmen|||1|30|0|7,5000|Icepharma hf|Meda AB|Flúkloxacillín||2241||2241|4489|31.7.2018|2 006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|2764|5414|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim|Meloxícam||||2764|5414||1 006637|D05AX5201|Daivobet|smyrsli|||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2013||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|10922|16438|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||10922||10922|16438|31.8.2018|1 006732|A16AB0401|Fabrazyme|irþ|5|mg/ml|35|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|0|0|1|GEB|0|1|0|100|XEU|392014|444258|lyfsjukr|||1|35|0|7,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||352291||352291|444258||1 006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|þpakki||C09CA01|01.05.2002||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|11357|17037|lyfalmen|V0099|6809|1|98|0|196,0000|Vistor hf|M.S.D.|Lósartan||11357||11357|17037||1 007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|9103|13934|lyfalmen|V0117|5154|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||9103||9103|13934||1 007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.06.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|13319|19737|lyfalmen|V0118|8391|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||13319||13319|19737||1 007165|C09AA0105|Captopril Actavis|töflur|50|mg|100|stk|1|þpakki||C09AA01|01.05.2013||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|1876|3987|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Kaptópríl||1876||1876|3987||1 007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|16301|23842|lyfalmen|V0195|9874|1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||16301||16301|23842||1 007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|0|0|0|1|0|1|PLS|0|1|0|100|DKK|74218|96941|lyfsjukr|||1|3000|0|5,0000|Icepharma hf|Pfizer ApS|Linezolíd||74218||74218|96941||1 007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|þpakki||J01XX08|01.12.2001||R|0|0|0|1|0|1|PLS|0|1|0|100|DKK|192302|245277|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Linezolíd||192302||192302|245277||1 007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|2235|4481|lyfalmen|V0374|3545|1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Tímólól í blöndum||2235||2235|4481||1 007448|B05XC04|Cernevit|sts|||5|ml|10|hgl||B05XC|01.05.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5723|9282|lyfsjukr|||1|50|0||Icepharma hf|Baxter Medical AB|Vítamín||5723||5723|9282||2 007449|V03AB3401|Fomepizole OPi|irþ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|0|0|0|0|0|1|OPO|0|0|0|100|XEU|87275|113456|lyfsjukr|||1|100|0||Swedish Orphan International AB|OPi Orphan Pharma international (S)|Fómepízól||87275||87275|113456||3 007462|N01AB0801|Sevorane|innö.guf|100|%|250|ml|1|plastf||N01AB08|01.03.2002||R|0|0|0|0|0|1|ABV|0|0|0|100|DKK|17900|26042|lyfsjukr|||1|250|0||Vistor hf|AbbVie Ltd.|Sevóflúran||17900||17900|26042||1 007505|G04BD0702|Detrusitol Retard|forðahlk|2|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|4707|7884|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tólteródín||4707||4707|7884|31.7.2018|1 007601|A16AB0301|Replagal|irþ|1|mg/ml|3,5|ml|1|hgl|lausn|A16AB03|01.09.2014||R|0|0|0|0|0|1|SHG|0|1|0|100|XEU|192146|245083|lyfsjukr|||1|3,5|0|3,5000|Shire Human Genetics Therapies AB|Shire Human Genetic Therapies AB|Agalsídasi alfa||||192146|245083||3 007760|G04BD0702|Detrusitol Retard|forðahlk|4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|3815|6656|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tólteródín||3815||3815|6656||1 007769|G04BD0702|Detrusitol Retard|forðahlk|4|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|12926|19196|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Tólteródín||12926||12926|19196|31.8.2018|1 007778|N05AX0802|Rison|filmhtfl|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1371|2802|lyfalmen|V0290|2231|2|60|0|6,0000|Actavis Group hf|Actavis Group PTC ehf|Risperídón||1015||1015|2802||1 007852|G02BB0101|NuvaRing|sk-hring|||3|stk|1|pakki|með forðaverkun|G02BB01|01.11.2002||R|0|0|0|0|0|0|DSM|0|0|0|100|DKK|3103|5676|lyfalmen|||1|3|0|84,0000|Vistor hf|Merck Sharp & Dohme|Skeiðarinnleg með progestógeni og östrógeni||3103||3103|5676||1 007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|1090|2905|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Ólópatadín||1090||1090|2905||1 008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|þpakki||A10BA02|01.01.2002||R|1|0|0|0|G|0|MCK|0|0|0|100|SEK|264|1768|lyfalmen|V0502|967|1|30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||264||264|1768||2 008301|N02AX0209|Tramol-L|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|IVS|0|0|1|100|XEU|695|2362|lyfalmen|||2|20|0|6,6700|Actavis Group PTC hf|Actavis ehf|Tramadól||695||695|2362||1 008326|D07AC0101|Betnovat|húðlausn|1|mg/g|100|ml|1|plglas|í hársvörð|D07AC01|01.07.1988||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|815|2527|lyfalmen|||1|100|0||Vistor hf|GlaxoSmithKline Pharma A/S|Betametasón||815||815|2527||1 008338|N02AX0209|Tramol-L|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|IVS|0|0|1|100|XEU|2236|4483|lyfalmen|V0226|4483|2|100|0|33,3300|Actavis Group PTC hf|Actavis ehf|Tramadól||2236||2236|4483||1 008360|N02AX0209|Tramol-L|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|IVS|0|0|1|100|XEU|3298|5944|lyfalmen|||2|100|0|50,0000|Actavis Group PTC hf|Actavis ehf|Tramadól||3298||3298|5944||1 008368|N02AX0209|Tramol-L|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|IVS|0|0|1|100|XEU|4564|7687|lyfalmen|||2|100|0|66,6700|Actavis Group PTC hf|Actavis ehf|Tramadól||4564||4564|7687||1 008370|H01AB0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|H01AB01|01.01.2006||R|0|0|0|0|0|1|GEB|0|0|0|100|XEU|108566|141133|lyfsjukr|||1|2|0||Vistor hf|Genzyme Europe B.V.|Thyrotropin alfa||108566||108566|141133||1 008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|6148|10597|vetorma|||0|1000|0||Icepharma hf|Chanelle Pharmaceuticals |||6148||6148|10597||2 008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|9215|17653|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals |||9215||9215|17653||2 008519|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|G|0|RTH|0|0|1|100|XEU|||lyfalmen|V0575|1584|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Cetirizín|||||2378||2 008545|G03FB0506|NovoFem|filmhtfl|||84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2241|4489|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2241||2241|4489||1 008673|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|10|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Alvogen|ratiopharm GmbH|Cetirizín|||||||2 008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRG|0|0|0|100|DKK|80198|104505|lyfsjukr|||1|2|0|20,7700|Icepharma hf|Roche Registration GmbH|Peginterferón alfa 2a||80198||80198|104505||2 008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRG|0|0|0|100|DKK|83197|108298|lyfsjukr|||1|2|0|27,6900|Icepharma hf|Roche Registration GmbH|Peginterferón alfa 2a||83197||83197|108298||2 008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|5484|8953|lyfalmen|V0145|2805|1|4|0|8,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||||5484|8953||2 008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|10874|16372|lyfalmen|V0145|5609|1|8|0|16,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||||10874|16372||2 008959|R01AA0706|Naso-ratiopharm|nefúði|0,5|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Alvogen|ratiopharm GmbH|Xýlómetazólín|||||||2 009099|N06AG0202|Moclobemid ratiopharm|filmhtfl|300|mg|60|stk|1|þpakki||N06AG02|01.03.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|4383|6222|lyfalmen|||2|60|0|60,0000|Alvogen|ratiopharm GmbH|Móklóbemíð||3500||3500|6222||2 009113|B05DB0005|Balance|kvið.sk|1,5|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6084|9779|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6084||6084|9779||2 009117|N06AG0202|Moclobemid ratiopharm|filmhtfl|150|mg|100|stk|1|þpakki||N06AG02|01.02.2013||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|2737|4311|lyfalmen|V0063|4311|2|100|0|50,0000|Alvogen|ratiopharm GmbH|Móklóbemíð||2111||2111|4311||2 009213|B05DB0005|Balance|kvið.sk|2,3|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6084|9779|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6084||6084|9779||2 009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|0|0|0|0|0|0|PHH|0|0|1|100|DKK|9302|14208|lyfalmen|||1|10|0|10,0000|Icepharma hf|Pfizer Limited|Parekoxíb||9302||9302|14208||1 009216|B05DB0005|Balance|kvið.sk|4,25|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6084|9779|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6084||6084|9779||2 009270|R01AA0706|Naso-ratiopharm|nefúði|1|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Alvogen|ratiopharm GmbH|Xýlómetazólín|||||||2 009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|1|1|0|0|0|1|PHH|0|0|0|100|DKK|40443|54223|lyfsjukr|||1|30|0|3,7500|Icepharma hf|Pfizer Limited|Voricónazól||40443||40443|54223||1 009409|G03CA0316|Vivelle Dot|forðapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|NAA|0|0|0|100|DKK|885|2623|lyfalmen|||1|8|0|21,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||885||885|2623||1 009443|G03CA0316|Vivelle Dot|forðapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|NAA|0|0|0|100|DKK|976|2748|lyfalmen|||1|8|0|28,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||976||976|2748||1 009465|G03CA0316|Vivelle Dot|forðapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|NAA|0|0|0|100|DKK|1128|2957|lyfalmen|||1|8|0|42,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1128||1128|2957||1 009489|G03CA0316|Vivelle Dot|forðapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|NAA|0|0|0|100|DKK|1413|3350|lyfalmen|||1|8|0|56,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1413||1413|3350||1 009525|B05DB0005|Balance|kvið.sk|1,5|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|NOK|5541|9032|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5541||5541|9032||2 009560|B05DB0005|Balance|kvið.sk|4,25|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5756|9327|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5756||5756|9327||2 009591|B05DB0005|Balance|kvið.sk|2,3|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|NOK|5541|9032|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5541||5541|9032||2 009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|1|1|0|0|0|1|PHH|0|0|0|100|DKK|144752|186138|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer Limited|Voricónazól||144752||144752|186138||1 009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|1|1|0|1|0|1|GSL|0|0|0|100|DKK|43830|58506|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Tenófóvír dísóproxíl||43830||43830|58506||2 009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|7659|10825|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||6844||6844|10825||1 009905|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8299|11911|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||7633||7633|11911||1 009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|6598|10486|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||6598||6598|10486||1 009942|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8299|11911|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||7633||7633|11911||1 009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|6689|10612|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||6689||6689|10612||1 009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|7659|10171|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||6369||6369|10171||1 010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|DSM|0|0|0|100|DKK|1668|3701|lyfalmen|V0329|2589|1|30|0|15,0000|Vistor hf|Merck Sharp & Dohme|Mirtazapín||1668||1668|3701||1 010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|1|0|0|0|0|1|ROA|0|0|0|100|DKK|116483|150979|lyfsjukr|||1|60|0|30,0000|Icepharma hf|Roche A.S.|Valgancíklóvír||116483||116483|150979||2 010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|5239|8616|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Ertapenem||5239||5239|8616||1 010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|DSM|0|0|0|100|DKK|9955|15107|lyfalmen|V0331|3019|1|96|0|96,0000|Vistor hf|Merck Sharp & Dohme|Mirtazapín||9955||9955|15107||1 010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|DSM|0|0|0|100|DKK|14037|20725|lyfalmen|||1|96|0|144,0000|Vistor hf|Merck Sharp & Dohme|Mirtazapín||14037||14037|20725||1 010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|þpakki||N06DX01|01.10.2002||R|1|0|0|0|G|0|LUN|0|0|0|100|DKK|13624|20157|lyfalmen|V0605|2781|1|100|0|50,0000|Vistor hf|H. Lundbeck A/S|Memantín||13624||13624|20157||1 010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|8753|13453|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||8753||8753|13453||1 010534|B05BA0108|Vaminolac|irl|||100|ml|10|fl||B05BA01|01.03.2004||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|7145|11239|lyfsjukr|||1|1000|0||Vistor hf|Fresenius Kabi AB|Amínósýrur||7145||7145|11239||1 010573|S01AE0501|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AE05|01.08.2002||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|969|2739|lyfalmen|||1|5|0||Icepharma hf|Santen Oy|Levófloxacín||969||969|2739||2 010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|ACV|0|1|0|100|SEK|239458|303926|lyfsjukr|||1|56|0|14,0000|Vistor hf|Actelion Registration Ltd.|Bósentan||239458||239458|303926||3 010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|ACV|0|1|0|100|SEK|239458|303926|lyfsjukr|||1|56|0|28,0000|Vistor hf|Actelion Registration Ltd.|Bósentan||239458||239458|303926||3 010837|H01AX0101|Somavert|sts|15|mg|30|hgl|1|pakki|+ leysir, lausn|H01AX01|01.11.2016|30.06.2018|R|0|0|0|1|0|1|PIZ|0|0|0|100|DKK|424817|534460|lyfsjukr|||1|30|0|45,0000|Icepharma hf|Pfizer Ltd|Pegvisómant||424817||424817|534460||1 010848|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+ leysir, lausn|H01AX01|01.11.2016||R|0|0|0|1|0|1|PIZ|0|0|0|100|DKK|571044|716326|lyfsjukr|||1|30|0|60,0000|Icepharma hf|Pfizer Ltd|Pegvisómant||571044||571044|716326||1 010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|32514|44194|lyfsjukr|||2|10|0||Icepharma hf|Baxter Medical AB|Bleómýcín||32514||32514|44194||2 010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|0|0|0|0|0|1|MEA|0|0|0|100|DKK|2146|4359|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Meda AB|Kloxacillín||2146||2146|4359||2 010947|C08CA0203|Felodipin ratiopharm|forðatfl|5|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|2231|2630|lyfalmen|||2|100|0|100,0000|Alvogen|ratiopharm GmbH|Felódipín||890||890|2630||2 010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|15689|22999|lyfalmen|V0204|5809|1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||15689||15689|22999||1 010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|G|0|OTS|0|0|0|100|DKK|10816|16292|lyfalmen|V0716|4846|1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||10816||10816|16292||1 010980|C08CA0203|Felodipin ratiopharm|forðatfl|10|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|2980|3057|lyfalmen|V0059|3057|2|100|0|200,0000|Alvogen|ratiopharm GmbH|Felódipín||1200||1200|3057||2 010989|R06AE0707|Cetirizin STADA|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.05.2018||L|1|0|0|0|G|0|ASR|0|0|1|100|IKR|||lyfalmen|V0575|1584|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Cetirizín|||||1584||2 011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|24101|33553|lyfalmen|V0683|3787|1|56|0|37,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||24101||24101|33553||1 011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|G|0|OTS|0|0|0|100|DKK|19473|28208|lyfalmen|V0684|3787|1|56|0|56,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||19473||19473|28208||1 011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|3508|6233|lyfalmen|V0825|2789|1|28|0|28,0000|Vistor hf|M.S.D.|Etoríkoxíb||3508||3508|6233||1 011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|3645|6422|lyfalmen|V0826|2789|1|28|0|42,0000|Vistor hf|M.S.D.|Etoríkoxíb||3645||3645|6422||1 011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|12422|18503|lyfalmen|V0327|4450|1|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||12422||12422|18503||1 011326|M01AH0501|Arcoxia|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|930|2685|lyfalmen|V0827|1680|1|7|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||930||930|2685||1 011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1905|2959|lyfalmen|V0069|2456|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lósartan||1129||1129|2959||1 011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|skammtar|1|innö.t|320+9 mcg/sk|R03AK07|01.05.2003||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|4640|7791|lyfalmen|||1|60|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||4640||4640|7791||1 011489|N06BA0402|Concerta|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|1|1|0|0|0|JAS|0|0|0|100|SEK|4441|7249|lyfalmen|V0691|4930|1|30|0|18,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||4246||4246|7249||1 011555|N06BA0402|Concerta|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|1|1|0|0|0|JAS|0|0|0|100|SEK|5687|6726|lyfalmen|V0624|4759|1|30|0|36,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||3866||3866|6726||1 011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|1501|2950|vetalmen|||0|25|0||Icepharma hf|Chanelle Pharmaceuticals |||1501||1501|2950||2 011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|0|0|1|0|0|1|PLS|0|0|0|100|DKK|3664|6448|lyfsjukr|||1|20|0||Icepharma hf|Pfizer ApS|Esketamín||3664||3664|6448||1 011690|J05AP0101|Copegus|töflur|200|mg|168|stk|1|plglas||J05AP01|01.03.2003||R|0|0|0|1|0|1|ROA|0|0|0|100|DKK|49394|65544|lyfsjukr|||1|168|0|33,6000|Icepharma hf|Roche A.S.|Ribavirin||49394||49394|65544||2 011718|QJ01CE0101|Geepenil, vet.|sts|24|g|1|hgl|1|pakki|+ leysir, lausn|QJ01CE01|01.09.2012||R|0|0|0|0|0|0|OCO|0|0|0|100|DKK|2436|4788|vetalmen|||0|1|0||Icepharma hf|Orion Corporation (I)|Benzylpenicillín sodíum||2436||2436|4788||2 011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|þpakki||N06AB06|01.10.2005||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|855|2468|lyfalmen|V0152|2289|2|28|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Sertralín||772||772|2468||1 011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.10.2005||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2836|4280|lyfalmen|V0323|3804|2|98|0|196,0000|Actavis Group hf|Actavis Group PTC ehf|Sertralín||2089||2089|4280||1 011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|MAR|0|0|0|100|DKK|3145|5734|lyfsjukr|||1|20|0||Icepharma hf|Aspen Pharma|Búpívakaín||3145||3145|5734||2 011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|MAR|0|0|0|100|DKK|1741|3801|lyfsjukr|||1|20|0||Icepharma hf|Aspen Pharma|Búpívakaín||1741||1741|3801||2 012030|J05AG0301|Stocrin|filmhtfl|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|21924|30800|lyfsjukr|||1|30|0|30,0000|Vistor hf|M.S.D.|Efavirenz||21924||21924|30800||1 012243|G04CB0201|Avodart|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.03.2012||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|2886|5377|lyfalmen|V0909|3447|1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Dútasteríð||2886||2886|5377||1 012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|5277|8668|lyfalmen|V0924|3221|1|4|0|4,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||5277||5277|8668||2 012278|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|3,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 012326|N06BA0402|Concerta|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|1|1|1|0|0|0|JAS|0|0|0|100|SEK|7141|8564|lyfalmen|V0622|4241|1|30|0|54,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||5201||5201|8564||1 012716|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|7,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|0|0|0|0|0|0|GPH|0|0|1|100|DKK|740|2423|lyfalmen|||1|80|0|4,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill ||740||740|2423||1 012921|G03AA1301|Evra|forðapl|||9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|3121|5701|lyfalmen|||1|9|0||Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og ethinylestradíól||3121||3121|5701||1 012953|G03BA0306|Testogel|hlaup|50|mg|30|skpokar|1|pakki||G03BA03|01.12.2003||R|0|0|0|0|G|0|LBI|0|0|0|100|DKK|4854|8086|lyfalmen|||1|30|0|30,0000|Icepharma hf|Laboratoires Besins International|Testósterón||4854||4854|8086||2 012966|N03AX1208|Gabapentin ratiopharm|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.03.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|1972|2439|lyfalmen|V0250|2031|2|100|0|16,6667|Alvogen|ratiopharm GmbH|Gabapentín||751||751|2439||2 012988|N03AX1208|Gabapentin ratiopharm|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.03.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|2587|2558|lyfalmen|V0251|2123|2|100|0|22,2200|Alvogen|ratiopharm GmbH|Gabapentín||838||838|2558||2 013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|5144|8485|lyfalmen|||1|30|0|20,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||5144||5144|8485||1 013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|7410|11604|lyfalmen|||1|30|0|40,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||7410||7410|11604||1 013172|J06BB0101|Rhophylac|stl|300|mcg|2|ml|1|áfspr||J06BB01|01.02.2004||R|0|0|0|0|0|1|CSB|0|0|0|100|SEK|4679|7845|lyfsjukr|||1|2|0||Icepharma hf|CSL Behring GmbH|And-D(rh) immúnóglóbúlín||4679||4679|7845||2 013302|C02CA0405|Cardosin Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.09.2009||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|1670|3704|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Doxazósín||1670||1670|3704||1 013347|L01XE0201|Iressa|töflur|250|mg|30|stk|1|þpakki||L01XE02|01.03.2010||R|0|0|0|1|0|1|AZD|0|1|0|100|SEK|243714|269981|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca A/S DK|Gefitiníb||212165||212165|269981||1 013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|990|2768|lyfalmen|||1|5|0|1,6700|Icepharma hf|Norpharma|Oxýcódon||990||990|2768||2 013615|M01AE0113|Ibuxin|filmhtfl|400|mg|100|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|RHA|0|0|1|100|XEU|593|2169|lyfalmen|V0562|1954|2|100|0|33,3300|Alvogen|ratiopharm Oy|Íbúprófen||555||555|2169||2 013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|1903|4024|lyfalmen|||1|10|0|3,3300|Icepharma hf|Norpharma|Oxýcódon||1903||1903|4024||2 013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|291|1805|lyfalmen|||1|30|0||Icepharma hf|Aspen Pharma|Lídókaín||291||291|1805||2 013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4790|7998|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||4790||4790|7998||1 013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|1888|4004|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||1888||1888|4004||1 013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|3599|6359|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||3599||3599|6359||1 013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.06.2012||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|144333|185617|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||144333||144333|185617||1 013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.05.2004||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|262700|332832|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||262700||262700|332832||1 014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|1867|3975|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||1867||1867|3975||1 014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|5348|8766|lyfsjukr|||1|50|0|13,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5348||5348|8766||1 014081|N03AX1401|Keppra|mixtúra|100|mg/ml|300|ml|1|glas||N03AX14|01.12.2006||R|0|0|0|0|G|0|UCB|0|0|0|100|DKK|14115|20833|lyfalmen|||1|300|0|20,0000|Vistor hf|U.C.B|Levetíracetam||14115||14115|20833||1 014094|H05AA0202|Forsteo|stl|250|mcg/ml|2,4|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|43979|58695|lyfalmen|||1|2,4|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Teriparatíð||43979||43979|58695||2 014147|J01CA0417|Amoxicillin Sandoz|mixtduft|100|mg/ml|60|ml|1|glas||J01CA04|01.08.2015||R|0|0|0|0|0|0|SHS|0|0|1|100|DKK|1245|2843|lyfalmen|V0479|2644|2|60|0|6,0000|Artasan ehf|Sandoz A/S|Amoxicillín||1045||1045|2843||1 014158|J01CA0417|Amoxicillin Sandoz|mixtduft|100|mg/ml|100|ml|1|glas||J01CA04|01.08.2015||R|0|0|0|0|0|0|SHS|0|0|1|100|DKK|1584|3585|lyfalmen|||2|100|0|10,0000|Artasan ehf|Sandoz A/S|Amoxicillín||1584||1584|3585||1 014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|skammtar|3|innö.t|320+9 mcg/sk|R03AK07|01.08.2009||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|13922|20567|lyfalmen|||1|180|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||13922||13922|20567||1 014365|M01AE0113|Ibuxin|filmhtfl|600|mg|30|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|RHA|0|0|1|100|XEU|285|1679|lyfalmen|V0563|1679|2|30|0|15,0000|Alvogen|ratiopharm Oy|Íbúprófen||199||199|1679||2 014435|QM01AE0303|Dolovet vet.|duft|2,4|g|15|g|3|pokar||QM01AE03|01.06.2009||R|0|0|0|0|0|0|VET|0|0|0|100|XEU|1971|3874|vetalmen|||0|45|0||Dýraheilsa ehf|Vetcare Ltd.|Ketóprófen||1971||1971|3874||2 014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|0|0|0|1|0|1|GEI|0|0|0|100|DKK|64363|84477|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland|Adefovír||||64363|84477||2 014597|M01AE0113|Ibuxin|filmhtfl|600|mg|100|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|RHA|0|0|1|100|XEU|720|2053|lyfalmen|V0564|2053|2|100|0|50,0000|Alvogen|ratiopharm Oy|Íbúprófen||471||471|2053||2 014679|N02AA0501|Oxycontin|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.12.2005||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|730|2410|lyfalmen|V0596|2057|1|28|0|1,8600|Icepharma hf|Norpharma |Oxýcódon||730||730|2410||2 014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|20599|29124|lyfalmen|||1|60|0|10,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||20599||20599|29124||1 014852|A06AD6502|Movicol|mixtduft|13,8|g|20|pokar|1|pakki|lausn|A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||||1 014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|53378|70583|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||53378||53378|70583||1 014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|35771|48313|lyfalmen|||1|60|0|20,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||35771||35771|48313||1 014889|A16AA0501|Carbaglu|dreifit.|200|mg|60|stk|1|glas||A16AA05|01.12.2016||R|0|0|0|1|0|0|OEU|0|0|0|100|XEU|563070|706408|lyfalmen|||1|60|0|60,0000|Orphan Europe S.a.r.l.|Orphan Europe S.a.r.l.|Carglumicsýra||563070||563070|706408||3 015072|V04CX0005|Hexvix|stofn|85|mg|1|hgl|1|pakki|og leysir|V04CX|01.08.2016||R|0|0|0|0|0|1|CUR|0|0|0|100|XEU|58582|77165|lyfsjukr|||0|1|0||PhotoCure ASA|PhotoCure ASA|Önnur sjúkdómsgreiningarefni||||58582|77165||0 015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2048|4061|lyfalmen|V0673|3057|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1930||1930|4061||1 015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|6228|9977|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||6228||6228|9977||1 015419|G03CA0316|Vivelle Dot|forðapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|0|0|0|0|G|0|NAA|0|0|0|100|DKK|848|2572|lyfalmen|||1|8|0|14,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||848||848|2572||1 015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|þpakki||N02CC01|01.10.2005||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|1414|2510|lyfalmen|V0234|1478|1|6|0|12,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||803||803|2510||1 015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|þpakki||N02CC01|01.10.2005||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|2019|2510|lyfalmen|V0233|1946|1|12|0|12,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||803||803|2510||1 015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|7315|11473|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||7315||7315|11473||1 015532|L01CX0101|Yondelis|irþ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|0|0|1|PAM|0|0|0|100|DKK|247442|313856|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabectedín||247442||247442|313856||3 015598|L01CX0101|Yondelis|irþ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|0|0|1|PAM|0|0|0|100|DKK|70264|91940|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabectedín||||70264|91940||3 015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|3976|6877|lyfalmen|||1|30|0|3,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||3976||3976|6877||1 015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|10511|15872|lyfalmen|||1|100|0|11,1100|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||10511||10511|15872||1 015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|4006|6919|lyfalmen|||1|30|0|10,0000|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||4006||4006|6919||1 015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|11074|16647|lyfalmen|V0900|14682|1|100|0|33,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||11074||11074|16647||1 015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|4006|6919|lyfalmen|||1|30|0|6,6700|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||4006||4006|6919||1 015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|9675|14722|lyfalmen|V0829|12671|1|100|0|22,2200|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||9675||9675|14722||1 015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008|30.06.2018|R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|54354|71817|lyfsjukr|||1|60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||54354||54354|71817||1 015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|0|1|0|1|G|0|HES|0|0|0|100|DKK|17124|24974|lyfalmen|||1|120|0|10,8000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||17124||17124|24974||1 015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|0|1|0|1|G|0|HES|0|0|0|100|DKK|34249|46388|lyfalmen|||1|120|0|21,6000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||34249||34249|46388||1 015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3075|5300|vetorma|||0|2,4|0||Icepharma hf|Bayer Animal Health GmbH|||3075||3075|5300||2 015855|QP54AB5206|Advocate yfirstærðar hundar|bl.lausn|125|mg|4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4727|8147|vetorma|||0|12|0||Icepharma hf|Bayer Animal Health GmbH|||4727||4727|8147||2 015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2557|4407|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|||2557||2557|4407||2 015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2595|4473|vetorma|||0|3|0||Icepharma hf|Bayer Animal Health GmbH|||2595||2595|4473||2 015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4538|7822|vetorma|||0|7,5|0||Icepharma hf|Bayer Animal Health GmbH|||4538||4538|7822||2 015910|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|100|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RHA|0|0|1|100|IKR|||lyflausa|||0|100|0||Alvogen|ratiopharm Oy|Ketókónazól|||||||2 015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1137|2970|lyfalmen|||2|10|0|3,3300|Icepharma hf|Martindale Pharmaceuticals|Morfín||1137||1137|2970||2 015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2495|4300|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|||2495||2495|4300||2 015956|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|60|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RHA|0|0|1|100|IKR|||lyflausa|||0|60|0||Alvogen|ratiopharm Oy|Ketókónazól|||||||2 015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|þpakki||N06AB05|01.12.2006||R|1|0|0|0|0|0|GPH|0|0|0|100|DKK|1298|3191|lyfalmen|||1|28|0|14,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Paroxetín||1298||1298|3191||1 016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|845|2568|lyfalmen|||2|10|0|1,2500|Icepharma hf|Martindale Pharmaceuticals|Petidín||845||845|2568||2 016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|895|2637|lyfalmen|||2|20|0|2,5000|Icepharma hf|Martindale Pharmaceuticals|Petidín||895||895|2637||2 016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|2129|4335|lyfalmen|||1|14|0|7,0000|Icepharma hf|Pfizer ApS|Pregabalín||2129||2129|4335||1 016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|5310|8714|lyfalmen|V0686|2083|1|56|0|14,0000|Icepharma hf|Pfizer ApS|Pregabalín||5310||5310|8714||1 016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|8048|12482|lyfalmen|V0687|2849|1|56|0|28,0000|Icepharma hf|Pfizer ApS|Pregabalín||8048||8048|12482||1 016317|C03CA0110|Impugan|töflur|40|mg|1000|stk|1|glas||C03CA01|01.01.2016||R|2|0|0|0|G|0|GRP|0|0|0|100|XEU|3992|6900|lyfalmen|||2|1000|0|1000,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Fúrósemíð||3992||3992|6900||1 016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|1406|3340|lyfalmen|||1|14|0|3,5000|Icepharma hf|Pfizer ApS|Pregabalín||1406||1406|3340||1 016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|11354|17033|lyfalmen|V0689|3498|1|56|0|56,0000|Icepharma hf|Pfizer ApS|Pregabalín||11354||11354|17033||1 016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|0|1|0|0|0|1|PHH|0|0|0|100|DKK|74950|97867|lyfsjukr|||1|70|0|7,0000|Icepharma hf|Pfizer Limited|Voricónazól||74950||74950|97867||1 016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|2932|5441|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Cýtarabín||2932||2932|5441||1 016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2007||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|2066|4249|lyfalmen|V0685|1500|1|56|0|4,6667|Icepharma hf|Pfizer ApS|Pregabalín||2066||2066|4249||1 016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016527|J01CE0206|Apocillin|mixt.kyr|50|mg/ml|200|ml|1|glerfl||J01CE02|01.06.2015||R|0|0|0|0|0|0|GRP|0|0|1|100|XEU|1023|2813|lyfalmen|||2|200|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Fenoxýmetýlpenicillín||1023||1023|2813||1 016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.02.2006||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|12860|19105|lyfalmen|V0690|6032|1|28|0|9,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||12860||12860|19105||1 016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016622|A06AG1101|Microlax|innhl|||5|ml|50|túpa||A06AG11|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|250|0|50,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||6745||1 016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.02.2006||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|24569|34145|lyfalmen|V0682|3787|1|56|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||24569||24569|34145||1 016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|0|0|0|0|0|0|LDD|0|0|1|100|XEU|1418|2180|lyfalmen|||2|12|0|10,5000|Actavis Group hf|LEK Pharmaceuticals d.d|Amoxicillín og beta-laktamasa hemill ||563||563|2180||1 016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|5849|9455|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||5849||5849|9455||1 016736|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|G|0|LVR|0|0|0|100|DKK|2389|4693|lyfalmen|V0240|4693|3|200|0|40,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||2389||2389|4693||3 016772|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|G|0|LVR|0|0|0|100|DKK|4410|7475|lyfalmen|V0433|7475|3|200|0|80,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||4410||4410|7475||3 016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|40076|53758|lyfalmen|V0721|11071|1|28|0|28,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||40076||40076|53758||1 016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|59042|77747|lyfalmen|V0722|18969|1|28|0|42,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||59042||59042|77747||1 016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|21951|30834|lyfalmen|V0720|9432|1|28|0|14,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||21951||21951|30834||1 016930|A16AB0401|Fabrazyme|irþ|5|mg/ml|5|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|0|0|1|GEB|0|1|0|100|XEU|57988|68907|lyfsjukr|||1|5|0|1,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||52053||52053|68907||1 016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|þpakki||A02BC03|01.11.2009||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|1392|3321|lyfalmen|||1|56|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||||1392|3321||1 016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|1|0|0|1|0|1|GEI|0|0|0|100|DKK|30859|41710|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland|Emtrícítabín||30550||30550|41710||2 016979|N02AE0103|Norspan|forðapl|5|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|MUP|0|0|0|100|DKK|2408|4719|lyfalmen|V0943|2644|1|4|0|2,8000|Icepharma hf|Mundipharma A/S|Búprenorfín||2408||2408|4719||2 017020|G03AC0601|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03AC06|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|1195|3050|lyfalmen|||1|3|0|89,8204|Icepharma hf|Pfizer ApS|Medroxýprógesterón||1195||1195|3050||1 017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|0|0|0|0|0|1|SKY|0|1|0|100|DKK|206266|262644|lyfsjukr|||1|5|0||Icepharma hf|SkyPharma PLC|Cýtarabín||206266||206266|262644||2 017182|N05CF0106|Zopiclone Actavis|filmhtfl|5|mg|500|stk|1|plglas||N05CF01|01.10.2012||R|2|0|0|0|0|0|GRP|0|0|0|100|XEU|5337|8751|lyfalmen|||2|500|0|333,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zópíklón||5337||5337|8751||1 017193|N05CF0106|Zopiclone Actavis|filmhtfl|7,5|mg|500|stk|1|glas||N05CF01|01.05.2013||R|2|0|0|0|0|0|GRP|0|0|0|100|SEK|5527|9012|lyfalmen|||2|500|0|500,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zópíklón||5527||5527|9012||1 017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|83371|108518|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||83371||83371|108518||2 017266|N02AE0103|Norspan|forðapl|10|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|MUP|0|0|0|100|DKK|4379|7432|lyfalmen|V0944|3401|1|4|0|5,6000|Icepharma hf|Mundipharma A/S|Búprenorfín||4379||4379|7432||2 017326|N02AE0103|Norspan|forðapl|20|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|MUP|0|0|0|100|DKK|7961|12362|lyfalmen|V0945|5259|1|4|0|11,2000|Icepharma hf|Mundipharma A/S|Búprenorfín||7961||7961|12362||2 017331|A04AD1201|Emend|hylki|||3|stk|1|þpakki|samsett pakkning|A04AD12|01.04.2004||R|1|0|0|0|0|1|MSD|0|0|0|100|DKK|6805|10771|lyfsjukr|||1|3|0|3,0000|Vistor hf|M.S.D.|Aprepitant||6805||6805|10771||1 017365|J01CR0201|Amoksiklav|filmhtfl|375|mg|20|stk|1|þpakki|250+125 mg|J01CR02|01.12.2003||R|0|0|0|0|0|0|LDD|0|0|1|100|XEU|919|2670|lyfalmen|||2|20|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d|Amoxicillín og beta-laktamasa hemill ||919||919|2670||1 017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|1|0|0|0|G|0|MEA|0|0|1|100|DKK|2117|4319|lyfalmen|||1|30|0|150,0000|Icepharma hf|Meda AB|Prednisón||2117||2117|4319||2 017556|J01CR0201|Amoksiklav|filmhtfl|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.12.2003||R|0|0|0|0|0|0|LDD|0|0|1|100|XEU|1063|2788|lyfalmen|V0168|2428|2|20|0|10,0000|Actavis Group hf|LEK Pharmaceuticals d.d|Amoxicillín og beta-laktamasa hemill ||1005||1005|2788||1 017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|5236|10104|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|Meloxícam||5236||5236|10104||1 017668|J02AC0107|Fluconazol Krka|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|0|KRK|0|0|1|100|IKR|1500|2093|lyfalmen|V0556|1763|2|4|0|3,0000|LYFIS ehf|Krka Sverige AB|Flúkónazól||500||500|2093||2 017701|J02AC0107|Fluconazol Krka|hylki|150|mg|6|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|0|KRK|0|0|1|100|IKR|2300|2644|lyfalmen|V0556|2644|2|6|0|4,5000|LYFIS ehf|Krka Sverige AB|Flúkónazól||900||900|2644||2 017712|J02AC0107|Fluconazol Krka|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|0|KRK|0|0|1|100|IKR|1271|2024|lyfalmen|V0551|2024|2|7|0|1,7500|LYFIS ehf|Krka Sverige AB|Flúkónazól||450||450|2024||2 017745|J02AC0107|Fluconazol Krka|hylki|50|mg|28|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|0|KRK|0|0|1|100|IKR|3500|3332|lyfalmen|V0552|3251|2|28|0|7,0000|LYFIS ehf|Krka Sverige AB|Flúkónazól||1400||1400|3332||2 017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|6937|10953|lyfalmen|V0107|2724|1|30|0|15,0000|Icepharma hf|Pfizer ApS|Eplerenón||6937||6937|10953||1 018420|C07AG0207|Carvedilol STADA|töflur|6,25|mg|100|stk|1|þpakki||C07AG02|01.03.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|1544|2506|lyfalmen|V0946|2506|2|100|0|16,6700|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||800||800|2506||2 018431|C07AG0207|Carvedilol STADA|töflur|12,5|mg|100|stk|1|þpakki||C07AG02|01.03.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|2300|3332|lyfalmen|V0947|3332|2|100|0|33,3300|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||1400||1400|3332||2 018442|C07AG0207|Carvedilol STADA|töflur|25|mg|100|stk|1|pakki||C07AG02|01.03.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|2975|3882|lyfalmen|V0948|3882|0|100|0|66,6666|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||1800||1800|3882||2 018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.11.2004||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|774|2056|lyfalmen|V0243|1874|1|42|0|3,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||473||473|2056||1 018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|5684|9228|lyfalmen|||1|30|0|60,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||5684||5684|9228||1 018663|J01DD0401|Rocephalin|sts|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|10694|16124|lyfsjukr|||1|5|0|2,5000|Icepharma hf|Roche|Ceftríaxón||10694||10694|16124||2 018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|14451|21295|lyfalmen|V0441|17890|1|90|0|180,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||14451||14451|21295||1 018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|þpakki||H02AB06|01.06.2004||R|1|0|0|0|G|0|MKA|0|0|1|100|SEK|646|2294|lyfalmen|V0414|2294|1|100|0|50,0000|Icepharma hf|Merck KgaA|Prednisólón||646||646|2294||2 018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|4578|7706|lyfalmen|V0438|6423|1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||4578||4578|7706||1 018689|J01EA0108|Idotrim|filmhtfl|100|mg|100|stk|1|glas||J01EA01|01.08.2015||R|1|0|0|0|0|0|COR|0|0|1|100|DKK|853|2579|lyfalmen|||2|100|0|25,0000|Vistor hf|Orion Corporation|Trímetóprím||853||853|2579||1 018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|11898|17781|lyfalmen|V0440|14923|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||11898||11898|17781||1 018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|25014|34708|lyfalmen|V0111|8211|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Eplerenón||25014||25014|34708||1 018718|L03AX0302|BCG-medac|duft|||3|hgl|1|pakki|+ leysir|L03AX03|01.01.2016||R|0|0|0|0|0|1|WIL|0|0|0|100|XEU|40087|53772|lyfsjukr|||1|3|0|21,0000|Williams & Halls efh|medac Gesellschaft|BCG bóluefni||40087||40087|53772||2 018726|J06BA0209|Nanogam|irl|50|mg/ml|20|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|6998|11037|lyfsjukr|||1|20|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||6998||6998|11037||2 018770|J01EA0108|Idotrim|filmhtfl|160|mg|14|stk|1|glas||J01EA01|01.08.2015||R|1|0|0|0|0|0|COR|0|0|1|100|DKK|239|1734|lyfalmen|||2|14|0|5,6000|Vistor hf|Orion Corporation|Trímetóprím||239||239|1734||1 018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|0|0|0|1|0|1|TEI|0|0|0|100|NOK|69317|90742|lyfsjukr|||1|28|0|28,0000|Actavis Pharmaceuticals Iceland ehf.|Teva Pharmaceuticals Limited|Glatíramer acetat||69317||69317|90742||1 018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|1|0|0|1|0|1|VIH|0|0|0|100|DKK|43883|58573|lyfsjukr|||1|60|0|30,0000|Vistor hf|Viiv Healthcare UK Ltd|Fosamprenavír||43883||43883|58573||1 018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|NOK|817|1606|vetalmen|||0|100|0||Icepharma hf|Kela Laboratoria NV|||817||817|1606||2 018995|N02AB0301|Durogesic|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|4159|7129|lyfalmen|V0221|6989|1|5|0|22,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||4159||4159|7129||1 019066|V08AB0201|Omnipaque|stl|140|mg J/ml|50|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|4935|8197|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||4935||4935|8197||2 019094|N02AB0301|Durogesic|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|3010|5548|lyfalmen|V0220|5180|1|5|0|15,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||3010||3010|5548||1 019098|J06BA0209|Nanogam|irl|50|mg/ml|400|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|139956|180173|lyfsjukr|||1|400|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||139956||139956|180173||2 019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|15003|22055|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||15003||15003|22055||2 019108|N02AB0301|Durogesic|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|1657|3686|lyfalmen|V0219|3672|1|5|0|7,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||1657||1657|3686||1 019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|17943|26102|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||17943||17943|26102||2 019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|16134|23612|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||16134||16134|23612||2 019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|21712|30532|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||21712||21712|30532||2 019150|J06BA0209|Nanogam|irl|50|mg/ml|200|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|69978|91578|lyfsjukr|||1|200|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||69978||69978|91578||2 019167|N02AB0301|Durogesic|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|5111|8440|lyfalmen|V0223|7458|1|5|0|30,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||5111||5111|8440||1 019175|C09CA0601|Atacand|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|7958|12358|lyfalmen|V0215|8649|1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||7958||7958|12358||1 019214|J06BA0209|Nanogam|irl|50|mg/ml|100|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|34989|47324|lyfsjukr|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||34989||34989|47324||2 019221|J06BA0209|Nanogam|irl|50|mg/ml|50|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|17495|25485|lyfsjukr|||1|50|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||17495||17495|25485||2 019308|QG03XB9001|Alizin, vet|stl|30|mg/ml|10|ml|1|hgl|fyrir hunda (tíkur)|QG03XB90|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|3822|7422|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Aglepristonum||3822||3822|7422||1 019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006|31.07.2018|L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 019372|C03CA0110|Impugan|töflur|20|mg|100|stk|1|glas||C03CA01|01.02.2014||R|1|0|0|0|G|0|GRP|0|0|0|100|SEK|286|1761|lyfalmen|V0633|1761|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Fúrósemíð||259||259|1761||1 019403|QJ51CE0901|Carepen vet.|spenalyf|600|mg|10|g|100|dælur||QJ51CE09|01.04.2010||R|0|0|0|0|0|0|CAR|0|0|0|100|DKK|25490|48530|vetalmen|||0|1000|0||Vistor hf|Vetcare Ltd.|Benzylpenicillínprokaín||25490||25490|48530||1 019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|5339|8754|lyfalmen|||1|56|0|18,6700|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||5339||5339|8754||2 019445|L01XC0701|Avastin|irþ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|0|0|1|RRG|0|1|0|100|DKK|39526|53063|lyfsjukr|||1|4|0||Icepharma hf|Roche Registration GmbH|Bevacizúmab||39526||39526|53063||2 019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|5339|8754|lyfalmen|||1|56|0|37,3300|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||5339||5339|8754||2 019621|C09AA0504|Ramipril ratiopharm|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.06.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|829|2370|lyfalmen|V0496|2359|2|100|0|200,0000|Alvogen|ratiopharm GmbH|Ramipríl||701||701|2370||2 019669|C09AA0504|Ramipril ratiopharm|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.06.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|766|2317|lyfalmen|V0648|2306|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Ramipríl||663||663|2317||2 019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006|31.07.2018|L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 019682|C09AA0504|Ramipril ratiopharm|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.06.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|1160|2781|lyfalmen|V0649|2781|2|100|0|400,0000|Alvogen|ratiopharm GmbH|Ramipríl||1000||1000|2781||2 019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.01.2005|31.07.2018|L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 019781|L01XC0701|Avastin|irþ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|0|0|1|RRG|0|1|0|100|DKK|145712|187332|lyfsjukr|||1|16|0||Icepharma hf|Roche Registration GmbH|Bevacizúmab||145712||145712|187332||2 019786|J01CA0411|Amoxicillin Mylan|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|743|2203|lyfalmen|V0159|2066|2|20|0|10,0000|Icepharma hf|Mylan AB|Amoxicillín||580||580|2203||2 019797|L01BA0401|Alimta|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|0|0|0|0|0|1|NED|0|1|0|100|XEU|132791|171262|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||132791||132791|171262||2 019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|0|DAN|0|0|0|100|XEU|10077|15275|lyfalmen|V0812|5218|1|28|0|3,5000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||10077||10077|15275||2 019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|0|DAN|0|0|0|100|XEU|10077|15275|lyfalmen|V0813|5218|1|28|0|6,3000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||10077||10077|15275||2 019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|0|DAN|0|0|0|100|XEU|10077|15275|lyfalmen|V0814|5218|1|28|0|8,7500|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||10077||10077|15275||2 019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|0|DAN|0|0|0|100|XEU|10077|15275|lyfalmen|V0815|5218|1|28|0|14,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||10077||10077|15275||2 019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|0|DAN|0|0|0|100|XEU|10077|15275|lyfalmen|V0816|5218|1|28|0|21,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||10077||10077|15275||2 019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|þpakki||N04BC04|01.12.2006||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|255|1756|lyfalmen|||1|12|0|0,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||||255|1756||1 019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|þpakki|600+300 mg|J05AR02|01.05.2004||R|0|1|0|1|0|1|RGO|0|0|0|100|DKK|47901|63655|lyfsjukr|||1|30|0|30,0000|Vistor hf|Glaxo Group Limited|Lamívúdín og abacavír||47901||47901|63655||1 019966|N06AB0405|Citalopram PCD|filmhtfl|10|mg|100|stk|1|þpakki||N06AB04|01.04.2018||R|1|0|0|0|G|0|PDA|0|0|0|100|IKR|1600|2781|lyfalmen|V0317|2781|2|100|0|50,0000|LYFIS ehf|PharmaCoDane ApS|Cítalópram||1000||1000|2781||2 019968|J01CA0411|Amoxicillin Mylan|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|922|2495|lyfalmen|V0160|2368|2|30|0|15,0000|Icepharma hf|Mylan AB|Amoxicillín||792||792|2495||2 019969|N06AB0405|Citalopram PCD|filmhtfl|20|mg|100|stk|1|þpakki||N06AB04|01.04.2018||R|1|0|0|0|G|0|PDA|0|0|0|100|IKR|2600|3470|lyfalmen|V0318|3470|2|100|0|100,0000|LYFIS ehf|PharmaCoDane ApS|Cítalópram||1500||1500|3470||2 020011|N06AB0405|Citalopram PCD|filmhtfl|40|mg|100|stk|1|þpakki||N06AB04|01.04.2018||R|1|0|0|0|G|0|PDA|0|0|0|100|IKR|4500|2781|lyfalmen|V0320|2781|2|100|0|200,0000|LYFIS ehf|PharmaCoDane ApS|Cítalópram||1000||1000|2781||2 020016|B03AA0704|Duroferon|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|1|0|0|0|0|0|AHN|0|0|1|100|IKR|||lyflausa|||0|100|0|50,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Ferrósúlfat|||||||1 020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|100|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 020156|C08DB0109|Dilmin|töflur|60|mg|100|stk|1|þpakki||C08DB01|01.09.2013||R|0|0|0|0|G|0|RTH|0|0|0|100|XEU|2187|4415|lyfalmen|||2|100|0|25,0000|Alvogen|ratiopharm GmbH|Diltíazem||2187||2187|4415||2 020227|J07CA0204|Boostrix Polio|stl|||0,5|ml|1|áf.spr|dreifa|J07CA02|01.09.2014||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|3059|5615|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Barnaveiki, kíghósti, mænusótt, stífkrampi||3059||3059|5615||1 020244|J07CA0204|Boostrix Polio|stl|||0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|24721|34337|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Pharma A/S|barnaveiki, kíghósti, mænusótt, stífkrampi||24721||24721|34337||1 020276|A06AB0203|Dulcolax (Lyfjaver)|eþ-stíll|10|mg|50|stk|1|þpakki||A06AB02|01.07.2005||R|0|0|0|0|0|0|LVR|0|0|0|100|NOK|1737|3796|lyfalmen|||3|50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||1737||1737|3796||3 020282|L01XX2301|Lysodren|töflur|500|mg|100|stk|1|glas||L01XX23|01.04.2015||R|0|0|0|1|0|1|LHR|0|0|0|100|XEU|75979|99168|lyfsjukr|||1|100|0||Laboratoire HRA Pharma|Laboratoire HRA Pharma|Mitotanum||75979||75979|99168||0 020292|M02AA1502|Voltaren|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.06.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|50|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|39643|53211|lyfalmen|||1|2|0|155,7500|Vistor hf|Astellas Pharma A/S|Leuprórelín||39643||39643|53211||1 020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|þpakki||N04BC04|01.06.2006||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|2735|3885|lyfalmen|||1|84|0|7,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||1802||1802|3885||1 020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|þpakki||N04BC04|01.12.2006||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|5195|4412|lyfalmen|||1|84|0|28,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||2185||2185|4412||1 020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|18431|26773|lyfalmen|||1|2|0|51,9400|Vistor hf|Astellas Pharma A/S|Leuprórelín||18431||18431|26773||1 020685|C08DB0109|Dilmin|forðatfl|120|mg|100|stk|1|þpakki||C08DB01|01.09.2013||R|0|0|0|0|G|0|RTH|0|0|0|100|XEU|5134|3475|lyfalmen|V0599|3475|2|100|0|50,0000|Alvogen|ratiopharm GmbH|Diltíazem||1504||1504|3475||2 020770|QP54AA5101|Eqvalan Duo|pasta|||7,74|g|1|sk-dæl||QP54AA51|01.10.2006||R|0|0|0|0|0|0|MES|0|0|0|100|XEU|1735|2990|vetorma|||0|7,74|0||Vistor hf|Merial SAS|Ivermectinum í blöndum||1735||1735|2990||1 020845|N07XX0401|Xyrem|mixtúra|500|mg/ml|180|ml|1|glas|millist., mælispr. + 2 bollar|N07XX04|01.02.2016||R|0|1|1|1|0|0|UCC|0|0|0|100|DKK|46508|61894|lyfalmen|||1|180|0||Vistor hf|UCB Pharma S.A.|sodium oxybate||||46508|61894||1 020861|QP52AF0203|Nematel Vet.|pasta|439|mg/g|52|g|1|spr||QP52AF02|01.08.2011||R|0|0|0|0|0|0|VEB|0|0|0|100|XEU|2029|3497|vetorma|||0|52|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||2029||2029|3497||2 020924|J01FA1003|Zithromax (Lyf og heilsa)|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.09.2007||R|1|0|0|0|0|0|DAC|0|0|1|100|DKK|1341|3251|lyfalmen|V0174|2506|3|3|0|5,0000|D.A.C. ehf|D.A.C. ehf|Azitrómýcín||1341||1341|3251||2 020992|C09AA0402|Coversyl Novum|filmhtfl|5|mg|30|stk|1|glas||C09AA04|01.08.2011||R|1|0|0|0|0|0|LLS|0|0|0|100|DKK|2144|4356|lyfalmen|||1|30|0|37,5000|Icepharma hf|Les Laboratoires Servier|Perindópríl||2144||2144|4356||2 021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|0|0|0|0|0|0|GAN|0|0|0|100|XEU|1780|3855|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen||1780||1780|3855||2 021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.03.2005||R|1|0|0|0|G|0|TCA|0|0|1|100|IKR|505|2100|lyfalmen|V0188|2100|2|30|0|15,0000|Actavis Group hf|Actavis hf|Díklófenak||505||505|2100||1 021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|0|0|0|0|G|0|HEG|0|0|0|100|XEU|1737|3796|lyfalmen|||1|10|0||Actavis Group hf|Gerhard Mann|Dexpantenól||||1737|3796||1 021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.2005||R|1|0|0|0|G|0|TCA|0|0|1|100|XEU|1103|2403|lyfalmen|V0189|2403|2|100|0|50,0000|Actavis Group hf|Actavis hf|Díklófenak||725||725|2403||1 021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|10921|16437|lyfalmen|V0490|2419|1|98|0|98,0000|Vistor hf|M.S.D.|Montelúkast||10921||10921|16437||1 021428|A06AB0201|Dulcolax|eþ-stíll|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|0|0|0|0|0|0|SNP|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Bisakódýl|||||||1 021465|A16AX0501|Wilzin|hylki|25|mg|250|stk|1|glas||A16AX05|01.10.2016||R|1|0|0|0|G|0|URE|0|0|0|100|XEU|25745|35633|lyfalmen|||1|250|0|41,6700|Orphan Europe Nordic AB|Orphan Europe|zinc acetate||25745||25745|35633||3 021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1233|3102|lyfsjukr|||2|100|0||Vistor hf|Fresenius Kabi AB|Própófól||1233||1233|3102||1 021589|A16AX0501|Wilzin|hylki|50|mg|250|stk|1|glas||A16AX05|01.10.2016||R|1|0|0|0|G|0|URE|0|0|0|100|XEU|47170|62731|lyfalmen|||1|250|0|83,3300|Orphan Europe Nordic AB|Orphan Europe|zinc acetate||47170||47170|62731||3 021593|H01BA0201|Minirin|frþ.tfl|60|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|3359|6028|lyfalmen|||1|30|0|4,5000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||3359||3359|6028||1 021604|H01BA0201|Minirin|frþ.tfl|60|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|10424|15753|lyfalmen|||1|100|0|15,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||10424||10424|15753||1 021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|þpakki||C10AA07|01.01.2006||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|9652|14690|lyfalmen|V0214|4452|1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||9652||9652|14690||1 021614|H01BA0201|Minirin|frþ.tfl|120|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|5541|9032|lyfalmen|||1|30|0|9,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||5541||5541|9032||1 021625|A07EC0203|Pentasa Sachet|forðakyr|2|g|60|pokar|1|pakki||A07EC02|01.05.2011||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|11774|17611|lyfalmen|||1|60|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||11774||11774|17611||1 021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|12326|18370|lyfsjukr|||2|1000|0||Vistor hf|Fresenius Kabi AB|Própófól||12326||12326|18370||1 021641|H01BA0201|Minirin|frþ.tfl|120|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|16054|23502|lyfalmen|||1|100|0|30,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||16054||16054|23502||1 021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|14175|20915|lyfsjukr|||2|500|0||Vistor hf|Fresenius Kabi AB|Própófól||14175||14175|20915||1 021659|V01AA0304|Alutard SQ, derm. pter.|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18973|27519|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||18973||18973|27519||1 021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|7087|11159|lyfsjukr|||2|500|0||Vistor hf|Fresenius Kabi AB|Própófól||7087||7087|11159||1 021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|3577|6328|lyfsjukr|||1|50|0|2,5000|Icepharma hf|Pfizer ApS|Tranexamsýra||3577||3577|6328||1 021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|15189|22311|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||15189||15189|22311||1 021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|2714|5140|lyfalmen|V0692|2275|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||2714||2714|5140||2 021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|4405|7468|lyfalmen|V0693|3110|1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||4405||4405|7468||2 021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|10911|16423|lyfalmen|V0694|5153|1|98|0|98,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||10911||10911|16423||2 021999|L01XX3501|Xagrid|hylki|0,5|mg|100|stk|1|glas|hart|L01XX35|01.10.2012||R|0|0|0|1|0|1|SHI|0|0|0|100|DKK|59945|78889|lyfsjukr|||1|100|0||Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Anagrelidum||59945||59945|78889||3 022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|0|1|0|1|0|1|RRG|0|1|0|100|DKK|64554|84718|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration GmbH|Erlótiníb||64554||64554|84718||2 022050|J01CF0202|Cloxacillin Villerton|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.03.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|XEU|2103|4299|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Villerton Invest SA|Kloxacillín||2103||2103|4299||2 022112|B05AA0112|Flexbumin|irl|200|g/líter|100|ml|12|pokar|lausn|B05AA01|01.06.2010||R|0|0|0|0|0|1|BAG|0|0|0|100|SEK|82532|107457|lyfsjukr|||1|1200|0||Shire Sweden AB |Baxalta Innovations GmbH|Albúmín||82532||82532|107457||2 022165|A10AB0606|Apidra [Clikstar]|stl|100|ein/ml|3|ml|5|lykjur|Clikstar/JuniorStar pennar|A10AB06|01.07.2010||R|0|0|0|0|G|0|SDH|0|0|0|100|XEU|3478|6192|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insúlín glúlisín||3478||3478|6192||1 022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|0|1|0|1|0|1|RRG|0|1|0|100|DKK|225511|286580|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration GmbH|Erlótiníb||225511||225511|286580||2 022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|0|1|0|1|0|1|RRG|0|1|0|100|DKK|234407|297644|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration GmbH|Erlótiníb||234407||234407|297644||2 022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|0|0|0|1|0|0|IRE|0|0|0|100|XEU|12597|18743|lyfalmen|||1|1|0||Actavis ehf|Allergan Pharmaceuticals Ireland|Clostridium botulinum toxín-A||12597||12597|18743||1 022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1770|3051|vetorma|||0|2,24|0||Icepharma hf|Bayer Animal Health GmbH|||1770||1770|3051||2 022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|2964|2769|lyfalmen|V0056|2320|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Amlódipín||991||991|2769||1 022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|5256|3559|lyfalmen|V0057|2320|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Amlódipín||1565||1565|3559||1 022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1676|2889|vetorma|||0|1,4|0||Icepharma hf|Bayer Animal Health GmbH|||1676||1676|2889||2 022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|1428|3370|lyfalmen|V0949|3370|1|100|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||1428||1428|3370||1 022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1085|1870|vetorma|||0|0,7|0||Icepharma hf|Bayer Animal Health GmbH|||1085||1085|1870||2 022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|1564|3463|lyfalmen|V0321|3463|2|100|0|100,0000|Actavis Group hf|Actavis hf|Paroxetín||1495||1495|3463||1 022757|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|60|sk-hyl||S01XA20|01.07.2012||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|30|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||5362||2 022783|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|10|áf.spr||B01AX05|01.10.2011||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|19317|27993|lyfalmen|||1|8|0|40,0000|Icepharma hf|Aspen Pharma Trading Limited|Fondaparinux||19317||19317|27993||2 022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|15|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||3574||2 022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|0|1|0|1|G|0|TCA|0|0|0|30|XEU|1429|3372|lyfalmen|||2|30|0|10,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1429||1429|3372||1 022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|0|1|0|1|G|0|TCA|0|0|0|30|XEU|2487|3767|lyfalmen|V0125|3767|2|30|0|20,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1716||1716|3767||1 023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|0|1|0|1|0|1|GEI|0|0|0|100|DKK|62449|82056|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland|Tenófóvír dísóproxíl og emtrícítabín||62449||62449|82056||2 023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SHI|0|0|0|100|DKK|20079|28466|lyfalmen|||1|90|0|20,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||20079||20079|28466||3 023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SHI|0|0|0|100|DKK|31349|42720|lyfalmen|||1|90|0|30,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||31349||31349|42720||3 023114|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.09.2014||R|0|1|0|1|G|0|RTH|0|0|0|30|IKR|3000|5534|lyfalmen|V0125|3767|2|30|0|20,0000|Alvogen|ratiopharm GmbH|Ísótretínóín||3000||3000|5534||2 023124|G04BD1001|Emselex|forðatfl|7,5|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|0|0|0|0|G|0|LUX|0|0|0|100|DKK|15259|22407|lyfalmen|||1|98|0|98,0000|POA Pharma Scandinavia AB|Merus Labs Luxco S.à R.L.|Darífenacín||15259||15259|22407||1 023125|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|60|stk|1|þpakki||D10BA01|01.09.2014||R|0|1|0|1|G|0|RTH|0|0|0|30|IKR|5231|8605|lyfalmen|V0125|7534|2|60|0|40,0000|Alvogen|ratiopharm GmbH|Ísótretínóín||5231||5231|8605||2 023154|N03AX1208|Gabapentin ratiopharm|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.01.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|13213|16132|lyfalmen|V0256|16132|2|100|0|44,4400|Alvogen|ratiopharm GmbH|Gabapentín||10700||10700|16132||2 023162|N03AX1208|Gabapentin ratiopharm|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.01.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|6514|9663|lyfalmen|V0254|9663|2|100|0|33,3300|Alvogen|ratiopharm GmbH|Gabapentín||6000||6000|9663||2 023193|G04BD1001|Emselex|forðatfl|15|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|0|0|0|0|G|0|LUX|0|0|0|100|DKK|16037|23478|lyfalmen|||1|98|0|196,0000|POA Pharma Scandinavia AB|Merus Labs Luxco S.à R.L.|Darífenacín||16037||16037|23478||1 023329|N03AX1206|Gabapentin Mylan|hylki|300|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1816|2608|lyfalmen|V0250|2031|2|100|0|16,6667|Icepharma hf|Mylan AB|Gabapentín||874||874|2608||2 023376|N03AX1206|Gabapentin Mylan|hylki|400|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2344|2935|lyfalmen|V0251|2123|2|100|0|22,2200|Icepharma hf|Mylan AB|Gabapentín||1112||1112|2935||2 023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.07.2007||R|1|0|0|0|G|0|SND|0|0|0|100|XEU|13447|19913|lyfalmen|V0029|5669|1|100|0|100,0000|Vistor hf|Sanofi Clir SNC|Klópídógrel||13447||13447|19913||1 023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1601|3609|lyfalmen|||1|12|0|30,0000|Icepharma hf|Santen Oy|Tímólól||1601||1601|3609||2 023608|N01AB0802|Sevofluran Baxter|innö.guf|100|%|250|ml|6|fl||N01AB08|01.04.2012||R|0|0|0|0|0|1|BAX|0|0|0|100|SEK|97780|126742|lyfsjukr|||2|1500|0||Icepharma hf|Baxter|Sevóflúran||97780||97780|126742||2 023641|C09AA0211|Enalapril Krka|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|900|2644|lyfalmen|V0066|2389|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||900||900|2644||2 023649|C09AA0211|Enalapril Krka|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1050|2850|lyfalmen|V0449|2737|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||1050||1050|2850||2 023738|C09AA0211|Enalapril Krka|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|536|2143|lyfalmen|V0448|2072|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||536||536|2143||2 023847|N06AX1106|Mirtazapin Krka|filmhtfl|45|mg|100|stk|1|þpakki||N06AX11|01.04.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|4049|6222|lyfalmen|||2|100|0|150,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||3500||3500|6222||2 023897|N06AX1106|Mirtazapin Krka|filmhtfl|30|mg|100|stk|1|þpakki||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2327|3057|lyfalmen|V0673|3057|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||1200||1200|3057||2 023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.08.2006||R|0|0|0|1|0|1|PHH|0|0|0|100|DKK|58034|76472|lyfsjukr|||1|90|0|36,0000|Icepharma hf|Pfizer Limited|Síldenafíl||58034||58034|76472||1 023993|A02BC0308|Lansoprazol Krka|sþ-hylki|30|mg|98|stk|1|ílát||A02BC03|01.08.2018||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|3500|6222|lyfalmen|V0007|6222|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Lansóprazól||3500||3500|6222||2 024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|2176|4400|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2176||2176|4400||1 024056|N02AB0301|Durogesic|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.02.2006||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|1647|3672|lyfalmen|V0222|3193|1|5|0|3,6000|Vistor hf|Janssen-Cilag AB|Fentanýl||1647||1647|3672||1 024112|A16AA0501|Carbaglu|dreifit.|200|mg|5|stk|1|glas||A16AA05|01.12.2016||R|0|0|0|1|0|0|OEU|0|0|0|100|XEU|48637|64586|lyfalmen|||1|5|0|5,0000|Orphan Europe S.a.r.l.|Orphan Europe S.a.r.l.|Carglumicsýra||48637||48637|64586||3 024198|C07AB0213|Metoprololsuccinat Hexal|forðatfl|50|mg|100|stk|1|plglas|47,5 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|1092|2667|lyfalmen|V0048|2300|2|100|0|31,6600|Artasan ehf|Hexal A/S|Metóprólól||917||917|2667||1 024231|C07AB0213|Metoprololsuccinat Hexal|forðatfl|100|mg|100|stk|1|plglas|95 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|1801|3527|lyfalmen|V0049|2919|2|100|0|63,3300|Artasan ehf|Hexal A/S|Metóprólól||1542||1542|3527||1 024253|C07AB0213|Metoprololsuccinat Hexal|forðatfl|200|mg|100|stk|1|plglas|190 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|3174|5472|lyfalmen|V0054|3607|2|100|0|126,6600|Artasan ehf|Hexal A/S|Metóprólól||2955||2955|5472||1 024276|N06AB0607|Sertralin Krka|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.07.2018||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|3264|3882|lyfalmen|V0323|3882|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Sertralín||1800||1800|3882||2 024366|N06AB0607|Sertralin Krka|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.07.2018||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1926|2506|lyfalmen|V0322|2506|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Sertralín||800||800|2506||2 024478|V04CL0016|Soluprick SQ ALK553 - hundahár|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|5973|9626|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||5973||5973|9626||1 024482|V04CL0017|Soluprick SQ ALK555 - kattahár|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|5973|9626|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||5973||5973|9626||1 024504|V04CL0003|Soluprick SQ ALK106 - Rauðölur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|10064|15257|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||10064||10064|15257||1 024526|V04CL0006|Soluprick SQ ALK113 - Hesliviður|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|10081|15280|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||10081||10081|15280||1 024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|4307|7333|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||4307||4307|7333||1 024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|0|1|0|1|0|0|OPH|0|0|0|100|DKK|42387|56681|lyfalmen|||1|100|0|1,2500|Artasan ehf|Novartis Europharm Ltd|Zoledronsýra||42387||42387|56681||1 024600|V04CL0013|Soluprick SQ ALK231 - Rúgur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|10184|15422|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||10184||10184|15422||1 024603|V04CL0001|Soluprick Negativ Kontrol|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1226|3092|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1226||1226|3092||1 024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|4307|7333|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||4307||4307|7333||1 024644|V04CL0015|Soluprick SQ ALK552 - Hrossaværur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|5973|9626|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||5973||5973|9626||1 024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|5973|9626|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||5973||5973|9626||1 024681|V04CL0002|Soluprick Positiv Kontrol|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1226|3092|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1226||1226|3092||1 024901|C07AB0212|Metoprolin|töflur|100|mg|100|stk|1|þpakki||C07AB02|01.01.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|1848|3949|lyfalmen|||2|100|0|66,6660|Alvogen|ratiopharm GmbH|Metóprólól||1848||1848|3949||2 025142|D07AB0202|Locoid Crelo|húðfl|1|mg/g|30|g|1|glas|á húð|D07AB02|01.04.1994||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|484|2071|lyfalmen|V0950|2071|1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||484||484|2071||1 025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|15189|22311|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||15189||15189|22311||1 025239|C07AB0212|Metoprolin|töflur|50|mg|100|stk|1|þpakki||C07AB02|01.01.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|1212|2093|lyfalmen|V0051|2093|2|100|0|33,3333|Alvogen|ratiopharm GmbH|Metóprólól||500||500|2093||2 025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|58088|76540|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||58088||58088|76540||1 025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|7527|14451|vetalmen|||0|20|0||Vistor hf|Boehringer Ingelheim|Meloxícam||7527||7527|14451||1 025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|12217|18220|lyfalmen|||1|30|0||Vistor hf|ALK-Abello A/S|grasfrjó||12217||12217|18220||1 025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|þpakki||M05BA06|01.01.2006||R|0|0|0|0|0|0|ATN|0|0|0|100|DKK|4122|7078|lyfalmen|V0205|1290|1|1|0|30,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Íbandrónsýra||4122||4122|7078||2 025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2006||R|0|0|0|0|0|0|ATN|0|0|0|100|DKK|11045|16607|lyfalmen|V0205|3869|1|3|0|90,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Íbandrónsýra||11045||11045|16607||2 025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|35324|47748|lyfalmen|||1|100|0||Vistor hf|ALK-Abello A/S|grasfrjó||35324||35324|47748||1 025747|C01BB0101|Xylocard 100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|0|0|0|0|0|1|MAR|0|0|0|100|DKK|5292|8689|lyfsjukr|||1|25|0|0,1667|Icepharma hf|Aspen Pharma|Lídókaín||5292||5292|8689||2 025841|V01AA1106|Alutard SQ, kattahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18973|27519|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||18973||18973|27519||1 025895|N02AA0505|Oxycodone ratiopharm|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RTH|0|0|0|100|XEU|790|2428|lyfalmen|V0597|2428|2|28|0|3,7300|Alvogen|ratiopharm GmbH|Oxýcódon||743||743|2428||2 025906|N02AA0505|Oxycodone ratiopharm|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RTH|0|0|0|100|XEU|2648|4569|lyfalmen|V0598|4569|2|98|0|13,0700|Alvogen|ratiopharm GmbH|Oxýcódon||2299||2299|4569||2 025917|L04AX0201|Thalidomide Celgene|hylki|50|mg|28|stk|1|þpakki|hart|L04AX02|01.09.2011||R|0|1|0|1|0|1|CEE|0|1|0|100|XEU|40572|54386|lyfsjukr|||1|28|0|14,0000|Celgene Europe ltd|Celgene Europe ltd|Thalidómíde||||40572|54386||2 025927|N06AX2601|Brintellix|filmhtfl|20|mg|98|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LUN|0|0|0|100|DKK|27276|37569|lyfalmen|||1|98|0|196,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||27276||27276|37569||1 025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|3054|5264|vetorma|||0|1|0||Vistor hf|Merial (MSD)|Ivermectinum||3054||3054|5264||1 025978|L03AX1302|Remurel|stl|20|mg/ml|28|áf.spr|1|pakki||L03AX13|01.07.2017||R|0|0|0|1|0|1|IPC|0|0|0|100|XEU|72302|76802|lyfsjukr|||2|28|0|28,0000|Alvogen|Alvogen IPco S.á.r.l.|Glatíramer acetat||58295||58295|76802||2 025997|A07DA0303|Immex|töflur|2|mg|20|stk|1|þpakki||A07DA03|01.09.2015||L|1|0|0|0|0|0|GOV|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Alvogen|Alvogen ehf|Lóperamíð|||||||2 026000|QS02CA0301|Easotic|eyrnadr|||10|ml|1|fl|dreifa|QS02CA03|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|1720|3380|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Hýdrókortisón,miconazol,gentamicin||1720||1720|3380||1 026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|7286|12558|vetorma|||0|2,5|0||Vistor hf|Merial (MSD)|Ivermectinum||7286||7286|12558||1 026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|15189|22311|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||15189||15189|22311||1 026101|L01CA0501|Javlor|irþ|25|mg/ml|2|ml|1|hgl|lausn|L01CA05|01.12.2010||R|0|0|0|0|0|1|PFM|0|0|0|100|DKK|33503|45445|lyfsjukr|||1|2|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||33503||33503|45445||1 026114|L01CA0501|Javlor|irþ|25|mg/ml|10|ml|1|hgl|lausn|L01CA05|01.12.2010||R|0|0|0|0|0|1|PFM|0|0|0|100|DKK|167515|214449|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||167515||167515|214449||1 026569|R02AA0305|Strepsils Cool|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 026571|N03AX1801|Vimpat|filmhtfl|50|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|1427|3369|lyfalmen|||1|14|0|2,3300|Vistor hf|U.C.B|Lacosamíð||||1427|3369||1 026582|N03AX1801|Vimpat|filmhtfl|50|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|5721|9279|lyfalmen|||1|56|0|9,3300|Vistor hf|U.C.B|Lacosamíð||||5721|9279||1 026593|N03AX1801|Vimpat|filmhtfl|100|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|2820|5286|lyfalmen|||1|14|0|4,6700|Vistor hf|U.C.B|Lacosamíð||||2820|5286||1 026605|N03AX1801|Vimpat|filmhtfl|100|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|11169|16778|lyfalmen|||1|56|0|18,6700|Vistor hf|U.C.B|Lacosamíð||||11169|16778||1 026627|N03AX1801|Vimpat|filmhtfl|150|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|16736|24440|lyfalmen|||1|56|0|28,0000|Vistor hf|U.C.B|Lacosamíð||||16736|24440||1 026638|N03AX1801|Vimpat|filmhtfl|200|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|22304|31280|lyfalmen|||1|56|0|37,3300|Vistor hf|U.C.B|Lacosamíð||||22304|31280||1 026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|0|MEA|0|0|1|100|DKK|1030|2823|lyfalmen|||2|100|0|25,0000|Icepharma hf|Meda AB|Nítrófúrantóín||1030||1030|2823||2 026692|L01XE2701|IMBRUVICA|filmhtfl|140|mg|120|stk|1|glas||L01XE27|01.02.2016||R|1|0|0|1|0|1|JCI|0|1|0|100|SEK|822466|1029024|lyfsjukr|||1|120|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||||822466|1029024||1 026698|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|14|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|0|RTH|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Alvogen|ratiopharm GmbH|Ómeprazól|||||||2 026943|C09CA0106|Losatrix|filmhtfl|100|mg|100|stk|1|þpakki||C09CA01|01.01.2014||R|1|0|0|0|0|0|RTH|0|0|0|100|IKR|4027|6948|lyfalmen|V0099|6948|2|100|0|200,0000|Alvogen|ratiopharm GmbH|Lósartan||4027||4027|6948||2 026946|J01CA0412|Amoxicillin Mylan (Lyf og heilsa)|hylki|500|mg|30|stk|1|glas||J01CA04|01.07.2011||R|0|0|0|0|0|0|HOL|0|0|1|100|SEK|795|2499|lyfalmen|V0160|2368|3|30|0|15,0000|Lyf og heilsa|Lyf og heilsa|Amoxicillín||795||795|2499||2 026957|J01CA0412|Amoxicillin Mylan (Lyf og heilsa)|hylki|500|mg|20|stk|1|glas||J01CA04|01.05.2011||R|0|0|0|0|0|0|DAC|0|0|1|100|SEK|550|2162|lyfalmen|V0159|2066|3|20|0|10,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||550||550|2162||2 027017|N06BA0202|Attentin|töflur|5|mg|30|stk|1|þpakki||N06BA02|01.08.2017||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|4622|7767|lyfalmen|||1|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Dexamfetamine ||||4622|7767||2 027051|A10BK0301|Jardiance|filmhtfl|10|mg|90|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|16151|23635|lyfalmen|||1|90|0|51,4300|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||16151||16151|23635||1 027058|N06AX1106|Mirtazapin Krka|filmhtfl|15|mg|100|stk|1|þpakki||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2043|2988|lyfalmen|V0823|2988|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||1150||1150|2988||2 027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|0|MEA|0|0|1|100|DKK|582|2206|lyfalmen|||2|50|0|1,2500|Icepharma hf|Meda AB|Nítrófúrantóín||582||582|2206|| 027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|1705|3752|lyfalmen|||1|5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Tímólól í blöndum||1705||1705|3752||1 027281|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|10700|6766|lyfalmen|||2|100|0|66,6600|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||3895||3895|6766||1 027305|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|10001|6766|lyfalmen|V0342|6766|2|100|0|133,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||3895||3895|6766||1 027505|B05BB0121|Plasmalyte|irl|||1000|ml|10|pokar|lausn|B05BB01|01.05.2014||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1911|4035|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1911||1911|4035||2 027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|4914|8169|lyfalmen|||1|56|0|7,0000|Vistor hf|Eisai Ltd|Zonisamíð||4914||4914|8169||1 027627|N02AE0101|Bupremyl|forðapl|20|mcg/klst|4|stk|1|skpoki||N02AE01|01.03.2018||R|0|0|1|0|G|0|MYL|0|0|0|100|IKR|3502|5259|lyfalmen|V0945|5259|2|4|0|11,2000|Icepharma hf|Mylan AB|Búprenorfín||2800||2800|5259||2 027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|1|0|0|0|G|0|TDA|0|0|0|100|DKK|474|2057|lyfalmen|||2|100|0|33,3300|Vistor hf|Takeda Danmark A/S|Levótýroxínnatríum||474||474|2057||1 027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|1|0|0|0|G|0|TDA|0|0|0|100|DKK|546|2156|lyfalmen|||2|100|0|66,6667|Vistor hf|Takeda Danmark A/S|Levótýroxínnatríum||546||546|2156||1 027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|16108|23576|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||16108||16108|23576||1 027976|N05AH0307|Zypadhera|sts|210|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|NED|0|0|0|100|XEU|18540|26923|lyfsjukr|||1|1|0|21,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||18540|26923||2 027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|18267|26548|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||18267||18267|26548||1 027988|N05AH0307|Zypadhera|sts|300|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|NED|0|0|0|100|XEU|25323|35099|lyfsjukr|||1|1|0|30,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||25323||25323|35099||2 027999|N05AH0307|Zypadhera|sts|405|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|NED|0|0|0|100|XEU|37418|50397|lyfsjukr|||1|1|0|40,5000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||37418|50397||2 028045|G03AB0801|Qlaira|töflur|||84|stk|1|þpakki|3x28 stk|G03AB08|01.11.2009||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|3374|6049|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Kaflaskipt lyf, prógestógen og östrógen||3374||3374|6049||2 028110|A10BD0701|Janumet|filmhtfl|900|mg|196|stk|1|þpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|0|G|0|MBV|0|0|0|100|DKK|17840|25960|lyfalmen|V0387|25960|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Metforminum og sitagliptinum||17840||17840|25960||1 028112|R06AX2602|Nefoxef|filmhtfl|120|mg|30|stk|1|þpakki||R06AX26|01.07.2008||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyfalmen|||2|30|0|30,0000|Icepharma hf|Mylan AB|Fexófenadín|||||2850||2 028121|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|þpakki|50/1000mg|A10BD07|01.01.2010||R|1|0|0|0|G|0|MBV|0|0|0|100|DKK|15795|23145|lyfalmen|V0386|23145|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Metforminum og sitagliptinum||15795||15795|23145||1 028268|R03DX0501|Xolair|stl|150|mg|1|áf.spr|1|pakki||R03DX05|01.04.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|39754|53351|lyfsjukr|||1|1|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||39754||39754|53351||1 028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ aðsk. nál|J07AP03|01.05.2008||R|0|0|0|0|0|0|SSS|0|0|0|100|XEU|2067|4250|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Taugaveiki, hreinsaðir mótefnavakar||2067||2067|4250||1 028351|J07BL0101|Stamaril|sts|||0,5|ml|10|hgl|+ 10 áf.spr. með leysi|J07BL01|01.01.1996||R|0|0|0|0|0|0|SSS|0|0|0|100|XEU|33219|45086|lyfalmen|||1|5|0||Vistor hf|Sanofi Pasteur Europe|Gulusótt, veikluð veira||||33219|45086||1 028387|M03BX0105|Baklofen Mylan|töflur|25|mg|50|stk|1|glas||M03BX01|01.10.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1269|3152|lyfalmen|V0202|3152|2|50|0|25,0000|Icepharma hf|Mylan AB|Baklófen||1269||1269|3152||2 028405|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1423|3364|lyfalmen|V0428|2643|2|50|0|50,0000|Icepharma hf|Mylan AB|Naproxen||1423||1423|3364||2 028497|N04BC0505|Oprymea|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2018||R|1|0|0|0|G|0|KAN|0|0|0|100|IKR|632|1997|lyfalmen|V0266|1997|2|30|0|1,5000|Krka Sverige AB|Krka d.d. Novo mesto|Pramipexól||430||430|1997||2 028519|N04BC0505|Oprymea|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2018||R|1|0|0|0|G|0|KAN|0|0|0|100|IKR|2582|2988|lyfalmen|V0267|2988|2|100|0|10,0000|Krka Sverige AB|Krka d.d. Novo mesto|Pramipexól||1150||1150|2988||2 028531|N04BC0505|Oprymea|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.05.2018||R|1|0|0|0|G|0|KAN|0|0|0|100|IKR|14853|21849|lyfalmen|V0269|21630|2|100|0|40,0000|Krka Sverige AB|Krka d.d. Novo mesto|Pramipexól||14853||14853|21849||2 028575|N03AX0901|Lamictal|dreifit.|5|mg|56|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|1318|3219|lyfalmen|||1|56|0|0,9334|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||1318||1318|3219||1 028586|N03AX0901|Lamictal|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|5358|4299|lyfalmen|V0245|3804|1|98|0|32,6667|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||2103||2103|4299||1 028598|N03AX0901|Lamictal|dreifit.|200|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|9898|9294|lyfalmen|V0232|7447|1|98|0|65,3333|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||5732||5732|9294||1 028599|N04BC0508|Pramipexole Alvogen|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.02.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|626|2262|lyfalmen|V0266|1997|2|30|0|1,5000|Alvogen|Alvogen|Pramipexól||623||623|2262||2 028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|0|0|0|0|0|0|OCO|1|0|0|100|DKK|6247|12022|vetalmen|||0|10|0||Icepharma hf|Orion Corporation (I)|||6247||6247|12022||2 028610|N04BC0508|Pramipexole Alvogen|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.02.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|2555|3752|lyfalmen|V0267|2988|2|100|0|10,0000|Alvogen|Alvogen|Pramipexól||1705||1705|3752||2 029066|R01AD0801|Flixonase|nefúði|50|mcg/sk|120|skammtar|1|stauk||R01AD08|01.04.1992||R|0|0|0|0|G|0|SDF|0|0|1|100|IKR|1084|2781|lyfalmen|V0625|2005|1|120|0|30,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Flútíkasón||1000||1000|2781||1 029078|N06AX2201|Valdoxan|filmhtfl|25|mg|28|stk|1|þpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|LLS|0|0|0|100|DKK|5173|8525|lyfalmen|||1|28|0|28,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||5173||5173|8525||2 029100|N06AX2201|Valdoxan|filmhtfl|25|mg|84|stk|1|þpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|LLS|0|0|0|100|DKK|12894|19152|lyfalmen|||1|84|0|84,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||12894||12894|19152||2 029198|R06AX2201|Kestine|filmhtfl|20|mg|30|stk|1|þpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|2275|4536|lyfalmen|||1|30|0|60,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||2275||2275|4536||1 029211|N02AB0309|Abstral|tungur.t|200|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|DKK|29426|40288|lyfalmen|V0802|40288|1|30|0|10,0000|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||29426||29426|40288||2 029222|N02AB0309|Abstral|tungur.t|400|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|DKK|29460|40331|lyfalmen|||1|30|0|20,0000|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||29460||29460|40331||2 029255|N02AB0309|Abstral|tungur.t|800|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|DKK|29460|40331|lyfalmen|||1|30|0|40,0000|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||29460||29460|40331||2 029276|J04BA0202|Dapsone|töflur|50|mg|28|stk|1|þpakki||J04BA02|01.04.2013||R|0|0|0|1|G|0|UAK|0|0|0|100|XEU|1149|2986|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis UK Ltd.|Dapsón||1149||1149|2986||1 029277|N02AB0309|Abstral|tungur.t|100|mcg|10|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|DKK|9719|14782|lyfalmen|V0801|13316|1|10|0|1,6700|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||9719||9719|14782||2 029287|C03DB0105|Amiloride|töflur|5|mg|28|stk|1|þpakki||C03DB01|01.04.2009||R|0|0|0|0|G|0|UAK|0|0|0|100|GBP|240|1735|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Amiloridhýdróklóríð||240||240|1735||1 029292|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.07.2016||L|1|0|0|0|0|0|GOP|0|0|1|100|IKR|||lyflausa|||0|10|0|5,0000|Sofus Regulatory Affairs AB|Gen. Orph|Meklózín|||||||1 029300|N02AB0309|Abstral|tungur.t|100|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|DKK|29157|39948|lyfalmen|V0801|39948|1|30|0|5,0000|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||29157||29157|39948||2 029311|N02AB0309|Abstral|tungur.t|200|mcg|10|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|DKK|9808|14905|lyfalmen|V0802|13429|1|10|0|3,3300|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||9808||9808|14905||2 029335|N02AB0309|Abstral|tungur.t|300|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|DKK|29426|40288|lyfalmen|||1|30|0|15,0000|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||29426||29426|40288||2 029357|N02AB0309|Abstral|tungur.t|600|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|DKK|29460|40331|lyfalmen|||1|30|0|30,0000|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||29460||29460|40331||2 029429|L01XX4101|Halaven|stl|0,44|mg/ml|2|ml|1|hgl|lausn|L01XX41|01.11.2011||R|0|0|0|0|0|1|EIS|0|1|0|100|SEK|43626|58248|lyfsjukr|||1|2|0||Vistor hf|Eisai Ltd|Eribulin||43626||43626|58248||1 029517|L01BB0503|Fludarabin Actavis|sts/irs|25|mg/ml|50|mg|1|hgl||L01BB05|01.04.2009|30.06.2018|R|0|0|0|0|0|1|GPA|0|0|0|100|XEU|15314|22483|lyfsjukr|||2|50|0||Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||15314||15314|22483||1 029528|L01CA0402 |Vinorelbin Actavis|irþ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|0|0|0|0|0|1|GPA|0|0|0|100|XEU|3363|6034|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Vínorelbín||3363||3363|6034||1 029706|C09DA0601|Atacand Plus|töflur|44,5|mg|98|stk|1|þpakki|32+12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|9147|13995|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||9147|13995||1 029729|C09DA0601|Atacand Plus|töflur|57|mg|98|stk|1|þpakki|32+25 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|8873|13618|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||8873|13618||1 029800|J01AA0208|Oracea|hylki|40|mg|56|stk|1|þpakki|með br.losunarhraða|J01AA02|01.12.2011||R|0|0|0|0|0|0|GAN|0|0|1|100|XEU|4641|7793|lyfalmen|||1|56|0|22,4000|Icepharma hf|Galderma Nordic AB|Doxýcýklín||4641||4641|7793||2 029811|B02BX0401|Nplate|sts|250|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|0|1|0|1|0|1|AEB|0|1|0|100|DKK|74830|97715|lyfsjukr|||1|1|0|8,3300|Vistor hf|Amgen Europe B.V.|Romiplóstím||74830||74830|97715||1 029822|B02BX0401|Nplate|sts|500|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|0|1|0|1|0|1|AEU|0|1|0|100|DKK|149659|192241|lyfsjukr|||1|1|0|16,6600|Vistor hf|Amgen Europe B.V.|Romiplóstím||149659||149659|192241||1 029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029867|N07BA0152|Zonnic Mint|munnh.du|4|mg|20|stk|1|krukka|munnh.duft í posa|N07BA01|01.09.2017||L|0|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|20|0|2,6666|LYFIS ehf|Niconovum AB|Nikótín|||||||2 029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 030136|J01CR0205|Spectracillin|filmhtfl|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.01.2017||R|0|0|0|0|0|0|WEH|0|0|1|100|IKR|1096|2428|lyfalmen|V0168|2428|2|20|0|10,0000|Williams & Halls efh|Williams & Halls ehf|Amoxicillín og beta-laktamasa hemill ||743||743|2428||2 030170|J07AL0202|Prevenar 13|stl|2,2|mcg|0,5|ml|1|áf.spr||J07AL02|01.07.2014||R|0|0|0|0|0|0|PHH|0|0|0|100|DKK|6451|10284|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Limited|Hreinsuð pneumococca poly­sakkaríð mótefnavakar (cojugated)||6451||6451|10284||1 030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|1|0|0|0|G|0|PGB|0|0|0|100|IKR|12900|19160|lyfalmen|V0277|4840|1|100|0|33,3333|Icepharma hf|BGP Products ApS|Klózapín||12900||12900|19160||2 030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|1|0|0|0|0|0|PGB|0|0|0|100|IKR|4000|6911|lyfalmen|V0276|3057|1|100|0|8,3333|Icepharma hf|BGP Products ApS|Klózapín||4000||4000|6911||2 030822|QI02AB0001|Startvac|stl|||2|ml|20|glös|fleyti|QI02AB|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|12943|22309|vetorma|||0|40|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||12943||12943|22309||2 030940|C07AB0210|Metoprolol Mylan|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|940|2554|lyfalmen|V0051|2093|2|100|0|33,3333|Icepharma hf|Mylan AB|Metóprólól||835||835|2554||2 031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|0|0|0|0|G|0|NED|0|0|0|100|XEU|2290|4557|lyfalmen|||1|10|0|25,0000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||2290||2290|4557||2 031201|L04AX0307|Metoject|stl|50|mg/ml|0,25|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|1973|4121|lyfalmen|||1|0,25|0|5,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||1973||1973|4121||2 031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4569|7694|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||4569||4569|7694||1 031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|17156|25018|lyfsjukr|||1|5|0|0,4200|Vistor hf|Ferring Lægemidler A/S|Terlípressín||17156||17156|25018||1 032175|N03AX1606|Pregabalin Mylan|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|3461|2781|lyfalmen|V0686|2083|2|56|0|14,0000|Mylan AB|Generics (UK) Ltd.|Pregabalín||1000||1000|2781||2 032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|0|0|0|0|G|0|OTS|0|0|0|100|DKK|16608|24264|lyfalmen|||1|150|0|10,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||16608||16608|24264||1 032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|0|0|0|0|0|0|MEF|1|0|0|100|XEU|11492|19808|vetorma|||0|200|0||Vistor hf|Merial (MSD)|Ivermectinum||11492||11492|19808||1 032706|C03EA0113|Diuramin|töflur|55|mg|100|stk|1|þpakki|5+50 mg|C03EA01|01.05.2013||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|965|2733|lyfalmen|||2|100|0|100,0000|Alvogen|ratiopharm GmbH|Hýdróklórtíazíð og kalíumsparandi lyf||965||965|2733||2 032836|C09CA0107|Losartan Medical Valley|filmhtfl|50|mg|100|stk|1|þpakki||C09CA01|01.06.2016||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|2100|2506|lyfalmen|V0069|2506|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Lósartan||800||800|2506||2 033124|L02BX0201|Firmagon|sts|80|mg|1|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|G|0|FER|0|0|0|100|DKK|16833|24574|lyfalmen|||1|1|0|29,6300|Vistor hf|Ferring|Degarelix||||16833|24574||1 033135|L02BX0201|Firmagon|sts|120|mg|2|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|G|0|FER|0|0|0|100|DKK|33573|45533|lyfalmen|||1|2|0|88,8900|Vistor hf|Ferring|Degarelix||||33573|45533||1 033193|QP54AA0105|Noromectin|pasta|18,7|mg/g|7,49|g|1|áf.spr|Fyrir hesta|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|965|1663|vetorma|||0|7,49|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||965||965|1663||2 033195|N02AA5501|Targin|forðatfl|15|mg|28|stk|1|þpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|2426|4744|lyfalmen|||1|28|0|3,7400|Icepharma hf|Norpharma|Oxycodonum í blöndum||2426||2426|4744||2 033201|QJ01DD9001|Eficur vet.|stl|50|mg/ml|100|ml|1|hgl||QJ01DD90|01.02.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|7222|13872|vetalmen|||0|100|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Ceftiofurhydróklóríð||||7222|13872||2 033206|N02AA5501|Targin|forðatfl|15|mg|98|stk|1|þpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|8267|12784|lyfalmen|||1|98|0|13,0700|Icepharma hf|Norpharma|Oxycodonum í blöndum||8267||8267|12784||2 033218|N02AA5501|Targin|forðatfl|30|mg|28|stk|1|þpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|4855|8087|lyfalmen|||1|28|0|7,4700|Icepharma hf|Norpharma|Oxycodonum í blöndum||4855||4855|8087||2 033229|N02AA5501|Targin|forðatfl|30|mg|98|stk|1|þpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|14330|21129|lyfalmen|||1|98|0|26,1400|Icepharma hf|Norpharma|Oxycodonum í blöndum||14330||14330|21129||2 033251|S01CA0102|Tobradex|augndr|||5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|0|0|0|0|G|0|HES|0|0|1|100|DKK|1112|2935|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Dexametasón||1112||1112|2935||1 033357|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.08.2013||R|1|0|0|0|G|0|RHA|0|0|1|100|XEU|1175|2403|lyfalmen|V0189|2403|2|100|0|50,0000|Alvogen|ratiopharm Oy|Díklófenak||725||725|2403||2 033498|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.08.2013||R|1|0|0|0|G|0|RHA|0|0|1|100|XEU|522|2100|lyfalmen|V0188|2100|2|30|0|15,0000|Alvogen|ratiopharm Oy|Díklófenak||505||505|2100||2 033777|L02BG0404|Letromal|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.04.2011||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|13295|11710|lyfalmen|V0185|11710|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Letrózól||7487||7487|11710||2 033833|J02AC0107|Fluconazol Krka|hylki|50|mg|98|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|0|KRK|0|0|1|100|IKR|10456|8287|lyfalmen|||2|98|0|24,5000|LYFIS ehf|Krka Sverige AB|Flúkónazól||5000||5000|8287||2 033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|62826|82533|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||62826||62826|82533||1 034033|QJ01MA9001|Baytril vet.|töflur|50|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1953|3838|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||1953|3838||2 034124|C09BA0202|Enalapril comp ratiopharm|töflur|32,5|mg|100|stk|1|þpakki|20+12,5 mg|C09BA02|01.12.2013||R|1|0|0|0|G|0|RHA|0|0|0|100|XEU|1494|2655|lyfalmen|||2|100|0|100,0000|Alvogen|ratiopharm Oy|Enalapríl og þvagræsilyf||908||908|2655||2 034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|12541|18666|lyfsjukr|||1|25|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||12541||12541|18666||2 034494|N05CM1801|Dexdor|irþ|100|mcg/ml|10|ml|4|hgl|lausn|N05CM18|01.03.2012||R|0|0|0|0|0|1|ORC|0|0|0|100|DKK|53144|70287|lyfsjukr|||1|40|0|4,0000|Vistor hf|Orion Corporation|Dexmedetómid||53144||53144|70287||1 034796|N06AB0604|Sertralin Bluefish|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.10.2017||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|3278|4158|lyfalmen|V0323|3882|2|100|0|200,0000|Vistor hf|Bluefish Pharmaceuticals AB|Sertralín||2000||2000|4158||1 034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|1111|2934|lyfalmen|||1|6|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||1111||1111|2934||1 034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|2005|4165|lyfalmen|||1|12|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||2005||2005|4165||1 034988|L03AB0702|Rebif|stl|44|mcg/,5ml|1,5|ml|4|rörlyk|132 mcg pr. rörlykju|L03AB07|01.03.2010||R|0|0|0|1|0|1|MRP|0|0|0|100|SEK|82750|107732|lyfsjukr|||1|6|0|122,7907|Icepharma hf|Merck Europe B.V.|Interferón beta-1a||82750||82750|107732||2 035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|0|0|0|0|0|1|LEP|0|0|0|100|DKK|6041|9720|lyfsjukr|||1|25|0||Vistor hf|LEO Pharma A/S|Prótamín||6041||6041|9720||1 035113|B05XA0501|Addex-Magnesium|irþ|1|mmol/ml|10|ml|10|plhgl||B05XA05|01.03.2010||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1768|3838|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Magnesíum súlfat||1768||1768|3838|| 035134|B01AF0201|Eliquis|filmhtfl|5|mg|14|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BSM|0|0|0|100|DKK|1966|4111|lyfalmen|||1|14|0|7,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||1966|4111||1 035212|A07EC0202|Pentasa|forðatfl|500|mg|300|stk|1|þpakki||A07EC02|01.04.1992||R|1|0|0|0|G|0|FER|0|0|0|100|DKK|12332|18379|lyfalmen|||1|300|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||12332||12332|18379||1 035494|C07AB0211|Metoprolol ratiopharm|forðatfl|23,75|mg|100|stk|1|þpakki||C07AB02|01.05.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|866|2200|lyfalmen|V0050|2079|2|100|0|15,8300|Alvogen|ratiopharm GmbH|Metóprólól||578||578|2200||2 035495|N02AJ0602|Parkodin forte|filmhtfl|530|mg|20|stk|1|þpakki|30+500 mg|N02AJ06|01.05.2018||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|505|2100|lyfalmen|||2|20|0|6,6667|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||505||505|2100||1 035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|1872|2344|lyfalmen|V0244|2344|2|56|0|9,3300|Actavis Group hf|Actavis Group PTC ehf|Lamótrigín||682||682|2344||1 035528|C07AB0211|Metoprolol ratiopharm|forðatfl|47,5|mg|100|stk|1|þpakki||C07AB02|01.06.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|1052|2452|lyfalmen|V0048|2300|2|100|0|31,6600|Alvogen|ratiopharm GmbH|Metóprólól||761||761|2452||2 035563|C07AB0211|Metoprolol ratiopharm|forðatfl|95|mg|100|stk|1|þpakki||C07AB02|01.05.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|1878|2986|lyfalmen|V0049|2919|2|100|0|63,3300|Alvogen|ratiopharm GmbH|Metóprólól||1149||1149|2986||2 035568|C09CA0601|Atacand|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|6205|9945|lyfalmen|V0080|5215|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||6205||6205|9945||1 035597|C07AB0211|Metoprolol ratiopharm|forðatfl|190|mg|100|stk|1|þpakki||C07AB02|01.06.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|4104|3640|lyfalmen|V0054|3607|2|100|0|126,6600|Alvogen|ratiopharm GmbH|Metóprólól||1624||1624|3640||2 035722|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|18|stk|1|þpakki||N02CC01|01.12.2015||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|4409|2919|lyfalmen|V0233|2919|2|18|0|18,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||1100||1100|2919||1 035926|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 036062|V03AE0202|Renvela|filmhtfl|800|mg|180|stk|1|pakki||V03AE02|01.04.2010||R|0|0|0|0|0|0|GEB|0|0|0|100|XEU|22457|31474|lyfalmen|V0680|10434|1|180|0|22,5000|Vistor hf|Genzyme Europe B.V.|Sevelamer||22457||22457|31474||1 036228|C09CA0601|Atacand|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5515|8996|lyfalmen|V0081|5215|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||5515||5515|8996||1 036261|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|þpakki||B01AC22|01.11.2016||R|0|1|0|0|G|0|DSA|0|0|0|100|XEU|6549|10419|lyfalmen|||1|28|0|28,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Prasugrel||||6549|10419||2 036431|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.09.2018||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|1304|3200|lyfalmen|V0426|3200|1|1|0|6,2500|Icepharma hf|Pfizer Aps|Metýlprednisólón||||1304|3200||1 036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|þpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|585|2210|lyfalmen|V0929|2162|1|20|0|8,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||585||585|2210||2 036502|N06DA0301|Exelon|forðapl|13,3|mg/sólh|30|pokar|1|pakki||N06DA03|01.02.2014||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|15599|22875|lyfalmen|||1|30|0|42,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||15599||15599|22875||1 036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|1028|2820|lyfalmen|||1|60|0|3,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||1028||1028|2820||2 036529|QI09AB1302|Ingelvac MycoFLEX|stl|||50|ml|1|glas|handa svínum|QI09AB13|01.12.2013||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|1127|1942|vetorma|||1|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Óvirkar bakteríur í bóluefnum||1127||1127|1942||1 036541|A03AX1301|Minifom|dropar|||30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|0|0|0|0|0|0|AHN|0|0|0|100|IKR|||lyflausa|||0|30|0|6,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Silíkonsambönd|||||||1 036577|L01XE0104|Imatinib Mylan|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.02.2017||R|1|0|0|1|0|1|MYL|0|1|0|100|SEK|132057|56666|lyfsjukr|||2|30|0||Icepharma hf|Mylan AB|Imatiníb||42375||42375|56666||2 036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|2030|4199|lyfalmen|||1|125|0|6,2500|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||2030||2030|4199||2 036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|þpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|615|2251|lyfalmen|||1|30|0|12,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||615||615|2251||2 036754|N03AX1608|Pregabalina Tecnigen|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.01.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|8501|3498|lyfalmen|V0689|3498|2|56|0|56,0000|Williams & Halls efh|Williams & Halls ehf|Pregabalín||1521||1521|3498||2 036968|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|60|stk|1|glas|hart|A02BC01|01.03.2017||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|2300|1955|lyfalmen|V0006|1231|2|60|0|60,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||400||400|1955||2 037287|N04BC0404|Requip Depot|forðatfl|2|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|5968|6291|lyfalmen|V0532|6092|1|84|0|28,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||3550||3550|6291||1 037305|N04BC0404|Requip Depot|forðatfl|4|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|10157|8720|lyfalmen|V0533|8657|1|84|0|56,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||5315||5315|8720||1 037323|N04BC0404|Requip Depot|forðatfl|8|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|15205|16132|lyfalmen|V0534|15999|1|84|0|112,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||10700||10700|16132||1 037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|1954|4094|lyfalmen|V0434|4094|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1954||1954|4094||2 037471|C07AB0214|Bloxazoc|forðatfl|200|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|3533|3607|lyfalmen|V0054|3607|2|100|0|126,6600|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||1600||1600|3607||2 037846|A12BA0101|Kaleorid|forðatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|G|0|LEP|0|0|0|100|DKK|||lyfalmen|||0|100|0|25,0000|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||2415||1 037853|A12BA0101|Kaleorid|forðatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|G|0|LEP|0|0|0|100|DKK|||lyfalmen|||0|250|0|62,5000|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||3523||1 037895|C09CA0601|Atacand|töflur|4|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5487|8957|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||5487|8957||1 038305|N06AX1611|Duofaxin|forðatfl|150|mg|98|stk|1|þpakki||N06AX16|01.07.2015|30.06.2018|R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|2391|2668|lyfalmen|||2|98|0|147,0000|Vistor hf|MediLink A/S|Venlafaxín||918||918|2668||1 038386|R06AE0706|Zensitin|filmhtfl|10|mg|30|stk|1|þpakki||R06AE07|01.07.2017||L|1|0|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Williams & Halls efh|Williams & Halls ehf|Cetirizín|||||||2 038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|þpakki||N06AB05|01.04.1993||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|2750|3664|lyfalmen|V0321|3463|1|100|0|100,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Paroxetín||1641||1641|3664||1 038494|C10AA0106|Simvastatin Bluefish|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.02.2014||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|1347|2456|lyfalmen|V0110|2456|2|100|0|133,3333|Vistor hf|Bluefish Pharmaceuticals AB|Simvastatín||764||764|2456||1 038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|0|0|0|0|0|0|SON|0|0|1|100|DKK|811|2521|lyfalmen|||1|50|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||811||811|2521||2 038540|G04BE0808|Tadalafil Sandoz|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.01.2018||R|1|0|0|0|0|0|SHS|0|0|0|100|DKK|3803|5215|lyfalmen|V0924|3221|2|4|0|4,0000|Artasan ehf|Sandoz A/S|Tadalafíl||2768||2768|5215||1 039141|B01AF0101|Xarelto|filmhtfl|15|mg|42|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|11318|16983|lyfalmen|||1|42|0|31,5000|Icepharma hf|Bayer AG|Rivaoxaban||||11318|16983||2 039147|N04BC0701|Apomorfin PharmSwed|irl|5|mg/ml|20|ml|5|hgl|lausn|N04BC07|01.03.2013||R|0|0|0|1|0|1|PSS|0|0|0|100|SEK|22721|31808|lyfsjukr|||1|100|0|25,0000|Williams & Halls efh|PharmSwed|Apómorfín||22721||22721|31808||2 039395|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|50|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BFP|0|0|1|100|IKR|13831|13930|lyfalmen|||2|50|0|25,0000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||9100||9100|13930||1 039413|H02AB0205|Dexametason Abcur|töflur|1|mg|20|stk|1|þpakki||H02AB02|01.06.2016||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|1271|3154|lyfalmen|||2|20|0|13,3300|Icepharma hf|Abcur AB|Dexametasón||1271||1271|3154||2 039430|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|m.nál, dreifa|J07AL52|01.04.2012||R|0|0|0|0|0|0|GBI|0|0|0|100|DKK|4667|7829|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||4667||4667|7829||1 039643|C01BD0701|Multaq|filmhtfl|400|mg|100|stk|1|þpakki||C01BD07|01.08.2010||R|1|1|0|1|0|0|SGB|0|0|0|100|XEU|15440|22657|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi-aventis groupe|Dronedarón||15440||15440|22657||1 039676|N06AX0307|Mianserin Mylan|filmhtfl|30|mg|100|stk|1|þpakki||N06AX03|01.06.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2378|4678|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Míanserín||2378||2378|4678||2 039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|þpakki||C07AB03|01.04.1992||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|303|1822|lyfalmen|V0541|1752|2|98|0|32,6667|Icepharma hf|Mylan AB|Atenólól||303||303|1822||2 039709|C07AB0311|Atenolol Mylan|töflur|50|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|436|1921|lyfalmen|V0542|1760|2|98|0|65,3333|Icepharma hf|Mylan AB|Atenólól||375||375|1921||2 039776|J01FA1001|Zitromax|mixtduft|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|0|0|0|0|0|0|PLS|0|0|1|100|DKK|836|2556|lyfalmen|V0821|1997|1|15|0|2,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||836||836|2556||1 039784|J01FA1001|Zitromax|mixtduft|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|0|0|0|0|0|0|PLS|0|0|1|100|DKK|1466|3423|lyfalmen|V0822|2506|1|22,5|0|3,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1466||1466|3423||1 039837|N02BE0107|Paratabs|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.03.2013||L|1|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1655|2472|lyfalmen|V0110|2407|2|98|0|130,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||775||775|2472||1 039957|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|42|stk|1|þpakki||J05AB11|01.01.2010||R|1|0|0|0|G|0|GPA|0|0|1|100|GBP|5288|3595|lyfalmen|V0182|3595|2|42|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||1591||1591|3595||1 039968|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.01.2010||R|1|0|0|0|G|0|GPA|0|0|1|100|GBP|1350|1960|lyfalmen|V0033|1960|2|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||403||403|1960||1 040313|N02AB0306|Instanyl|nefúði|200|mcg|6|sk-ílát|1|pakki||N02AB03|01.08.2014||R|0|1|1|1|0|0|TPA|0|0|0|100|DKK|7666|11956|lyfalmen|||1|6|0|2,0000|Vistor hf|Takeda Pharma A/S|Fentanýl||7666||7666|11956||1 040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|0|0|0|0|G|0|HES|0|0|0|100|DKK|||lyfalmen|||0|15|0||Vistor hf|Novartis Healthcare A/S|Gervitár og aðrar óvirkar samsetningar|||||2207||1 040708|G02AD0601|Misodel|sk-innl|200|mcg|5|stk|1|askja||G02AD06|01.09.2014||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|70363|92065|lyfsjukr|||1|5|0|5,0000|Vistor hf|Ferring Lægemidler A/S|Misóprostól||||70363|92065||1 040742|C08CA0203|Felodipin ratiopharm|forðatfl|2,5|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|2339|4295|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Felódipín||2100||2100|4295||2 040977|J01DD0402|Ceftriaxona Normon|sts|1000|mg|100|stk|1|hgl|+ 100 lykjur með leysi.|J01DD04|01.06.2018||R|0|0|0|0|0|1|LNA|0|0|0|100|SEK|194773|248350|lyfsjukr|||2|100|0|50,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftríaxón||194773||194773|248350||2 041086|C01EB1701|Procoralan|filmhtfl|5|mg|56|stk|1|þpakki||C01EB17|01.04.2014||R|1|0|0|0|0|0|LLS|0|0|0|100|DKK|7024|11073|lyfalmen|||1|56|0|28,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||7024||7024|11073||2 041105|C01EB1701|Procoralan|filmhtfl|7,5|mg|56|stk|1|þpakki||C01EB17|01.04.2014||R|1|0|0|0|0|0|LLS|0|0|0|100|DKK|7170|11274|lyfalmen|||1|56|0|42,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||7170||7170|11274||2 041693|QG03XA9101|Improvac|stl|300|mcg|100|ml|10|glös||QG03XA91|01.07.2016||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|45364|86235|vetalmen|||0|1000|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||45364||45364|86235||2 041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|2808|4840|vetorma|||0|100|0||Vistor hf|Intervet International BV|||2808||2808|4840||1 041898|N06AX0307|Mianserin Mylan|filmhtfl|10|mg|90|stk|1|þpakki||N06AX03|01.06.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|802|2509|lyfalmen|||2|90|0|15,0000|Icepharma hf|Mylan AB|Míanserín||802||802|2509||2 041942|N06AX1106|Mirtazapin Krka|filmhtfl|15|mg|300|stk|1|glas||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|7000|9663|lyfalmen|||2|300|0|150,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||6000||6000|9663||2 041951|N06AX1106|Mirtazapin Krka|filmhtfl|30|mg|250|stk|1|glas||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|7926|9663|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||6000||6000|9663||2 041996|A06AG1101|Microlax|innhl|||5|ml|4|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||||1 042270|D01BA0207|Terbinafin Medical Valley|töflur|250|mg|98|stk|1|þpakki||D01BA02|01.08.2017||R|1|0|0|0|0|0|VAL|0|0|0|100|IKR|6000|9526|lyfalmen|||2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Terbínafín||5900||5900|9526||2 042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1889|4005|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||1889||1889|4005||1 042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3146|5735|lyfsjukr|||1|7500|0||Vistor hf|Fresenius Kabi AB|Kolvetni||3146||3146|5735||1 042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1709|3757|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||1709||1709|3757||1 042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|||1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2260|4516|lyfsjukr|||2|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með kol­vetnum||2260||2260|4516||1 042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1651|3677|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||1651||1651|3677||1 042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1870|3979|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||1870||1870|3979||1 042549|J07BF0301|Imovax Polio|stl|||0,5|ml|1|áf.spr|með nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SSS|0|0|0|100|XEU|1797|3878|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Mænusótt, dauð veira||1797||1797|3878||1 042551|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|||1000|ml|10|plpok||B05BB02|01.04.2009||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2579|4955|lyfsjukr|||2|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með kol­vetnum||2579||2579|4955||2 042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1802|3885|lyfsjukr|||2|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með kol­vetnum||1802||1802|3885||1 042669|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyflausa|||0|4000|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||||1 042775|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|500|stk|1|glas||A06AB06|01.10.2012||R|1|0|0|0|0|0|FMV|0|0|0|100|GBP|2776|5226|lyfalmen|||3|500|0||Icepharma hf|Icepharma hf|Senna||2776||2776|5226||2 042865|N01BB0204|Lidokain Mylan|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.09.2016||R|0|0|0|0|0|0|MLT|0|0|1|100|XEU|1107|2929|lyfalmen|V0560|2929|2|100|0||BGP Products AsP|Mylan Ireland Limited|Lídókaín||1107||1107|2929||2 043232|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|30|stk|1|þpakki||N05CD03|01.10.1992||R|1|0|1|0|0|0|MYL|0|0|0|100|SEK|387|1938|lyfalmen|||2|30|0|30,0000|Icepharma hf|Mylan AB|Flúnítrazepam||387||387|1938||2 043345|N03AX1405|Matever|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.02.2012||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|12394|5648|lyfalmen|V0516|5259|2|100|0|66,6700|Alvogen|Pharmathen S.A.|Levetíracetam||3083||3083|5648||2 043379|R03AC1201|Serevent|innúðal|25|mcg/sk|120|skammtar|1|stauk|HFA 134a|R03AC12|01.04.2007||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|3007|5544|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról||3007||3007|5544||1 043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|þpakki||N05CD05|01.12.1983||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|414|1975|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tríazólam||414||414|1975||1 043988|B03AA0705|Ferrous Sulphate|töflur|200|mg|100|stk|1|glas|sykurhúðaðar|B03AA07|01.09.2009||L|1|0|0|0|0|0|UAK|0|0|1|100|IKR|||lyflausa|||0|100|0|32,5000|Actavis Group hf|Actavis UK Ltd.|Ferrósúlfat|||||||1 044360|B03AC0004|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.05.2006||R|0|1|0|0|G|0|LVR|0|0|1|100|CHF|10746|16196|lyfalmen|V0637|16196|3|25|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Járn, stungulyf||10746||10746|16196||3 044492|G02AD0602|Angusta|töflur|25|mcg|8|stk|1|pakki||G02AD06|01.06.2017||R|0|0|0|1|0|1|ZAA|0|0|0|100|DKK|11783|17623|lyfsjukr|||1|8|0|1,0000|Azanta Danmark A/S|Azanta Danmark A/S|Misóprostól||11783||11783|17623||2 044580|L01XE1001|Afinitor|töflur|5|mg|30|stk|1|þpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|261559|331413|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||261559||261559|331413||1 044591|L01XE1001|Afinitor|töflur|10|mg|30|stk|1|þpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|370542|466957|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||370542||370542|466957||1 044732|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|þpakki||L01AA01|01.06.2014||R|0|0|0|0|G|0|BAM|0|0|0|100|SEK|4169|7143|lyfalmen|||1|100|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||4169||4169|7143||2 044739|N04BC0502|Sifrol|forðatfl|0,52|mg|100|stk|1|pakki||N04BC05|01.02.2010|30.06.2018|R|0|0|0|0|G|0|BII|0|0|0|100|DKK|12736|18935|lyfalmen|||1|100|0|30,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||12736||12736|18935||1 044752|N04BC0502|Sifrol|forðatfl|2,1|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|34230|46364|lyfalmen|V0636|37379|1|100|0|120,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||34230||34230|46364||1 045332|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|600|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 045475|A10BK0301|Jardiance|filmhtfl|25|mg|30|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|5893|9516|lyfalmen|||1|30|0|42,8600|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||5893||5893|9516||1 045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1066|2232|lyfalmen|V0109|2081|2|98|0|65,3400|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||601||601|2232||1 045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|881|2090|lyfalmen|V0108|1954|2|98|0|32,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||498||498|2090||1 045588|J01DC0204 |Cefuroxim Villerton|sts|750|mg|10|hgl|1|pakki|lausn / dreifa|J01DC02|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|1622|3637|lyfsjukr|||2|10|0|2,5000|Icepharma hf|Villerton Invest SA|Cefúroxím||||1622|3637||2 045599|J01DC0204|Cefuroxim Villerton|sts/irs|1500|mg|10|hgl|1|pakki|lausn|J01DC02|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|2329|4611|lyfsjukr|||2|10|0|5,0000|Icepharma hf|Villerton Invest SA|Cefúroxím||||2329|4611||2 045634|N02AJ0603|Pinex Comp Forte|eþ-stíll|530|mg|10|stk|1|pakki|30+500 mg|N02AJ06|01.01.2011||R|0|0|0|0|0|0|GRP|0|0|1|100|XEU|313|1836|lyfalmen|||2|10|0|3,3333|Actavis Group PTC ehf|Actavis Group PTC ehf|Kódein og Paracetamól||313||313|1836||1 045765|C03CA0110|Impugan|dropar|10|mg/ml|30|ml|1|glas||C03CA01|01.06.2013||R|0|0|0|0|G|0|GRP|0|0|0|100|SEK|1482|3445|lyfalmen|||2|30|0|7,5000|Actavis Group PTC ehf|Actavis Group PTC ehf|Fúrósemíð||1482||1482|3445||1 046188|M01AH0108|Celecoxib Medical|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.05.2018||R|1|0|0|0|G|0|DIC|0|0|1|100|IKR|2075|3745|lyfalmen|V0429|3745|2|100|0|50,0000|LYFIS ehf|Medical ehf|Celekoxíb||1700||1700|3745||2 046214|J02AC0107|Fluconazol Krka|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|0|KRK|0|0|1|100|IKR|15729|11728|lyfalmen|V0419|11728|2|28|0|28,0000|LYFIS ehf|Krka Sverige AB|Flúkónazól||7500||7500|11728||2 046248|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|30|sk-hyl|án rotvarnarefnis|S01EE01|01.03.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|1110|2933|lyfalmen|||1|6|0|30,0000|Vistor hf|Laboratories THEA|Latanóprost||||1110|2933||1 046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.03.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|725|2306|lyfalmen|V0648|2306|2|100|0|100,0000|Actavis Group hf|Actavis hf|Ramipríl||655||655|2306||1 046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|518|1854|lyfalmen|V0021|1854|2|90|0|45,0000|Actavis Group hf|Actavis hf|Glímepíríð||326||326|1854||1 046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|629|2079|lyfalmen|V0022|2079|2|90|0|90,0000|Actavis Group hf|Actavis hf|Glímepíríð||490||490|2079||1 046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|806|2268|lyfalmen|V0023|2093|2|90|0|135,0000|Actavis Group hf|Actavis hf|Glímepíríð||627||627|2268||1 046485|L01BC0502|Gemcitabin Hospira|irþ|38|mg/ml|1|hgl|1|pakki||L01BC05|01.12.2015||R|0|0|0|0|0|1|PIS|0|0|0|100|SEK|5661|9197|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Gemcitabín||5661||5661|9197||1 046724|R01AD0802|Nasofan|nefúði|50|mcg/sk|150|skammtar|1|glas||R01AD08|01.12.2013||R|0|0|0|0|G|0|TSA|0|0|1|100|IKR|1264|2506|lyfalmen|V0625|2506|2|150|0|37,5000|Alvogen|Teva Sweden AB|Flútíkasón||800||800|2506||2 046812|M05BA0605|Ibandronic acid Alvogen|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.02.2012||R|0|1|0|0|G|0|POF|0|0|0|100|IKR|4372|3951|lyfalmen|V0205|3869|2|3|0|90,0000|Alvogen|Alvogen|Íbandrónsýra||1850||1850|3951||2 047159|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|688|2352|lyfalmen|||2|100|0|25,0000|Icepharma hf|Mylan AB|Sótalól||688||688|2352||2 047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|13388|19832|lyfsjukr|||1|10|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||13388||13388|19832||5 047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|47555|63218|lyfsjukr|||1|50|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||47555||47555|63218||5 047986|L02BB0305|Bicalutamide Alvogen|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.02.2011|30.06.2018|R|0|0|0|0|G|0|GOV|0|0|0|100|XEU|8352|4056|lyfalmen|||2|30|0|30,0000|Alvogen|Alvogen ehf|Bíkalútamíð||2200||1926|4056||2 047998|L02BB0305|Bicalutamide Alvogen|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.02.2011||R|0|0|0|0|G|0|GOV|0|0|0|100|XEU|11893|5785|lyfalmen|V0421|5056|2|30|0|90,0000|Alvogen|Alvogen ehf|Bíkalútamíð||3182||3182|5785||2 048015|B05AA0115|Albumin Baxalta|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BAG|0|0|0|100|SEK|3476|6189|lyfsjukr|||1|250|0||Shire Sweden AB |Baxalta Innovations GmbH|Albúmín||3476||3476|6189||2 048028|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|50|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|6796|10759|lyfsjukr|||1|5000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||6796||6796|10759||1 048043|B05AA0115|Albumin Baxalta|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BAG|0|0|0|100|SEK|5639|9166|lyfsjukr|||1|100|0||Shire Sweden AB |Baxalta Innovations GmbH|Albúmín||5639||5639|9166||2 048100|N06AB1004|Esopram|töflur|5|mg|100|stk|1|þpakki||N06AB10|01.04.2010||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|2072|2838|lyfalmen|V0324|2838|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1041||1041|2838||1 048111|N06AB1004|Esopram|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.04.2010||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|889|2629|lyfalmen|||2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||889||889|2629||1 048122|N06AB1004|Esopram|töflur|10|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|2341|2898|lyfalmen|V0325|2698|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1085||1085|2898||1 048144|N06AB1004|Esopram|töflur|15|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|2914|5102|lyfalmen|V0326|5102|2|100|0|150,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2686||2686|5102||1 048166|N06AB1004|Esopram|töflur|20|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|3213|4450|lyfalmen|V0327|4450|2|100|0|200,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2212||2212|4450||1 048196|R03AK0706|DuoResp Spiromax|innönddu|164,5|mcg/sk|120|skammtar|1|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2018||R|0|0|0|0|G|0|TAB|0|0|0|100|XEU|4357|6129|lyfalmen|||2|120|0|30,0000|Alvogen|Teva Pharma B.V.|Formóteról og budesonide||3432||3432|6129||2 048199|A03CA0201|Librax|töflur|||100|stk|1|glas||A03CA02|01.12.1972||R|1|0|0|0|G|0|MEA|0|0|0|100|DKK|895|2637|lyfalmen|||1|100|0||Icepharma hf|Meda AB|Klídín og geðlyf||895||895|2637||2 048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|þpakki|100+12,5 mg|C09DA01|01.06.2007||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|9598|14616|lyfalmen|||1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||9598||9598|14616||1 048447|G03AA0901|Marvelon|töflur|||63|stk|1|þpakki|150/30 mcg|G03AA09|01.07.1986||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|1409|3344|lyfalmen|||1|63|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Desógestrel og ethinylestradíól||1409||1409|3344||1 048505|L03AX1601|Mozobil|stl|20|mg/ml|1,2|ml|1|hgl|lausn|L03AX16|01.07.2010||R|0|0|0|0|0|1|GEB|0|1|0|100|XEU|676430|847397|lyfsjukr|||1|1,2|0|1,4300|Vistor hf|Genzyme Europe B.V.|Plerixaforum||676430||676430|847397||1 048744|N02BE0101|Panodil|filmhtfl|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|1|0|0|0|0|0|HCA|0|0|1|100|DKK|322|1848|lyfalmen|V0230|1848|1|100|0|16,6667|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól||322||322|1848||1 048770|B05ZB0001|Hemosol BO|blóð.sk|||5000|ml|2|pokar||B05ZB|01.04.2013||R|0|0|0|0|0|1|GAA|0|0|0|100|SEK|3047|5599|lyfsjukr|||1|10000|0||Baxter Medical AB|Gambro Lundia AB|Blóðsölt og stuðpúðalausn||3047||3047|5599||2 048784|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|31558|42985|lyfsjukr|||1|1|0||Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||31558||31558|42985||3 048797|G04CA0208|Tamsulosin Mylan|hylki|0,4|mg|90|stk|1|þpakki|með br. losunarhraða|G04CA02|01.11.2016||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3585|3197|lyfalmen|V0148|3023|2|90|0|90,0000|Icepharma hf|Mylan AB|Tamsúlósín||1302||1302|3197||2 049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|þpakki||A02BA02|01.10.1987||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|1571|3567|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Ranitidín||1571||1571|3567||1 049033|C08DB0108|Cardil|forðatfl|120|mg|60|stk|1|glas||C08DB01|01.05.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|3537|3542|lyfalmen|V0599|2085|2|60|0|30,0000|Vistor hf|Orion Corporation|Diltíazem||1553||1553|3542||1 049091|S01EE0101|Xalatan|augndr|50|mcg/ml|2,5|ml|3|glös||S01EE01|01.08.2013||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|4164|7136|lyfalmen|V0376|2659|1|7,5|0|75,0000|Icepharma hf|Pfizer ApS|Latanóprost||||4164|7136||1 049116|H01CB0501|Signifor|sts|20|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|0|1|NEL|0|0|0|100|DKK|307474|388519|lyfsjukr|||1|1|0|16,6700|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||307474||307474|388519||1 049169|M05BA0602|Bonviva|stl|3|mg|3|ml|1|áfspr||M05BA06|01.10.2006||R|0|1|0|0|0|0|ATN|0|0|0|100|DKK|12230|18238|lyfalmen|V0957|16366|1|3|0|0,5000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Íbandrónsýra||12230||12230|18238||2 049319|H02AB0910|Hydrokortison Orion|töflur|10|mg|30|stk|1|þpakki||H02AB09|01.11.2015||R|0|0|0|0|G|0|ARN|0|0|1|100|DKK|812|2523|lyfalmen|||2|30|0|10,0000|Vistor hf|Orion Corporation|Hýdrókortisón||812||812|2523||1 049579|C10AA0104|Simvastatin Alvogen|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|1154|2220|lyfalmen|V0109|2081|2|98|0|65,3400|Alvogen|Alvogen ehf|Simvastatín||592||592|2220||2 049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.04.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|733|2359|lyfalmen|V0496|2359|2|100|0|200,0000|Actavis Group hf|Actavis hf|Ramipríl||693||693|2359||1 049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||L|0|0|0|0|0|0|CON|0|0|1|100|DKK|||lyflausa|||0|30|0||Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Terbínafín|||||||1 049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.08.2005||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|1431|2931|lyfalmen|V0649|2781|2|100|0|400,0000|Actavis Group hf|Actavis hf|Ramipríl||1109||1109|2931||1 049834|N02BE0113|Pinex Junior|eþ-stíll|125|mg|10|stk|1|þpakki||N02BE01|01.12.2011||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyfalmen|||0|10|0|0,4167|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||1748||1 049845|N02BE0113|Pinex Junior|eþ-stíll|250|mg|10|stk|1|þpakki||N02BE01|01.12.2011||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyfalmen|||0|10|0|0,8333|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||1748||1 049856|N02BE0114|Pinex|eþ-stíll|500|mg|10|stk|1|pakki||N02BE01|01.01.2012||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyfalmen|||0|10|0|1,6667|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||1845||1 049894|N02BG1001|Sativex|munnhúði|52|mg|10|ml|3|úðagl|27 mg + 25 mg|N02BG10|01.07.2013||R|0|0|1|1|0|0|GWP|0|0|0|100|DKK|63956|83962|lyfalmen|||1|30|0|37,1400|Vistor hf|GW Pharma Ltd.|Cannabinoids||63956||63956|83962||1 049902|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BXG|0|1|0|100|SEK|131954|170221|lyfsjukr|||1|200|0||Shire Sweden AB |BaxterAG*|Immúnóglóbúlín, normal, manna, gefin í æð||131954||131954|170221||3 049913|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BXG|0|1|0|100|SEK|6598|10486|lyfsjukr|||1|10|0||Shire Sweden AB |BaxterAG*|Immúnóglóbúlín, normal, manna, gefin í æð||6598||6598|10486||3 049925|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BXG|0|1|0|100|SEK|16494|24107|lyfsjukr|||1|25|0||Shire Sweden AB |BaxterAG*|Immúnóglóbúlín, normal, manna, gefin í æð||16494||16494|24107||3 049936|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BXG|0|1|0|100|SEK|32988|44793|lyfsjukr|||1|50|0||Shire Sweden AB |BaxterAG*|Immúnóglóbúlín, normal, manna, gefin í æð||32988||32988|44793||3 049947|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BXG|0|1|0|100|SEK|65855|86364|lyfsjukr|||1|100|0||Shire Sweden AB |BaxterAG*|Immúnóglóbúlín, normal, manna, gefin í æð||65855||65855|86364||3 049964|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|7,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 050068|J05AP5401|Zepatier|filmhtfl|150|mg|28|stk|1|þpakki|100mg/50mg|J05AP54|01.05.2017||R|0|0|0|1|0|1|MBV|0|1|0|100|DKK|1641764|2048002|lyfsjukr|||1|28|0||Vistor hf|Merck Sharp & Dohme B.V.|Elbasvir og grazoprevir||1641764||1641764|2048002||1 050117|G04BE0309|Vizarsin|munndr.t|100|mg|24|stk|1|þpakki||G04BE03|01.01.2018||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|10000|6635|lyfalmen|||2|24|0|48,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||3800||3800|6635||2 050292|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|100|0|20,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||3508||1 050306|G04CA0104|Alfuzosin hydrochlorid ratiopharm|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.12.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|2925|5431|lyfalmen|||2|90|0|120,0000|Alvogen|ratiopharm GmbH|Alfúzósín||2925||2925|5431||2 050438|L04AA2701|Gilenya|hylki|0,5|mg|7|stk|1|þpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|55139|72810|lyfsjukr|||1|7|0|7,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||55139|72810||1 050510|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGH|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||||1 050563|N03AX1606|Pregabalin Mylan|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|923|2064|lyfalmen|V0685|1500|2|56|0|4,6667|Mylan AB|Generics (UK) Ltd.|Pregabalín||479||479|2064||2 050577|N06AX1614|Venlafaxin Krka|forðahlk|37,5|mg|100|stk|1|tfílát|hart|N06AX16|01.02.2018||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|3000|5534|lyfalmen|||2|100|0|37,5000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||3000||3000|5534||2 050604|C09DA0107|Losartan HCT Bluefish|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.01.2018||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|1877|2232|lyfalmen|V0088|2232|2|98|0|98,0000|Vistor hf|Bluefish Pharmaceuticals AB|Lósartan og þvagræsilyf||601||601|2232||1 050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2007||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|9849|14961|lyfalmen|V0688|4598|1|56|0|42,0000|Icepharma hf|Pfizer ApS|Pregabalín||9849||9849|14961||1 050679|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|0|0|AGH|0|0|0|100|IKR|4615|5837|lyfalmen|V0002|5837|2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||3220||3220|5837||1 050691|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|G|0|AGH|0|0|0|100|IKR|4360|2231|lyfalmen|V0006|2052|2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||600||600|2231||1 050702|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|100|stk|1|plglas||A02BC01|01.08.2010||R|1|0|0|0|G|0|AGH|0|0|0|100|IKR|6304|2919|lyfalmen|V0001|2781|2|100|0|200,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||1100||1100|2919||1 051109|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|50|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|851|2419|lyfalmen|V0363|2419|2|30|0|45,0000|Icepharma hf|Mylan AB|Fexófenadín||737||737|2419||2 051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|2617|4227|lyfalmen|V0365|4227|2|100|0|150,0000|Icepharma hf|Mylan AB|Fexófenadín||2050||2050|4227||2 051447|A07AA0203|Nystimex|mixtúra|100000|ae/ml|100|ml|1|glas|dreifa|A07AA02|01.04.2018||R|0|0|0|0|0|0|RPH|0|0|1|100|SEK|4427|7498|lyfalmen|||2|100|0||Vistor hf|RPH Pharmaceuticals AB|Nýstatín||4427||4427|7498||1 051550|N03AX1401|Keppra|irþ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|0|0|0|0|0|1|UCB|0|0|0|100|DKK|17259|25160|lyfsjukr|||1|50|0|3,3300|Vistor hf|U.C.B|Levetíracetam||17259||17259|25160||1 051761|R03AC0302|Bricanyl Turbuhaler|innönddu|0,5|mg/sk|100|skammtar|1|stauk||R03AC03|01.07.2012||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|623|2262|lyfalmen|||1|100|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||623||623|2262||1 052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|144|1603|lyfalmen|||2|20|0|5,0000|Icepharma hf|Mylan AB|Alprazólam||144||144|1603||2 052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|340|1873|lyfalmen|V0305|1033|2|50|0|12,5000|Icepharma hf|Mylan AB|Alprazólam||340||340|1873||2 052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.07.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|216|1702|lyfalmen|V0439|1702|2|20|0|10,0000|Icepharma hf|Mylan AB|Alprazólam||216||216|1702||2 052317|R02AX0101|Strefen|sogtfl|8,75|mg|16|stk|1|þpakki||R02AX01|01.11.2016||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|16|0|3,1800|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Flurbiprofen|||||||1 052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|496|2088|lyfalmen|||2|50|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||496||496|2088||2 052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|480|2066|lyfalmen|V0305|2066|2|100|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||480||480|2066||2 052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BMS|0|1|0|100|DKK|455615|572764|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Dasatíníb||455615||455615|572764||1 052405|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|1|glas||S01ED51|01.01.2010||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|2655|5059|lyfalmen|||1|3|0|30,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Tímólól í blöndum||2655||2655|5059||1 052414|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|3|glös||S01ED51|01.04.2018||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|6394|10206|lyfalmen|||1|9|0|180,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Tímólól í blöndum||6394||6394|10206||1 052478|D06BB0305|Zovirax (Lyf og heilsa)|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.03.2007||L|0|0|0|0|0|0|HOL|0|0|1|100|IKR|||lyflausa|||0|2|0||Lyf og heilsa|Lyf og heilsa|Acíklóvír|||||||2 052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|27451|37790|lyfsjukr|||1|8212|0||Vistor hf|Fresenius Kabi AB|Blöndur||27451||27451|37790||1 052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|22317|31297|lyfsjukr|||1|7698|0||Vistor hf|Fresenius Kabi AB|Blöndur||22317||22317|31297||1 052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|22965|32116|lyfsjukr|||1|7680|0||Vistor hf|Fresenius Kabi AB|Blöndur||22965||22965|32116||2 052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|20136|28538|lyfsjukr|||1|7200|0||Vistor hf|Fresenius Kabi AB|Blöndur||20136||20136|28538||2 052737|N05AX1205|Aripiprazol Krka|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|1|0|0|G|0|KRK|0|0|0|100|IKR|4946|4158|lyfalmen|V0682|3787|2|56|0|18,6670|LYFIS ehf|Krka Sverige AB|Aripiprazól||2000||2000|4158||2 052790|N06BA0904|Atomoxetine Sandoz|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.10.2017||R|1|1|0|0|0|0|SHS|0|0|0|100|DKK|9052|5358|lyfalmen|V0815|5218|2|28|0|14,0000|Artasan ehf|Sandoz A/S|Atomoxetín||2872||2872|5358||1 052838|A10BJ0201|Victoza|stl|6|mg/ml|3|ml|2|lyfjap|lausn,áfylltur lyfjapenni|A10BJ02|01.01.2012||R|0|0|0|0|0|0|NAS|0|0|0|100|DKK|11782|17622|lyfalmen|||1|6|0|30,0000|Vistor hf|Novo-Nordisk A/S|Liraglutide||11782||11782|17622||1 053055|C01BA0302|Durbis Retard|forðatfl|250|mg|100|stk|1|þpakki||C01BA03|01.05.1983||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|4280|7296|lyfalmen|||1|100|0|62,5000|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíð||4280||4280|7296||1 053155|N02AA5501|Targin|forðatfl|60|mg|28|stk|1|þpakki|40+20 mg|N02AA55|01.10.2012|30.06.2018|R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|9453|14416|lyfalmen|||1|28|0|14,9400|Icepharma hf|Norpharma|Oxycodonum í blöndum||9453||9453|14416||2 053166|N02AA5501|Targin|forðatfl|60|mg|98|stk|1|þpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|28404|38996|lyfalmen|||1|98|0|52,2700|Icepharma hf|Norpharma|Oxycodonum í blöndum||28404||28404|38996||2 053200|N02AA5501|Targin|forðatfl|7,5|mg|98|stk|1|þpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|4755|7950|lyfalmen|||1|98|0|6,5400|Icepharma hf|Norpharma|Oxycodonum í blöndum||4755||4755|7950||2 053211|N02AA5501|Targin|forðatfl|7,5|mg|28|stk|1|þpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|1394|3318|lyfalmen|||1|28|0|1,8700|Icepharma hf|Norpharma|Oxycodonum í blöndum||1390||1390|3318||2 053231|J07BB0201|Fluarix|stl|||0,5|ml|10|áf.spr||J07BB02|01.10.1994||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|4537|7650|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Inflúensa, hreinsaðir mótefnavakar||4537||4537|7650||1 053304|C10AA0508|Lipistad|filmhtfl|80|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|0|0|0|ASR|0|0|0|100|IKR|7435|8149|lyfalmen|V0115|8149|2|100|0|400,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||4900||4900|8149||2 053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|0|1|0|1|G|0|SDH|0|0|0|100|XEU|22992|32151|lyfalmen|V0453|29866|1|100|0|50,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíð||22992||22992|32151||1 053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|8524|13137|lyfalmen|||2|10|0|50,0000|Icepharma hf|Martindale Pharmaceuticals|Hýdrómorphón||8524||8524|13137||2 053932|N05AX1201|Abilify|stl|7,5|mg/ml|1,33|ml|1|hgl||N05AX12|01.01.2010||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|1220|3084|lyfalmen|||1|1,33|0|0,6650|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||1220||1220|3084||1 053991|D10AF0101|Dalacin|húðlausn|10|mg/ml|30|ml|1|glas||D10AF01|01.07.1985||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|901|2645|lyfalmen|||1|30|0||Icepharma hf|Pfizer ApS|Klindamýcín||901||901|2645|30.6.2018|1 054213|J07AG0101|Act-Hib|sts|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|0|0|0|0|0|0|SSS|0|0|0|100|XEU|2843|5318|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Haemophilus influenzae B||2843||2843|5318||1 054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0|1,2500|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1 054278|D01AE1502|Lamisil Once|húðlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|0|0|0|0|0|0|CON|0|0|1|100|IKR|||lyflausa|||0|4|0||Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Terbínafín|||||||1 054321|J01CA0801|Selexid|filmhtfl|400|mg|15|stk|1|þpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|1885|3999|lyfalmen|||1|15|0|10,0000|Vistor hf|LEO Pharma A/S|Pívmecillínam||1885||1885|3999||1 054332|J01CA0801|Selexid|filmhtfl|400|mg|20|stk|1|þpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|2584|4962|lyfalmen|||1|20|0|13,3300|Vistor hf|LEO Pharma A/S|Pívmecillínam||2584||2584|4962||1 054369|J05AP0101|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AP01|01.05.2007||R|0|0|0|1|0|1|ROA|0|0|0|100|DKK|33062|44887|lyfsjukr|||1|56|0|22,4000|Icepharma hf|Roche A.S.|Ribavirin||33062||33062|44887||2 054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0|2,5000|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1 054524|N05BB0101|Atarax|filmhtfl|25|mg|100|stk|1|þpakki||N05BB01|01.06.2014||R|1|0|0|0|0|0|UCN|0|0|1|100|SEK|930|2685|lyfalmen|V0907|2267|1|100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||930||930|2685||1 054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|0|0|0|0|0|0|UCN|0|0|0|100|SEK|878|2613|lyfalmen|||1|200|0|5,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||878||878|2613||1 054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|þpakki||N06AB03|01.10.2006||R|1|0|0|0|0|0|TCA|0|0|0|100|XEU|1143|2978|lyfalmen|V0061|2978|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||1143||1143|2978||1 054594|QN02AE0101|Vetergesic vet.|stl|300|mcg/ml|10|ml|1|hgl|lausn|QN02AE01|01.10.2010||R|0|0|1|0|0|0|CES|1|0|0|100|DKK|4436|8586|vetalmen|||0|10|0||Icepharma hf|Ceva Sante Animale|Buprenorphinhýdróklóríð||4436||4436|8586||2 055073|L04AA0606|Myfenax|hylki|250|mg|100|stk|1|þpakki||L04AA06|01.11.2013||R|1|1|0|1|G|0|TAB|0|0|0|100|XEU|16128|23603|lyfalmen|||2|100|0|12,5000|Alvogen|Teva Pharma B.V.|Mýcófenólsýra||16128||16128|23603||2 055084|L04AA0606|Myfenax|filmhtfl|500|mg|50|stk|1|þpakki||L04AA06|01.11.2013||R|1|1|0|1|G|0|TAB|0|0|0|100|XEU|5686|4803|lyfalmen|V0187|4072|2|50|0|12,5000|Alvogen|Teva Pharma B.V.|Mýcófenólsýra||2469||2469|4803||2 055164|S01AE0701|Vigamox|augndr|5|mg/ml|5|ml|1|glas|án rotvarnar|S01AE07|01.08.2010||R|0|0|0|0|0|0|HES|0|0|1|100|DKK|1627|3644|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Moxífloxacín||||1627|3644||1 055277|N02AA0101|Contalgin|forðatfl|60|mg|100|stk|1|þpakki||N02AA01|01.10.1995||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|7337|11504|lyfalmen|||1|100|0|60,0000|Icepharma hf|Pfizer ApS|Morfín||7337||7337|11504||1 055481|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|0|0|GRP|0|0|0|100|XEU|1492|3388|lyfalmen|V0467|1707|2|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1441||1441|3388||1 055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|36|0|1,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 055873|N05AX1304|Paliperidon Krka|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.08.2018||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|13500|18610|lyfalmen|V0965|18610|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Paliperídón||12500||12500|18610||2 055968|R03AC1302|Oxis Turbuhaler|innönddu|4,5|mcg/sk|60|skammtar|1|stauk||R03AC13|01.01.2016||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|2050|4227|lyfalmen|||1|60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||2050||2050|4227||1 056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2251|3077|lyfalmen|V0112|2713|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Atorvastatín||1215||1215|3077||1 056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|3161|3165|lyfalmen|V0113|2713|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Atorvastatín||1279||1279|3165||1 056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|4591|3165|lyfalmen|V0114|2713|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Atorvastatín||1279||1279|3165||1 056308|N07XX0701|Fampyra|forðatfl|10|mg|28|stk|1|þpakki||N07XX07|01.03.2013||R|0|0|0|1|0|0|BIB|0|0|0|100|XEU|25541|35374|lyfalmen|||1|28|0|14,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||25541||25541|35374||2 056442|QG03DA0401|Prid alpha|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.04.2011||R|0|0|0|0|0|0|CES|1|0|0|100|XEU|21486|37033|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||21486||21486|37033||2 056500|B01AF0301|Lixiana|filmhtfl|15|mg|10|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|0|G|0|OPE|0|0|0|100|DKK|2681|5095|lyfalmen|||1|10|0|2,5000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||2681||2681|5095||1 056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|glas||J01FA01|01.01.1986||R|1|0|0|0|0|0|MEA|0|0|1|100|DKK|1154|2993|lyfalmen|||1|40|0|10,0000|Icepharma hf|Meda AB|Erýtrómýcín||1154||1154|2993||2 056763|D11AH0201|Elidel|krem|1|%|15|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MEA|0|0|1|100|DKK|2112|4312|lyfalmen|||1|15|0||Icepharma hf|Meda AB|Pímekrólímus||2112||2112|4312||2 056915|L04AA2301|Tysabri|irþ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|0|1|0|0|0|1|BIB|0|1|0|100|XEU|171311|219170|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Biogen Idec Ltd|Natalizumab||171311||171311|219170||2 057042|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|6719|10653|lyfalmen|V0095|6254|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||6719||6719|10653||1 057304|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN05|01.08.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|4|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 057335|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2693|5112|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||2693||2693|5112||2 057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|3003|5538|lyfsjukr|||1|5|0|0,7100|Vistor hf|Novartis Healthcare A/S|Oktreótíð||3003||3003|5538||1 057365|N06AX1614|Venlafaxin Krka|forðahlk|75|mg|100|stk|1|tfílát|hart|N06AX16|01.02.2018||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2859|2781|lyfalmen|V0334|2781|2|100|0|75,0000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||1000||1000|2781||2 057376|N06AX1614|Venlafaxin Krka|forðahlk|150|mg|100|stk|1|tfílát|hart|N06AX16|01.02.2018||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|3700|2781|lyfalmen|V0335|2781|2|100|0|150,0000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||1000||1000|2781||2 057401|N06DA0406|Galantamine Alvogen|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.12.2011||R|1|0|0|0|G|0|POF|0|0|0|100|SEK|15283|20289|lyfalmen|V0350|19711|2|84|0|84,0000|Alvogen|Alvogen|Galantamín||13720||13720|20289||2 057422|B05XA3102|Tracel|irþ|||10|ml|20|plastl||B05XA31|01.01.1987||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3891|6760|lyfsjukr|||1|200|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með öðrum efnum||3891||3891|6760||1 057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|2116|4317|lyfsjukr|||1|5|0|0,3600|Vistor hf|Novartis Healthcare A/S|Oktreótíð||2116||2116|4317||1 057492|L01XC1001|Arzerra|irþ|20|mg/ml|50|ml|1|hgl|1000 mg pr. hgl.|L01XC10|01.03.2012||R|0|0|0|0|0|1|NEL|0|0|0|100|DKK|248254|314865|lyfsjukr|||1|50|0||Vistor hf|Novartis Europharm Ltd|Ofatúmúmabi||248254||248254|314865||1 057867|N06DX0107|Zalatine|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.03.2014||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|8340|3039|lyfalmen|V0607|2988|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||1187||1187|3039||2 057979|L01BC5901|Lonsurf|filmhtfl|21,14|mg|20|stk|1|þpakki|15 mg + 6,14 mg|L01BC59|01.09.2016||R|0|0|0|1|0|1|LLS|0|1|0|100|DKK|86698|112726|lyfsjukr|||1|20|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||86698|112726||2 058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|þpakki||N07BA03|01.03.2009||R|0|0|0|0|0|0|PHH|0|0|1|100|DKK|16050|23496|lyfalmen|||1|112|0|56,0000|Icepharma hf|Pfizer Limited|Vareniclin||||16050|23496||1 058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|0|0|0|0|G|0|SNP|0|0|0|100|XEU|335|1866|lyfalmen|||1|5|0|1,6667|Vistor hf|Sanofi-aventis Norge AS|Bútýlskópólamín||335||335|1866||1 058207|H01CB0501|Signifor|sts|40|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|0|1|NEL|0|0|0|100|DKK|328723|414946|lyfsjukr|||1|1|0|33,3300|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||328723||328723|414946||1 058283|QI01AD0401|Avipro Thymovac|frþlyf|||500|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|129088|222496|vetorma|||0|5000|0||Icepharma hf|Lohmann Animal Health|||||129088|222496||2 058294|QI01AD0401|Avipro Thymovac|frþlyf|||1000|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|196097|337993|vetorma|||0|10000|0||Icepharma hf|Lohmann Animal Health|||||196097|337993||2 058503|J01EA0107|Trimetoprim Meda|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|1029|2821|lyfalmen|||1|100|0|2,5000|Icepharma hf|Meda AB|Trímetóprím||1029||1029|2821||2 058609|N05AX1302|Xeplion|stl|50|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|27621|38005|lyfalmen|||1|1|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||27621||27621|38005||1 058622|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3958|6853|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Kolvetni||3958||3958|6853||2 058735|C03CA0105|Lasix Retard|forðahlk|30|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|953|2717|lyfalmen|||1|100|0|75,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||953||953|2717||1 058768|C03CA0105|Lasix Retard|forðahlk|60|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|1372|3293|lyfalmen|||1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||1372||1372|3293||1 059059|N06DA0405|Galantamin STADA|forðahlk|16|mg|84|stk|1|þpakki|Hart forðahylki|N06DA04|01.04.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|16000|19711|lyfalmen|V0350|19711|2|84|0|84,0000|LYFIS ehf|STADA Arzneimittel AG|Galantamín||13300||13300|19711||2 059070|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|þpakki||A02BC01|01.05.2011||R|1|0|0|0|G|0|AGH|0|0|0|100|IKR|2374|2644|lyfalmen|V0006|1149|2|56|0|56,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||900||900|2644||1 059224|A04AA0501|Aloxi|stl|250|mcg|5|ml|1|hgl|lausn|A04AA05|01.04.2013||R|0|0|0|0|0|0|HBP|0|0|1|100|DKK|8787|13499|lyfalmen|||1|5|0|1,0000|Swedish Orphan Biovitrum AB|Helsinn Birex Pharmaceuticals Ltd.|Palonosetrón||8787||8787|13499||3 059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|74958|97877|lyfalmen|||1|2|0|311,1900|Vistor hf|Astellas Pharma A/S|Leuprórelín||74958||74958|97877||1 059644|J02AX0601|Ecalta|st/irþ|100|mg|30|ml|1|hgl||J02AX06|01.11.2015||R|0|0|0|0|0|1|PHH|0|0|0|100|DKK|50721|67222|lyfsjukr|||1|30|0|30,0000|Icepharma hf|Pfizer Limited|Anidulafungin||50721||50721|67222||1 059767|N03AF0401|Zebinix|töflur|800|mg|30|stk|1|þpakki||N03AF04|01.03.2010||R|1|0|0|0|G|0|BPC|0|0|0|100|SEK|19694|28512|lyfalmen|||1|30|0|30,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||19694||19694|28512||1 059803|C08CA0502|Adalat Oros|forðatfl|30|mg|98|stk|1|þpakki||C08CA05|01.04.2013||R|1|0|0|0|G|0|BAB|0|0|0|100|DKK|4356|7401|lyfalmen|||1|98|0|98,0000|Icepharma hf|Bayer AB|Nífedipín||||4356|7401||2 059882|L04AD0203|Modigraf|mixt.kyr|0,2|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|0|1|0|0|ASP|0|0|0|100|XEU|7118|11202|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||7118||7118|11202||1 059938|L04AD0203|Modigraf|mixt.kyr|1|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|0|1|0|0|ASP|0|0|0|100|XEU|35590|48084|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||35590||35590|48084||1 059976|J01DD0402|Ceftriaxona Normon|irs|2000|mg|1|stk|1|hgl|lausn|J01DD04|01.06.2018||R|0|0|0|0|0|1|LNA|0|0|0|100|SEK|2740|5176|lyfsjukr|||2|1|0|1,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftríaxón||2740||2740|5176||2 060114|N02AB0305|Fentanyl ratiopharm|forðapl|25|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RTH|0|0|0|100|XEU|1652|3672|lyfalmen|V0219|3672|2|5|0|7,5000|Alvogen|ratiopharm GmbH|Fentanýl||1647||1647|3672||2 060123|N02AB0305|Fentanyl ratiopharm|forðapl|50|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RTH|0|0|0|100|XEU|2930|5180|lyfalmen|V0220|5180|2|5|0|15,0000|Alvogen|ratiopharm GmbH|Fentanýl||2743||2743|5180||2 060132|N02AB0305|Fentanyl ratiopharm|forðapl|75|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RTH|0|0|0|100|XEU|4225|6990|lyfalmen|V0221|6989|2|5|0|22,5000|Alvogen|ratiopharm GmbH|Fentanýl||4058||4058|6990||2 060141|N02AB0305|Fentanyl ratiopharm|forðapl|100|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RTH|0|0|0|100|XEU|4490|7458|lyfalmen|V0223|7458|2|5|0|30,0000|Alvogen|ratiopharm GmbH|Fentanýl||4398||4398|7458||2 060581|A10BD2001|Synjardy|filmhtfl|1012,5|mg|180|stk|1|þpakki|12,5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|17903|26047|lyfalmen|V0713|26047|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||17903||17903|26047||1 060930|J01AA0212|Doxycyklin EQL Pharma|töflur|100|mg|100|stk|1|þpakki||J01AA02|01.07.2018||R|1|0|0|0|0|0|EQL|0|0|1|100|IKR|3879|6744|lyfalmen|||2|100|0|100,0000|LYFIS ehf|EQL Pharma AB|Doxýcýklín||3879||3879|6744||2 061112|L04AA3101|AUBAGIO|filmhtfl|14|mg|28|stk|1|þpakki||L04AA31|01.09.2014||R|1|1|0|1|0|1|SGB|0|1|0|100|XEU|107102|139312|lyfsjukr|||1|28|0|28,0000|Vistor hf|Sanofi-aventis groupe|Teriflúnomíð||107102||107102|139312||1 061227|L01XE0103|Mylaukim|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.09.2014||R|0|0|0|1|0|1|WEH|0|1|0|100|XEU|84187|53309|lyfsjukr|||2|60|0||Williams & Halls efh|Williams & Halls ehf|Imatiníb||39721||39721|53309||2 061388|C10AA0508|Lipistad|filmhtfl|10|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|1994|2713|lyfalmen|V0112|2713|2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||950||950|2713||2 061460|G03CX0102|Livial (Lyf og heilsa)|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.04.2010||R|0|0|0|0|G|0|HOL|0|0|0|100|DKK|4856|7658|lyfalmen|V0133|6663|3|84|0|84,0000|Lyf og heilsa|Lyf og heilsa|Tíbólón||4543||4543|7658||2 061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PLS|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1 061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.07.1998||R|0|0|0|0|G|0|MBV|0|0|0|100|DKK|4544|7659|lyfalmen|V0133|6663|1|84|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Tíbólón||4544||4544|7659||1 061775|A06AH0301|Moventig|filmhtfl|25|mg|30|stk|1|þpakki||A06AH03|01.11.2017||R|1|0|0|0|0|0|KWA|0|0|0|100|XEU|10348|15648|lyfalmen|||1|30|0|30,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Naloxegol||10348||10348|15648||2 061937|L04AD0101|Sandimmun|irþ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|3297|5943|lyfsjukr|||1|10|0|2,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||3297||3297|5943||1 061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|1|0|1|0|1|MLD|0|0|0|100|DKK|12610|18761|lyfsjukr|||1|1|0|1,2500|Vistor hf|Merck Sharp & Dohme Limited|Daptomýcín||12610||12610|18761||1 061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|1|0|1|0|1|MLD|0|0|0|100|DKK|17548|25558|lyfsjukr|||1|1|0|1,7900|Vistor hf|Merck Sharp & Dohme Limited|Daptomýcín||17548||17548|25558||1 062341|L04AA0604|Mykofenolatmofetil Actavis|filmhtfl|500|mg|150|stk|1|þpakki||L04AA06|01.08.2010||R|0|1|0|1|G|0|GPA|0|0|0|100|XEU|11631|12217|lyfalmen|V0187|12217|2|150|0|37,5000|Actavis Group hf|Actavis Group PTC ehf|Mýcófenólsýra||7855||7855|12217||1 062347|G04BE0806|Tadalafil Krka|filmhtfl|10|mg|12|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|15000|9663|lyfalmen|V0924|9663|2|12|0|12,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||6000||6000|9663||2 062575|J05AP0801|Sovaldi|filmhtfl|400|mg|28|stk|1|glas||J05AP08|01.09.2015||R|0|0|0|1|0|1|GSE|0|1|0|100|XEU|1696789|2116437|lyfsjukr|||1|28|0|28,0000|Gilead Sience Sweden AB|Gilead Sciences Ireland|Sofosbuvir||||1696789|2116437||1 062704|R02AA0305|Strepsils Cool|sogtfl|||36|stk|1|þpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 062729|N05BA1204|Tafil Retard|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|737|2419|lyfalmen|V0308|2331|1|60|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||737||737|2419||1 062745|QP53AF0102|Sebacil vet.|húðlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|14319|24680|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|||14319||14319|24680||2 062793|J05AE1002|Darunavir Alvogen|filmhtfl|600|mg|60|stk|1|glas||J05AE10|01.07.2017||R|1|0|0|1|0|1|ALO|0|0|0|100|XEU|62041|78016|lyfsjukr|||2|60|0|30,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Darunavír||59255||59255|78016||2 062987|J07BM0201|Cervarix|stl|||0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|0|0|0|0|0|0|GBI|0|0|0|100|DKK|9962|12770|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||8257||8257|12770||1 063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|þpakki||J05AB09|01.10.1995||R|1|0|0|0|G|0|NAA|0|0|1|100|DKK|4551|7669|lyfalmen|||1|10|0|1,6667|Artasan ehf|Novartis Healthcare A/S|Famcíclóvír||4551||4551|7669||1 063180|N05AH0205|Clozapine Actavis|töflur|25|mg|100|stk|1|þpakki||N05AH02|01.05.2015||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|1456|3409|lyfalmen|V0276|3057|2|100|0|8,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Klózapín||1456||1456|3409||1 063255|N05AH0205|Clozapine Actavis|töflur|100|mg|100|stk|1|þpakki||N05AH02|01.07.2014||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|4495|4840|lyfalmen|V0277|4840|2|100|0|33,3333|Actavis Group PTC ehf|Actavis Group PTC ehf|Klózapín||2496||2496|4840||1 063514|C07AB0214|Bloxazoc|forðatfl|50|mg|30|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|500|2024|lyfalmen|||2|30|0|10,0000|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||450||450|2024||2 063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|0|0|0|0|0|0|MEA|0|0|0|100|DKK|||lyfalmen|||0|500|0|49,7761|Icepharma hf|Meda AB|Laktúlósa|||||2980||2 063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.11.2006||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|1730|3134|lyfalmen|V0123|3134|2|28|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Terbínafín||1256||1256|3134||1 063715|R06AX2702|Aerius (Lyf og heilsa)|töflur|5|mg|100|stk|1|þpakki||R06AX27|01.07.2011||R|1|0|0|0|G|0|HOL|0|0|1|100|XEU|3308|5958|lyfalmen|V0458|2644|3|100|0|100,0000|Lyf og heilsa|Lyf og heilsa|Deslóratadín||3308||3308|5958||2 063926|L04AC0701|RoActemra|stl|162|mg|4|áf.spr|1|pakki||L04AC07|01.12.2014||R|0|1|0|1|0|1|RRG|0|1|0|100|DKK|117737|152539|lyfsjukr|||1|4|0|32,4000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||117737||117737|152539||2 063958|N05BA1204|Tafil Retard|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|1621|3636|lyfalmen|V0310|3156|1|60|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||1621||1621|3636||1 064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|0|0|1|FEC|0|0|0|100|XEU|745837|933719|lyfsjukr|||1|20|0|11,6300|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||||745837|933719||2 064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|0|0|1|FEC|0|0|0|100|XEU|345282|435541|lyfsjukr|||1|20|0|4,6500|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||||345282|435541||2 064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|0|0|1|FEC|0|0|0|100|XEU|3048138|3797137|lyfsjukr|||1|20|0|46,5100|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||||3048138|3797137||2 064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|0|0|1|FEC|0|0|0|100|XEU|1356066|1692673|lyfsjukr|||1|20|0|23,2600|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||||1356066|1692673||2 064270|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|28|stk|1|þpakki||B01AC04|01.07.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|1628|3646|lyfalmen|V0009|3646|2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||1628||1628|3646||2 064281|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|100|stk|1|þpakki||B01AC04|01.07.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|5195|5669|lyfalmen|V0029|5669|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||3098||3098|5669||2 064402|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.06.2013||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|941|1849|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||941||941|1849||1 064727|QI09AE0401|Enterisol Ileitis vet.|frþlyf|||50|skammtar|1|hgl|+100 ml leysir, dreifa|QI09AE04|01.02.2016||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|5370|9256|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|lawsonia||||5370|9256||1 064732|A03BB0101|Buscopan|húðuðtfl|10|mg|100|stk|1|þpakki||A03BB01|01.03.2012||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|1646|3670|lyfalmen|||1|100|0|16,6700|Vistor hf|Sanofi-aventis Norge AS|Bútýlskópólamín||1646||1646|3670||1 064742|B02BD0101|Octaplex|irs|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.12.2011||R|0|0|0|1|0|1|OCT|0|0|0|100|DKK|32309|43935|lyfsjukr|||1|1|0||Vistor hf|Octapharma AB|Storkuþættir lX,ll,Vll,X||32309||32309|43935||1 064840|A03FA0102|Afipran|töflur|10|mg|50|stk|1|glas||A03FA01|01.03.2013||R|1|0|0|0|G|0|ASS|0|0|1|100|DKK|661|2315|lyfalmen|||2|50|0|6,6700|Vistor hf|Takeda AS|Metóklópramíð||661||661|2315||1 064956|A03FA0102|Afipran|stl|5|mg/ml|2|ml|10|lykjur|lausn|A03FA01|01.03.2013||R|0|0|0|0|G|0|ASS|0|0|1|100|DKK|380|1928|lyfalmen|||2|20|0|3,3300|Vistor hf|Takeda AS|Metóklópramíð||380||380|1928||1 065076|QM01AE0302|Ketodine vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.01.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|3967|7697|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Ketóprófen||3967||3967|7697||2 065200|J01DB0402|Cefazolina Normon|sts|1|g|1|stk|1|hgl|í vöðva|J01DB04|01.06.2018||R|0|0|0|0|0|1|LNA|0|0|0|100|SEK|469|2050|lyfsjukr|||2|1|0|0,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Cefazólín||469||469|2050||2 065314|G01AF0201|Canesten|sk-tfl|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2 065332|G01AF0201|Canesten|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2 065339|A07EA0604|Cortiment|forðatfl|9|mg|30|stk|1|þpakki||A07EA06|01.09.2015||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|12571|18708|lyfalmen|||1|30|0|30,0000|Vistor hf|Ferring Lægemidler A/S|Búdesóníð||12571||12571|18708||1 065441|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|8685|13359|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||8685||8685|13359||2 065468|M01AH0503|Coxerit|filmhtfl|60|mg|98|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|1|100|IKR|8600|7184|lyfalmen|V0830|7040|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||4199||4199|7184||2 065711|L02AE0306|Zoladex (Lyfjaver)|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.06.2011||R|0|0|0|1|G|0|LVR|0|0|0|100|SEK|39560|53106|lyfalmen|V0451|44152|3|1|0|83,7209|Lyfjaver ehf|Lyfjaver ehf|Góserelín||39560||39560|53106||3 065729|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|15,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065740|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|7,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065751|J01CR0204|Amoxin comp|mixtduft|80|mg/ml|70|ml|1|glas|80+11,4 mg|J01CR02|01.02.2013||R|0|0|0|0|0|0|RTH|0|0|1|100|IKR|954|2434|lyfalmen|V0163|2434|2|70|0|5,6000|Alvogen|ratiopharm GmbH|Amoxicillín og beta-laktamasa hemill ||748||748|2434||2 065752|N07BA0142|Nicorette Invisi|forðapl|10|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065753|N02AB0303|Fentanyl Actavis|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.05.2016||R|0|0|1|0|G|0|GPA|0|0|0|100|XEU|1300|3194|lyfalmen|V0222|3193|2|5|0|3,6000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||1300||1300|3194||1 065775|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|25,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065786|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|12,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065827|N02AJ0601|Parkodin|filmhtfl|510|mg|200|stk|1|ílát|10+500 mg|N02AJ06|01.02.2018||R|2|0|1|0|0|0|GPA|0|0|1|100|XEU|2116|4317|lyfalmen|||2|200|0|33,3333|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||2116||2116|4317||1 065870|V08AB0201|Omnipaque|stl|180|mg J/ml|10|ml|10|glhgl||V08AB02|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|2744|5182|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Jóhexól||2744||2744|5182||2 065934|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|28|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|GPA|0|0|0|100|SEK|553|2166|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||553||553|2166||1 065945|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|GPA|0|0|0|100|SEK|1870|3490|lyfalmen|||2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||1515||1515|3490||1 065956|C08CA1301|Lerkanidipin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|GPA|0|0|0|100|SEK|3248|5068|lyfalmen|||2|98|0|196,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||2661||2661|5068||1 066013|A11HA0801|Vedrop|mixtúra|50|mg/ml|20|ml|1|glas||A11HA08|01.07.2017||R|0|0|0|1|0|0|URE|0|0|0|100|XEU|8578|13212|lyfalmen|||0|20|0||Orphan Europe Nordic AB|Orphan Europe|Tocofersolanum||8578||8578|13212||3 066195|QM01AC0605|Melovem|stl|5|mg/ml|100|ml|1|hgl||QM01AC06|01.08.2011||R|0|0|0|0|0|0|DOR|1|0|0|100|DKK|3572|6947|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|Meloxícam||3572||3572|6947||2 066235|N05AX1209|Aripiprazole Sandoz|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.04.2016|31.07.2018|R|1|1|0|0|G|0|HSS|0|0|0|100|DKK|3752|4876|lyfalmen|||2|28|0|28,0000|Artasan ehf|Sandoz GmbH|Aripiprazól||2522||2522|4876||1 066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|4538|7651|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tíótrópíumbrómíð||4538||4538|7651||1 066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05AA07|01.05.2008||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|24387|33915|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Hýdróxyetýl sterkja||24387||24387|33915||1 066399|N07BA0106|Nicotinell|forðapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992|31.07.2018|L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|10,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 066407|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|21,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 066411|A01AA0101|Duraphat|tannpast|5|mg/ml|51|g|1|túpa||A01AA01|01.04.2011||R|0|0|0|0|0|0|GOG|0|0|1|100|DKK|749|2436|lyfalmen|||1|51|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||749||749|2436||2 066423|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|31,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 066497|N05AH0415|Quetiapin Krka|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.04.2018||R|0|1|0|0|G|0|KRK|0|0|0|100|IKR|7500|9388|lyfalmen|V0272|9388|2|100|0|75,0000|LYFIS ehf|Krka Sverige AB|Quetíapín||5800||5800|9388||2 066593|A02BC0111|Omeprazol Pensa|sþ-hylki|20|mg|100|stk|1|glas|2x50 stk|A02BC01|01.12.2012||R|1|0|0|0|G|0|PEN|0|0|0|100|XEU|1149|2986|lyfalmen|V0006|2052|2|100|0|100,0000|Lyfjaver ehf|Pensa Pharma AB|Ómeprazól||1149||1149|2986||3 066751|C01BD0103|Cordarone (Lyf og heilsa)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.11.2006||R|1|0|0|0|G|0|HOL|0|0|0|100|NOK|756|2445|lyfalmen|V0036|2445|3|30|0|15,0000|Lyf og heilsa|Lyf og heilsa|Amíódarón||756||756|2445||2 066862|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|þpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGH|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||||1 066897|L01CD0104|Paclitaxel Actavis|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.06.2010||R|0|0|0|0|0|1|GPA|0|0|0|100|XEU|6714|10646|lyfsjukr|||2|50|0||Actavis Group hf|Actavis Group PTC ehf|Paklítaxel||6714||6714|10646||1 067001|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|50|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|7002|11042|lyfsjukr|||1|5000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||7002||7002|11042||1 067215|C01BC0402|Flecainid STADA|töflur|100|mg|100|stk|1|þpakki||C01BC04|01.01.2018||R|1|0|0|1|G|0|ASR|0|0|0|100|IKR|3320|3979|lyfalmen|V0933|3979|2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Flekaíníð||1870||1870|3979||2 067229|J05AR1901|Odefsey|filmhtfl|250|mg|30|stk|1|glas|200+25+25 mg|J05AR19|01.09.2016||R|0|0|0|1|0|1|GIL|0|0|0|100|DKK|103184|134439|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Science International Limited|Emtricitabine, tenofovir alafenamide og rilpivirine||||103184|134439||2 067877|B05BA0314|Glucos Baxter Viaflo|irl|100|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1893|4010|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||||1893|4010||2 068358|L01XC1001|Arzerra|irþ|20|mg/ml|5|ml|3|hgl|100 mg pr. hgl.|L01XC10|01.03.2012||R|0|0|0|0|0|1|NEL|0|0|0|100|DKK|85648|111398|lyfsjukr|||1|15|0||Vistor hf|Novartis Europharm Ltd|Ofatúmúmabi||85648||85648|111398||1 068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|þpakki||C01BC04|01.04.1987||R|1|0|0|1|G|0|MEA|0|0|0|100|DKK|1167|3011|lyfalmen|||1|20|0|10,0000|Icepharma hf|Meda AB|Flekaíníð||1167||1167|3011|30.6.2018|2 068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|þpakki||C01BC04|01.04.1987||R|1|0|0|1|G|0|MEA|0|0|0|100|DKK|4020|5266|lyfalmen|V0933|3979|1|100|0|50,0000|Icepharma hf|Meda AB|Flekaíníð||2805||2805|5266||2 068509|R01AD0902|Kalmente|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.11.2015||L|0|0|0|0|G|0|IPC|0|0|1|100|IKR|||lyfalmen|V0677|2660|2|140|0|35,0000|Alvogen|Alvogen IPco S.á.r.l.|Mómetasón|||||3030||2 068555|J05AB1106|Valablis|filmhtfl|500|mg|40|stk|1|þpakki||J05AB11|01.06.2017||R|1|0|0|0|G|0|POF|0|0|1|100|GBP|5354|3490|lyfalmen|V0182|3424|2|40|0|6,6700|Alvogen|Alvogen|Valacíklóvír||1515||1515|3490||2 068629|A10BG0302|Pioglitazone Actavis|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.02.2017||R|1|1|0|0|G|0|GRP|0|0|0|100|XEU|5623|6489|lyfalmen|||2|98|0|49,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||3694||3694|6489||1 068776|R06AX2704|Desloratadine ratiopharm|munndr.t|5|mg|30|stk|1|þpakki||R06AX27|01.04.2014||L|0|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Alvogen|ratiopharm GmbH|Deslóratadín|||||||2 068811|L04AX0307|Metoject|stl|50|mg/ml|0,55|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2446|4772|lyfalmen|||1|0,55|0|11,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2446||2446|4772||2 068860|A02BC0308|Lansoprazol Krka|sþ-hylki|15|mg|28|stk|1|þpakki||A02BC03|01.08.2018||L|1|0|0|0|0|0|KRK|0|0|0|100|IKR|||lyflausa|||2|28|0|14,0000|LYFIS ehf|Krka Sverige AB|Lansóprazól|||||||2 068896|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA03|01.09.2010||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|2000|4158|lyfsjukr|||2|400|0||Actavis Group hf|B.Braun Melsungen AG|Natríumklóríð||2000||2000|4158||2 068905|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA01|01.09.2010||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|1869|3977|lyfsjukr|||2|400|0||Actavis Group hf|B.Braun Melsungen AG|Kalíumklóríð||1869||1869|3977||2 068923|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|200|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3529||2 068933|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|400|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3712||2 068951|V07AB0009|Sterilt Vann B. Braun|leysir|||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|200|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3483||2 068960|V07AB0009|Sterilt Vann B. Braun|leysir|||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|400|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3662||2 069106|H01BA0201|Minirin|frþ.tfl|240|mcg|30|stk|1|þpakki||H01BA02|01.08.2012||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|11251|16891|lyfalmen|||1|30|0|18,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||11251||11251|16891||1 069115|H01BA0201|Minirin|frþ.tfl|240|mcg|100|stk|1|þpakki||H01BA02|01.08.2012||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|35512|47986|lyfalmen|||1|100|0|60,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||35512||35512|47986||1 069177|C10AA0704|Rosuvastatin Xiromed|filmhtfl|40|mg|100|stk|1|þpakki||C10AA07|01.04.2018||R|0|0|0|0|0|0|VAL|0|0|0|100|IKR|9540|10076|lyfalmen|V0195|10076|2|100|0|400,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||6300||6300|10076||2 069347|C02KX0501|Adempas|filmhtfl|1|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|320328|404505|lyfsjukr|||1|84|0|18,6700|Vistor hf|Bayer AG|Riociguatum||320328||320328|404505||1 069423|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 069596|A02BC0308|Lansoprazol Krka|sþ-hylki|15|mg|56|stk|1|þpakki||A02BC03|01.08.2018||L|1|0|0|0|0|0|KRK|0|0|0|100|IKR|||lyflausa|||2|56|0|28,0000|LYFIS ehf|Krka Sverige AB|Lansóprazól|||||||2 069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|0|0|0|0|0|0|CON|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Terbínafín|||||||1 069912|J05AF1301|Vemlidy|filmhtfl|25|mg|30|stk|1|þpakki||J05AF13|01.08.2017||R|0|0|0|1|0|1|GEI|0|0|0|100|DKK|53204|70363|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland|Tenófóvír alafenamíð||||53204|70363||2 070113|B01AC0601|Hjartamagnyl|sþ-tfl|75|mg|500|stk|1|glas||B01AC06|01.10.2012||L|1|0|0|0|0|0|GPA|0|0|0|100|IKR|||lyflausa|||0|500|0|500,0000|Actavis Group hf|Actavis Group PTC ehf|Asetýlsalicýlsýra|||||||1 070563|B02BD0208|Afstyla|sts|250|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|0|1|0|1|CSB|0|1|0|100|SEK|17061|24888|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||17061||17061|24888||2 070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|með skammtasprautu|N05AX08|01.01.1997||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|7771|12101|lyfalmen|||1|100|0|20,0000|Vistor hf|Janssen-Cilag AB|Risperídón||7771||7771|12101||1 070921|QI04AB0901|Gudair|stl|||30|ml|1|glas|dreifa|QI04AB09|01.09.2016||R|0|0|0|0|0|0|CZV|1|0|0|100|XEU|5565|9592|vetorma|||0|30|0||Vistor hf|CZ Veterinaria SA|Bóluefni gegn Mycobacterium||5565||5565|9592||1 071029|C07AB0214|Bloxazoc|forðatfl|25|mg|30|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|445|2017|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||445||445|2017||2 071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|0|0|0|0|0|1|RIE|0|0|0|100|SEK|44330|59139|lyfsjukr|||1|1|0|8,3300|Vistor hf|RIEMSER Pharma GmbH|Ziconotíð||44330||44330|59139||1 071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|0|0|0|0|0|1|RIE|0|0|0|100|SEK|224196|284944|lyfsjukr|||1|5|0|41,6500|Vistor hf|RIEMSER Pharma GmbH|Ziconotíð||224196||224196|284944||1 071528|N03AX1608|Pregabalina Tecnigen|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.01.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|3860|2231|lyfalmen|V0686|2083|2|56|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Pregabalín||600||600|2231||2 071975|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.09.2011||R|0|0|0|1|0|1|GEB|0|0|0|100|XEU|60672|79808|lyfsjukr|||1|20|0||Vistor hf|Genzyme Europe B.V.|Flúdarabín||||60672|79808||1 071998|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|þpakki||H03AA01|01.06.2015||R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|475|2059|lyfalmen|||1|100|0|66,6700|Icepharma hf|Merck KgaA|Levótýroxínnatríum||475||475|2059||2 072021|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|þpakki||H03AA01|01.06.2015||R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|362|1903|lyfalmen|||1|100|0|33,3300|Icepharma hf|Merck KgaA|Levótýroxínnatríum||362||362|1903||2 072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|0|0|0|0|0|0|ORF|1|0|0|100|DKK|5581|10759|vetalmen|||0|5|0||Vistor hf|Orion-Farmos|||5581||5581|10759||1 072233|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|300|stk|1|þpakki||N07BA01|01.02.2010|31.07.2018|L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 072380|B01AC0402|Grepid|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.12.2009||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|5195|5701|lyfalmen|V0029|5669|2|100|0|100,0000|Alvogen|Pharmathen S.A.|Klópídógrel||3121||3121|5701||2 072641|V04CX0001|Lung test gas CO (HE) Aga|lyfjagas|0,28|%|20|l|1|hylki|undir þrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|184552|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Önnur sjúkdómsgreiningarefni||143477||143477|184552||5 072654|V04CX0002|Lung test gas CO (C2H2/CH4) Aga|lyfjagas|0,3|%|20|l|1|hylki|undir þrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|184552|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Önnur sjúkdómsgreiningarefni||143477||143477|184552||5 072701|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|200|stk|1|glas|með br. losunarhraða|G04CA02|01.12.2017||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|6000|6911|lyfalmen|V0148|6718|2|200|0|200,0000|Medical ehf|Medical ehf|Tamsúlósín||4000||4000|6911||2 072735|L04AX0306|Metojectpen|stl|20|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2751|5191|lyfalmen|||1|1|0|8,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2751||2751|5191||2 072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|421|1984|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag AB|Súfentaníl||421||421|1984||1 073027|J05AG0401|Intelence|töflur|200|mg|60|stk|1|glas||J05AG04|01.04.2012||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|44306|59108|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||44306||44306|59108||1 073030|N05AH0410|Quetiapin Actavis|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.08.2013||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|7052|6503|lyfalmen|V0286|6068|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||3704||3704|6503||1 073178|A10BA0204|Metformin Sandoz|filmhtfl|500|mg|100|stk|1|þpakki||A10BA02|01.01.2016||R|0|0|0|0|G|0|SHS|0|0|0|100|DKK|368|1883|lyfalmen|V0500|1873|2|100|0|25,0000|Artasan ehf|Sandoz A/S|Metformín||347||347|1883||1 073276|C02KX0401|Opsumit|filmhtfl|10|mg|30|stk|1|þpakki||C02KX04|01.09.2014||R|1|1|0|1|0|1|ACV|0|1|0|100|SEK|276107|349507|lyfsjukr|||1|30|0|30,0000|Vistor hf|Actelion Registration Ltd.|Macitentan||||276107|349507||1 073313|L01XE1601|Xalkori|hylki|200|mg|60|stk|1|þpakki||L01XE16|01.05.2013||R|1|1|0|1|0|1|PHH|0|1|0|100|DKK|534545|670931|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Limited|Crizotiníb||534545||534545|670931||1 073495|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|38 mg/8 mg|QP54AB51|01.04.2018||R|0|0|0|0|0|0|MER|0|0|0|100|XEU|2270|3913|vetorma|||0|3|0||Vistor hf|Merial|Milbemycin oxime í blöndum||2270||2270|3913||1 073520|N02AE0101|Bupremyl|forðapl|10|mcg/klst|4|stk|1|skpoki||N02AE01|01.03.2018||R|0|0|1|0|G|0|MYL|0|0|0|100|IKR|1874|3401|lyfalmen|V0944|3401|2|4|0|5,6000|Icepharma hf|Mylan AB|Búprenorfín||1450||1450|3401||2 073559|G04CA5201|Duodart|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.12.2010||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|2703|5125|lyfalmen|||1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Dútasteríð og tamsúlósínhýdroklóríð||2703||2703|5125||1 073682|L01XE1301|Giotrif|filmhtfl|50|mg|28|stk|1|þpakki||L01XE13|01.05.2016||R|0|0|0|1|0|1|BOE|0|1|0|100|DKK|232131|294813|lyfsjukr|||1|28|0||Vistor hf|Boehringer Ingelheim International GmbH|Afatiníb||232131||232131|294813||1 073708|L02BG0405|Letrozol Actavis|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.09.2011||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|13295|12144|lyfalmen|V0185|11710|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Letrózól||7802||7802|12144||1 073803|G04BE0806|Tadalafil Krka|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.12.2017||R|0|0|0|0|0|0|KNM|0|0|0|100|IKR|4700|3745|lyfalmen|V0924|3221|2|4|0|4,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||1700||1700|3745||2 073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|||lyfalmen|V0305||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Alprazólam|||||||1 073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|410|1969|lyfalmen|V0439|1702|1|20|0|10,0000|Icepharma hf|Pfizer ApS|Alprazólam||410||410|1969||1 073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|1113|2937|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Alprazólam||1113||1113|2937||1 073933|C09AA0211|Enalapril Krka|töflur|2,5|mg|100|stk|1|þpakki||C09AA02|01.04.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|926|2679|lyfalmen|||2|100|0|25,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||926||926|2679||2 073935|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|1|l|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|2792|4812|vetorma|||0|1|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||2792||2792|4812||2 073947|L04AX0102|Imurel|töflur|25|mg|50|stk|1|þpakki||L04AX01|01.12.2010||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|768|2462|lyfalmen|||1|50|0|8,3333|Icepharma hf|Aspen Pharma Trading Limited|Azatíóprín||768||768|2462||2 074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|1|0|0|0|0|0|NEL|0|0|0|100|DKK|2531|4889|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||2531||2531|4889||1 074364|J01CE0207|Fenoximetylpenicillin EQL Pharma|filmhtfl|1|g|40|stk|1|þpakki||J01CE02|01.01.2018||R|0|0|0|0|0|0|EQL|0|0|1|100|IKR|917|2667|lyfalmen|||2|40|0|20,0000|LYFIS ehf|EQL Pharma AB|Fenoxýmetýlpenicillín||917||917|2667||2 074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|GRP|0|0|1|100|DKK|619|2257|lyfalmen|||2|25|0|12,5000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||619||619|2257||1 074477|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.10.2013||L|1|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||2|30|0|5,0000|Alvogen|ratiopharm GmbH|Paracetamól|||||||2 074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|1|0|0|0|0|0|GRP|0|0|0|100|DKK|487|2075|lyfalmen|||2|50|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||487||487|2075||1 074492|N05BA0105|Stesolid|töflur|5|mg|100|stk|1|glas||N05BA01|01.08.2011||R|1|0|0|0|0|0|GRP|0|0|0|100|DKK|793|2496|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||793||793|2496||1 074608|N03AX1606|Pregabalin Mylan|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|IKR|5446|4433|lyfalmen|V0689|3498|2|56|0|56,0000|Mylan AB|Generics (UK) Ltd.|Pregabalín||2200||2200|4433||2 074667|N06AA0905|Amitriptyline|filmhtfl|10|mg|98|stk|1|þpakki||N06AA09|01.03.2011||R|1|0|0|0|G|0|UAK|0|0|0|100|GBP|574|2111|lyfalmen|V0923|2012|2|98|0|13,0700|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||513||513|2111||1 074679|N06AA0905|Amitriptyline|filmhtfl|25|mg|98|stk|1|þpakki||N06AA09|01.02.2011||R|1|0|0|0|G|0|UAK|0|0|0|100|GBP|724|2366|lyfalmen|V0510|2234|2|98|0|32,6600|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||698||698|2366||1 074758|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.12.2010||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|605|2238|lyfalmen|||1|60|0|12,0000|Icepharma hf|Aspen Pharma Trading Limited|Digoxín||605||605|2238||2 074782|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.09.2010||R|1|0|0|0|G|0|AEP|0|0|0|100|DKK|305|1825|lyfalmen|||1|100|0|100,0000|Icepharma hf|Aspen Pharma Trading Limited|Digoxín||305||305|1825||2 075009|L04AX0102|Imurel|töflur|50|mg|100|stk|1|þpakki||L04AX01|01.08.2011||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|1773|3845|lyfalmen|||1|100|0|33,3333|Icepharma hf|Aspen Pharma Trading Limited|Azatíóprín||1773||1773|3845||2 075031|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|0|G|0|NEL|0|0|1|100|DKK|4366|7414|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||4366||4366|7414||1 075042|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|0|G|0|NEL|0|0|1|100|DKK|12801|19024|lyfalmen|||1|90|0|90,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||12801||12801|19024||1 075064|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|0|G|0|NEL|0|0|1|100|DKK|4611|7752|lyfalmen|||1|30|0|60,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||4611||4611|7752||1 075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNP|0|0|1|100|XEU|1522|3500|lyfalmen|V0363|2419|1|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1522||1522|3500||1 075075|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|0|G|0|NEL|0|0|1|100|DKK|13503|19990|lyfalmen|||1|90|0|180,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||13503||13503|19990||1 075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 075087|N02AJ0601|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02AJ06|01.07.2007|30.06.2018|R|2|0|1|0|0|0|GPA|0|0|1|100|XEU|3162|5757|lyfalmen|||2|300|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||3162||3162|5757||1 075140|R03AL0601|Spiolto Respimat|innöndl|5|mcg|1|rörlyk|1|pakki|2,5+2,5 mcg|R03AL06|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|6685|10606|lyfalmen|||1|1|0||Vistor hf|Boehringer Ingelheim International GmbH|Olodaterol og tiotropiumbromide||6685||6685|10606||1 075187|A06AD0001|Moviprep|mixtduft|||4|pokar|1|pakki||A06AD|01.09.2011||L|0|0|0|0|0|0|NBV|0|0|0|100|DKK|||lyfalmen|||1|4|0||Norgine BV|Norgine BV|Hægðalyf með osmótíska verkun|||||4108||1 075451|G04CB0106|Finasteride Alvogen|filmhtfl|5|mg|98|stk|1|þpakki||G04CB01|01.05.2011||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|3296|3966|lyfalmen|||2|98|0|98,0000|Alvogen|Alvogen|Fínasteríð||1861||1861|3966|31.8.2018|2 075777|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|þpakki||QG03DA02|01.03.2011||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|968|1903|vetalmen|||0|20|0||Vistor hf|Dechra Veterinary Products A/S|Medroxyprogesteronum||968||968|1903||1 075865|G04BD0805|Solifenacin Alvogen|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|10157|14923|lyfalmen|V0440|14923|2|90|0|90,0000|Alvogen|Alvogen|Sólífenacín||9821||9821|14923||2 075869|B05DB0005|Balance|kvið.sk|1,5|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|NOK|4435|7509|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||4435||4435|7509||2 075888|B05DB0005|Balance|kvið.sk|2,3|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|NOK|4435|7509|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||4435||4435|7509||2 075906|B05DB0005|Balance|kvið.sk|4,25|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|4816|8034|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||4816||4816|8034||2 075936|P01BC0104|Quinine Sulphate Actavis|filmhtfl|200|mg|28|stk|1|þpakki||P01BC01|01.07.2010||R|1|0|0|0|0|0|UAK|0|0|0|100|GBP|560|2176|lyfalmen|||2|28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Kínín||560||560|2176||1 076024|A10BH0101|Januvia|filmhtfl|100|mg|28|stk|1|þpakki||A10BH01|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|5085|8404|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Sítagliptín||5085||5085|8404||1 076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|þpakki||A10BH01|01.11.2007||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|15579|22848|lyfalmen|||1|98|0|98,0000|Vistor hf|M.S.D.|Sítagliptín||||15579|22848||1 076043|A10BH0101|Januvia|filmhtfl|25|mg|98|stk|1|þpakki||A10BH01|01.02.2013||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|15628|22915|lyfalmen|||1|98|0|24,5000|Vistor hf|M.S.D.|Sítagliptín||15628||15628|22915||1 076052|A10BH0101|Januvia|filmhtfl|50|mg|98|stk|1|þpakki||A10BH01|01.10.2012||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|15659|22958|lyfalmen|||1|98|0|49,0000|Vistor hf|M.S.D.|Sítagliptín||15659||15659|22958||1 076237|G04BE0309|Vizarsin|filmhtfl|50|mg|4|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|1605|2368|lyfalmen|V0143|1140|2|4|0|4,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||700||700|2368||2 076248|G04BE0309|Vizarsin|filmhtfl|50|mg|8|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|2971|3478|lyfalmen|V0143|2280|2|8|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1506||1506|3478||2 076259|G04BE0309|Vizarsin|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|3742|3470|lyfalmen|V0143|3420|2|12|0|12,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1500||1500|3470||2 076270|G04BE0309|Vizarsin|filmhtfl|100|mg|4|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|1667|2520|lyfalmen|V0144|1302|2|4|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||810||810|2520||2 076282|G04BE0309|Vizarsin|filmhtfl|100|mg|8|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|3208|3804|lyfalmen|V0144|2604|2|8|0|16,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1743||1743|3804||2 076293|G04BE0309|Vizarsin|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|7023|4089|lyfalmen|V0144|3906|2|12|0|24,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1950||1950|4089||2 076361|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.12.2009||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5 076378|N05AX0805|Risperidon Alvogen|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|1553|2368|lyfalmen|V0290|2231|2|60|0|6,0000|Alvogen|Alvogen ehf|Risperídón||700||700|2368||2 076387|N05AX0805|Risperidon Alvogen|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|1604|2368|lyfalmen|V0291|2231|2|60|0|12,0000|Alvogen|Alvogen ehf|Risperídón||700||700|2368||2 076403|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|dropaí||S01GX08|01.06.2013||L|0|0|0|0|G|0|TEA|0|0|0|100|SEK|||lyfalmen|||1|5|0||Vistor hf|Laboratories THEA|Ketotifen|||||2982||1 076435|G04BE0313|Sildenafil Medical Valley|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.03.2018||R|1|0|0|0|0|0|VAL|0|0|0|100|XEU|4209|3906|lyfalmen|V0144|3906|2|12|0|24,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||1817||1817|3906||2 076628|N05AX0806|Risperidon Krka|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.08.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1500|2231|lyfalmen|V0290|2231|2|60|0|6,0000|LYFIS ehf|Krka Sverige AB|Risperídón||600||600|2231||2 076667|B02BD0207|ReFacto AF|sts|3000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PIZ|0|1|0|100|DKK|214411|272774|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Ltd|Storkuþáttur VIII||214411||214411|272774||1 076680|B02BD0207|ReFacto AF|sts|2000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PIZ|0|1|0|100|DKK|142941|183886|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Ltd|Storkuþáttur VIII||142941||142941|183886||1 076691|B02BD0207|ReFacto AF|sts|1000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PIZ|0|1|0|100|DKK|71580|93605|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Ltd|Storkuþáttur VIII||71580||71580|93605||1 076702|B02BD0207|ReFacto AF|sts|500|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PIZ|0|1|0|100|DKK|36001|48604|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Ltd|Storkuþáttur VIII||36001||36001|48604||1 076781|N02AA0506|Oxikodon Depot Actavis|forðatfl|10|mg|98|stk|1|glas||N02AA05|01.09.2015||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|2300|4571|lyfalmen|V0598|4569|2|98|0|13,0700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||2300||2300|4571||1 076792|B02BD0208|Afstyla|sts|1000|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|0|1|0|1|CSB|0|1|0|100|SEK|65982|86524|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||65982||65982|86524||2 076871|G01AF0202|Canesten (Lyf og heilsa)|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.12.2009||L|0|0|0|0|0|0|HOL|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Lyf og heilsa|Lyf og heilsa|Klótrímazól|||||||2 076995|G04BE0809|Tadalafil ratiopharm|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.07.2018||R|1|0|0|0|0|0|RTH|0|0|0|100|XEU|4037|3742|lyfalmen|V0145|2805|2|4|0|8,0000|Alvogen|ratiopharm GmbH|Tadalafíl||1698||1698|3742||2 077213|A02BC0509|Esomeprazole Alvogen|sþ-tfl|40|mg|30|stk|1|þpakki||A02BC05|01.09.2015||R|1|0|0|0|0|0|IPC|0|0|0|100|IKR|1933|2093|lyfalmen|V0005|2093|2|30|0|40,0000|Alvogen|Alvogen IPco S.á.r.l.|Esómeprazól||500||500|2093||2 077324|B02BD0102|Cofact|sts|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.02.2015||R|0|0|0|1|0|1|SPP|0|0|0|100|XEU|42403|56702|lyfsjukr|||1|1|0||Williams & Halls efh|Sanquin Plasma Product|Storkuþættir lX,ll,Vll,X||42403||42403|56702||2 077420|N02AJ0601|Parkodin|töflur|510|mg|30|stk|1|þpakki|10+500 mg|N02AJ06|01.01.1985|30.06.2018|R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|369|1913|lyfalmen|||2|30|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||369||369|1913||1 077446|N02AJ0601|Parkodin|töflur|510|mg|100|stk|1|þpakki|10+500 mg|N02AJ06|01.01.1985|30.06.2018|R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|1048|2847|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||1048||1048|2847||1 077606|N06BA0405|Medikinet|töflur|5|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|819|2532|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||819||819|2532||2 077615|N06BA0405|Medikinet|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|874|2300|lyfalmen|V0671|2300|2|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||650||650|2300||2 077624|N06BA0405|Medikinet|töflur|20|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|2324|4604|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||2324||2324|4604||2 077633|N06BA0406|Medikinet CR|hylki|10|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|3300|5947|lyfalmen|||2|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||3300||3300|5947||2 077642|N06BA0406|Medikinet CR|hylki|20|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|5000|8287|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||5000||5000|8287||2 077652|N06BA0406|Medikinet CR|hylki|30|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|6300|10076|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||6300||6300|10076||2 077661|N06BA0406|Medikinet CR|hylki|40|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|8120|12581|lyfalmen|||2|30|0|40,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||8120||8120|12581||2 077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|587|2213|lyfalmen|||1|10|0|0,8333|Vistor hf|GlaxoSmithKline Pharma A/S|Ranitidín||587||587|2213||1 077881|N05AH0413|Quetiapin ratiopharm|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.05.2016||R|1|1|0|0|G|0|TVA|0|0|0|100|IKR|8800|5534|lyfalmen|V0275|5259|2|100|0|12,5000|Alvogen|Teva B.V.|Quetíapín||3000||3000|5534||2 078145|B01AF0301|Lixiana|filmhtfl|30|mg|30|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|0|G|0|OPE|0|0|0|100|DKK|8042|12474|lyfalmen|||1|30|0|15,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||8042||8042|12474||1 078193|D01AC0102|Canesten (Lyf og heilsa)|krem|1|%|20|g|1|túpa||D01AC01|01.12.2009||L|0|0|0|0|0|0|HOL|0|0|1|100|IKR|||lyflausa|||0|20|0||Lyf og heilsa|Lyf og heilsa|Klótrímazól|||||||2 078457|QD11AH9001|Apoquel|töflur|16|mg|100|stk|1|þpakki||QD11AH90|01.06.2017||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|24951|47508|vetalmen|||0|100|0||Icepharma hf|Zoetis Belgium S.A.|Oclacitinib||24951||24951|47508||2 078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|532|2137|lyfalmen|||1|20|0|2,5000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||532||532|2137||2 078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|817|2529|lyfalmen|||1|40|0|5,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||817||817|2529|31.8.2018|2 078674|N06BA1201|Elvanse Adult|hylki|50|mg|30|stk|1|glas|hart|N06BA12|01.06.2018||R|1|1|1|0|0|0|SHI|0|0|0|100|DKK|10757|16211|lyfalmen|||1|30|0|50,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|lisdexamfetamine||10757||10757|16211||3 079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.01.1995||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|7057|5483|lyfalmen|V0069|2456|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan||2963||2963|5483||1 079109|J05AP0701|Daklinza|filmhtfl|60|mg|28|stk|1|þpakki||J05AP07|01.10.2015||R|1|0|0|1|0|1|BMS|0|1|0|100|DKK|1122160|1401760|lyfsjukr|||1|28|0|28,0000|Vistor hf|Bristol-Myers Squibb Pharma EEIG|Daclatasvír||1122160||1122160|1401760||1 079272|N06DX0109|Marbodin|filmhtfl|10|mg|30|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|2071|3882|lyfalmen|V0901|3882|2|30|0|15,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||1800||1800|3882||2 079358|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.05.2010|31.07.2018|L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 079409|N03AX1604|Brieka|hylki|225|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|8730|10288|lyfalmen|V0688|8211|2|100|0|75,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||6454||6454|10288||1 079410|N05AX1207|Lemilvo|töflur|10|mg|100|stk|1|glas||N05AX12|01.03.2016||R|1|1|0|0|G|0|GPA|0|0|0|100|XEU|10223|7420|lyfalmen|V0683|6763|2|100|0|66,6700|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||4370||4370|7420||1 079495|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|100|stk|1|þpakki||N06AB03|01.05.2010||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|2757|5200|lyfalmen|V0315|5200|2|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||2757||2757|5200||1 079597|L02BG0305|Anastrozole Teva|filmhtfl|1|mg|100|stk|1|þpakki||L02BG03|01.05.2014||R|0|0|0|0|G|0|TSA|0|0|0|100|IKR|9500|5476|lyfalmen|V0184|5393|2|100|0|100,0000|Alvogen|Teva Sweden AB|Anastrózól||2958||2958|5476||2 079654|R05CB0106|Mucolysin|freyðit|600|mg|10|stk|1|pakki||R05CB01|01.04.2016||L|0|0|0|0|0|0|SHS|0|0|1|100|IKR|||lyflausa|||2|10|0|12,0000|Artasan ehf|Sandoz A/S|Acetýlcýstein|||||||1 079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|0|0|0|0|0|1|BRS|0|0|0|100|DKK|1640|3662|lyfsjukr|||1|5|0|2,5000|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||1640||1640|3662||1 080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|399|1954|lyfalmen|||2|10|0|2,5000|Actavis Group hf|Actavis Group PTC ehf|Cíprófloxacín||399||399|1954||1 080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|648|2297|lyfalmen|V0418|2283|2|20|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Cíprófloxacín||648||648|2297||1 080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.05.2008||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|657|2309|lyfalmen|V0177|2295|2|10|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Cíprófloxacín||657||657|2309||1 080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1994||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|1182|3032|lyfalmen|V0411|3007|2|20|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Cíprófloxacín||1182||1182|3032||1 080145|QG02AD9002|Genestran|stl|75|mcg/ml|20|ml|1|hgl|lausn|QG02AD90|01.11.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|IKR|4985|9628|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|||4985||4985|9628||2 080156|QN02AF0101|Morphasol handa hundum og köttum|stl|4|mg/ml|10|ml|1|hgl||QN02AF01|01.06.2010||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|3177|6198|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||||3177|6198||2 080162|N03AX1608|Pregabalina Tecnigen|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.01.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|6512|2849|lyfalmen|V0687|2849|2|56|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Pregabalín||1049||1049|2849||2 080424|G01AF0502|Pevaryl Depot|sk-stíll|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|0|0|0|0|0|0|TRI|0|0|0|100|IKR|||lyflausa|||0|1|0|1,5000|Vistor hf|Trimb Healthcare AB|Ekónazól|||||||1 080431|H02AB0207|Dexamethasone Krka|töflur|4|mg|20|stk|1|þpakki|stakskammtaþynna|H02AB02|01.04.2018||R|0|0|0|0|G|0|KNM|0|0|1|100|IKR|3000|3745|lyfalmen|V0422|3745|2|20|0|53,3300|LYFIS ehf|Krka d.d. Novo mesto|Dexametasón||1700||1700|3745||2 080447|QP52AA5103|Drontal Vet.|filmhtfl|250|mg|24|stk|1|þpakki|230+20 mg|QP52AA51|01.11.2011||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|8620|14857|vetorma|||0|24|0||Icepharma hf|Bayer Animal Health GmbH|||8620||8620|14857||2 080470|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|30|stk|1|þpakki||L02BG04|01.03.2012||R|0|0|0|0|G|0|BFP|0|0|0|100|XEU|7673|5921|lyfalmen|||2|30|0|30,0000|Vistor hf|Bluefish Pharmaceuticals AB|Letrózól||3281||3281|5921||1 080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1811|3898|lyfalmen|||1|100|0|66,6667|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1811||1811|3898||1 080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|glas|m/br. losunarhraða|N06AX12|01.07.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|4362|7409|lyfalmen|||1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||4362||4362|7409||1 080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|glas|m/br. losunarhraða|N06AX12|01.07.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|2132|4339|lyfalmen|||1|30|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||2132||2132|4339||1 080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|11842|17704|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||11842||11842|17704||1 080621|B01AF0301|Lixiana|filmhtfl|30|mg|100|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|0|G|0|OPE|0|0|0|100|DKK|26807|36976|lyfalmen|||1|100|0|50,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||26807||26807|36976||1 080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|23345|32597|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||23345||23345|32597||1 080987|G03XB0101|Mifepristone Linepharma|töflur|200|mg|1|stk|1|þpakki||G03XB01|01.06.2015||R|0|0|0|1|0|1|LPF|0|0|0|100|XEU|2528|4875|lyfsjukr|||1|1|0|1,0000|Alvogen|Linepharma France|Mifepriston||2521||2521|4875||2 081185|N06BA0903|Atomoxetin Medical Valley|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|0|VAL|0|0|0|100|XEU|8351|5218|lyfalmen|V0815|5218|2|28|0|14,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||2770||2770|5218||2 081305|L01XE1601|Xalkori|hylki|250|mg|60|stk|1|þpakki||L01XE16|01.05.2013||R|1|1|0|1|0|1|PHH|0|1|0|100|DKK|581026|728741|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Limited|Crizotiníb||581026||581026|728741||1 081490|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.07.2013||L|0|0|0|0|0|0|BEE|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6667|Artasan ehf|SmithKline Beecham Ltd.|Klórhexidín|||||||1 081501|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.10.2013||L|0|0|0|0|0|0|BEE|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|Artasan ehf|SmithKline Beecham Ltd.|Klórhexidín|||||||1 081525|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081534|V03AN0101|Conoxia|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|20|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081543|V03AN0101|Conoxia|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|50|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081552|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081561|V03AN0101|Conoxia|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|600|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081589|V03AN0101|Conoxia|lyfjagas|100|%|1|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|1|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081625|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081634|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi. Bauluventill.|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081645|N03AX1405|Matever|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.02.2012||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|4263|3900|lyfalmen|V0515|3607|2|100|0|16,6700|Alvogen|Pharmathen S.A.|Levetíracetam||1813||1813|3900||2 081669|G03DA0404|Lutinus|sk-tafla|100|mg|21|stk|1|þpakki||G03DA04|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|3649|6427|lyfalmen|||1|21|0|23,3300|Vistor hf|Ferring Lægemidler A/S|Prógesterón||3649||3649|6427||1 081671|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi. Kranaventill|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081681|N06DA0304|Nimvastid|hylki|1,5|mg|28|stk|1|þpakki||N06DA03|01.04.2018||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|6070|9760|lyfalmen|V0344|9760|2|28|0|4,6700|LYFIS ehf|Krka d.d. Novo mesto|Rívastigmín||6070||6070|9760||2 081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|1665|3697|lyfsjukr|||1|10|0|3,3333|Icepharma hf|Roche|Mídazólam||1665||1665|3697||2 081987|A10AB0602|Apidra [Solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AB06|01.01.2008||R|0|0|0|0|G|0|SDH|0|0|0|100|XEU|3780|6608|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insúlín glúlisín||3780||3780|6608||1 081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AE04|01.01.2008||R|0|0|0|0|G|0|SDH|0|0|0|100|XEU|5323|8731|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||5323||5323|8731||1 082021|L02BG0302|Anastrozol Actavis|filmhtfl|1|mg|98|stk|1|þpakki||L02BG03|01.03.2011||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|13502|7926|lyfalmen|V0184|5285|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Anastrózól||4738||4738|7926||1 082233|V03AN0101|Conoxia|lyfjagas|100|%|36|l|1|hylki|kælt|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|36|0||Ísaga ehf|AGA AB|Súrefni|||||||5 082237|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.04.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|21868|30729|lyfsjukr|||1|60|0||Icepharma hf|Baxter Medical AB|Mesna||21868||21868|30729||2 082334|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 082512|QI06AH0701|Leucofeligen FeLV/RCP|stl|||10|hgl|1|pakki|frostþurrkað stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|10095|17400|vetorma|||0|10|0||Vistor hf|Virbac S.A|Bóluefni gegn nokkrum kattaveirum||10095||10095|17400||1 082523|QI06AH0701|Leucofeligen FeLV/RCP|stl|||50|hgl|1|pakki|frostþurrkað stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|43941|75737|vetorma|||0|50|0||Vistor hf|Virbac S.A|Bóluefni gegn nokkrum kattaveirum||43941||43941|75737||1 082548|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|494|2085|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||494||494|2085||1 082675|N02BE0118|Paracetamol-ratiopharm|töflur|1000|mg|100|stk|1|þpakki||N02BE01|01.10.2013|30.06.2018|R|1|0|0|0|0|0|RTH|0|0|1|100|XEU|577|2159|lyfalmen|||2|100|0|33,3300|Alvogen|ratiopharm GmbH|Paracetamól||548||548|2159||2 082685|R03BA0502|Flixotide Diskus|innönddu|250|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|2100|4295|lyfalmen|||1|60|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||2100||2100|4295||1 082719|R03BA0502|Flixotide Diskus|innönddu|500|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|3515|6243|lyfalmen|||1|60|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||3515||3515|6243||1 082830|N02BE0117|Panodil Zapp|filmhtfl|500|mg|20|stk|1|þpakki||N02BE01|01.01.2016||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 082883|R03BA0201|Pulmicort|innúðal|0,125|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|2663|5070|lyfalmen|||1|40|0|3,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2663||2663|5070||1 082933|R03BA0201|Pulmicort|innúðal|0,25|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|2899|5395|lyfalmen|||1|40|0|6,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2899||2899|5395||1 082940|C09CA0602|Candpress|töflur|16|mg|100|stk|1|þpakki||C09CA06|01.01.2012||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|4176|5928|lyfalmen|V0080|5321|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||3286||3286|5928||1 083019|L01XE0302|Varlota|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.04.2018||R|1|1|0|1|0|1|ALO|0|1|0|100|XEU|219319|268771|lyfsjukr|||2|30|0||Alvogen|Alvogen Malta Operations(ROW)Ltd.|Erlótiníb||211192||211192|268771||2 083053|A09AA0206|Creon 10.000|sh-hylki|||100|stk|1|plglas||A09AA02|01.12.2015||R|1|0|0|0|G|0|PGB|0|0|0|100|DKK|2943|5456|lyfalmen|||1|100|0|16,6700|Icepharma hf|BGP Products ApS|Hvatablöndur (lípasi, próteasi o.s.frv.)||2943||2943|5456||2 083154|R03BA0201|Pulmicort|innúðal|0,5|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|3935|6821|lyfalmen|V0701|6360|1|40|0|13,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3935||3935|6821||1 083275|N03AX1604|Brieka|hylki|75|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|5800|3719|lyfalmen|V0686|3719|2|100|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||1681||1681|3719||1 083413|QN05CM9102|Narcostart|stl|1|mg/ml|10|mg|1|hgl|fyrir hunda og ketti|QN05CM91|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|4881|9431|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Metetomidinum||4881||4881|9431||2 083644|N02BE0101|Panodil|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.02.2013||R|1|0|0|0|0|0|HCA|0|0|1|100|DKK|704|2295|lyfalmen|V0231|2235|1|300|0|50,0000|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól||647||647|2295||1 083875|N06BA0407|Metylfenidat Actavis|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|1|0|0|0|GPA|0|0|0|100|XEU|4068|4772|lyfalmen|V0624|4759|2|30|0|36,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||2446||2446|4772||1 084182|V03AC0301|Exjade|filmhtfl|180|mg|90|stk|1|þpakki||V03AC03|01.06.2017||R|1|1|0|1|0|0|NEL|0|0|0|100|DKK|130262|168116|lyfalmen|||1|90|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||130262||130262|168116||1 084192|N05BA1206|Alprazolam Krka|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|IKR|2430|4750|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||2430||2430|4750||2 084591|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.04.2012||R|0|1|0|1|0|1|PHH|0|1|0|100|DKK|54267|71707|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||54267||54267|71707||1 084744|C09CA0604|Kairasec|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.02.2017||R|1|0|0|0|0|0|VAL|0|0|0|100|XEU|5425|8649|lyfalmen|V0215|8649|2|98|0|392,0000|Acare ehf|Medical Valley Invest AB|Candesartan||5263||5263|8649||2 084866|N02AJ0602|Parkodin forte|filmhtfl|530|mg|40|stk|1|þpakki|30+500 mg|N02AJ06|01.05.2018||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|997|2777|lyfalmen|||2|40|0|13,3333|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||997||997|2777||1 084924|J05AG0301|Stocrin|filmhtfl|200|mg|90|stk|1|glas||J05AG03|01.10.2013||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|34042|46127|lyfsjukr|||1|90|0|30,0000|Vistor hf|M.S.D.|Efavirenz||34042||34042|46127||1 085068|N02AA0101|Contalgin|forðatfl|100|mg|100|stk|1|þpakki||N02AA01|01.10.1985||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|10033|15214|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Morfín||10033||10033|15214||1 085171|A10BJ0101|Byetta|stl|5|mcg/sk|60|skammtar|1|penni|lausn|A10BJ01|01.10.2015||R|0|0|0|0|0|0|AZA|0|0|0|100|SEK|11464|17184|lyfalmen|||1|60|0|20,0000|Vistor hf|AstraZeneca AB|Exenatide||11464||11464|17184||1 085184|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.09.2010||R|0|0|0|1|G|0|GAN|0|0|0|100|XEU|28873|39589|lyfalmen|||1|2|0||Icepharma hf|Galderma Nordic AB|Metýlamínólevúlínat||28873||28873|39589||2 085205|S01AE0501|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AE05|01.03.2008||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|2057|4236|lyfalmen|||1|15|0||Icepharma hf|Santen Oy|Levófloxacín||2057||2057|4236||2 085407|R03AC0206|Ventoline|lausn|1|mg/ml|20|lykjur|1|pakki|fyrir eimgjafa|R03AC02|01.04.1992||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|694|2360|lyfalmen|||1|20|0|5,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||694||694|2360||1 085423|B01AB0401|Fragmin|stl|25000|ae/ml|4|ml|1|hgl||B01AB04|01.05.2018||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|9777|14862|lyfsjukr|||1|4|0|40,0000|Icepharma hf|Pfizer Aps|Dalteparín||9777||9777|14862||1 085488|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3649|6427|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||3649||3649|6427||2 085515|G04CB0105|Finasterid STADA|filmhtfl|5|mg|100|stk|1|þpakki||G04CB01|01.05.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|4051|3951|lyfalmen|V0445|3951|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Fínasteríð||1850||1850|3951||2 085542|G03GA0202|Menopur|sts|||75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|16288|23824|lyfalmen|||1|375|0|5,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||16288||16288|23824||1 085574|B01AF0201|Eliquis|filmhtfl|5|mg|100|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BSM|0|0|0|100|DKK|13702|19253|lyfalmen|V0652|19159|1|100|0|50,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||12967||12967|19253||1 085770|G04BE0804|Adcirca|filmhtfl|20|mg|56|stk|1|þpakki||G04BE08|01.12.2010||R|0|0|0|1|0|1|NED|0|0|0|100|XEU|71610|93643|lyfsjukr|||1|56|0|112,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||71610||71610|93643||2 085771|N07XX0202|Riluzol Actavis|filmhtfl|50|mg|56|stk|1|þpakki||N07XX02|01.11.2012||R|1|0|0|1|G|0|GPA|0|0|0|100|SEK|18720|22288|lyfalmen|V0579|22288|2|56|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Rílúzól||15172||15172|22288||1 085804|M05BX0401|Prolia|stl|60|mg/ml|1|ml|1|áf.spr|lausn|M05BX04|01.10.2010||R|0|1|0|0|0|0|AEB|0|0|0|100|DKK|25514|35340|lyfalmen|||1|1|0|181,8100|Vistor hf|Amgen Europe B.V.|Denosúmab||25514||25514|35340||1 085830|L01XA0211|Carboplatin Actavis|irþ|10|mg/ml|60|ml|1|hgl||L01XA02|01.05.2013||R|0|0|0|0|0|1|GRP|0|0|0|100|XEU|6714|10646|lyfsjukr|||2|60|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Karbóplatín||6714||6714|10646||1 085838|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|1|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|2119|4322|lyfalmen|||1|3|0|30,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Bimatóprost||2119||2119|4322||1 085849|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|3|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|6255|10014|lyfalmen|||1|9|0|90,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Bimatóprost||6255||6255|10014||1 085860|N05CF0101|Imovane|filmhtfl|5|mg|30|stk|1|þpakki||N05CF01|01.12.2013||R|1|0|0|0|0|0|SNP|0|0|1|100|XEU|300|1818|lyfalmen|||1|30|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||300||300|1818||1 085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNP|0|0|1|100|XEU|1548|3536|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1548||1548|3536||1 086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNP|0|0|1|100|XEU|4640|7791|lyfalmen|V0365|4227|1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||4640||4640|7791||1 086142|N07XX0701|Fampyra|forðatfl|10|mg|56|stk|1|þpakki||N07XX07|01.03.2013||R|0|0|0|1|0|0|BIB|0|0|0|100|XEU|45067|60071|lyfalmen|||1|56|0|28,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||45067||45067|60071||2 086191|N03AX2201|Fycompa|filmhtfl|8|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|16623|24285|lyfalmen|||1|28|0|28,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||16623||16623|24285||1 086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GPH|0|0|0|100|DKK|6108|9812|lyfsjukr|||1|5|0|1,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Ceftazidím||6108||6108|9812||1 086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GPH|0|0|0|100|DKK|6630|10530|lyfsjukr|||1|5|0|2,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Ceftazidím||6630||6630|10530||1 086324|A02BC0501|Nexium|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2013||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|9049|13860|lyfalmen|V0012|5592|1|100|0|133,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||9049||9049|13860||1 086368|G03GA0202|Menopur|sts|||600|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|23186|32396|lyfalmen|||1|600|0|8,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||23186|32396||1 086380|G03GA0202|Menopur|sts|||1200|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|41976|56161|lyfalmen|||1|1200|0|16,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||41976|56161||1 086434|L04AA2401|Orencia|stl/irþ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|0|0|0|0|0|1|BSP|0|1|0|100|DKK|40509|54306|lyfsjukr|||1|1|0|9,2600|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Abatacept||40509||40509|54306||1 086530|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.08.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|13263|19660|lyfalmen|||1|1|0||Icepharma hf|Bayer AB|Plast lyfjalykkja (IUD) með prógestógen||||13263|19660||2 086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|0|0|0|0|0|1|ROA|0|0|0|100|DKK|39317|52798|lyfsjukr|||1|100|0|5,5000|Icepharma hf|Roche A.S.|Valgancíklóvír||39317||39317|52798||2 087046|R06AX2706|Flynise|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.10.2015||L|1|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín|||||||1 087094|J01CE0207|Fenoximetylpenicillin EQL Pharma|filmhtfl|1|g|30|stk|1|þpakki||J01CE02|01.01.2018||R|0|0|0|0|0|0|EQL|0|0|1|100|IKR|680|2300|lyfalmen|V0931|2300|2|30|0|15,0000|LYFIS ehf|EQL Pharma AB|Fenoxýmetýlpenicillín||650||650|2300||2 087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|þpakki|mjúk hylki|A03AX13|01.12.2008||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|30|0|14,4000|Vistor hf|McNeil Sweden AB|Silíkonsambönd|||||||1 087233|N05CF0201|Stilnoct|töflur|10|mg|30|stk|1|þpakki||N05CF02|01.08.2012||R|1|0|0|0|0|0|SNP|0|0|1|100|XEU|279|1789|lyfalmen|V0060|1789|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||279||279|1789||1 087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|1|0|0|1|0|1|VIH|0|0|0|100|DKK|96137|124664|lyfsjukr|||1|60|0|15,0000|Vistor hf|ViiV Healthcare UK Ltd|Maravíroc||96137||96137|124664||1 087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNP|0|0|1|100|XEU|188|1664|lyfalmen|V0312|513|1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||188||188|1664||1 087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNP|0|0|0|100|XEU|166|1633|lyfalmen|V0312|1540|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||166||166|1633||1 087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNP|0|0|0|100|XEU|1397|3328|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||1397||1397|3328||1 087332|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|0|G|0|GRP|0|0|0|100|XEU|12330|16077|lyfalmen|||2|250|0|166,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||10660||10660|16077||1 087354|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|0|G|0|GRP|0|0|0|100|XEU|12330|16077|lyfalmen|||2|250|0|333,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||10660||10660|16077||1 087445|A02BX1301|Gaviscon|mixtúra|||500|ml|1|glas||A02BX13|01.08.1984||L|0|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|500|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||4028||1 087727|D07AC1301|Elocon|húðlausn|0,1|%|100|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1501|3471|lyfalmen|V0952|2852|1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1501||1501|3471||1 087867|QP52AA5108|Prazitel Plus|töflur|||104|stk|1|þpakki|50/144/150|QP52AA51|01.07.2010||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|27297|47049|vetorma|||0|104|0||Icepharma hf|Chanelle Pharmaceuticals|||27297||27297|47049||2 087932|A02BX1301|Gaviscon|tuggutfl|||20|stk|1|þpakki||A02BX13|01.10.1993||L|1|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||0|20|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||||1 087969|QD07AC0001|Cortavance|húðúði|0,584|mg/ml|76|ml|1|fl|lausn|QD07AC|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|3521|6851|vetalmen|||0|76|0||Vistor hf|Virbac S.A|Hýdrókortisón aceponat||3521||3521|6851||1 088026|QG03DA0402|Prid delta|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.02.2012||R|0|0|0|0|0|0|CES|1|0|0|100|SEK|18888|32555|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||18888||18888|32555||2 088235|G03AA1204|Yasmin 28|filmhtfl|||84|stk|1|þpakki|3+0,03 mg|G03AA12|01.10.2013||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|2463|4795|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||2463||2463|4795||2 088261|R01AD1201|Avamys|nefúði|27,5|mcg/sk|120|skammtar|1|glas||R01AD12|01.04.2008||R|0|0|0|0|G|0|RGO|0|0|1|100|DKK|840|2561|lyfalmen|||1|120|0|30,0000|Vistor hf|Glaxo Group Limited|Flútíkasón fúróat||840||840|2561||1 088300|L04AX0306|Metojectpen|stl|17,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2543|4905|lyfalmen|||1|1|0|7,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2543||2543|4905||2 088445|N05AX1205|Aripiprazol Krka|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|1|0|0|G|0|KRK|0|0|0|100|IKR|9197|4158|lyfalmen|V0684|3787|2|56|0|56,0000|LYFIS ehf|Krka Sverige AB|Aripiprazól||2000||2000|4158||2 088558|N06AX2601|Brintellix|filmhtfl|15|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LUN|0|0|0|100|DKK|7241|11371|lyfalmen|||1|28|0|42,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||7241||7241|11371||1 088696|D05AX5201|Daivobet|hlaup|||30|g|1|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|3724|6531|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||3724||3724|6531||1 088697|N06AX1611|Duofaxin|forðatfl|75|mg|98|stk|1|þpakki||N06AX16|01.07.2015|30.06.2018|R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|2295|2668|lyfalmen|||2|98|0|73,5000|Vistor hf|MediLink A/S|Venlafaxín||918||918|2668||1 088705|D05AX5201|Daivobet|hlaup|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.02.2011||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|6435|10262|lyfalmen|||1|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||6435||6435|10262||1 088714|D05AX5201|Daivobet|hlaup|||60|g|2|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|11900|17784|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||11900||11900|17784||1 088917|B02BD0801|NovoSeven|sts|5|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|373261|470339|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||373261||373261|470339||1 088975|G03AA1005|Harmonet|töflur|||63|stk|1|þpakki|20+75 mcg|G03AA10|01.10.2011||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|1162|3004|lyfalmen|||1|63|0|84,0000|Icepharma hf|Pfizer ApS|Gestóden og ethinylestradíól||1162||1162|3004||1 089077|J07BD5204|M-M-RVAXPRO|sts|||10|hgl|1|pakki|+ lausn í áf.sp|J07BD52|01.02.2013||R|0|0|0|0|0|0|MPS|0|0|0|100|DKK|18391|26718|lyfalmen|||1|10|0||Vistor hf|Sanofi Pasteur MSD|Mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||18391||18391|26718||1 089089|B02BX0501|Revolade|filmhtfl|25|mg|28|stk|1|þpakki||B02BX05|01.08.2016||R|1|1|0|1|0|1|NEL|0|1|0|100|DKK|104525|136107|lyfsjukr|||1|28|0|14,0000|Vistor hf|Novartis Europharm Ltd|Eltrombópag||104525||104525|136107||1 089094|A02BX1301|Gaviscon|tuggutfl|||120|stk|1|þpakki||A02BX13|01.01.1989||L|1|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|120|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||6129||1 089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|1|0|0|1|0|1|VIH|0|0|0|100|DKK|96137|124664|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare UK Ltd|Maravíroc||96137||96137|124664||1 089190|H01AC0101|Genotropin|sts|5|mg|1|áf-penni|1|pakki||H01AC01|01.02.2015||R|0|0|0|1|0|1|PLS|0|1|0|100|DKK|16851|24599|lyfsjukr|||1|1|0|7,5000|Icepharma hf|Pfizer ApS|Sómatrópín||16851||16851|24599||1 089212|H01AC0101|Genotropin|sts|12|mg|1|áf-penni|1|pakki||H01AC01|01.02.2015||R|0|0|0|1|0|1|PLS|0|1|0|100|DKK|40442|54221|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Pfizer ApS|Sómatrópín||40442||40442|54221||1 089293|R06AX1305|Loratadin LYFIS|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.05.2012||L|1|0|0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||||2 089304|R06AX1305|Loratadin LYFIS|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.05.2012||L|1|0|0|0|G|0|LYF|0|0|1|100|XEU|||lyfalmen|V0362|1858|2|100|0|100,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||1858||2 089692|C07AB0214|Bloxazoc|forðatfl|50|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|1419|2300|lyfalmen|V0048|2300|2|100|0|31,6600|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||650||650|2300||2 089801|B03AC0001|Monofer|irl|100|mg/ml|1|ml|5|hgl||B03AC|01.10.2012||R|0|1|0|0|G|0|PAC|0|0|1|100|DKK|19478|28214|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||19478||19478|28214||1 089936|B03AC0001|Monofer|irl|100|mg/ml|10|ml|2|hgl||B03AC|01.10.2012||R|0|1|0|0|G|0|PAC|0|0|1|100|DKK|77910|101611|lyfalmen|||1|20|0|20,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||77910||77910|101611||1 090153|N05AH0414|Quetiapin Hexal|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.09.2017||R|1|1|0|0|G|0|SSA|0|0|0|100|DKK|12591|14815|lyfalmen|V0261|13793|2|100|0|100,0000|Artasan ehf|Hexal A/S|Quetíapín||9743||9743|14815||1 090229|J01DB0101|Keflex|töflur|500|mg|20|stk|1|þpakki||J01DB01|01.07.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|1944|4081|lyfalmen|||1|20|0|5,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||1944||1944|4081||2 090240|J01DB0101|Keflex|töflur|500|mg|40|stk|1|þpakki||J01DB01|01.05.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|3889|6758|lyfalmen|||1|40|0|10,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||3889||3889|6758||2 090320|J01DB0101|Keflex|mixt.kyr|50|mg/ml|100|ml|1|fl|dreifa|J01DB01|01.03.2012||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|589|2216|lyfalmen|||1|100|0|2,5000|Icepharma hf|PharmaCoDane ApS|Cefalexín||589||589|2216||2 090354|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.06.2011||R|0|0|0|0|0|1|PAD|0|0|0|100|DKK|4568|7692|lyfsjukr|||1|10|0|3,3333|Icepharma hf|PharmaCoDane ApS|Cefazólín||4568||4568|7692||2 090547|M09AB0201|Xiapex|sts|0,9|mg/hgl|1|hgl|1|stk|+ leysir|M09AB02|01.10.2014||R|0|1|0|1|G|0|BIO|0|0|0|100|DKK|102371|133428|lyfalmen|||1|1|0|1,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Clostridíum||102371||102371|133428||3 090607|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|6,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 090662|R01AD1101|Nasacort|nefúði|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|0|0|0|0|G|0|SNP|0|0|1|100|XEU|1540|3525|lyfalmen|||1|16,5|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1540||1540|3525||1 090784|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|635|2279|lyfalmen|||1|10|0|0,7100|Vistor hf|Eisai Ltd|Rúfínamíð||635||635|2279||1 090979|S01JA0101|Anatera|stl|100|mg/ml|5|ml|12|hgl|lausn|S01JA01|01.10.2011||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|11832|17690|lyfsjukr|||1|60|0||Vistor hf|Novartis Healthcare A/S|Flúorescein||||11832|17690||1 091015|N06AX1614|Venlafaxin Krka|forðahlk|37,5|mg|28|stk|1|þpakki|hart|N06AX16|01.02.2018||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|1084|2644|lyfalmen|V0333|2644|2|28|0|10,5000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||900||900|2644||2 091219|N05AH0414|Quetiapin Hexal|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.09.2017||R|1|1|0|0|G|0|SSA|0|0|0|100|DKK|7057|8700|lyfalmen|V0273|7736|2|100|0|50,0000|Artasan ehf|Hexal A/S|Quetíapín||5300||5300|8700||1 091266|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|2054|4232|lyfsjukr|||1|2,5|0|0,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||2054||2054|4232||1 091277|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|3553|6295|lyfsjukr|||1|5|0|1,6667|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||3553||3553|6295||1 091289|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|10429|15759|lyfsjukr|||1|17,5|0|5,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||10429||10429|15759||1 091345|N06BA0403|Ritalin Uno|hylki|10|mg|30|stk|1|glas||N06BA04|01.03.2011||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|2789|5244|lyfalmen|||1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||2789||2789|5244||1 091493|A10BH0501|Trajenta|filmhtfl|5|mg|30|stk|1|þpakki||A10BH05|01.12.2012||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|5152|8496|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||5152||5152|8496||1 091736|S01BA0102|Opnol|augndr|1|mg/ml|30|sk-hyl|1|sk-ílá|lausn|S01BA01|01.05.2011||R|0|0|0|0|G|0|TRI|0|0|1|100|SEK|2870|5355|lyfalmen|||1|30|0||Vistor hf|Trimb Healthcare AB|Dexametasón||2870||2870|5355||1 091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|814|1933|lyfalmen|V0021|1854|1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||384||384|1933||1 091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|1408|2198|lyfalmen|V0022|2079|1|90|0|90,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||576||576|2198||1 091872|C07AA0512|Pranolol|töflur|80|mg|100|stk|1|glas||C07AA05|01.12.2011||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|915|2664|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Própranólól||915||915|2664||1 092097|QD11AH9001|Apoquel|töflur|16|mg|20|stk|1|þpakki||QD11AH90|01.06.2017||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|5413|10440|vetalmen|||0|20|0||Icepharma hf|Zoetis Belgium S.A.|Oclacitinib||5413||5413|10440||2 092176|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|14|stk|1|þpakki||A02BC05|01.05.2016||L|1|0|0|0|0|0|KRK|0|0|0|100|IKR|||lyflausa|||2|14|0|9,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól|||||||2 092188|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|28|stk|1|þpakki||A02BC05|01.08.2017||L|1|0|0|0|0|0|KRK|0|0|0|100|IKR|||lyfalmen|||2|28|0|18,6700|LYFIS ehf|Krka Sverige AB|Esómeprazól|||||2746||2 092199|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|56|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|2065|4158|lyfalmen|V0011|2650|2|56|0|37,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól||2000||2000|4158||2 092210|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|98|stk|1|glas||A02BC05|01.10.2016||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|3453|4708|lyfalmen|V0011|4638|2|98|0|65,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól||2400||2400|4708||2 092234|A02BC0511|Esomeprazol Krka|sþ-hylki|40|mg|28|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|1510|2781|lyfalmen|V0005|1953|2|28|0|37,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól||1000||1000|2781||2 092245|A02BC0511|Esomeprazol Krka|sþ-hylki|40|mg|56|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|2400|4158|lyfalmen|V0012|3132|2|56|0|74,6700|LYFIS ehf|Krka Sverige AB|Esómeprazól||2000||2000|4158||2 092256|A02BC0511|Esomeprazol Krka|sþ-hylki|40|mg|98|stk|1|glas||A02BC05|01.10.2016||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|4794|5527|lyfalmen|V0012|5480|2|98|0|130,6700|LYFIS ehf|Krka Sverige AB|Esómeprazól||2995||2995|5527||2 092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|þpakki||B01AC04|01.12.1999||R|1|0|0|0|G|0|SND|0|0|0|100|XEU|3814|6655|lyfalmen|V0009|3646|1|28|0|28,0000|Vistor hf|Sanofi Clir SNC|Klópídógrel||3814||3814|6655||1 092553|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 092575|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 092655|G03CA0310|Vagifem|sk-tfl|10|mcg|18|stk|1|pakki||G03CA03|01.03.2011||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|1781|3856|lyfalmen|||1|18|0|7,2000|Vistor hf|Novo-Nordisk A/S|Estradíól||1781||1781|3856||1 092879|M01AB0103|Indometacin Actavis|hylki|25|mg|28|stk|1|þpakki||M01AB01|01.03.2010||R|0|0|0|0|G|0|UAK|0|0|1|100|GBP|638|2283|lyfalmen|||2|28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||638||638|2283||1 092891|M01AB0103|Indometacin Actavis|hylki|50|mg|28|stk|1|þpakki||M01AB01|01.03.2010||R|0|0|0|0|G|0|UAK|0|0|1|100|GBP|1209|3069|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||1209||1209|3069||1 092958|M05BA0408|Ostacid|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.05.2010||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|2630|2845|lyfalmen|V0203|2843|2|12|0|84,0000|Williams & Halls efh|Williams & Halls ehf|Alendrónsýra||1046||1046|2845||2 093016|N02AA0504|OxyNorm Dispersa|munndr.t|5|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|781|2480|lyfalmen|||1|28|0|1,8700|Icepharma hf|Norpharma|Oxýcódon||781||781|2480||2 093027|N02AA0504|OxyNorm Dispersa|munndr.t|10|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|1794|3874|lyfalmen|||1|28|0|3,7300|Icepharma hf|Norpharma|Oxýcódon||1794||1794|3874||2 093038|N02AA0504|OxyNorm Dispersa|munndr.t|20|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|3488|6206|lyfalmen|||1|28|0|7,4700|Icepharma hf|Norpharma|Oxýcódon||3488||3488|6206||2 093072|L01XE1101|Votrient|filmhtfl|200|mg|90|stk|1|glas||L01XE11|01.01.2017||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|237954|302055|lyfsjukr|||1|90|0||Vistor hf|Novartis Europharm Ltd|Pazópaníb||237954||237954|302055||1 093083|L01XE1101|Votrient|filmhtfl|400|mg|60|stk|1|glas||L01XE11|01.01.2017||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|347202|437929|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Pazópaníb||347202||347202|437929||1 093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|3861|6719|lyfalmen|||1|1|0|2,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||3861||3861|6719||1 093284|G04BD1201|Betmiga|forðatfl|50|mg|30|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|4634|7783|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||4634||4634|7783||1 093306|M03AX0105|Xeomin|sts|100|ein/hgl|1|hgl|1|pakki||M03AX01|01.08.2015||R|0|0|0|1|0|1|ERZ|0|0|0|100|XEU|19337|28020|lyfsjukr|||1|1|0||Williams & Halls efh|Merz Pharmaceuticals GmbH|Clostridium botulinum toxín-A||19337||19337|28020||2 093343|C09CA0301|Diovan|mixtúra|3|mg/ml|160|ml|1|fl|lausn|C09CA03|01.03.2012||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1559|3551|lyfalmen|||1|160|0|6,0000|Vistor hf|Novartis Healthcare A/S|Valsartan||1559||1559|3551||1 093496|A07EC0204|Asacol|sþ-tfl|800|mg|60|stk|1|þpakki||A07EC02|01.03.2016||R|1|0|0|0|G|0|TIL|0|0|0|100|SEK|4372|7423|lyfalmen|||1|60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||4372|7423||2 093514|A07EC0204|Asacol|sþ-tfl|400|mg|100|stk|1|þpakki||A07EC02|01.03.2016||R|1|0|0|0|G|0|TIL|0|0|0|100|SEK|3237|5860|lyfalmen|||1|100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||3237|5860||2 093668|N01BB0203|Xylocain|húðúði|100|mg/ml|50|ml|1|glas|+ sk-úðari|N01BB02|01.10.2014||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1899|4019|lyfalmen|||1|50|0||Icepharma hf|Aspen Pharma|Lídókaín||1899||1899|4019|30.6.2018|2 093725|C03BA0802|Metolazon Abcur|töflur|5|mg|100|stk|1|þpakki||C03BA08|01.01.2014||R|0|0|0|0|G|0|ABC|0|0|0|100|SEK|26349|36396|lyfalmen|||2|100|0|100,0000|Icepharma hf|Abcur AB|Metólazón||26349||26349|36396||2 093757|N02AA0501|Oxycontin|forðatfl|80|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|6691|10614|lyfalmen|||1|28|0|29,8700|Icepharma hf|Norpharma |Oxýcódon||6691||6691|10614||2 093799|N02AA0501|Oxycontin|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|17321|25246|lyfalmen|V0588|16987|1|98|0|104,5300|Icepharma hf|Norpharma |Oxýcódon||17321||17321|25246||2 093827|L04AC0501|Stelara|stl|45|mg/spr|0,5|ml|1|áf.spr||L04AC05|01.04.2011||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|336346|424427|lyfsjukr|||1|0,5|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||336346||336346|424427||1 093838|L04AC0501|Stelara|stl|90|mg/spr|1|ml|1|áf.spr||L04AC05|01.05.2011||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|336346|424427|lyfsjukr|||1|1|0|166,6700|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||336346||336346|424427||1 094122|N02CC0501|Almogran|filmhtfl|12,5|mg|9|stk|1|þpakki||N02CC05|01.07.2010||R|1|0|0|0|G|0|AAC|0|0|0|100|DKK|4554|7673|lyfalmen|||1|9|0|9,0000|Icepharma hf|Almirall S.A.|Almótriptan||4554||4554|7673||2 094132|QM01AC0604|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|1396|2744|vetalmen|||0|15|0||Vistor hf|Boehringer Ingelheim|Meloxícam||1396||1396|2744||1 094441|J05AB0103|Aclovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.04.2013||R|1|0|0|0|G|0|RTH|0|0|1|100|XEU|829|2546|lyfalmen|||2|25|0|1,2500|Alvogen|ratiopharm GmbH|Acíklóvír||829||829|2546||2 094652|B01AC0602|Hjarta-Aspirín|sþ-tfl|75|mg|500|stk|1|glas||B01AC06|01.02.2014||L|1|0|0|0|0|0|LYF|0|0|0|100|IKR|||lyflausa|||0|500|0|500,0000|LYFIS ehf|LYFIS ehf|Asetýlsalicýlsýra|||||||2 094757|N04BC0406|Ropinirole Portfarma|forðatfl|8|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|13302|15999|lyfalmen|V0534|15999|2|84|0|112,0000|Alvogen|Alvogen|Rópíníról||10603||10603|15999||2 094801|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|þpakki|300+150+300 mg|J05AR04|01.08.2003||R|1|1|0|1|0|1|VIH|0|0|0|100|DKK|59545|78383|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare UK Ltd|Zídóvúdín, lamívúdín og abacavír||59545||59545|78383||1 094812|N01BX0403|Qutenza|plástur|179|mg|1|plástur|1|pakki||N01BX04|01.01.2011||R|0|1|0|0|0|0|HAL|0|0|0|100|DKK|37081|49970|lyfalmen|||1|1|0||Vistor hf|Grunenthal GmbH|Capsaicin||||37081|49970||1 094834|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|5066|8732|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Bakteríubólefni gegn Escherichia coli + Clostridium||5066||5066|8732||2 094843|D02AX0001|Oviderm|krem|250|mg/g|100|g|1|túpa||D02AX|01.03.2018||L|0|0|0|0|0|0|GAB|0|0|0|100|IKR|||lyflausa|||0|100|0||Vistor hf|Galenica AB|Önnur húðverndandi efni|||||||1 095005|B02BC3001|TachoSil|vefjal.n|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.01.2014||R|0|0|0|0|0|1|TAG|0|0|0|100|DKK|31630|43076|lyfsjukr|||2|1|0||Vistor hf|Takeda Austria GmbH|Blöndur||31630||31630|43076||1 095092|M03AX0101|Botox|sts|200|ae/hgl|1|hgl|1|pakki||M03AX01|01.04.2016||R|0|0|0|1|0|1|IRE|0|0|0|100|XEU|40782|52186|lyfsjukr|||1|1|0||Actavis ehf|Allergan Pharmaceuticals Ireland|Clostridium botulinum toxín-A||38833||38833|52186||1 095514|L04AX0501|Esbriet|hylki|267|mg|252|stk|1|þpakki|hart|L04AX05|01.02.2016||R|1|1|0|1|0|0|RRG|0|0|0|100|DKK|297760|376437|lyfalmen|V0919|376437|1|252|0|28,0300|Icepharma hf|Roche Registration GmbH|Pírfenidon||||297760|376437||2 095588|N07BB0101|Antabus|freyðit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|0|0|0|0|G|0|GRP|0|0|0|100|DKK|6854|10839|lyfalmen|||1|50|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Dísúlfíram||6854||6854|10839||1 095652|N05AX1301|Invega|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|12230|18238|lyfalmen|V0963|15857|1|28|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||12230||12230|18238||1 095680|N05AX1301|Invega|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|12413|18490|lyfalmen|V0964|15857|1|28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||12413||12413|18490||1 095707|N05AX1301|Invega|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|14451|21295|lyfalmen|V0965|18610|1|28|0|42,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||14451||14451|21295||1 095715|J02AC0105|Fluconazole Alvogen|irl|2|mg/ml|50|ml|1|hgl|lausn|J02AC01|01.10.2011||R|0|0|0|0|0|1|GOV|0|0|0|100|XEU|1728|3783|lyfsjukr|||2|50|0|0,5000|Alvogen|Alvogen ehf|Flúkónazól||||1728|3783||2 095726|J02AC0105|Fluconazole Alvogen|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.09.2011||R|0|0|0|0|0|1|GOV|0|0|0|100|XEU|2731|5164|lyfsjukr|||2|100|0|1,0000|Alvogen|Alvogen ehf|Flúkónazól||||2731|5164||2 095748|N02AX0212|Tramadol Actavis|hylki|50|mg|100|stk|1|glas||N02AX02|01.09.2011||R|1|0|1|0|G|0|GPA|0|0|1|100|XEU|770|1958|lyfalmen|V0225|1958|2|100|0|16,6700|Actavis Group hf|Actavis Group PTC ehf|Tramadól||402||402|1958||1 095767|R03BA0203|Budesonide Teva|innúðal|0,5|mg/ml|2|ml|20|lykjur||R03BA02|01.07.2015||R|0|0|0|0|G|0|TAB|0|0|0|100|IKR|3740|6360|lyfalmen|V0701|6360|2|40|0|13,3400|Alvogen|Teva Pharma B.V.|Búdesóníð||3600||3600|6360||2 095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHP|0|0|0|100|IKR|4156|8055|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|||4156||4156|8055||2 095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHP|0|0|0|100|IKR|5733|11047|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|||5733||5733|11047||2 095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHP|0|0|0|100|IKR|9534|18258|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|||9534||9534|18258||2 096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl||J06BA01|01.10.2008||R|0|0|0|1|0|1|OCT|0|1|0|100|DKK|96425|125029|lyfsjukr|||1|100|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||96425||96425|125029||1 096201|L01XC3201|Tecentriq|irþ|1200|mg|20|ml|1|hgl|lausn|L01XC32|01.01.2018||R|0|1|0|0|0|1|RRG|0|0|0|100|DKK|550173|690368|lyfsjukr|||1|20|0||Icepharma hf|Roche Registration GmbH|Atezolizumab||550173||550173|690368||2 096260|N06DA0301|Exelon|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|11617|17395|lyfalmen|V0347|15315|1|30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||11617||11617|17395||1 096473|J01CE0207|Fenoximetylpenicillin EQL Pharma|filmhtfl|1|g|20|stk|1|þpakki||J01CE02|01.01.2018||R|0|0|0|0|0|0|EQL|0|0|1|100|IKR|470|2011|lyfalmen|V0930|2011|2|20|0|10,0000|LYFIS ehf|EQL Pharma AB|Fenoxýmetýlpenicillín||440||440|2011||2 096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CPV|0|1|0|100|XEU|587957|737361|lyfsjukr|||1|21|0|10,5000|Celgene Europe ltd|Celgene Europe B.V.|Lenalídómíd||587957||587957|737361||2 096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CPV|0|1|0|100|XEU|544990|683922|lyfsjukr|||1|21|0|21,0000|Celgene Europe ltd|Celgene Europe B.V.|Lenalídómíd||544990||544990|683922||2 096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CPV|0|1|0|100|XEU|573673|719596|lyfsjukr|||1|21|0|31,5000|Celgene Europe ltd|Celgene Europe B.V.|Lenalídómíd||573673||573673|719596||2 096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CPV|0|1|0|100|XEU|628992|788397|lyfsjukr|||1|21|0|52,5000|Celgene Europe ltd|Celgene Europe B.V.|Lenalídómíd||628992||628992|788397||2 096679|N06DA0301|Exelon|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|10567|15949|lyfalmen|V0349|15949|1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||10567||10567|15949||1 096685|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|30|stk|1|þpakki||C03BA11|01.03.1999|30.06.2018|R|1|0|0|0|G|0|SEV|0|0|0|100|DKK|819|2532|lyfalmen|||1|30|0|18,0000|Icepharma hf|Servier|Indapamíð||819||819|2532||2 096768|L02AE0102|Suprecur|nefúði|0,15|mg/sk|10|g|2|fl|lausn|L02AE01|01.01.2012||R|0|0|0|1|G|0|SNP|0|0|0|100|XEU|9700|14756|lyfalmen|||1|20|0|16,6700|Vistor hf|Sanofi-aventis Norge AS|Búserelín||9700||9700|14756||1 097061|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.10.2012||R|0|0|0|0|0|0|ELA|0|0|0|100|DKK|57420|98969|vetorma|||1|1000|0||Icepharma hf|Elanco Animal Health A/S|Óvirkar bakteríur í bóluefnum||57420||57420|98969||2 097092|QN02AF0102|Alvegesic vet.|stl|10|mg/ml|10|ml|1|hgl||QN02AF01|01.08.2010||R|0|0|0|0|0|0|AUW|1|0|0|100|XEU|6330|12180|vetalmen|||0|10|0||Icepharma hf|ALVETRA u. WERFFTt GmbH|Bútorfanóltartrat||||6330|12180||2 097152|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|36|0|2,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 097531|N06AX1602|Efexor Depot|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.07.2012||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|8684|13358|lyfalmen|V0334|2725|1|98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||8684||8684|13358||1 097577|N06AX1602|Efexor Depot|forðahlk|150|mg|98|stk|1|þpakki||N06AX16|01.09.2011||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|16155|23641|lyfalmen|V0335|2725|1|98|0|147,0000|Icepharma hf|Pfizer ApS|Venlafaxín||||16155|23641||1 097603|C10AX1301|Repatha|stl|140|mg|1|áf-penni|1|pakki||C10AX13|01.01.2016||R|0|0|0|0|0|0|AEB|0|0|0|100|DKK|27312|37614|lyfalmen|||1|1|0|14,0000|Vistor hf|Amgen Europe B.V.|Evolocumab||27312||27312|37614||1 097662|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|4841|9355|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||4841||4841|9355||2 097847|G03AC0803|Nexplanon|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.12.2016||R|0|0|0|0|0|0|DSM|0|0|0|100|DKK|15819|23178|lyfalmen|||1|1|0|1000,0000|Vistor hf|Merck Sharp & Dohme|Etónógestrel||15819||15819|23178||1 097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|2021|2419|lyfalmen|V0023|2093|1|90|0|135,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||737||737|2419||1 097889|J01MA0205|Ciprofloxacin Villerton|irl|2|mg/ml|200|ml|10|pokar||J01MA02|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|2368|4664|lyfsjukr|||2|2000|0|8,0000|Icepharma hf|Villerton Invest SA|Cíprófloxacín||||2368|4664||2 097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|0|0|GPA|0|0|0|100|XEU|860|2589|lyfalmen|V0329|2589|2|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||860||860|2589||1 098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2448|3856|lyfalmen|||2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan||1781||1781|3856|31.8.2018|1 098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|3388|3856|lyfalmen|||2|98|0|196,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan||1781||1781|3856|31.8.2018|1 098074|QM01AE9001|Quadrisol|hlaup|100|mg/ml|30|ml|3|spr|f. hesta|QM01AE90|01.04.2015||R|0|0|0|0|0|0|VCL|0|0|0|100|DKK|4457|8626|vetalmen|||0|90|0||Icepharma hf|VETCOOL BV.|Vedaprófen||4457||4457|8626||2 098233|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|0|0|0|0|G|0|BIG|0|0|1|100|SEK|459|2037|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||459||459|2037||2 098245|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.08.2011||R|0|0|0|0|G|0|BIG|0|0|1|100|SEK|459|2037|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||459||459|2037||2 098290|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.06.2011||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|250|0||Icepharma hf|Bioglan AB|Klórhexidín|||||||2 098378|N03AX0904|Lamotrigin ratiopharm|dreifit.|25|mg|50|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RTH|0|0|0|100|IKR|953|2231|lyfalmen|V0243|2231|2|50|0|4,1600|Alvogen|ratiopharm GmbH|Lamótrigín||600||600|2231||2 098387|N03AX0904|Lamotrigin ratiopharm|dreifit.|50|mg|50|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RTH|0|0|0|100|IKR|1609|2368|lyfalmen|V0244|2093|2|50|0|8,3300|Alvogen|ratiopharm GmbH|Lamótrigín||700||700|2368||2 098405|N03AX0904|Lamotrigin ratiopharm|dreifit.|100|mg|100|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RTH|0|0|0|100|IKR|4409|3882|lyfalmen|V0245|3882|2|100|0|33,3300|Alvogen|ratiopharm GmbH|Lamótrigín||1800||1800|3882||2 098423|N03AX0904|Lamotrigin ratiopharm|dreifit.|200|mg|100|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RTH|0|0|0|100|IKR|9120|7599|lyfalmen|V0232|7599|2|100|0|66,6600|Alvogen|ratiopharm GmbH|Lamótrigín||4500||4500|7599||2 098469|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|10|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BFP|0|0|1|100|IKR|2793|4144|lyfalmen|V0381|4144|2|10|0|2,5000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||1990||1990|4144||2 098722|J07BM0101|Gardasil|stl|||0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|0|0|0|0|0|0|MPS|0|0|0|100|DKK|12607|18757|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur MSD|Papillomavírus (manna gerð 6, 11, 16, 18)||12607||12607|18757||1 099204|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|2|spr||L02BA03|01.12.2010||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|53512|70752|lyfsjukr|||1|10|0|60,2400|Vistor hf|AstraZeneca AB|Fulvestrant||53512||53512|70752||1 099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1902|2167|lyfalmen|V0284|2167|2|100|0|6,2500|Icepharma hf|Mylan AB|Quetíapín||554||554|2167||2 099482|N05AH0414|Quetiapin Hexal|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.09.2017||R|1|1|0|0|G|0|SSA|0|0|0|100|DKK|8646|10770|lyfalmen|V0272|9388|2|100|0|75,0000|Artasan ehf|Hexal A/S|Quetíapín||6804||6804|10770||1 099485|N05AH0406|Quetiapin Mylan|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3555|3566|lyfalmen|V0285|3470|2|100|0|25,0000|Icepharma hf|Mylan AB|Quetíapín||1570||1570|3566||2 099494|N05AH0406|Quetiapin Mylan|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|6363|6105|lyfalmen|V0286|6068|2|100|0|50,0000|Icepharma hf|Mylan AB|Quetíapín||3415||3415|6105||2 099705|D08AG0201|Betadine|húðlausn|100|mg/ml|500|ml|1|brusar|vatnslausn|D08AG02|01.04.1985||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2 099707|N03AX1604|Brieka|hylki|25|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|3104|2678|lyfalmen|V0685|2678|2|100|0|8,3300|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||925||925|2678||1 099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2 099835|N03AX1107|Topiramat Actavis|filmhtfl|25|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1358|2023|lyfalmen|V0247|2023|2|60|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||449||449|2023||1 099847|N03AX1107|Topiramat Actavis|filmhtfl|50|mg|60|stk|1|plglas||N03AX11|01.09.2010||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2492|3297|lyfalmen|V0248|3297|2|60|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||1375||1375|3297||1 099858|N03AX1107|Topiramat Actavis|filmhtfl|100|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|4495|3727|lyfalmen|V0249|3727|2|60|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||1687||1687|3727||1 099863|L01XE0401|Sutent|hylki|12,5|mg|28|stk|1|þpakki||L01XE04|01.12.2012||R|1|0|0|1|0|1|PHH|0|1|0|100|DKK|136695|176117|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||136695||136695|176117||1 099872|L01XE0401|Sutent|hylki|25|mg|28|stk|1|þpakki||L01XE04|01.03.2014||R|1|0|0|1|0|1|PHH|0|1|0|100|DKK|263477|333799|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||263477||263477|333799||1 099881|L01XE0401|Sutent|hylki|50|mg|28|stk|1|þpakki||L01XE04|01.03.2014||R|1|0|0|1|0|1|PHH|0|1|0|100|DKK|526935|661467|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||526935||526935|661467||1 099902|H02AB0605|Prednisolone Actavis|töflur|5|mg|98|stk|1|þpakki||H02AB06|01.01.2011||R|1|0|0|0|G|0|UAK|0|0|1|100|GBP|615|2251|lyfalmen|V0414|2248|2|98|0|49,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||615||615|2251||1 099959|L01BA0403|Pemetrexed Accord|irþ|500|mg|500|mg|1|hgl|storn f. innr.þykkni lausn|L01BA04|01.04.2018||R|0|0|0|0|0|1|ARD|0|1|0|100|XEU|116071|150467|lyfsjukr|||2|500|0||Artasan ehf|Accord Healthcare Limited|Pemetrexed||116071||116071|150467||1 100211|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|25|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|4356|7022|veteldis|||0|25|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||4356||4356|7022||1 100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|9076|13897|lyfalmen|V0935|12624|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||||9076|13897||2 100428|N06AX1103|Miron|filmhtfl|15|mg|100|stk|1|plglas||N06AX11|01.01.2012||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1570|3333|lyfalmen|V0823|2988|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1401||1401|3333||1 100441|M01AE0116|Ibuprofen Bril|filmhtfl|600|mg|30|stk|1|þpakki||M01AE01|01.11.2016||R|1|0|0|0|G|0|BLL|0|0|1|100|IKR|322|1683|lyfalmen|V0563|1679|2|30|0|15,0000|Williams & Halls efh|Bristol Laboratories Limited|Íbúprófen||202||202|1683||2 100807|N03AX1603|Pregabalin Krka|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|1726|2099|lyfalmen|V0685|1500|2|56|0|4,6667|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||504||504|2099||2 100830|J01FA1007|Azithromycin STADA|mixtduft|40|mg/ml|15|ml|1|glas|dreifa|J01FA10|01.06.2017||R|0|0|0|0|0|0|ASR|0|0|1|100|IKR|700|1997|lyfalmen|V0821|1997|2|15|0|2,0000|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||430||430|1997||2 100843|J01FA1007|Azithromycin STADA|mixtduft|40|mg/ml|22,5|ml|1|glas|dreifa|J01FA10|01.06.2017||R|0|0|0|0|0|0|ASR|0|0|1|100|IKR|1000|2506|lyfalmen|V0822|2506|2|22,5|0|3,0000|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||800||800|2506||2 100884|J01AA0401|Lymecycline Actavis|hylki|300|mg|100|stk|1|þpakki||J01AA04|01.07.2015||R|0|0|0|0|0|0|GPA|0|0|1|100|XEU|3381|6059|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Lymecycline||3381||3381|6059||1 101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|8563|11093|lyfalmen|V0254|9663|1|100|0|33,3300|Icepharma hf|Pfizer ApS|Gabapentín||7039||7039|11093||1 101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|12528|18648|lyfalmen|V0256|16132|1|100|0|44,4400|Icepharma hf|Pfizer ApS|Gabapentín||12528||12528|18648||1 101148|QI10AB0301|Alpha Ject 5-3|stl|||500|ml|1|poki||QI10AB03|01.09.2013||R|0|0|0|0|0|0|PHA|0|0|0|100|NOK|51201|82536|veteldis|||0|500|0||Vistor hf|Pharmaq AS|Aeromónas + moritella + vibrio||51201||51201|82536||1 101367|QM01AE9104|Canicaral vet|töflur|40|mg|100|stk|1|þpakki||QM01AE91|01.09.2016||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|5189|10015|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||5189||5189|10015||2 101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|992|2317|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||663||663|2317||1 101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|2177|3019|lyfalmen|V0331|3019|2|96|0|96,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1173||1173|3019||1 101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|9728|18626|vetalmen|||0|250|0||Vistor hf|Boehringer Ingelheim|Meloxícam||9728||9728|18626||1 101893|G03DB0801|Visanne|töflur|2|mg|28|stk|1|þpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|4822|8042|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer AB|Díenógest||4822||4822|8042||2 101904|G03DB0801|Visanne|töflur|2|mg|84|stk|1|þpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|14304|21093|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Díenógest||14304||14304|21093||2 102051|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|839|2560|lyfalmen|||1|100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||839||839|2560||1 102062|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1265|3146|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1265||1265|3146||1 102121|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4499|7597|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||4499||4499|7597||2 102173|N02BE0107|Paratabs|filmhtfl|500|mg|100|stk|1|þpakki||N02BE01|01.03.2013||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|327|1855|lyfalmen|||2|100|0|16,6667|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól||327||327|1855||1 102353|N06AX2108|Aritavi|sþ-hylki|60|mg|28|stk|1|glas||N06AX21|01.12.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|2459|3219|lyfalmen|V0693|3110|2|28|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Duloxetín||1318||1318|3219||1 102355|J01CR0202|Augmentin|sts|1200|mg/hgl|10|hgl|1|pakki|1000+200 mg|J01CR02|01.07.2018||R|0|0|0|0|0|1|GPH|0|0|0|100|DKK|4484|7577|lyfsjukr|||1|10|0|3,3333|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill||4484||4484|7577||1 102518|N05AX1208|Aripiprazol W&H|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|0|1|0|0|G|0|WEH|0|0|0|100|XEU|7290|3787|lyfalmen|V0684|3787|2|56|0|56,0000|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||1731||1731|3787||2 102871|C01DA1401|Imdur|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.07.1989||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2503|4850|lyfalmen|V0041|2951|1|98|0|147,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||2503||2503|4850||1 102952|G04BD0805|Solifenacin Alvogen|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|12483|17890|lyfalmen|V0441|17890|2|90|0|180,0000|Alvogen|Alvogen|Sólífenacín||11977||11977|17890||2 103050|N05CF0205|Zovand|filmhtfl|10|mg|30|stk|1|þpakki||N05CF02|01.04.2015||R|1|0|0|0|0|0|WEH|0|0|1|100|IKR|321|1790|lyfalmen|V0060|1789|2|30|0|30,0000|Williams & Halls efh|Williams & Halls ehf|Zolpidem||280||280|1790||2 103114|L04AX0306|Metojectpen|stl|7,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2063|4244|lyfalmen|||1|1|0|3,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2063||2063|4244||2 103197|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.01.2017||R|1|0|0|1|0|0|PMA|0|0|0|100|DKK|5844|7857|lyfalmen|V0657|7857|1|30|0|10,0000|Actavis hf|Teva Pharma B.V.|Modafinil||4688||4688|7857||1 103379|L03AA1401|Lonquex|stl|6|mg|0,6|ml|1|áfspr||L03AA14|01.10.2015||R|0|0|0|1|0|1|UAB|0|0|0|100|NOK|82925|107954|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|UAB Sicor Biotech|Lipegfilgrastim||82925||82925|107954||1 103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2008||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|2030|3068|lyfalmen|V0088|2232|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan og þvagræsilyf||1208||1208|3068||2 103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.02.2008||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|2590|3654|lyfalmen|V0089|2492|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan og þvagræsilyf||1634||1634|3654||2 103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.02.2008||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|1845|3841|lyfalmen|V0069|2456|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan||1770||1770|3841||2 103678|N06AX1615|Venlafaxine Alvogen|forðahlk|75|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|2859|3882|lyfalmen|V0334|2781|2|100|0|75,0000|Alvogen|Alvogen|Venlafaxín||1800||1800|3882||2 103687|N06AX1604|Venlafaxin (Portfarma)|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|4715|3975|lyfalmen|V0335|2781|2|100|0|150,0000|Alvogen|Alvogen|Venlafaxín||1867||1867|3975||2 103806|N02AB0305|Fentanyl ratiopharm|forðapl|12|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RTH|0|0|0|100|XEU|1413|3193|lyfalmen|V0222|3193|2|5|0|3,6000|Alvogen|ratiopharm GmbH|Fentanýl||1299||1299|3193||2 103813|B02BC3002|TISSEEL|vefjalím|||4|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|231036|293451|lyfsjukr|||1|40|0||Icepharma hf|Baxter Medical AB|Blöndur||231036||231036|293451||2 103854|L01XE1701|INLYTA|filmhtfl|1|mg|56|stk|1|þpakki||L01XE17|01.05.2013||R|1|0|0|1|0|1|PIZ|0|1|0|100|DKK|96251|124809|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Ltd|Axitinib||96251||96251|124809||1 103906|QD08AC5201|Malaseb vet.|hársápa|2|%|250|ml|1|glas|w/v|QD08AC52|01.10.2012||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|3109|6069|vetalmen|||1|250|0||Vistor hf|Dechra Veterinary Products A/S|Bígvaníð og amídín-Klórhexidín í blöndum||3109||3109|6069||1 103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|0|0|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Orion Pharma|Bisakódýl|||||2137||1 103952|A06AG0201|Toilax|innhl/tf|||1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|1|0|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Vistor hf|Orion Pharma|Bisakódýl|||||||1 104026|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|7422|11621|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||7422||7422|11621||2 104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|2218|4458|lyfalmen|||1|2,5|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||2218||2218|4458||1 104489|H01BA0201|Minirin|nefúði|0,1|mg/ml|5|ml|1|úðagl||H01BA02|01.09.2013||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|5316|8722|lyfalmen|||1|5|0|20,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||5316||5316|8722||1 104503|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 104593|R01AX0301|Atrovent|nefúði|21|mcg/sk|15|ml|1|glas|180 sk, lausn|R01AX03|01.08.2017||L|0|0|0|0|G|0|BOI|0|0|1|100|NOK|||lyfalmen|||1|15|0|15,7500|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíð|||||2646||1 104675|C09DX0401|Entresto|filmhtfl|50|mg|28|stk|1|þpakki|24 + 26 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|8307|12839|lyfalmen|||1|28|0|14,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||8307||8307|12839||1 104688|N05AH0415|Quetiapin Krka|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.04.2018||R|0|1|0|0|G|0|KRK|0|0|0|100|IKR|4500|5259|lyfalmen|V0275|5259|2|100|0|12,5000|LYFIS ehf|Krka Sverige AB|Quetíapín||2800||2800|5259||2 104760|A07EC0202|Pentasa|eþ-stíll|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|6130|9842|lyfalmen|||1|28|0|18,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||6130||6130|9842||1 104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|3177|5778|lyfalmen|V0017|4884|1|700|0|4,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||3177||3177|5778||1 104851|A07EC0202|Pentasa|forðatfl|500|mg|100|stk|1|þpakki||A07EC02|01.04.1992||R|1|0|0|0|G|0|FER|0|0|0|100|DKK|4116|7070|lyfalmen|||1|100|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||4116||4116|7070||1 104856|R03AK1101|Flutiform|innúðal|55|mcg/sk|120|skammtar|1|pakki|50+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|MUP|0|0|0|100|DKK|3559|6304|lyfalmen|||1|120|0|30,0000|Icepharma hf|Mundipharma A/S|Formóteról og flútikasón||3559||3559|6304||2 104959|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|86298|112220|lyfsjukr|||1|2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||||86298|112220||1 105306|A02BC0505|Nexium (Lyf og heilsa)|sh-tfl|40|mg|100|stk|1|glas||A02BC05|23.09.2007||R|1|0|0|0|0|0|HOL|0|0|0|100|SEK|9632|13857|lyfalmen|V0012|5592|3|100|0|133,3300|Lyf og heilsa|Lyf og heilsa|Esómeprazól||9047||9047|13857||2 105315|G03AA0705|Microgynon (Lyf og heilsa)|töflur|||63|stk|1|þpakki||G03AA07|01.05.2009||R|0|0|0|0|0|0|HOL|0|0|0|100|DKK|1010|2795|lyfalmen|V0545|1955|3|63|0|84,0000|Lyf og heilsa|Lyf og heilsa|Levónorgestrel og ethinylestradíól||1010||1010|2795||2 105363|C03DA0403|Eplerenon Bluefish|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.05.2015||R|1|0|0|0|0|0|BFP|0|0|0|100|IKR|2983|2781|lyfalmen|V0107|2724|2|30|0|15,0000|Vistor hf|Bluefish Pharmaceuticals AB|Eplerenón||1000||1000|2781||1 105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1740|3800|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Mepívakaín||1740||1740|3800||2 105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|2057|4236|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Mepívakaín||2057||2057|4236||2 106006|J05AH0201|Tamiflu|hylki|30|mg|10|stk|1|þpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRG|0|0|0|100|DKK|1441|3388|lyfalmen|||1|10|0|2,0000|Icepharma hf|Roche Registration GmbH|Oseltamivír||1441||1441|3388||2 106017|J05AH0201|Tamiflu|hylki|45|mg|10|stk|1|þpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRG|0|0|0|100|DKK|2760|3386|lyfalmen|||1|10|0|3,0000|Icepharma hf|Roche Registration GmbH|Oseltamivír||1439||1439|3386||2 106182|G03AA1203|Yasminelle|filmhtfl|||63|stk|1|þpakki|3+0,02 mg|G03AA12|01.04.2013|30.06.2018|R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|2733|5167|lyfalmen|||1|63|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||2733||2733|5167||2 106390|L01XE1801|Jakavi|töflur|10|mg|56|stk|1|þpakki||L01XE18|01.03.2016||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|357581|450838|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||357581||357581|450838||1 106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|0|0|0|0|0|1|GPH|0|0|0|100|DKK|13762|20347|lyfsjukr|||1|5|0|0,6250|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||13762||13762|20347||1 106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|0|0|0|0|0|1|GPH|0|0|0|100|DKK|7610|11879|lyfsjukr|||1|5|0|0,3125|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||7610||7610|11879||1 106978|C03DA0404|Kalspar|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|2836|2724|lyfalmen|V0107|2724|2|30|0|15,0000|Williams & Halls efh|Williams & Halls ehf|Eplerenón||958||958|2724||2 107002|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.2015||R|0|0|0|0|0|1|CHI|0|0|0|100|DKK|126523|163466|lyfsjukr|||1|3|0|1,5000|Chiesi Farmaceutici SpA|Chiesi Farmaceutici SpA|Náttúrulegir fosfólípíðar||126523||126523|163466||1 107194|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|75 mg/15 mg|QP54AB51|01.04.2018||R|0|0|0|0|0|0|MER|0|0|0|100|XEU|2535|4369|vetorma|||0|3|0||Vistor hf|Merial|Milbemycin oxime í blöndum||2535||2535|4369||1 107203|R06AX2201|Kestine|filmhtfl|10|mg|30|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1 107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|1229|3097|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1229||1229|3097||1 107464|G04BD0805|Solifenacin Alvogen|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|3646|6423|lyfalmen|V0438|6423|2|30|0|30,0000|Alvogen|Alvogen|Sólífenacín||3646||3646|6423||2 107575|N01AB0803|Sevoflurane Piramal|innö.guf|100|%|250|ml|1|fl||N01AB08|01.03.2015||R|0|0|0|0|0|1|PCC|0|0|0|100|XEU|16784|21747|lyfsjukr|||1|250|0||Williams & Halls efh|Piramal Critical Care Limited|Sevóflúran||14779||14779|21747||2 107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|þpakki||A02BA02|01.07.1986||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|724|2401|lyfalmen|||2|60|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||724||724|2401||1 107643|N06BA0902|Atomoxetin Actavis|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017||R|1|1|0|0|0|0|GPA|0|0|0|100|XEU|10062|5392|lyfalmen|V0814|5218|2|28|0|8,7500|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||2897||2897|5392||1 107657|N05AX1205|Aripiprazol Krka|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|1|0|0|G|0|KRK|0|0|0|100|IKR|20582|4158|lyfalmen|V0683|3787|2|56|0|37,3300|LYFIS ehf|Krka Sverige AB|Aripiprazól||2000||2000|4158||2 107935|QN01AX0304|Aniketam vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2015||R|0|0|1|0|0|0|VEB|1|0|0|100|IKR|7285|13992|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Ketaminum||||7285|13992||2 108126|G04BD0402|Oxybutynin Mylan|töflur|5|mg|100|stk|1|þpakki||G04BD04|01.05.2013||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|1729|3785|lyfalmen|||2|100|0|33,3300|Icepharma hf|Mylan AB|Oxýbútýnín||1729||1729|3785||2 108205|QN02AC5201|Synthadon|stl|10|mg/ml|10|ml|1|pakki||QN02AC52|01.07.2016||R|0|0|1|0|0|0|VEB|1|0|0|100|IKR|3258|6352|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Metadón í blöndum nema með geðlyfjum||||3258|6352||2 108347|J05AP0701|Daklinza|filmhtfl|30|mg|28|stk|1|þpakki||J05AP07|01.10.2015||R|1|0|0|1|0|1|BMS|0|1|0|100|DKK|1122160|1401760|lyfsjukr|||1|28|0|14,0000|Vistor hf|Bristol-Myers Squibb Pharma EEIG|Daclatasvír||1122160||1122160|1401760||1 108413|C10AX1401|Praluent|stl|75|mg/ml|1|ml|2|áfpen|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|0|SGB|0|0|0|100|XEU|57404|75675|lyfalmen|||1|2|0|27,7778|Vistor hf|Sanofi-aventis groupe|Alirocumab||57404||57404|75675||1 108433|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.10.2013|30.06.2018|R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|42445|56755|lyfsjukr|||1|4|0|26,6700|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||42445||42445|56755||1 108455|N04BD0203|Rasagilin WH|töflur|1|mg|30|stk|1|þpakki||N04BD02|01.04.2016||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|5823|8286|lyfalmen|||2|30|0|30,0000|Williams & Halls efh|Williams & Halls ehf|Rasagilín||4999||4999|8286|31.8.2018|2 108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|þpakki||A10BH02|01.09.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|7654|11940|lyfalmen|||1|90|0|45,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||7654||7654|11940||1 108697|A16AA0601|Cystadane|duft|1|g|180|g|1|glas||A16AA06|01.07.2013||R|0|0|0|1|0|0|OEU|0|0|0|100|XEU|58249|76744|lyfalmen|||1|180|0|30,0000|Orphan Europe S.a.r.l.|Orphan Europe S.a.r.l.|Betain anhydrous||58249||58249|76744||3 109338|M01AH0502|Coxient|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|ALO|0|0|1|100|IKR|987|1928|lyfalmen|V0827|1680|2|7|0|14,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Etoríkoxíb||380||380|1928||2 109421|V01AA0303|Alutard SQ, derm.farinae|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18973|27519|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||18973||18973|27519||1 109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|15189|22311|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||15189||15189|22311||1 109569|N02AA0505|Oxycodone ratiopharm|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RTH|0|0|0|100|XEU|1289|3113|lyfalmen|V0584|3110|2|28|0|7,4700|Alvogen|ratiopharm GmbH|Oxýcódon||1241||1241|3113||2 109578|N02AA0505|Oxycodone ratiopharm|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RTH|0|0|0|100|XEU|4508|6575|lyfalmen|V0585|6575|2|98|0|26,1300|Alvogen|ratiopharm GmbH|Oxýcódon||3756||3756|6575||2 109588|N02AA0505|Oxycodone ratiopharm|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RTH|0|0|0|100|XEU|2357|4649|lyfalmen|V0586|4649|2|28|0|14,9300|Alvogen|ratiopharm GmbH|Oxýcódon||2357||2357|4649||2 109597|N02AA0505|Oxycodone ratiopharm|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RTH|0|0|0|100|XEU|7645|11524|lyfalmen|V0587|11524|2|98|0|52,2700|Alvogen|ratiopharm GmbH|Oxýcódon||7352||7352|11524||2 109615|N02AA0505|Oxycodone ratiopharm|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RTH|0|0|0|100|XEU|12771|16987|lyfalmen|V0588|16987|2|98|0|104,5300|Alvogen|ratiopharm GmbH|Oxýcódon||11321||11321|16987||2 110033|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|30|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Alvogen|ratiopharm GmbH|Cetirizín|||||||2 110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|278|1788|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||278||278|1788||2 110177|N06AX2108|Aritavi|sþ-hylki|60|mg|90|stk|1|glas||N06AX21|01.12.2015||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|6462|4732|lyfalmen|V0694|4732|2|90|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Duloxetín||2417||2417|4732||1 110184|S01ED5117|DUOKOPT|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml, án rotvarnar|S01ED51|01.06.2016||R|0|0|0|0|G|0|LTH|0|0|0|100|SEK|1464|3420|lyfalmen|||1|5|0|25,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||1464||1464|3420|31.7.2018|1 110242|V03AN0101|Conoxia|lyfjagas|100|%|3|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.04.2008||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|3|0||Ísaga ehf|AGA AB|Súrefni|||||||5 110287|N05AX0806|Risperidon Krka|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1500|2231|lyfalmen|V0291|2231|2|60|0|12,0000|LYFIS ehf|Krka Sverige AB|Risperídón||600||600|2231||2 110306|N05AX0806|Risperidon Krka|filmhtfl|2|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2608|3057|lyfalmen|V0292|3057|2|60|0|24,0000|LYFIS ehf|Krka Sverige AB|Risperídón||1200||1200|3057||2 110324|N05AX0806|Risperidon Krka|filmhtfl|3|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|3684|6476|lyfalmen|||2|60|0|36,0000|LYFIS ehf|Krka Sverige AB|Risperídón||3684||3684|6476||2 110342|N05AX0806|Risperidon Krka|filmhtfl|4|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|5000|8287|lyfalmen|||2|60|0|48,0000|LYFIS ehf|Krka Sverige AB|Risperídón||5000||5000|8287||2 110395|G03AA0902|Mercilon|töflur|||63|stk|1|þpakki|150/20 mcg|G03AA09|01.07.1990||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|1203|3061|lyfalmen|||1|63|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Desógestrel og ethinylestradíól||1203||1203|3061||1 110397|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.01.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5 110421|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|áf.spr||H01CC01|01.12.2015||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|20831|29417|lyfalmen|||1|2,5|0|5,0000|Vistor hf|Merck Sharp & Dohme Limited|Ganirelix||20831||20831|29417||1 110635|C08DA0104|Veraloc Retard|forðatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|3355|6023|lyfalmen|||1|100|0|83,3333|Vistor hf|Orion Corporation|Verapamíl||3355||3355|6023||1 110750|J05AX0801|Isentress|filmhtfl|400|mg|60|stk|1|glas||J05AX08|01.04.2012||R|1|0|0|1|0|1|MBV|0|0|0|100|DKK|72084|94242|lyfsjukr|||1|60|0|30,0000|Vistor hf|Merck Sharp & Dohme B.V.|Raltegravír||72084||72084|94242||1 110820|L01XE0104|Imatinib Mylan|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.02.2017||R|1|0|0|1|0|1|MYL|0|1|0|100|SEK|72032|26030|lyfsjukr|||2|60|0||Icepharma hf|Mylan AB|Imatiníb||17891||17891|26030||2 110958|L01AX0304|Temozolomide Accord|hylki|100|mg|5|stk|1|skpoki|hart|L01AX03|01.04.2018||R|0|0|0|1|0|1|ARD|0|1|0|100|XEU|9400|14343|lyfsjukr|||2|5|0||Artasan ehf|Accord Healthcare Limited|Temozolomid||9400||9400|14343||1 111295|G02BA0304|Levosert|leginnle|20|mcg/sólh|1|stk|1|poki||G02BA03|01.09.2015||R|0|1|0|0|0|0|GED|0|0|0|100|XEU|12584|15996|lyfalmen|||2|1|0||Gedeon Ricther Nordics AB|Gedeon Richter Plc.|Plast lyfjalykkja (IUD) með prógestógen||10601||10601|15996||1 111479|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|3|glas|+ dorzólamid 20 mg/ml|S01ED51|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|2311|4233|lyfalmen|V0373|4233|2|15|0|75,0000|Alvogen|Alvogen|Tímólól í blöndum||2055||2055|4233||2 111678|A06AB5802|CitraFleet|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.12.2013||L|0|0|0|0|0|0|CRC|0|0|0|100|IKR|||lyflausa|||0|2|0||Recordati AB|Casen Recordati S.L.|Natríumpicosúlfat|||||||1 111955|N02BE0101|Panodil|filmhtfl|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|1|0|0|0|0|0|HCA|0|0|1|100|DKK|548|2159|lyfalmen|||1|100|0|33,3300|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól||548||548|2159||1 112191|C02KX0501|Adempas|filmhtfl|1|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|159018|203881|lyfsjukr|||1|42|0|9,3300|Vistor hf|Bayer AG|Riociguatum||159018||159018|203881||1 112873|J01CA0413|Amoxin|mixtduft|50|mg/ml|100|ml|1|glas||J01CA04|01.12.2015||R|0|0|0|0|0|0|RTH|0|0|1|100|IKR|1627|3644|lyfalmen|||2|100|0|5,0000|Alvogen|ratiopharm GmbH|Amoxicillín||1627||1627|3644||2 113058|N07BA0148|Nicovel Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.02.2013||L|0|0|0|0|0|0|ORI|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Orifarm Generics A/S|Nikótín|||||||1 113143|N05AX1205|Aripiprazol Krka|töflur|30|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|1|0|0|G|0|KRK|0|0|0|100|IKR|14883|16545|lyfalmen|||2|56|0|112,0000|LYFIS ehf|Krka Sverige AB|Aripiprazól||11000||11000|16545||2 113251|D01AE1602|Amorolfin ratiopharm|lakk|5|%|5|ml|1|glas||D01AE16|01.09.2014||L|0|0|0|0|0|0|RHA|0|0|1|100|IKR|||lyfalmen|V0655|3995|2|5|0||Alvogen|ratiopharm Oy|Amorolfín|||||4984||2 113394|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|6059|9745|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||6059||6059|9745||1 113412|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|5458|8917|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||5458||5458|8917||1 113414|B05AA0114|Albuman|irl|40|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SPP|0|0|0|100|XEU|1813|3900|lyfsjukr|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|Albúmín||1813||1813|3900||2 113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|áf.spr|einnota dæla|B01AB05|01.10.1995||R|0|0|0|0|G|0|SNP|0|0|1|100|XEU|2265|4522|lyfalmen|||1|2|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||2265||2265|4522||1 113648|N06BA0404|Methylphenidate Sandoz|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.03.2015||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|4598|6343|lyfalmen|V0681|6343|2|30|0|27,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||3588||3588|6343||1 113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|áf.spr|einnota dæla|B01AB05|01.10.1995||R|0|0|0|0|G|0|SNP|0|0|1|100|XEU|3891|6760|lyfalmen|||1|4|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3891||3891|6760||1 113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|þpakki||L01XE08|01.06.2008||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|391253|492716|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||391253||391253|492716||1 113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|474|2057|lyfalmen|V0930|2011|1|20|0|10,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||474||474|2057||2 113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|689|2353|lyfalmen|V0931|2300|1|30|0|15,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||689||689|2353||2 113982|B05AA0510|RescueFlow|irl|||250|ml|6|pokar|60/75 g/l|B05AA05|01.03.2017||R|0|0|0|0|0|1|ARM|0|0|0|100|DKK|38302|51515|lyfsjukr|||1|1500|0||Williams & Halls efh|Pharmanovia A/S|Dextran||38302||38302|51515||2 114033|R03AC0210|Ventolin Diskus|innönddu|200|mcg/sk|60|skammtar|1|stk|Diskus tæki|R03AC02|01.03.1999||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|570|2189|lyfalmen|||1|60|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||570||570|2189||1 114063|G04BE0806|Tadalafil Krka|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|5000|3745|lyfalmen|V0145|2805|2|4|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||1700||1700|3745||2 114072|A07DA0301|Imodium|filmhtfl|2|mg|16|stk|1|þpakki||A07DA03|01.02.2014||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|16|0|3,2000|Vistor hf|McNeil Sweden AB|Lóperamíð|||||||1 114134|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAR|0|1|0|100|SEK|16337|23891|lyfsjukr|||1|1|0||Icepharma hf|Bayer AG|Storkuþáttur VIII||||16337|23891||2 114328|L01AX0303|Temomedac|hylki|100|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|1|0|100|XEU|27649|38041|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||||27649|38041||2 114440|M01AH0501|Arcoxia|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|3229|5849|lyfalmen|V0824|2789|1|28|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||3229||3229|5849||1 114461|G04BE0809|Tadalafil ratiopharm|filmhtfl|20|mg|12|stk|1|þpakki||G04BE08|01.07.2018||R|1|0|0|0|0|0|RTH|0|0|0|100|XEU|16245|8414|lyfalmen|V0145|8414|2|12|0|24,0000|Alvogen|ratiopharm GmbH|Tadalafíl||5092||5092|8414||2 114512|D06BB0401|Condyline|húðlausn|5|mg/ml|3,5|ml|1|glas|til penslunar|D06BB04|01.11.2010|31.07.2018|R|0|0|0|0|0|0|GAN|0|0|1|100|XEU|1724|3778|lyfalmen|||1|3,5|0||Icepharma hf|Galderma Nordic AB|Pódófýllótoxín||1724||1724|3778||2 114755|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|90|stk|1|þpakki||L02BB03|01.11.2014||R|0|0|0|0|G|0|MED|0|0|0|100|IKR|14000|10076|lyfalmen|V0420|10076|2|90|0|90,0000|Medical ehf|Medical ehf|Bíkalútamíð||6300||6300|10076||2 114912|QP54AA0501|Stronghold|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|4745|8178|vetorma|||0|3|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||4745||4745|8178||2 114941|N05AH0312|Zalasta|töflur|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|1929|2674|lyfalmen|V0278|2674|2|28|0|7,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||922||922|2674||2 114952|N05AH0312|Zalasta|töflur|5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|2543|2739|lyfalmen|V0279|2739|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||969||969|2739||2 114963|N05AH0312|Zalasta|töflur|7,5|mg|56|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|6598|4061|lyfalmen|V0280|4061|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1930||1930|4061||2 114985|N05AH0312|Zalasta|töflur|10|mg|56|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|9118|3037|lyfalmen|V0282|3037|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1186||1186|3037||2 114996|N05AH0312|Zalasta|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|5276|8667|lyfalmen|V0457|8667|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||5276||5276|8667||2 115007|N05AH0312|Zalasta|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|8022|12446|lyfalmen|||2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||8022||8022|12446||2 115015|G03GA1001|REKOVELLE|stl|72|mcg|2,16|ml|1|pakki|+ 9 inndælingarnálar|G03GA10|01.08.2017||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|67415|88337|lyfalmen|||1|2,16|0||Vistor hf|Ferring Lægemidler A/S|Follitrópín delta||||67415|88337||1 115018|N05AH0312|Zalasta|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|5779|9359|lyfalmen|V0475|9359|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||5779||5779|9359||2 115029|N05AH0312|Zalasta|munndr.t|20|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|13896|20531|lyfalmen|V0540|20531|2|28|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||13896||13896|20531||2 115126|B02BD0801|NovoSeven|sts|1|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|74652|97490|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||74652||74652|97490||1 115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009|31.08.2018|R|0|1|0|0|G|0|BII|0|0|0|100|DKK|1505|3476|lyfalmen|||1|10|0|2,5000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1505||1505|3476||1 115241|V03AB1504|Naloxon B. Braun|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.09.2010||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|6929|10942|lyfsjukr|||2|10|0||Actavis Group hf|B.Braun Melsungen AG|Naloxón||6929||6929|10942||2 115285|J01CA0411|Amoxicillin Mylan|töflur|750|mg|20|stk|1|þpakki||J01CA04|01.10.1998||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|895|2579|lyfalmen|V0158|2437|2|20|0|15,0000|Icepharma hf|Mylan AB|Amoxicillín||853||853|2579||2 115309|N05AH0206|Clozapin Medical|töflur|25|mg|100|stk|1|þpakki||N05AH02|01.06.2015||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|1862|3057|lyfalmen|V0276|3057|2|100|0|8,3300|Medical ehf|Medical ehf|Klózapín||1200||1200|3057|| 115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|8929|13695|lyfalmen|||1|60|0|15,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||8929||8929|13695||1 115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009|31.08.2018|R|0|1|0|0|G|0|BII|0|0|0|100|DKK|1505|3476|lyfalmen|||1|10|0|3,6700|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1505||1505|3476||1 115348|R06AE0501|Postafen|töflur|25|mg|25|stk|1|þpakki||R06AE05|01.07.2016||R|1|0|0|0|G|0|GOP|0|0|1|100|SEK|136|1592|lyfalmen|V0505|1592|1|25|0|12,5000|Sofus Regulatory Affairs AB|Gen. Orph|Meklózín||136||136|1592||1 115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|8157|12632|lyfalmen|||1|60|0|22,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||8157||8157|12632||1 115554|B03AC0001|Monofer|irl|100|mg/ml|10|ml|1|hgl||B03AC|01.07.2013||R|0|1|0|0|G|0|PAC|0|0|1|100|DKK|40546|54353|lyfalmen|||1|10|0|10,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||40546||40546|54353||1 115613|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 115770|D10AF5101|Duac|hlaup|||30|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.03.2018||R|0|0|0|0|0|0|STE|0|0|0|100|DKK|2678|5091|lyfalmen|||1|30|0||Vistor hf|Stiefel Laboratories L.(Ireland) Ltd.|Klindamýcín í blöndum||2678||2678|5091||1 115931|R03AC1202|Serevent Diskus|innönddu|50|mcg/sk|60|skammtar|1|pakki||R03AC12|01.01.1995||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|2640|5039|lyfalmen|||1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról||2640||2640|5039||1 116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|0|0|0|0|0|1|GPH|0|0|0|100|DKK|2745|5183|lyfsjukr|||1|5|0|2,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Cefúroxím||2745||2745|5183||1 116046|J01DC0202|Zinacef|sts|750|mg|5|hgl|1|pakki||J01DC02|01.09.1983||R|0|0|0|0|0|1|GPH|0|0|0|100|DKK|1435|3380|lyfsjukr|||1|5|0|1,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Cefúroxím||1435||1435|3380||1 116244|D11AF01|Verucid|áburður|||10|ml|1|glas||D11AF|01.11.1981||L|0|0|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||0|10|0||Icepharma hf|Galderma Nordic AB|Lyf við vörtum og líkþornum|||||||2 116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|þpakki||M01AE01|01.12.2008||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1 116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|þpakki||M01AE01|01.05.2008||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1 116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|glas||M01AE01|01.05.2008||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|704|2355|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen||690||690|2355|30.6.2018|1 116694|G04BD1101|Toviaz|forðatfl|4|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|PHH|0|0|0|100|DKK|12367|18427|lyfalmen|||1|84|0|84,0000|Icepharma hf|Pfizer Limited|Fesóteródín||12367||12367|18427||1 116697|C09CA0602|Candpress|töflur|8|mg|100|stk|1|þpakki||C09CA06|01.01.2012||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|3498|5738|lyfalmen|V0081|5321|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||3148||3148|5738||1 116705|G04BD1101|Toviaz|forðatfl|4|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|PHH|0|0|0|100|DKK|4820|8039|lyfalmen|||1|28|0|28,0000|Icepharma hf|Pfizer Limited|Fesóteródín||4820||4820|8039||1 116716|G04BD1101|Toviaz|forðatfl|8|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|PHH|0|0|0|100|DKK|5165|8514|lyfalmen|||1|28|0|56,0000|Icepharma hf|Pfizer Limited|Fesóteródín||5165||5165|8514||1 116727|G04BD1101|Toviaz|forðatfl|8|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|PHH|0|0|0|100|DKK|13258|19653|lyfalmen|||1|84|0|168,0000|Icepharma hf|Pfizer Limited|Fesóteródín||13258||13258|19653||1 116841|D07AC1302|Ovixan|húðlausn|0,1|%|30|ml|1|dropaí||D07AC13|01.08.2013|31.07.2018|R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|419|1982|lyfalmen|||2|30|0||Vistor hf|Galenica AB|Mómetasón||||419|1982||1 116907|N02AE0104|Buprenorphine ratiopharm|forðapl|10|mcg/klst|4|stk|1|skpoki||N02AE01|01.06.2018||R|0|0|1|0|G|0|RTH|0|0|0|100|SEK|1460|3414|lyfalmen|V0944|3401|2|4|0|5,6000|Alvogen|ratiopharm GmbH|Búprenorfín||1460||1460|3414||2 117408|QA12AX0001|Calcimag vet. Kela|irl|||500|ml|12|plastf||QA12AX|01.04.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|XEU|7649|14682|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum í blöndum með D-vítamíni/eða öðrum efnum||7649||7649|14682||2 117424|M01AE0303|Orudis|forðahlk|100|mg|100|stk|1|glas||M01AE03|01.12.2014||R|1|0|0|0|G|0|SNP|0|0|1|100|XEU|1226|3092|lyfalmen|||1|100|0|66,6700|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||1226||1226|3092||1 117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|3448|6151|lyfalmen|V0435|5787|1|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3448||3448|6151||2 117550|N05AH0405|Seroquel Prolong|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|0|0|ASZ|0|0|0|100|SEK|9059|13279|lyfalmen|V0275|5259|1|100|0|12,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||8627||8627|13279||1 117561|N05AH0405|Seroquel Prolong|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|G|0|ASZ|0|0|0|100|SEK|16687|22395|lyfalmen|V0273|7736|1|100|0|50,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||15250||15250|22395||1 117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|1157|2997|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1157||1157|2997||2 117584|N05AH0405|Seroquel Prolong|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|G|0|ASZ|0|0|0|100|SEK|23950|33362|lyfalmen|V0272|9388|1|100|0|75,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||23950||23950|33362||1 117595|N05AH0405|Seroquel Prolong|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|G|0|ASZ|0|0|0|100|SEK|35055|47408|lyfalmen|V0261|13793|1|100|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||35055|47408||1 117676|L01DB0103|Caelyx|irþ|2|mg/ml|10|ml|1|hgl||L01DB01|01.01.2011||R|0|0|0|0|0|1|JCI|0|1|0|100|SEK|44440|59278|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||44440||44440|59278||1 117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|5738|9890|vetorma|||0|250|0||Icepharma hf|Bayer Animal Health GmbH|Toltrazuril||5738||5738|9890||2 117787|N06BA0904|Atomoxetine Sandoz|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.10.2017||R|1|1|0|0|0|0|SHS|0|0|0|100|DKK|9052|5332|lyfalmen|V0816|5218|2|28|0|21,0000|Artasan ehf|Sandoz A/S|Atomoxetín||2853||2853|5332||1 117929|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA03|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|NOK|4620|8936|vetalmen|||0|1200|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||4620||4620|8936||2 117937|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA03|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|XEU|9058|17355|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||9058||9058|17355||2 118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.05.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1416|3354|lyfalmen|V0278|2674|2|28|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1416||1416|3354||1 118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2322|3442|lyfalmen|V0279|2739|2|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1480||1480|3442||1 118074|J01CE0207|Fenoximetylpenicillin EQL Pharma|filmhtfl|800|mg|20|stk|1|þpakki||J01CE02|01.01.2018||R|0|0|0|0|0|0|EQL|0|0|1|100|IKR|600|2162|lyfalmen|V0929|2162|2|20|0|8,0000|LYFIS ehf|EQL Pharma AB|Fenoxýmetýlpenicillín||550||550|2162||2 118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|7929|3379|lyfalmen|V0282|3037|2|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1434||1434|3379||1 118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1369|3289|lyfalmen|V0283|2853|2|28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1369||1369|3289||1 118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|9512|14497|lyfsjukr|||1|4|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||9512||9512|14497||5 118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|þpakki||A02BA02|01.04.1994||L|1|0|0|0|0|0|TCA|0|0|0|100|IKR|||lyflausa|||0|30|0|15,0000|Actavis Group hf|Actavis hf|Ranitidín|||||||1 118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|6598|5018|lyfalmen|V0280|4061|2|56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||2625||2625|5018||1 118575|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|4210|8158|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||4210||4210|8158||2 118612|A07EC0203|Pentasa Sachet|forðakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|17134|24988|lyfalmen|||1|150|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||17134||17134|24988||1 118658|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2255|4509|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||2255||2255|4509||2 118793|C01AA0504|Lanoxin mite|töflur|62,5|mcg|120|stk|1|þpakki||C01AA05|01.12.2010||R|1|0|0|0|G|0|AEP|0|0|0|100|DKK|382|1931|lyfalmen|||1|120|0|30,0000|Icepharma hf|Aspen Pharma Trading Limited|Digoxín||382||382|1931||2 119394|C07AG0101|Trandate|filmhtfl|100|mg|50|stk|1|glas||C07AG01|01.04.2013||R|1|0|0|0|G|0|AEP|0|0|0|100|DKK|1017|2805|lyfalmen|||1|50|0|8,3333|Icepharma hf|Aspen Pharma Trading Limited|Labetalól||1017||1017|2805||2 119520|M01AH0503|Coxerit|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|1|100|IKR|2800|2857|lyfalmen|V0824|2789|2|28|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||1055||1055|2857||2 119528|D11AX2201|Soolantra|krem|10|mg/g|30|g|1|túpa||D11AX22|01.07.2016||R|0|0|0|0|0|0|GAN|0|0|0|100|XEU|3193|5800|lyfalmen|||1|30|0||Icepharma hf|Galderma Nordic AB|Ivermectin||3193||3193|5800||2 119710|N03AX1603|Pregabalin Krka|hylki|100|mg|84|stk|1|þpakki||N03AX16|01.01.2018||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|5500|5259|lyfalmen|||2|84|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||2800||2800|5259||2 119825|N05BA1206|Alprazolam Krka|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|IKR|1297|3190|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1297||1297|3190||2 119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|RGO|0|1|0|100|DKK|264550|335133|lyfsjukr|||1|30|0|20,0000|Vistor hf|Glaxo Group Limited|Ambrisentanum||264550||264550|335133||1 120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|RGO|0|1|0|100|DKK|245605|311571|lyfsjukr|||1|30|0|40,0000|Vistor hf|Glaxo Group Limited|Ambrisentanum||245605||245605|311571||1 120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1418|3357|lyfalmen|||1|10|0||Vistor hf|Novartis Healthcare A/S|Cýklópentólat||1418||1418|3357||1 120062|L01BA0401|Alimta|irþ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|0|0|0|0|0|1|NED|0|1|0|100|XEU|33598|45565|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||33598||33598|45565||2 120768|C10AA0703|Rosuvastatin Krka|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.03.2015||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|10373|8562|lyfalmen|V0118|8562|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||5200||5200|8562||2 121104|L01XC1401|Kadcyla|irþ|160|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|0|0|1|RRG|0|1|0|100|DKK|354093|446500|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration GmbH|Trastuzumab emtansine||354093||354093|446500||2 121133|C10AA0704|Rosuvastatin Xiromed|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.04.2018||R|0|0|0|0|0|0|VAL|0|0|0|100|IKR|7410|8562|lyfalmen|V0118|8562|2|100|0|200,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||5200||5200|8562||2 121164|A02BC0501|Nexium|mixt.kyr|10|mg|28|sk-pokar|1|pakki|dreifa|A02BC05|01.04.2009||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|3434|6131|lyfalmen|||1|28|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||3434||3434|6131||1 121286|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.04.2009||R|0|0|0|0|0|1|MBV|0|0|0|100|DKK|5932|9570|lyfsjukr|||1|50|0||Vistor hf|Merck Sharp & Dohme B.V.|Rókúrón, brómíð||5932||5932|9570||1 121302|N02BA5102|Treo|freyðit|||60|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|0|MEA|0|0|1|100|DKK|||lyflausa|||0|60|0|10,0000|Icepharma hf|Meda AB|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||2 121327|R03AC0204|Ventolin|innúðal|0,1|mg/sk|200|skammtar|1|stauk|dreifa|R03AC02|01.12.1972||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|366|1909|lyfalmen|||1|200|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||366||366|1909||1 121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|þpakki||B03BB01|01.01.2008||R|1|0|0|0|G|0|UAK|0|0|1|100|GBP|395|1949|lyfalmen|||2|28|0|350,0000|Actavis Group hf|Actavis UK Ltd.|Fólínsýra||395||395|1949||1 121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|þpakki||N06AA04|01.03.1977||R|1|0|0|0|G|0|NAA|0|0|0|100|DKK|1334|3241|lyfalmen|V0314|2735|1|100|0|25,0000|Artasan ehf|Novartis Healthcare A/S|Klómípramín||1334||1334|3241||1 121691|H02AB0605|Prednisolone Actavis|töflur|1|mg|28|stk|1|þpakki||H02AB06|01.01.2011||R|1|0|0|0|G|0|UAK|0|0|1|100|GBP|303|1822|lyfalmen|||2|28|0|2,8000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||303||303|1822||1 121792|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.07.2017||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|218|1705|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag AB|Fentanýl||218||218|1705||1 121912|L04AX0306|Metojectpen|stl|25|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2904|5402|lyfalmen|||1|1|0|10,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2904||2904|5402||2 122133|G04BE0807|Tadalafil Mylan|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.01.2018||R|1|0|0|0|0|0|GEN|0|0|0|100|IKR|3416|3676|lyfalmen|V0145|2805|2|4|0|8,0000|Icepharma hf|Generics UK Ltd|Tadalafíl||1650||1650|3676||2 122301|R01AD0802|Nasofan|nefúði|50|mcg/sk|60|skammtar|1|glas||R01AD08|01.05.2014||L|0|0|0|0|0|0|TSA|0|0|1|100|IKR|||lyflausa|||2|60|0|15,0000|Alvogen|Teva Sweden AB|Flútíkasón|||||||2 122326|A02BC0404|Rabeprazol Medical Valley|sþ-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.09.2018||R|0|0|0|0|G|0|VAL|0|0|0|100|IKR|2500|2768|lyfalmen|V0010|2179|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Rabeprazól||990||990|2768||2 122411|QI09AA0701|Ingelvac CircoFLEX|stl|||50|ml|1|hgl|dreifa|QI09AA07|01.12.2010||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|7229|12460|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Porcine circovirus Type ORF-2 protein||7229||7229|12460||1 122471|L01XE1301|Giotrif|filmhtfl|30|mg|28|stk|1|þpakki||L01XE13|01.05.2016||R|0|0|0|1|0|1|BOE|0|1|0|100|DKK|232131|294813|lyfsjukr|||1|28|0||Vistor hf|Boehringer Ingelheim International GmbH|Afatiníb||232131||232131|294813||1 122547|N07BC0202|Metadon Abcur|töflur|5|mg|20|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|439|2009|lyfalmen|||1|20|0|5,0000|Icepharma hf|Abcur AB|Metadón||439||439|2009||2 123216|N05BA0105|Stesolid|eþ-stíll|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|0|0|0|0|0|0|GRP|0|0|1|100|DKK|672|2330|lyfalmen|||2|10|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||672||672|2330||1 123224|N05BA0105|Stesolid|eþ-stíll|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|0|0|0|0|0|0|GRP|0|0|1|100|DKK|1110|2933|lyfalmen|||2|10|0|10,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||1110||1110|2933||1 123256|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|þpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|25761|44402|vetorma|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|||25761||25761|44402||2 123435|N05AX1205|Aripiprazol Krka|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.04.2017||R|1|1|0|0|G|0|KRK|0|0|0|100|IKR|5668|4846|lyfalmen|V0716|4846|2|28|0|28,0000|LYFIS ehf|Krka Sverige AB|Aripiprazól||2500||2500|4846||2 123456|R03DX0701|Daxas|filmhtfl|500|mcg|90|stk|1|þpakki||R03DX07|01.10.2013||R|0|1|0|0|0|0|AZA|0|0|0|100|SEK|15404|22607|lyfalmen|||1|90|0|90,0000|Vistor hf|AstraZeneca AB|Roflumílast||15404||15404|22607||1 123641|QP51AJ0102|Baycox Sheep vet.|mixtúra|50|mg/ml|1000|ml|1|glas||QP51AJ01|01.03.2014||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|21834|37633|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|Toltrazuril||21834||21834|37633||2 123806|C07AA0512|Pranolol|töflur|20|mg|100|stk|1|glas||C07AA05|01.09.2011||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|517|2117|lyfalmen|||2|100|0|12,5000|Actavis Group PTC ehf|Actavis Group PTC ehf|Própranólól||517||517|2117||1 123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|þpakki||N07XX02|01.05.1998||R|1|0|0|1|G|0|AVS|0|0|0|100|XEU|18526|26904|lyfalmen|V0579|22288|1|56|0|28,0000|Vistor hf|Aventis Pharma SA|Rílúzól||18526||18526|26904||1 124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|1425|2801|vetalmen|||0|42|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||||1425|2801||2 124119|B01AC0401|Plavix|töflur|300|mg|30|stk|1|þpakki||B01AC04|01.09.2009||R|1|0|0|0|0|0|SND|0|0|0|100|XEU|24554|34126|lyfalmen|||1|30|0|120,0000|Vistor hf|Sanofi Clir SNC|Klópídógrel||24554||24554|34126||1 124141|A11HA0801|Vedrop|mixtúra|50|mg/ml|60|ml|1|glas||A11HA08|01.07.2017||R|0|0|0|1|0|0|URE|0|0|0|100|XEU|25447|35256|lyfalmen|||0|60|0||Orphan Europe Nordic AB|Orphan Europe|Tocofersolanum||25447||25447|35256||3 124168|N07BC0202|Metadon Abcur|töflur|20|mg|100|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|6968|10996|lyfalmen|||1|100|0|100,0000|Icepharma hf|Abcur AB|Metadón||6968||6968|10996||2 124356|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|36|0|1,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 124870|S01ED5110|Duotrav|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|7612|11882|lyfalmen|||1|7,5|0|75,0000|Vistor hf|Novartis Europharm Ltd|Tímólól í blöndum||7612||7612|11882||1 124908|D02AX0001|Oviderm|krem|250|mg/g|500|g|1|túpa|fjölskammtaílát m.dælu|D02AX|01.03.2018||L|0|0|0|0|G|0|GAB|0|0|0|100|IKR|||lyfalmen|||0|500|0||Vistor hf|Galenica AB|Önnur húðverndandi efni|||||4436||1 125038|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.01.1994||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|715|2389|lyfalmen|V0066|2389|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Enalapríl||715||715|2389||1 125125|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2013||R|0|0|0|1|G|0|AEP|0|0|0|100|DKK|9915|15052|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma Trading Limited|Melphalan||9915||9915|15052||2 125197|R03DC0303|Montelukast Actavis|filmhtfl|10|mg|100|stk|1|þpakki||R03DC03|01.08.2017||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|5150|2600|lyfalmen|V0490|2468|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Montelúkast||868||868|2600||1 125457|N05AH0411|Quetiapine Teva|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.09.2014||R|1|0|0|0|G|0|TSA|0|0|0|100|IKR|4399|3470|lyfalmen|V0285|3470|2|100|0|25,0000|Alvogen|Teva Sweden AB|Quetíapín||1500||1500|3470||2 125661|G04BE0805|Tadalafil Actavis|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.12.2017||R|0|0|0|0|0|0|GPA|0|0|0|100|XEU|10126|6171|lyfalmen|V0145|5609|2|8|0|16,0000|Actavis Group hf|Actavis Group PTC ehf|Tadalafíl||3463||3463|6171||1 125688|D11AH0101|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AH01|01.08.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|1794|3874|lyfalmen|||1|10|0||Vistor hf|LEO Pharma A/S|Takrólímus||||1794|3874||1 126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|25081|34793|lyfsjukr|||1|50|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||25081||25081|34793||2 126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|50162|66515|lyfsjukr|||1|100|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||50162||50162|66515||2 126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|100324|130882|lyfsjukr|||1|200|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||100324||100324|130882||2 126803|S01LA0501|Eylea|stl|40|mg/ml|1|hgl|1|pakki|lausn|S01LA05|01.10.2013||R|0|1|0|0|0|1|FIN|0|1|0|100|DKK|106053|138007|lyfsjukr|||1|1|0||Icepharma hf|Bayer AG|Aflibercept||106053||106053|138007||2 126926|B01AF0101|Xarelto|filmhtfl|15|mg|100|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|26834|37010|lyfalmen|||1|100|0|75,0000|Icepharma hf|Bayer AG|Rivaoxaban||||26834|37010||2 126949|S01BC1001|Nevanac|augndr|3|mg/ml|3|ml|1|glas||S01BC10|01.02.2014||R|0|0|0|0|G|0|NEL|0|0|1|100|DKK|2938|5449|lyfalmen|||1|3|0||Vistor hf|Novartis Europharm Ltd|Nepafenak||||2938|5449||1 126955|H02AB0205|Dexametason Abcur|töflur|1|mg|100|stk|1|þpakki||H02AB02|01.08.2016||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|5876|9493|lyfalmen|||2|100|0|66,6700|Icepharma hf|Abcur AB|Dexametasón||5876||5876|9493||2 127362|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.02.2015||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|2610|4733|lyfalmen|V0011|4733|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||2418||2418|4733||1 127383|R02AA0302|Strepsils med honning og citron|sogtfl|||36|stk|1|þpakki||R02AA03|01.01.2009||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 127403|G04B00001|Lyngonia|filmhtfl|||60|stk|1|þpakki|425,25-519,75 mg|G04B000|01.11.2017||L|0|0|0|0|0|0|FLO|0|0|0|100|IKR|||lyflausa|||0|60|0||Florealis ehf|Florealis ehf|Dry Bearberry leaf extract|||||||1 127881|N07BA0149|Nicovel Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.02.2013||L|0|0|0|0|0|0|ORI|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Orifarm Generics A/S|Nikótín|||||||1 128003|N05CF0205|Zovand|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.04.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|IKR|944|2704|lyfalmen|V0313|2704|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Zolpidem||944||944|2704||2 128058|N05AH0301|Zyprexa|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|1|0|0|0|0|0|NED|0|0|0|100|XEU|5568|9069|lyfalmen|V0279|2739|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||5568||5568|9069||2 128131|QG51AG0101|Sulfa-Streptocillin vet.|legstíl|||30|stk|1|þpakki||QG51AG01|01.03.2009||R|0|0|0|0|0|0|BID|1|0|0|100|DKK|11298|21605|vetalmen|||0|30|0||Vistor hf|Boehringer Ingelheim Danmark|Súlfónamíðar í blöndu með öðrum lyfjum||11298||11298|21605||1 128348|C03AB0102|Centyl mite med kaliumklorid|töflur|||100|stk|1|glas||C03AB01|01.05.1999||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|1029|2821|lyfalmen|||1|100|0|50,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||1029||1029|2821||1 128625|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2015||R|0|0|0|0|0|0|PLS|0|0|0|100|SEK|2898|5394|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer ApS|Heilabólguveira óvirk, borin með blóðmaur||2898||2898|5394||1 129106|N05AH0301|Zyprexa|húðuðtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|1|0|0|0|G|0|NED|0|0|0|100|XEU|21805|30649|lyfalmen|V0282|3037|1|56|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||21805||21805|30649||2 129158|H02AB0605|Prednisolone Actavis|töflur|5|mg|28|stk|1|þpakki||H02AB06|01.02.2011||R|1|0|0|0|G|0|UAK|0|0|1|100|GBP|360|1900|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||360||360|1900||1 129188|V03AE0204|Sevelamerkarbonat WH|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.03.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|15506|10434|lyfalmen|V0680|10434|2|180|0|22,5000|Williams & Halls efh|Williams & Halls ehf|Sevelamer||6560||6560|10434||2 129668|A02AH0003|Natriumbikarbonat Meda|töflur|1|g|100|stk|1|glas||A02AH|01.08.2005||L|1|0|0|0|0|0|MEA|0|0|0|100|DKK|||lyfalmen|||0|100|0||Icepharma hf|Meda AB|Natríumhýdrógenkarbonat|||||2996||2 129817|R03BB0101|Atrovent|lausn|0,25|mg/ml|60|sk-ílát|1|pakki|fyrir eimgjafa|R03BB01|01.04.1989||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|2793|5249|lyfalmen|||1|60|0|100,0000|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||2793||2793|5249||1 129923|N06BA0903|Atomoxetin Medical Valley|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|0|VAL|0|0|0|100|XEU|8351|5218|lyfalmen|V0812|5218|2|28|0|3,5000|Acare ehf|Medical Valley Invest AB|Atomoxetín||2770||2770|5218||2 129936|N06BA0406|Medikinet CR|hylki|50|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|9929|15071|lyfalmen|||2|30|0|50,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||9929||9929|15071||2 130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1560|3552|lyfalmen|||2|10|0|20,0000|Icepharma hf|Mylan AB|Adrenalín tartrat||1560||1560|3552||2 130309|L01AB0102|Busilvex|irþ|6|mg/ml|10|ml|8|hgl||L01AB01|01.06.2016||R|0|0|0|0|0|1|PFM|0|0|0|100|DKK|249700|316664|lyfsjukr|||1|80|0||Vistor hf|Pierre Fabre Médicament|Búsúlfan||249700||249700|316664||1 130397|QH01CA9301|Suprelorin|vefjalyf|4,7|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|16139|30789|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||16139||16139|30789||1 130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1219|3083|lyfalmen|||2|10|0|3,3400|Icepharma hf|Mylan AB|Atrópínsúlfat||1219||1219|3083||2 130596|N07BA0301|Champix|filmhtfl|||53|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|0|0|0|0|0|0|PHH|0|0|1|100|DKK|8889|13640|lyfalmen|||1|53|0|23,7500|Icepharma hf|Pfizer Limited|Vareniclin||||8889|13640||1 130772|QI10AB0201|Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10AB02|01.05.2009||R|0|0|0|0|0|0|PHA|0|0|0|100|NOK|36450|58757|veteldis|||0|500|0||Vistor hf|PHARMAQ AS|Aeromónas+Vibrio||||36450|58757||1 131010|QN01BB0301|Mepidor vet.|stl|20|mg/ml|10|ml|6|hgl|lausn|QN01BB03|01.06.2017||R|0|0|0|0|0|0|RPG|1|0|0|100|XEU|5533|10668|vetalmen|||0|60|0||Icepharma hf|Richter Pharma AG|Mepivacaine||5533||5533|10668||2 131136|C01CA2601|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||C01CA26|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|0|100|SEK|2235|4481|lyfalmen|||2|10|0|10,0000|Icepharma hf|Mylan AB|Efedrínhýdróklóríð||||2235|4481||2 131155|H05BX0104|Cinacalcet Mylan|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.11.2016||R|1|0|0|0|0|0|ASD|0|0|0|100|IKR|34212|19298|lyfalmen|V0722|18969|2|28|0|42,0000|Icepharma hf|Mylan S.A.S.|Cinacalcet||13000||13000|19298||2 131334|N03AB0209|Fenantoin Meda|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|1|0|0|0|G|0|MEA|0|0|0|100|DKK|791|2494|lyfalmen|||2|100|0|33,3333|Icepharma hf|Meda AB|Fenýtóín||791||791|2494||2 131383|N03AA0207|Fenemal Meda|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|MEA|0|0|0|100|DKK|1303|3198|lyfalmen|||2|100|0|15,0000|Icepharma hf|Meda AB|Fenemal||1303||1303|3198||2 131417|N03AA0207|Fenemal Meda|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|MEA|0|0|0|100|DKK|1476|3436|lyfalmen|||2|100|0|50,0000|Icepharma hf|Meda AB|Fenemal||1476||1476|3436||2 131441|N03AA0207|Fenemal Meda|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|MEA|0|0|0|100|DKK|2105|4302|lyfalmen|||2|100|0|100,0000|Icepharma hf|Meda AB|Fenemal||2105||2105|4302|31.7.2018|2 132260|N06DA0404|Galantamine Portfarma|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.12.2011||R|1|0|0|0|G|0|POF|0|0|0|100|SEK|2975|4623|lyfalmen|V0348|4266|2|28|0|14,0000|Alvogen|Alvogen|Galantamín||2338||2338|4623||2 132322|A02BC0404|Rabeprazol Medical Valley|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.09.2018||R|0|0|0|0|0|0|VAL|0|0|0|100|IKR|1000|2107|lyfalmen|V0003|2107|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Rabeprazól||510||510|2107||2 132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|4176|3141|lyfalmen|||2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||1261||1261|3141|31.8.2018|1 132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2596|3141|lyfalmen|||2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||1261||1261|3141|31.8.2018|1 132488|L01XC1201|ADCETRIS|irþ|50|mg|1|hgl|1|pakki||L01XC12|01.08.2016||R|0|0|0|0|0|1|TPA|0|0|0|100|DKK|369097|465160|lyfsjukr|||1|1|0||Vistor hf|Takeda Pharma A/S|Brentuximabum vedotinum||369097||369097|465160||1 132494|M01AX0503|Glucosamin LYFIS|mixtduft|1178|mg|30|skpokar|1|pakki||M01AX05|01.05.2016||L|0|0|0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|LYFIS ehf|LYFIS ehf|Glúkósamín|||||||2 132546|A06AX0401|Constella|hylki|290|mcg|28|stk|1|glas||A06AX04|01.05.2013||R|0|0|0|0|G|0|AIP|0|0|0|100|XEU|7883|12255|lyfalmen|||1|28|0|28,0000|Actavis ehf|Allergan Pharmaceuticals Ltd.|Linaclotídum||7883||7883|12255||1 132635|C09DA0108|Losartan/Hydrochlorothiazide Medical Val|filmhtfl|125|mg|98|stk|1|þpakki|100 + 25 mg|C09DA01|01.02.2017||R|1|0|0|0|G|0|VAL|0|0|0|100|XEU|2138|2492|lyfalmen|V0089|2492|2|98|0|100,0000|Acare ehf|Medical Valley Invest AB|Lósartan og þvagræsilyf||790||790|2492||2 132662|R05DA0403|Kodein Meda|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|1|0|1|0|G|0|MEA|0|0|1|100|DKK|1049|2849|lyfalmen|||2|100|0|25,0000|Icepharma hf|Meda AB|Kódein||1049||1049|2849||2 132663|N06BA0402|Concerta|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|1|1|1|0|0|0|JAS|0|0|0|100|SEK|4331|7366|lyfalmen|V0681|6343|1|30|0|27,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||4331||4331|7366||1 132717|QN05CM9204|Nerfasin vet.|stl|100|mg/ml|50|ml|1|hgl|fyrir nautgripi og hesta|QN05CM92|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|5160|9960|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet B.V.|||||5160|9960||2 132748|N06AX1610|Venlafaxine Bluefish|forðahlk|150|mg|100|stk|1|þpakki|hart|N06AX16|01.05.2015||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|3700|3470|lyfalmen|V0335|2781|2|100|0|150,0000|Vistor hf|Bluefish Pharmaceuticals AB|Venlafaxín||1500||1500|3470||1 132761|D08AG0201|Betadine|húðlausn|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|8|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2 132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|0|0|0|0|0|0|HES|0|0|0|100|DKK|402|1958|lyfalmen|||1|15|0||Vistor hf|Novartis Healthcare A/S|Proxýmetakaín||402||402|1958||1 132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|0|0|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||0|100|0|3,0000|Vistor hf|Abigo Medical AB|Lyfjakol|||||||1 133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|18128|26356|lyfsjukr|||1|0,5|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||18128||18128|26356||1 133101|M01AH0108|Celecoxib Medical|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.05.2018||R|1|0|0|0|G|0|DIC|0|0|1|100|IKR|1323|2231|lyfalmen|V0037|2231|2|20|0|20,0000|LYFIS ehf|Medical ehf|Celekoxíb||600||600|2231||2 133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|24104|33557|lyfsjukr|||1|1|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||24104||24104|33557||1 133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|32776|44525|lyfsjukr|||1|2|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||32776|44525||1 133384|B05ZB0002|Phoxilium|blóð.sk|1,2|mmól/l|5000|ml|2|pokar|Blóðsk.- blóðsíunarlausn|B05ZB|01.10.2017||R|0|0|0|0|0|1|GAA|0|0|0|100|SEK|3332|5991|lyfsjukr|||1|10000|0||Baxter Medical AB|Gambro Lundia AB|Blóðsölt og stuðpúðalausn||3332||3332|5991||2 133411|B06AC0101|Cinryze|sts|500|ae|2|hgl|1|pakki|+ leysir, lausn|B06AC01|01.03.2013||R|0|1|0|1|0|1|BVB|0|0|0|100|DKK|183872|234792|lyfsjukr|||1|2|0||Lyfjaver ehf|Shire Services BVBA|C1 hemill||||183872|234792||3 133508|A06AD6501|Moxalole|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEA|0|0|0|100|DKK|||lyflausa|||0|8|0||Icepharma hf|Meda AB|Makrógól 3350|||||||2 133530|A06AD6501|Moxalole|mixtduft|13,8|g|20|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEA|0|0|0|100|DKK|||lyflausa|||0|20|0|10,0000|Icepharma hf|Meda AB|Makrógól 3350|||||||2 133551|J05AG0101|Viramune|töflur|200|mg|14|stk|1|þpakki||J05AG01|01.03.2013||R|1|0|0|1|0|1|BII|0|0|0|100|DKK|6656|10566|lyfsjukr|||1|14|0|7,0000|Vistor hf|Boehringer Ingelheim International|Nevírapín||6656||6656|10566||1 133856|N06BA0904|Atomoxetine Sandoz|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.10.2017||R|1|1|0|0|0|0|SHS|0|0|0|100|DKK|9052|5358|lyfalmen|V0814|5218|2|28|0|8,7500|Artasan ehf|Sandoz A/S|Atomoxetín||2872||2872|5358||1 133949|H01BB0201|Syntocinon|nefúði|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.02.2015||R|0|0|0|0|G|0|STI|0|0|0|100|NOK|2058|4238|lyfalmen|||1|5|0|13,3333|Lyfjaver ehf|Sigma-Tau Industrie Farmaceutiche|Oxýtócín||2058||2058|4238||3 133974|N06AX1610|Venlafaxine Bluefish|forðahlk|37,5|mg|30|stk|1|þpakki|hart|N06AX16|01.04.2014||R|1|0|0|0|0|0|BFP|0|0|0|100|IKR|1084|2897|lyfalmen|V0333|2833|2|30|0|11,2500|Vistor hf|Bluefish Pharmaceuticals AB|Venlafaxín||1084||1084|2897||1 134352|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|30|sk-hyl||S01EE05|01.03.2010||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|2382|4684|lyfalmen|||1|9|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||2382||2382|4684||2 134374|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|90|sk-hyl||S01EE05|01.06.2010||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|6228|9977|lyfalmen|||1|27|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||6228||6228|9977||2 134520|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.04.2009||R|0|0|0|0|0|1|GRP|0|0|0|100|GBP|3251|5880|lyfsjukr|||2|25|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Epírúbicín||3251||3251|5880||1 134642|J05AE0801|Reyataz|hylki|300|mg|30|stk|1|plglas||J05AE08|01.01.2010||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|46860|62339|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||46860||46860|62339||1 134862|J05AR0601|Atripla|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|0|1|0|1|0|1|GSL|0|0|0|100|DKK|94064|122042|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||94064||94064|122042||2 134920|N04BA0303|Levodopa+Carbidopa+Entacapona WH|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|0|100|IKR|8924|13688|lyfalmen|||2|100|0|11,1100|Williams & Halls efh|Williams & Halls ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||8924||8924|13688|31.8.2018|2 135062|C09CA0306|Valsartan Krka|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.08.2018||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2000|4158|lyfalmen|||2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Valsartan||2000||2000|4158||2 135084|C09CA0306|Valsartan Krka|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.08.2018||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|3500|6222|lyfalmen|||2|98|0|196,0000|LYFIS ehf|Krka Sverige AB|Valsartan||3500||3500|6222||2 135090|C02KX0501|Adempas|filmhtfl|1,5|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|320328|404505|lyfsjukr|||1|84|0|28,0000|Vistor hf|Bayer AG|Riociguatum||320328||320328|404505||1 135216|A10AE0406|Toujeo [SoloStar]|stl|300|ein/ml|1,5|ml|5|pennar|áfylltir lyfjapennar|A10AE04|01.10.2015||R|0|1|0|0|G|0|SDH|0|0|0|100|XEU|8247|12756|lyfalmen|||1|7,5|0|56,2500|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||8247||8247|12756||1 135434|R03BA0502|Flixotide Diskus|innönddu|100|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|997|2777|lyfalmen|||1|60|0|10,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||997||997|2777||1 135498|G04CB0202|Dutasteride Medical Valley|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.09.2017||R|1|0|0|0|G|0|VAL|0|0|0|100|DKK|2573|3447|lyfalmen|V0909|3447|2|30|0|30,0000|Acare ehf|Medical Valley Invest AB|Dútasteríð||1484||1484|3447||2 136181|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.01.2013||R|0|0|0|1|G|0|PHH|0|0|0|100|DKK|31603|43042|lyfalmen|||1|60|0|20,0000|Icepharma hf|Pfizer Limited|Sirolimus||31603||31603|43042||1 136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|1|0|0|0|0|0|MEA|0|0|0|100|DKK|4899|8148|lyfalmen|||1|100|0|100,0000|Icepharma hf|Meda AB|Ísóníazíð||4899||4899|8148||2 136281|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.03.2012||R|0|1|0|1|0|1|PHH|0|1|0|100|DKK|54267|71707|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||54267||54267|71707||1 136653|N06AX2601|Brintellix|filmhtfl|5|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LUN|0|0|0|100|DKK|2522|4876|lyfalmen|||1|28|0|14,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||2522||2522|4876||1 136658|N05BA1206|Alprazolam Krka|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|IKR|804|2512|lyfalmen|||2|30|0|15,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||804||804|2512||2 136953|D06BX0106|Rosazol|krem|10|mg/g|25|g|1|túpa||D06BX01|01.04.2016||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||2|25|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Metrónídazól|||||||1 137635|N05AH0413|Quetiapin ratiopharm|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|0|G|0|TAB|0|0|0|100|IKR|39000|13793|lyfalmen|V0261|13793|2|100|0|100,0000|Alvogen|Teva Pharma B.V.|Quetíapín||9000||9000|13793||2 137820|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|0|1|0|0|0|1|PZA|0|0|0|100|XEU|4896|8144|lyfsjukr|||2|10|0|0,5000|Icepharma hf|Pfizer ApS|Pamídrónsýra||4896||4896|8144||1 137831|M05BA0302|Pamidronatdinatrium Hospira|irþ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|0|1|0|0|0|1|PZA|0|0|0|100|XEU|4277|7292|lyfsjukr|||2|10|0|1,0000|Icepharma hf|Pfizer ApS|Pamídrónsýra||4277||4277|7292||1 137842|M05BA0302|Pamidronatdinatrium Hospira|irþ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|0|1|0|0|0|1|PZA|0|0|0|100|XEU|4833|8057|lyfsjukr|||2|10|0|1,5000|Icepharma hf|Pfizer ApS|Pamídrónsýra||4833||4833|8057||1 137881|N06BA0407|Metylfenidat Actavis|forðatfl|18|mg|90|stk|1|glas||N06BA04|01.07.2017||R|1|1|1|0|0|0|GPA|0|0|0|100|XEU|9589|11637|lyfalmen|V0958|11637|2|90|0|54,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||7434||7434|11637||1 137883|N05AH0415|Quetiapin Krka|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.04.2018||R|0|1|0|0|G|0|KRK|0|0|0|100|IKR|6500|7736|lyfalmen|V0273|7736|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Quetíapín||4600||4600|7736||2 138302|N03AX1603|Pregabalin Krka|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.04.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|8197|3657|lyfalmen|V0689|3498|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1636||1636|3657||2 138318|L04AX0307|Metoject|stl|50|mg/ml|0,35|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2168|4389|lyfalmen|||1|0,35|0|7,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2168||2168|4389||2 138505|J05AP5601|Vosevi|filmhtfl|600|mg|28|stk|1|glas|400/100/100 mg|J05AP56|01.11.2017||R|0|0|0|1|0|1|GSE|0|0|0|100|DKK|2103178|2621872|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|sofosbuvir,velpatasvir,voxilaprevir||||2103178|2621872||2 138567|C10AA0509|Atorvastatin Xiromed|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.01.2018||R|1|0|0|0|G|0|MVX|0|0|0|100|IKR|2500|2713|lyfalmen|V0114|2713|2|100|0|200,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||950||950|2713||2 138594|S01ED0105|Optimol|augndr|5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1271|3154|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól||1271||1271|3154||2 138603|N07BB0501|Selincro|filmhtfl|18|mg|28|stk|1|þpakki||N07BB05|01.06.2013||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|13390|19835|lyfalmen|||1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||13390||13390|19835||1 138619|L04AX0306|Metojectpen|stl|22,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2854|5333|lyfalmen|||1|1|0|9,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2854||2854|5333||2 138687|N06BA0407|Metylfenidat Actavis|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|1|0|0|0|GPA|0|0|0|100|XEU|4040|4933|lyfalmen|V0691|4930|2|30|0|18,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||2563||2563|4933||1 139050|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.01.2012||R|0|0|0|0|G|0|GRP|0|0|0|100|XEU|2171|4383|lyfalmen|V0373|4233|2|15|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||2164||2164|4383||1 139604|L04AA3201|Otezla|filmhtfl|30|mg|56|stk|1|þpakki||L04AA32|01.05.2016||R|1|0|0|1|0|1|CLC|0|1|0|100|XEU|96106|124625|lyfsjukr|||1|56|0|28,0000|Celgene AB|Celgene Europe Limited|Apremilast||96106||96106|124625||2 139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|þpakki||R06AA04|01.08.1981||L|1|0|0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen|||0|100|0|50,0000|Artasan ehf|Novartis Healthcare A/S|Klemastín|||||4608||1 139959|N06DA0304|Nimvastid|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.04.2018||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|27510|37865|lyfalmen|V0346|37865|2|112|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Rívastigmín||27510||27510|37865||2 140013|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.12.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|455|2031|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||455||455|2031||1 140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|892|2633|lyfalmen|V0266|1997|1|30|0|1,5000|Vistor hf|Boehringer Ingelheim International |Pramipexól||892||892|2633||1 140330|N02AA0506|Oxikodon Depot Actavis|forðatfl|80|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|12578|16987|lyfalmen|V0588|16987|2|98|0|104,5300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||11321||11321|16987||1 140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|0|0|0|0|0|1|LBK|0|0|0|100|DKK|8569|13199|lyfsjukr|||1|10|0|16,6700|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||8569||8569|13199||1 140500|N07BC0202|Metadon Abcur|töflur|40|mg|25|stk|1|glas||N07BC02|01.03.2016||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|4206|7194|lyfalmen|||1|25|0|40,0000|Icepharma hf|Abcur AB|Metadón||4206||4206|7194||2 140563|A07DA0201|Dropizol|dropar|10|mg/ml|10|ml|1|dropaí||A07DA02|01.06.2018||R|0|0|1|1|0|0|ARO|0|0|0|100|DKK|5576|9080|lyfalmen|||2|10|0|1,0000|Pharmanovia A/S|Pharmanovia A/S|opium||5576||5576|9080||1 140729|QN01AX0001|Finquel, vet|duft|100|%|1000|g|1|fl|baðlausn handa fiskum|QN01AX|01.01.2012||R|0|0|0|0|0|0|SRR|0|0|0|100|NOK|64277|122117|vetalmen|||0|1000|0||Scan Aqua AS|Scan Aqua AS|Tricaine mesylate||64277||64277|122117||1 140887|J01DD0402|Ceftriaxona Normon|irs|2000|mg|50|stk|1|hgl|lausn|J01DD04|01.06.2018||R|0|0|0|0|0|1|LNA|0|0|0|100|SEK|130014|167808|lyfsjukr|||2|50|0|50,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftríaxón||130014||130014|167808|30.6.2018|2 140954|N07BA0103|Nicorette|nefúði|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 141015|J05AR1401|REZOLSTA|filmhtfl|950|mg|30|stk|1|glas|800+150 mg|J05AR14|01.01.2016||R|0|0|0|1|0|1|JAS|0|0|0|100|SEK|41469|55520|lyfsjukr|||1|30|0||Vistor hf|Janssen-Cilag AB|Darunavir og kóbísistat||41469||41469|55520||1 141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|áfspr||H02AB04|01.04.1994||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|945|2706|lyfalmen|V0413|2513|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||945||945|2706||1 141063|S01BC1001|Nevanac|augndr|1|mg/ml|5|ml|1|dropaí||S01BC10|01.08.2013||R|0|0|0|0|G|0|NEL|0|0|1|100|DKK|2809|5271|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Nepafenak||||2809|5271||1 141153|R01AB0601|Otrivin Comp|nefúði|1,1|mg/ml|10|ml|1|glas|0,5+0,6 mg/ml|R01AB06|01.05.2013||L|0|0|0|0|0|0|NAA|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S|Xýlómetazóín og Ípratrópíum|||||||1 141388|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3056|5611|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||3056||3056|5611||1 141438|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|11596|17366|lyfalmen|||1|0,5|0|4,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||||11596|17366||2 141569|H02AB0908|Plenadren|töflur|5|mg|50|stk|1|glas|með breyttan losunarhraða|H02AB09|01.01.2013||R|1|0|0|0|G|0|BVB|0|0|1|100|DKK|34008|46084|lyfalmen|||1|50|0|8,3300|Lyfjaver ehf|Shire Services BVBA|Hýdrókortisón||34008||34008|46084||3 141684|G03AA1205|Yaz|filmhtfl|||84|stk|1|þpakki|0,02mg/3mg|G03AA12|01.02.2009||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|3144|5732|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||||3144|5732||2 141751|J01EE0106|Co-Trimoxazole|töflur|480|mg|28|stk|1|glas|80+400 mg|J01EE01|01.02.2009||R|0|0|0|0|0|0|UAK|0|0|1|100|XEU|810|2520|lyfalmen|||2|28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Súlfametoxazól og trímetóprím||810||810|2520||1 141783|R02AX0101|Strefen|munnhúði|16,2|mg/ml|15|ml|1|glas||R02AX01|01.08.2018||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|15|0||Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Flurbiprofen|||||||1 141805|A07DA0201|Dropizol|dropar|10|mg/ml|10|ml|3|dropaí||A07DA02|01.06.2018||R|0|0|1|1|0|0|ARO|0|0|0|100|DKK|15743|23074|lyfalmen|||2|30|0|3,0000|Pharmanovia A/S|Pharmanovia A/S|opium||15743||15743|23074||1 141856|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.06.2015||L|0|0|0|0|0|0|FKA|0|0|0|100|DKK|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3142||1 141872|R03DC0304|Montelukast Teva|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.02.2013||R|1|0|0|0|G|0|TVA|0|0|0|100|XEU|4704|7880|lyfalmen|V0492|7880|2|98|0|39,2000|Alvogen|Teva B.V.|Montelúkast||4704||4704|7880||2 141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|5173|8525|lyfalmen|V0267|2988|1|100|0|10,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||5173||5173|8525||1 142034|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.07.2012||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1315|3215|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||1315||1315|3215||2 142123|R07AX0101|INOmax|innö.gas|800|ppm|2|l|1|gashyl||R07AX01|01.09.2014||R|0|1|0|0|0|1|LIN|0|0|0|100|XEU|18129|26358|lyfsjukr|||1|2|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíð||||18129|26358||5 142177|QP54AA5401|BROADLINE|bl.lausn|||0,3|ml|3|sk-ílá||QP54AA54|01.04.2018||R|0|0|0|0|0|0|MER|0|0|0|100|XEU|2108|3633|vetorma|||0|0,9|0||Vistor hf|Merial|Praziquantelum ,Fipronil, s-Methoprene ,Eprinomectinum||2108||2108|3633||1 142266|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|10|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BFP|0|0|1|100|IKR|3320|4041|lyfalmen|V0384|2992|2|10|0|5,0000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||1915||1915|4041||1 142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.04.1987||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|673|2331|lyfalmen|||1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||673||673|2331||1 142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|1|0|0|0|0|0|MEA|0|0|1|100|DKK|2477|4814|lyfalmen|||1|100|0|50,0000|Icepharma hf|Meda AB|Metenamín||2477||2477|4814||2 142410|H01AX0101|Somavert|sts|15|mg|30|hgl|1|pakki|+30 áf.spr.m.leysi|H01AX01|01.10.2017||R|0|0|0|1|0|1|PIZ|0|0|0|100|DKK|428589|539152|lyfsjukr|||1|30|0|45,0000|Icepharma hf|Pfizer Ltd|Pegvisómant||428589||428589|539152||1 142615|C07AG0205|Carveratio|töflur|6,25|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|0|G|0|RTH|0|0|0|100|IKR|1544|2919|lyfalmen|V0946|2506|2|100|0|16,6700|Alvogen|ratiopharm GmbH|Carvedílól||1100||1100|2919||2 142914|C07AB0214|Bloxazoc|forðatfl|100|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2043|2919|lyfalmen|V0049|2919|2|100|0|66,6600|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||1100||1100|2919||2 143139|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||100|ml|50|hgl|fyrir stungulyf|V07AB|01.11.2012||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyfalmen|||0|5000|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||16727||1 143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|1304|3200|lyfalmen|V0426|3200|1|1|0|6,2500|Icepharma hf|Pfizer ApS|Metýlprednisólón||1304||1304|3200||1 143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|1764|3833|lyfsjukr|||1|1|0|25,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1764||1764|3833||1 143410|N03AX1604|Brieka|hylki|150|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|9723|5487|lyfalmen|V0687|5088|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||2966||2966|5487||1 143511|J07BC2002|Twinrix Paediatric|stl|||0,5|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GBI|0|0|0|100|NOK|4281|7297|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||4281||4281|7297||1 143526|C07AB0309|Atenolol Actavis|filmhtfl|50|mg|100|stk|1|þpakki||C07AB03|01.10.2012||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|456|1796|lyfalmen|V0542|1796|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Atenólól||284||284|1796||1 143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|0|0|0|0|0|0|HES|0|0|0|100|DKK|856|2583|lyfalmen|||1|15|0||Vistor hf|Novartis Healthcare A/S|Trópíkamíð||856||856|2583||1 143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|þpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|1063|2868|lyfalmen|V0173|2038|1|2|0|3,3333|Icepharma hf|Pfizer ApS|Azitrómýcín||1063||1063|2868||1 143609|A10BD0701|Janumet|filmhtfl|900|mg|56|stk|1|þpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|0|G|0|MBV|0|0|0|100|DKK|5108|8436|lyfalmen|V0387|7417|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Metforminum og sitagliptinum||5108||5108|8436||1 143631|A10BD0701|Janumet|filmhtfl|1050|mg|56|stk|1|þpakki|50/1000mg|A10BD07|01.03.2009||R|1|0|0|0|G|0|MBV|0|0|0|100|DKK|5139|8478|lyfalmen|V0386|6613|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Metforminum og sitagliptinum||5139||5139|8478||1 143787|N06AX1611|Duofaxin|forðatfl|225|mg|28|stk|1|þpakki||N06AX16|01.07.2015|30.06.2018|R|1|0|0|0|0|0|MEV|0|0|0|100|DKK|1254|3014|lyfalmen|||2|28|0|63,0000|Vistor hf|MediLink A/S|Venlafaxín||1169||1169|3014||1 143800|N05AN0101|Litarex|forðatfl|6|mmól|100|stk|1|glas||N05AN01|01.04.1974||R|1|0|0|0|G|0|GRP|0|0|0|100|DKK|2282|4546|lyfalmen|||2|100|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Litíum||2282||2282|4546||1 143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|1342|3252|lyfalmen|V0174|2506|1|3|0|5,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1342||1342|3252||1 144030|N04BA0207|Sinemet depot mite|forðatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|1624|3640|lyfalmen|V0938|3640|1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||1624||1624|3640||1 144035|N05AH0501|Sycrest|tungur.t|10|mg|60|stk|1|þpakki||N05AH05|01.10.2011|30.06.2018|R|0|0|0|0|0|0|NVO|0|0|0|100|DKK|21588|30375|lyfalmen|||1|60|0|30,0000|Vistor hf|N.V. Organon|Asenapíne||21588||21588|30375||1 144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|54189|71608|lyfsjukr|||1|1,5|0|22,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||54189||54189|71608||1 144419|R03AC1302|Oxis Turbuhaler|innönddu|9|mcg/sk|60|skammtar|1|stauk||R03AC13|01.01.2016||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|2674|5085|lyfalmen|||1|60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||2674||2674|5085||1 144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|36132|48770|lyfsjukr|||1|1,5|0|15,0000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||36132||36132|48770||1 144498|N02AA0506|Oxikodon Depot Actavis|forðatfl|40|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|7353|11526|lyfalmen|V0587|11524|2|98|0|52,2700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||7353||7353|11526||1 144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|18066|26271|lyfsjukr|||1|1,5|0|7,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||18066||18066|26271||1 145077|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.06.2011||R|0|1|0|0|0|1|JAN|0|1|0|100|DKK|61060|80299|lyfsjukr|||1|1|0|26,6700|Vistor hf|Janssen Biologics B.V.|Infliximab||61060||61060|80299||1 145158|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.08.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|4024|6944|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Takrólímus||||4024|6944||1 145440|QG04CX9001|Ypozane|töflur|1,875|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|2414|4744|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||2414||2414|4744||1 145451|QG04CX9001|Ypozane|töflur|3,75|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|3479|6771|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||3479||3479|6771||1 145545|D07AD0101|Dermovat|krem|0,5|mg/g|30|g|1|túpa||D07AD01|01.12.2017||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|398|1953|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||||398|1953||1 145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|þpakki||P02CX01|01.12.1972||L|1|0|0|0|0|0|MEA|0|0|0|100|DKK|||lyflausa|||0|8|0|1,1400|Icepharma hf|Meda AB|Pýrvín|||||||2 145616|QG04CX9001|Ypozane|töflur|7,5|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|4651|8994|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||4651||4651|8994||1 145627|QG04CX9001|Ypozane|töflur|15|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|5658|10905|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||5658||5658|10905||1 145648|B05BB0121|Plasmalyte|irl|||500|ml|20|pokar|lausn|B05BB01|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7443|11649|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||7443||7443|11649||2 145784|B03AC0005|Ferinject|irl|50|mg/ml|2|ml|1|hgl||B03AC|01.06.2014||R|0|1|0|0|G|0|VIF|0|0|1|100|CHF|4252|7257|lyfalmen|||1|2|0|1,0000|Vistor hf|Vifor France SA|Járn, stungulyf||4252||4252|7257||1 145806|B03AC0005|Ferinject|irl|50|mg/ml|10|ml|1|hgl||B03AC|01.06.2014||R|0|1|0|0|G|0|VIF|0|0|1|100|CHF|22020|30921|lyfalmen|||1|10|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||22020||22020|30921||1 146082|L04AA2601|Benlysta|irs|120|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|0|0|1|RGO|0|1|0|100|DKK|22423|31431|lyfsjukr|||1|1|0|4,8000|Vistor hf|Glaxo Group Limited|Belimumab||22423||22423|31431||1 146229|L01XX1903|Irinotecan Hospira|irþ|20|mg/ml|25|ml|1|hgl|lausn|L01XX19|01.12.2015||R|0|0|0|0|0|1|PLS|0|0|0|100|XEU|6698|10624|lyfsjukr|||2|25|0||Icepharma hf|Pfizer Aps|Írinótekan||6698||6698|10624||1 146473|N06BA0901|Strattera|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.01.2010||R|1|1|0|0|0|0|DAN|0|0|0|100|XEU|13900|20537|lyfalmen|V0817|6171|1|28|0|28,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13900||13900|20537||2 146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|þpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNP|0|0|1|100|XEU|261|1764|lyfalmen|||1|10|0|2,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||261||261|1764||1 147426|N06BA0404|Methylphenidate Sandoz|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.04.2015||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|3465|4930|lyfalmen|V0691|4930|2|30|0|18,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||2561||2561|4930||1 147578|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||20|ml|20|plastl|fyrir stungulyf|V07AB|01.06.2015||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyfalmen|||0|400|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3277||1 147605|J01CF0104|Dicloxacillin Bluefish|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.01.2017||R|0|0|0|0|0|0|BFP|0|0|1|100|XEU|1851|2593|lyfalmen|V0353|2593|2|30|0|3,7500|Vistor hf|Bluefish Pharmaceuticals AB|Díkloxacillín||863||863|2593||1 147788|N03AX1603|Pregabalin Krka|hylki|150|mg|100|stk|1|glas||N03AX16|01.04.2017||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|6431|5534|lyfalmen|V0687|5088|2|100|0|50,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||3000||3000|5534||2 148087|J01DD0402|Ceftriaxona Normon|irs|2000|mg|50|stk|1|hgl|lausn|J01DD04|01.06.2018||R|0|0|0|0|0|1|LNA|0|0|0|100|SEK|132129|170438|lyfsjukr|||2|50|0|50,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftríaxón||||132129|170438||2 148213|R05CB1301|Pulmozyme|innúðal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|0|0|0|1|0|0|ROA|0|0|0|100|DKK|87598|113864|lyfalmen|||1|75|0|30,0000|Icepharma hf|Roche A.S.|Dornase alfa||87598||87598|113864||2 148263|J01CA0802|Penomax|filmhtfl|200|mg|20|stk|1|þpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|COR|0|0|1|100|DKK|940|2473|lyfalmen|V0577|2473|2|20|0|6,6667|Vistor hf|Orion Corporation|Pívmecillínam||776||776|2473||1 148274|J01CA0802|Penomax|filmhtfl|200|mg|30|stk|1|þpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|COR|0|0|1|100|DKK|1399|3331|lyfalmen|||2|30|0|10,0000|Vistor hf|Orion Corporation|Pívmecillínam||1399||1399|3331||1 148285|J01CA0802|Penomax|filmhtfl|200|mg|100|stk|1|glas||J01CA08|01.09.2012||R|0|0|0|0|0|0|COR|0|0|1|100|DKK|4808|7703|lyfalmen|||2|100|0|33,3300|Vistor hf|Orion Corporation|Pívmecillínam||4576||4576|7703||1 148363|D11AH0401|Toctino|hylki|10|mg|30|stk|1|þpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|SLA|0|0|0|100|DKK|48175|64002|lyfalmen|||1|30|0|15,0000|Vistor hf|Stiefel Laboratories Ireland Ltd.|Alítretínóín||48175||48175|64002||1 148374|D11AH0401|Toctino|hylki|30|mg|30|stk|1|þpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|SLA|0|0|0|100|DKK|48175|64002|lyfalmen|||1|30|0|45,0000|Vistor hf|Stiefel Laboratories Ireland Ltd.|Alítretínóín||48175||48175|64002||1 148411|C03CA0110|Impugan|töflur|40|mg|100|stk|1|glas||C03CA01|01.08.2013||R|1|0|0|0|G|0|GRP|0|0|0|100|SEK|308|1756|lyfalmen|V0601|1756|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Fúrósemíð||255||255|1756||1 148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|þpakki||N04AA02|01.11.2005||R|1|0|0|0|G|0|LFS|0|0|0|100|DKK|895|2637|lyfalmen|||1|100|0|20,0000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||895||895|2637||1 148642|N01AX6301|Livopan|lyfjagas|||5|l|1|hylki|50% + 50%|N01AX63|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|62097|81611|lyfsjukr|||1|5|0||Ísaga ehf|AGA AB|Tvínituroxíð og súrefni||62097||62097|81611||5 148752|L01CA0207|Vincristine Hospira|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|0|0|0|0|0|1|PLS|0|0|0|100|XEU|10693|16123|lyfsjukr|||2|10|0||Icepharma hf|Pfizer Aps|Vínkristín||10693||10693|16123||2 148917|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|0|0|0|0|0|1|ALV|0|0|0|100|XEU|22876|32004|lyfsjukr|||1|1|0||Alvogen|Hospira Nordic AB|Raltítrexed||22876||22876|32004||2 148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|0|0|0|0|0|0|BAN|1|0|0|100|DKK|2831|5541|vetalmen|||0|25|0||Icepharma hf|Bayer Animal Health GmbH|||2831||2831|5541||2 149279|L01XC2401|Darzalex|irþ|20|mg/ml|20|ml|1|hgl|lausn|L01XC24|01.06.2017||R|0|1|0|0|0|1|JCI|0|1|0|100|SEK|217780|276964|lyfsjukr|||1|20|0||Vistor hf|Janssen-Cilag International N.V.|Daratumumab||217780||217780|276964||1 149624|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1914|4039|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||1914||1914|4039||1 149908|J02AC0303|Vortil|irs|200|mg|1|hgl|1|pakki|lausn|J02AC03|01.10.2017||R|0|0|0|0|0|1|WEH|0|0|0|100|IKR|14270|21046|lyfsjukr|||2|1|0|0,5000|Williams & Halls efh|Williams & Halls ehf|Voricónazól||14270||14270|21046||2 150162|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.01.2013||L|0|0|0|0|G|0|TEA|0|0|0|100|SEK|||lyfalmen|||1|24|0||Vistor hf|Laboratories THEA|Ketotifen|||||6248||1 150281|N03AX1408|Levetiracetam STADA|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.08.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|4613|5534|lyfalmen|V0253|5534|2|100|0|33,3300|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||3000||3000|5534||2 150448|L01XX4501|Kyprolis|irs|60|mg|1|hgl|1|pakki||L01XX45|01.10.2016||R|0|0|0|0|0|1|AEB|0|1|0|100|DKK|150158|192862|lyfsjukr|||1|1|0||Vistor hf|Amgen Europe B.V.|Carfilzomibum||150158||150158|192862||1 150521|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|34518|46729|lyfsjukr|||1|1,6|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||||34518|46729||1 151037|N06DX0109|Marbodin|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|4300|2988|lyfalmen|V0607|2988|2|98|0|98,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||1150||1150|2988||2 151060|J01DB0402|Cefazolina Normon|sts|1|g|100|stk|1|hgl|í bláæð|J01DB04|01.06.2018||R|0|0|0|0|0|1|LNA|0|0|0|100|SEK|37947|51066|lyfsjukr|||2|100|0|33,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Cefazólín||37947||37947|51066||2 151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|4985|8266|lyfalmen|||1|10|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||4985||4985|8266||1 151217|G01AF0102|Flagyl|sk-stíll|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|0|0|0|0|G|0|SNP|0|0|0|100|XEU|1137|2970|lyfalmen|||1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1137||1137|2970||1 151250|J05AP5301|Viekirax|filmhtfl|137,5|mg|56|stk|1|þpakki|12,5mg/75mg/50mg|J05AP53|01.10.2015||R|0|0|0|1|0|1|ABD|0|1|0|100|DKK|1540753|1922372|lyfsjukr|||1|56|0||Vistor hf|AbbVie Deutschland GmbH & Co. KG|Ombitasvir, paritaprevir og ritonavir||1540753||1540753|1922372||1 151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.11.2008||R|1|0|0|0|G|0|LUN|0|0|0|100|DKK|26227|36242|lyfalmen|V0607|2988|1|98|0|98,0000|Vistor hf|H. Lundbeck A/S|Memantín||26227||26227|36242||1 151532|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|330|1859|lyfalmen|V0633|1761|2|100|0|50,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||330||330|1859||1 151627|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|pakki|lausn,áf.lyfjap.+ spr.nál|G03GA08|01.04.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|3351|6017|lyfalmen|||1|0,5|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||||3351|6017||2 151682|N05AX1210|Aripiprazol Medical Valley|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.10.2016||R|1|1|0|0|G|0|VAL|0|0|0|100|IKR|5688|3869|lyfalmen|V0682|3787|2|56|0|18,6670|Acare ehf|Medical Valley Invest AB|Aripiprazól||1790||1790|3869||2 151737|S01AA2601|Azyter|augndr|15|mg/g|0,25|g|6|sk-ílá||S01AA26|01.04.2016||R|0|0|0|0|0|0|LTH|0|0|1|100|SEK|878|2613|lyfalmen|||1|1,5|0||Vistor hf|Laboratoires THEA|azithromycin||878||878|2613||1 151810|QJ01CE9003|Penethaone vet.|sts|10|m.ae/hgl|1|hgl|1|pakki|+leysir|QJ01CE90|01.03.2016||R|0|0|0|0|0|0|DIV|0|0|0|100|IKR|1195|2349|vetalmen|||0|1|0||Dýraheilsa ehf|Divasa-Farmavic S.A.|||||1195|2349||2 151873|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|þpakki||N02CC01|01.03.2018||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|1494|2444|lyfalmen|V0234|1478|2|6|0|12,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||755||755|2444||1 151905|L03AX1302|Remurel|stl|40|mg/ml|12|áf.spr|1|pakki||L03AX13|01.07.2018||R|0|0|0|1|0|1|IPC|0|0|0|100|XEU|91435|118717|lyfsjukr|||2|12|0|24,0000|Alvogen|Alvogen IPco S.á.r.l.|Glatíramer acetat||91435||91435|118717||2 151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|1222|3087|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Doxepín||1222||1222|3087||1 152197|C07AB0213|Metoprololsuccinat Hexal|forðatfl|25|mg|100|stk|1|plglas|23,75 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|697|2355|lyfalmen|V0050|2079|2|100|0|15,8300|Artasan ehf|Hexal A/S|Metóprólól||690||690|2355||1 152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|1488|3453|lyfsjukr|||1|5|0|0,4500|Vistor hf|Novartis Healthcare A/S|Baklófen||1488||1488|3453||1 152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PLS|0|0|1|100|IKR|||lyflausa|||0|25|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1 152397|R03BA0202|Pulmicort Turbuhaler|innönddu|100|mcg/sk|200|skammtar|1|stauk||R03BA02|01.04.1991||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|2173|4396|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2173||2173|4396||1 152413|R03BA0202|Pulmicort Turbuhaler|innönddu|200|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|3488|6206|lyfalmen|||1|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3488||3488|6206||1 152421|R03BA0202|Pulmicort Turbuhaler|innönddu|400|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|G|0|ASZ|0|0|0|100|SEK|6377|10182|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Búdesóníð||6377||6377|10182||1 152635|B01AC0601|Hjartamagnyl|sþ-tfl|75|mg|100|stk|1|glas||B01AC06|01.06.2012||L|1|0|0|0|0|0|GPA|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Asetýlsalicýlsýra|||||||1 152663|N04BC0504|Oprymea (Lyfis)|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|14694|21630|lyfalmen|V0269|21630|3|100|0|40,0000|LYFIS ehf|LYFIS ehf|Pramipexól||14694||14694|21630||2 152675|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|42|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|0|G|0|BFP|0|0|1|100|XEU|5080|3647|lyfalmen|V0182|3595|2|42|0|7,0000|Vistor hf|Bluefish Pharmaceuticals AB|Valacíklóvír||1629||1629|3647||1 152687|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|90|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|0|G|0|BFP|0|0|1|100|IKR|5235|7599|lyfalmen|||2|90|0|15,0000|Vistor hf|Bluefish Pharmaceuticals AB|Valacíklóvír||4500||4500|7599||1 153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Cetirizín|||||||1 153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1279|3165|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Lídókaín í blöndum||1279||1279|3165||2 153190|S01EC0402|Brinzolamide ratiopharm|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.04.2016||R|0|0|0|0|G|0|RTH|0|0|0|100|IKR|1176|2713|lyfalmen|V0444|2713|2|5|0|25,0000|Alvogen|ratiopharm GmbH|Brinzólamíð||950||950|2713||2 153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Cetirizín|||||||1 153222|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|25889|35815|lyfsjukr|||1|1,2|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||||25889|35815||1 153288|R06AE0704|Histasin|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|G|0|GPA|0|0|1|100|XEU|||lyfalmen|V0575|1584|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Cetirizín|||||3624||1 153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|0|0|0|0|0|1|GSL|0|0|0|100|DKK|167409|214317|lyfsjukr|||1|10|0|14,2857|Gilead Nordic|Gilead Science International Ltd|Amfóterícín||167409||167409|214317||2 153417|C07AA0512|Pranolol|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.2011||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|563|2180|lyfalmen|||2|100|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Própranólól||563||563|2180||1 153507|L02BG0602|Exemestan- Actavis|filmhtfl|25|mg|100|stk|1|þpakki||L02BG06|01.08.2011||R|0|0|0|0|G|0|GRP|0|0|0|100|XEU|25486|35305|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Exemestan||25486||25486|35305|31.8.2018|1 153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|þpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|2872|5358|lyfalmen|||1|15|0|7,5000|Vistor hf|Janssen-Cilag AB|Ítracónazól||2872||2872|5358||1 153553|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|1306|2096|lyfalmen|||2|24|0|8,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klórdíazepoxíð||502||502|2096||1 153564|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|941|2700|lyfalmen|||2|24|0|20,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klórdíazepoxíð||941||941|2700||1 154014|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.09.2013||R|1|0|0|0|G|0|TVA|0|0|1|100|XEU|498|2017|lyfalmen|V0908|1680|2|30|0|30,0000|Alvogen|Teva B.V.|Deslóratadín||445||445|2017||2 154048|L02AE0307|Reseligo|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.05.2016||R|0|0|0|1|G|0|IPC|0|0|0|100|SEK|17173|16193|lyfalmen|V0183|16193|2|1|0|27,9070|Alvogen|Alvogen IPco S.á.r.l.|Góserelín||10744||10744|16193||2 154480|R06AX2201|Kestine|filmhtfl|20|mg|100|stk|1|þpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|6929|10942|lyfalmen|||1|100|0|200,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||6929||6929|10942||1 154618|B05BA1021|SmofKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|15847|23217|lyfsjukr|||1|3944|0||Vistor hf|Fresenius Kabi AB|Blöndur||15847||15847|23217||1 154629|B05BA1021|SmofKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|18106|26326|lyfsjukr|||1|5908|0||Vistor hf|Fresenius Kabi AB|Blöndur||18106||18106|26326||1 154640|B05BA1021|SmofKabiven|irl|2200|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|22650|31718|lyfsjukr|||1|7880|0||Vistor hf|Fresenius Kabi AB|Blöndur||22650||22650|31718||1 154651|B05BA1021|SmofKabiven|irl|2700|kcal|2463|ml|3|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|20665|29207|lyfsjukr|||1|7389|0||Vistor hf|Fresenius Kabi AB|Blöndur||20665||20665|29207||1 154662|B05BA1022|SmofKabiven Elektrolytfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|20702|29254|lyfsjukr|||1|3944|0||Vistor hf|Fresenius Kabi AB|Blöndur||20702||20702|29254||1 154673|B05BA1022|SmofKabiven Elektrolytfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|25090|34804|lyfsjukr|||1|5908|0||Vistor hf|Fresenius Kabi AB|Blöndur||25090||25090|34804||1 154706|B05BA1023|SmofKabiven Perifer|irl|800|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|13510|20000|lyfsjukr|||1|4824|0||Vistor hf|Fresenius Kabi AB|Blöndur||13510||13510|20000||1 154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|þpakki|0,2+50 mg|M01AB55|01.04.1993||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|2375|4674|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||2375||2375|4674||1 154717|B05BA1023|SmofKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|19965|28885|lyfsjukr|||1|7616|0||Vistor hf|Fresenius Kabi AB|Blöndur||19965||19965|28885||1 154739|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2738|3157|lyfalmen|V0334|2725|2|98|0|73,5000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1273||1273|3157||1 154761|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|4799|3428|lyfalmen|V0335|2725|2|98|0|147,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1470||1470|3428||1 155033|N06DX0106|Memantine ratiopharm|filmhtfl|10|mg|30|stk|1|þpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|2320|3898|lyfalmen|V0901|3882|2|30|0|15,0000|Alvogen|ratiopharm GmbH|Memantín||1811||1811|3898||2 155219|N03AX1106|Topiramate Alvogen|filmhtfl|25|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|GOV|0|0|0|100|XEU|1358|2023|lyfalmen|V0247|2023|2|60|0|5,0000|Alvogen|Alvogen ehf|Tópíramat||449||449|2023||2 155230|N03AX1106|Topiramate Alvogen|filmhtfl|50|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|GOV|0|0|0|100|XEU|2492|3297|lyfalmen|V0248|3297|2|60|0|10,0000|Alvogen|Alvogen ehf|Tópíramat||1375||1375|3297||2 155241|N03AX1106|Topiramate Alvogen|filmhtfl|100|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|GOV|0|0|0|100|XEU|4495|3727|lyfalmen|V0249|3727|2|60|0|20,0000|Alvogen|Alvogen ehf|Tópíramat||1687||1687|3727||2 155246|C10BA0501|Atozet|filmhtfl|30|mg|90|stk|1|þpakki|10 mg + 20 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|13819|20425|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||13819||13819|20425||1 155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1212|3073|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1212||1212|3073||1 155410|A02BC0403|Rabeprazol Krka|sþ-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|0|0|KRK|0|0|0|100|IKR|1347|2506|lyfalmen|V0466|2183|2|28|0|14,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||800||800|2506||2 155415|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|7328|6374|lyfalmen|V0253|5534|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||3610||3610|6374||1 155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|522|2123|lyfalmen|||1|100|0|5,0000|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||522||522|2123||1 155478|G03AC0902|Gestrina|filmhtfl|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2013||R|0|0|0|0|0|0|GRP|0|0|0|100|XEU|1107|2929|lyfalmen|V0590|2929|2|84|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Desógestrel||1107||1107|2929||1 155494|M01AE0113|Ibuxin|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.09.2014||L|1|0|0|0|0|0|RHA|0|0|1|100|IKR|||lyflausa|||2|30|0|10,0000|Alvogen|ratiopharm Oy|Íbúprófen|||||||2 155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|þpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|4375|7427|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||4375||4375|7427||1 156195|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|100|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BFP|0|0|1|100|IKR|16000|23427|lyfalmen|V0383|23427|2|100|0|25,0000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||16000||16000|23427||1 156427|J02AC0106|Fungyn|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.11.2017||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|4589|3483|lyfalmen|V0552|3483|2|30|0|7,5000|Alvogen|Alvogen|Flúkónazól||1510||1510|3483||2 156506|A10AB0405|Humalog KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AB04|01.05.2011||R|0|0|0|0|G|0|NED|0|0|0|100|XEU|4215|7206|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||4215||4215|7206||2 156517|A10AD0403|Humalog Mix25 KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AD04|01.05.2011||R|0|0|0|0|G|0|NED|0|0|0|100|XEU|4719|7900|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||4719||4719|7900||2 156528|J01XE0101|Furadantin|töflur|50|mg|15|stk|1|þpakki||J01XE01|01.08.2010||R|1|0|0|0|0|0|MEA|0|0|1|100|DKK|307|1827|lyfalmen|||2|15|0|3,7500|Icepharma hf|Meda AB|Nítrófúrantóín||307||307|1827||2 156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|þpakki||P02CA01|01.12.1982||R|1|0|0|0|0|0|JAS|0|0|0|100|SEK|500|2093|lyfalmen|||1|6|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||500||500|2093||1 156723|QN01AX0303|Ketador vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2013||R|0|0|1|0|0|0|RPG|1|0|0|100|IKR|6850|13166|vetalmen|||0|50|0||Icepharma hf|Richter Pharma AG|Ketaminum||6850||6850|13166||2 157047|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 157054|N06BA0202|Attentin|töflur|10|mg|30|stk|1|þpakki||N06BA02|01.08.2017||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|8684|13358|lyfalmen|||1|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Dexamfetamine ||||8684|13358||2 157257|QJ01DB0101|Cefabactin vet.|töflur|50|mg|100|stk|1|þpakki||QJ01DB01|01.03.2018||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2589|5082|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Cefalexin||||2589|5082||2 157331|QN03AA0201|Phenoleptil|töflur|100|mg|100|stk|1|þpakki|handa hundum|QN03AA02|01.05.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2895|5663|vetalmen|||1|100|0||Dýraheilsa ehf|Le Vet B.V.|Phenobarbitalum||2895||2895|5663||2 157745|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|20|ml|10|áfspr|lausn,áf.spr.|V08CA02|01.10.2017||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|59587|78436|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||59587||59587|78436||2 157756|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2015||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|33314|45206|lyfsjukr|||1|2,5|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||33314|45206||1 157863|N03AF0104|Tegretol|töflur|200|mg|100|stk|1|þpakki||N03AF01|01.01.2010||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|1190|3043|lyfalmen|||1|100|0|20,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||1190||1190|3043||1 157869|D11AX1601|Vaniqa|krem|11,5|%|30|g|1|túpa||D11AX16|01.01.2013||R|0|0|0|0|0|0|ALM|0|0|0|100|DKK|5243|8621|lyfalmen|||1|30|0||Vistor hf|Almirall S.A.|Eflórníthin||5243||5243|8621||1 158098|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|6|lykjur||C01BD01|01.08.2013||R|0|0|0|0|0|1|SNP|0|0|0|100|XEU|800|2506|lyfsjukr|||1|18|0|4,5000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||800||800|2506||1 158185|N05AH0405|Seroquel Prolong|forðatfl|150|mg|100|stk|1|þpakki||N05AH04|01.10.2011||R|1|1|0|0|G|0|ASA|0|0|0|100|SEK|15523|22771|lyfalmen|V0910|8012|1|100|0|37,5000|Vistor hf|Astra Zeneca A/S|Quetíapín||||15523|22771||1 158608|J02AX0501|Mycamine|irs|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|0|0|1|APG|0|0|0|100|XEU|35575|48066|lyfsjukr|||1|1|0|0,5000|Vistor hf|Astellas Pharma GmbH|Micafungin||||35575|48066||1 158619|J02AX0501|Mycamine|irs|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|0|0|1|APG|0|0|0|100|XEU|46825|62295|lyfsjukr|||1|1|0|1,0000|Vistor hf|Astellas Pharma GmbH|Micafungin||46825||46825|62295||1 158639|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.12.2016||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|3143|3475|lyfalmen|V0143|3420|2|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||1504||1504|3475||1 158698|L01BC5901|Lonsurf|filmhtfl|21,14|mg|60|stk|1|þpakki|15 mg + 6,14 mg|L01BC59|01.09.2016||R|0|0|0|1|0|1|LLS|0|1|0|100|DKK|260093|329590|lyfsjukr|||1|60|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||260093|329590||2 158725|M01AB0516|Diklofenak Mylan|sþ-tfl|50|mg|100|stk|1|glas||M01AB05|01.12.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|689|2317|lyfalmen|V0469|2231|2|100|0|50,0000|Icepharma hf|Mylan AB|Díklófenak||663||663|2317||2 158849|N06BA0903|Atomoxetin Medical Valley|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|0|VAL|0|0|0|100|XEU|11370|6171|lyfalmen|V0817|6171|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||3463||3463|6171||2 158860|J01FA0904|Clarithromycin Krka|filmhtfl|250|mg|14|stk|1|þpakki||J01FA09|01.09.2018||R|1|0|0|0|0|0|KNM|0|0|1|100|IKR|2000|3607|lyfalmen|V0967|3607|2|14|0|7,0000|LYFIS ehf|Krka d.d. Novo mesto|Klaritrómýcín||1600||1600|3607||2 158866|G03GA1001|REKOVELLE|stl|12|mcg|0,36|ml|1|pakki|+ 3 inndælingarnálar|G03GA10|01.08.2017||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|11236|16870|lyfalmen|||1|0,36|0||Vistor hf|Ferring Lægemidler A/S|Follitrópín delta||||11236|16870||1 159107|N02AB0303|Fentanyl Actavis|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|GPA|0|0|0|100|XEU|1648|3673|lyfalmen|V0219|3672|2|5|0|7,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||1648||1648|3673||1 159118|N02AB0303|Fentanyl Actavis|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|GPA|0|0|0|100|XEU|2743|5180|lyfalmen|V0220|5180|2|5|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||2743||2743|5180||1 159130|N02AB0303|Fentanyl Actavis|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|GPA|0|0|0|100|XEU|4057|6989|lyfalmen|V0221|6989|2|5|0|22,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||4057||4057|6989||1 159141|N02AB0303|Fentanyl Actavis|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|GPA|0|0|0|100|XEU|4399|7460|lyfalmen|V0223|7458|2|5|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||4399||4399|7460||1 159295|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|172,5|mg|98|stk|1|þpakki|160/12,5 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|3218|2575|lyfalmen|||2|98|0|98,0000|Alvogen|ratiopharm GmbH|Valsartan og þvagræsilyf||850||850|2575|30.6.2018|2 159341|L02BB0306|Bicalutamid LYFIS|filmhtfl|150|mg|90|stk|1|þpakki||L02BB03|01.06.2015||R|0|0|0|0|G|0|LYF|0|0|0|100|IKR|27000|15169|lyfalmen|V0421|15169|2|90|0|270,0000|LYFIS ehf|LYFIS ehf|Bíkalútamíð||10000||10000|15169||2 159454|L01XX3202|VORTEMYEL|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.12.2015||R|0|1|0|0|0|1|IPC|0|1|0|100|SEK|101477|132316|lyfsjukr|||2|1|0||Alvogen|Alvogen IPco S.á.r.l.|Bortezomíb||101477||101477|132316||2 159458|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.11.2016||L|1|0|0|0|0|0|VAL|0|0|0|100|IKR|||lyflausa|||2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól|||||||2 159605|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.09.2017||R|0|0|0|0|0|1|ESS|0|0|0|100|DKK|37353|50314|lyfsjukr|||1|5|0|5,0000|Essential Pharma Ltd.|Essential Pharma Ltd.|Samtengt laxakalsítónín||37353||37353|50314||2 159672|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|25|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|G|0|MYL|0|0|1|100|SEK|353|1891|lyfalmen|||2|25|0|10,0000|Icepharma hf|Mylan AB|Acetýlcýstein||353||353|1891||2 159683|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|100|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|G|0|MYL|0|0|1|100|SEK|1071|2879|lyfalmen|||2|100|0|40,0000|Icepharma hf|Mylan AB|Acetýlcýstein||1071||1071|2879||2 159751|J01DB0402|Cefazolina Normon|sts|1|g|1|stk|1|hgl|í bláæð|J01DB04|01.06.2018||R|0|0|0|0|0|1|LNA|0|0|0|100|SEK|420|1983|lyfsjukr|||2|1|0|0,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Cefazólín||420||420|1983||2 159762|N06DA0304|Nimvastid|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.04.2018||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|27510|37865|lyfalmen|V0355|37865|2|112|0|74,6700|LYFIS ehf|Krka d.d. Novo mesto|Rívastigmín||27510||27510|37865||2 159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|0|0|0|0|0|1|GRP|0|0|0|100|DKK|107100|139309|lyfsjukr|||1|2|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||107100||107100|139309||1 159973|QM01AG9002|Flunixin|stl|50|mg/ml|50|ml|1|hgl|nautg,hesta og svín|QM01AG90|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|3287|6407|vetalmen|||0|50|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||3287||3287|6407||2 160047|M01AH0504|Etoricoxib Krka|filmhtfl|120|mg|100|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|12000|6911|lyfalmen|||2|100|0|200,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||4000||4000|6911||2 160155|L04AB0102|Benepali|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.10.2017||R|0|1|0|1|0|1|SAM|0|1|0|100|XEU|54586|72111|lyfsjukr|||2|4|0|14,2900|Biogen Idec Ltd.|Samsung Bioepis UK Ltd.|Etanercept||54586||54586|72111||2 160279|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2011||R|0|0|0|0|0|0|GRP|0|0|0|100|XEU|4479|3534|lyfalmen|V0010|2179|2|56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1547||1547|3534||1 160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|0|0|0|0|0|1|GRP|0|0|0|100|DKK|5885|4825|lyfsjukr|||2|50|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||2485||2485|4825||1 160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|þpakki||N05AB04|01.06.1981||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|642|2289|lyfalmen|||1|100|0|5,0000|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||642||642|2289||1 160531|C10AC0101|Questran|mixtduft|4|g|50|skammtar|1|skpoki||C10AC01|01.05.2016||R|0|0|0|0|0|0|BRS|0|0|0|100|DKK|3185|5789|lyfalmen|||1|50|0|14,2800|Vistor hf|Bristol-Myers Squibb|Kólestýramín||3185||3185|5789||1 161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|533|2139|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||533||533|2139||1 161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|720|2396|lyfsjukr|||1|1|0|8,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||720||720|2396||1 161113|J01CR0202|Augmentin|töflur|1|g|14|stk|1|þpakki|875+125 mg|J01CR02|01.11.2015||R|0|0|0|0|0|0|GPH|0|0|1|100|DKK|1150|2988|lyfalmen|V0169|2231|1|14|0|12,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill ||1150||1150|2988||1 161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|1984|4136|lyfalmen|||1|5|0|16,6667|Icepharma hf|Pfizer ApS|Hýdrókortisón||1984||1984|4136||1 161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|474|2057|lyfalmen|||1|1|0|3,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||474||474|2057||1 161180|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.2017||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|1323|2356|lyfalmen|V0143|1140|2|4|0|4,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||691||691|2356||1 161424|G04BE0806|Tadalafil Krka|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|10000|6222|lyfalmen|V0145|5609|2|8|0|16,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||3500||3500|6222||2 161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|þpakki||L02BG06|01.06.2001||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|44804|59738|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Exemestan||44804||44804|59738||1 161592|J01DD0101|Cefotaxim Villerton|sts|1|g|10|ml|10|hgl|lausn|J01DD01|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|5086|8405|lyfsjukr|||2|100|0|2,5000|Icepharma hf|Villerton Invest SA|Cefotaximum||||5086|8405||2 161824|A06AX0401|Constella|hylki|290|mcg|90|stk|1|glas||A06AX04|01.12.2016||R|0|0|0|0|G|0|AIP|0|0|0|100|XEU|23309|32551|lyfalmen|||1|90|0|90,0000|Actavis ehf|Allergan Pharmaceuticals Ltd.|Linaclotídum||23309||23309|32551||1 162261|H01CB0501|Signifor|stl|0,6|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|426750|536865|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||426750||426750|536865||1 162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|1581|3581|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1581||1581|3581||1 162440|G04BE0806|Tadalafil Krka|filmhtfl|20|mg|12|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|16000|8425|lyfalmen|V0145|8414|2|12|0|24,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||5100||5100|8425||2 162778|QN05CM9002|Detonervin, vet.|stl|10|mg/ml|5|ml|1|hgl|f.hesta og nautgr.|QN05CM90|01.12.2011||R|0|0|0|0|0|0|LEV|1|0|0|100|XEU|4426|8568|vetalmen|||0|5|0||Le Vet B.V.|Le Vet B.V.|||4426||4426|8568||2 162808|C01DA1404|Fem-Mono Retard|forðatfl|60|mg|100|stk|1|þpakki||C01DA14|01.10.2013||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1928|3011|lyfalmen|V0041|3011|2|100|0|150,0000|Icepharma hf|Mylan AB|Ísósorbíð mónónítrat||1167||1167|3011||2 162841|A10BA0203|Metformin Bluefish|filmhtfl|500|mg|100|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|387|1873|lyfalmen|V0500|1873|2|100|0|25,0000|Vistor hf|Bluefish Pharmaceuticals AB|Metformín||340||340|1873||1 162852|A10BA0203|Metformin Bluefish|filmhtfl|850|mg|100|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|580|2203|lyfalmen|||2|100|0|42,5000|Vistor hf|Bluefish Pharmaceuticals AB|Metformín||580||580|2203||1 162863|A10BA0203|Metformin Bluefish|filmhtfl|1000|mg|60|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|500|2093|lyfalmen|V0502|1933|2|60|0|30,0000|Vistor hf|Bluefish Pharmaceuticals AB|Metformín||500||500|2093||1 162933|R03BA0501|Flixotide|innúðal|50|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|1089|2904|lyfalmen|||1|120|0|20,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1089||1089|2904||1 163036|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|7532|11772|lyfalmen|||1|60|0|8,5700|Vistor hf|Eisai Ltd|Rúfínamíð||7532||7532|11772||1 163082|N02BA5103|Triplo|freyðit|550|mg|20|stk|1|tfílát|500+50 mg|N02BA51|01.08.2018||L|0|0|0|0|0|0|OEC|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Artasan ehf|Orifarm Generics A/S|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||1 163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.12.1972||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|959|2725|lyfalmen|V0671|2300|1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||959||959|2725||1 163239|L04AX0306|Metojectpen|stl|30|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|3258|5889|lyfalmen|||1|1|0|12,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3258||3258|5889||2 163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|þpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNP|0|0|1|100|XEU|1081|2893|lyfalmen|||1|30|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1081||1081|2893||1 163354|C10BA0501|Atozet|filmhtfl|30|mg|30|stk|1|þpakki|10 mg + 20 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|4939|8203|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||4939||4939|8203||1 163429|C01CA0601|Fenylefrin Abcur|stl|0,1|mg/ml|5|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|8941|13711|lyfsjukr|||2|50|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||8941||8941|13711||2 163453|M01AH0504|Etoricoxib Krka|filmhtfl|30|mg|100|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|8350|8287|lyfalmen|||2|100|0|50,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||5000||5000|8287||2 163493|R03BA0501|Flixotide|innúðal|125|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|1900|4020|lyfalmen|||1|120|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1900||1900|4020||1 163494|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|þpakki||L01XE05|01.06.2013||R|0|0|0|1|0|1|BYP|0|1|0|100|DKK|410214|516298|lyfsjukr|||1|112|0||Icepharma hf|Bayer Pharma AG|Sorafeníb||410214||410214|516298||2 163646|L04AX0305|Methotrexate Pfizer|töflur|2,5|mg|100|stk|1|þpakki||L04AX03|01.06.2016||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|1546|3533|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Metótrexat||1546||1546|3533||1 163667|M01AE0113|Ibuxin|filmhtfl|800|mg|30|stk|1|þpakki||M01AE01|01.03.2013||R|1|0|0|0|G|0|RHA|0|0|1|100|XEU|477|1942|lyfalmen|||2|30|0|20,0000|Alvogen|ratiopharm Oy|Íbúprófen||390||390|1942||2 163675|M01AE0113|Ibuxin|filmhtfl|800|mg|100|stk|1|þpakki||M01AE01|01.03.2013||R|1|0|0|0|G|0|RHA|0|0|1|100|XEU|1314|2697|lyfalmen|||2|100|0|66,6700|Alvogen|ratiopharm Oy|Íbúprófen||939||939|2697||2 163967|M01AH0504|Etoricoxib Krka|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|800|1680|lyfalmen|V0827|1680|2|7|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||200||200|1680||2 164256|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3099|5670|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||3099||3099|5670||1 164324|L01BB0202|Xaluprine|mixtúra|20|mg/ml|100|ml|1|glas||L01BB02|01.05.2015||R|0|0|0|1|0|1|VON|0|0|0|100|DKK|30901|42154|lyfsjukr|||1|100|0||Williams & Halls efh|Nova Laboratories Limited|Merkaptópúrín||30901||30901|42154||2 164592|QN03AX9001|Pexion|töflur|400|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|7518|14434|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||7518||7518|14434||1 164827|C02KX0501|Adempas|filmhtfl|2,5|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|320328|404505|lyfsjukr|||1|84|0|46,6700|Vistor hf|Bayer AG|Riociguatum||320328||320328|404505||1 164829|N06AA0406|Klomipramin Mylan|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|786|2487|lyfalmen|||2|100|0|10,0000|Icepharma hf|Mylan AB|Klómípramín||786||786|2487||2 164840|N06AA0406|Klomipramin Mylan|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|966|2735|lyfalmen|V0314|2735|2|100|0|25,0000|Icepharma hf|Mylan AB|Klómípramín||966||966|2735||2 164871|A07EC0204|Asacol|eþ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|0|0|0|0|G|0|TIL|0|0|0|100|SEK|4215|7206|lyfalmen|V0014|7206|1|60|0|20,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||4215|7206||2 164944|M01AX0001|Harpatinum|hylki|225|mg|90|stk|1|þpakki||M01AX00|01.01.2018||L|0|0|0|0|0|0|FLO|0|0|1|100|IKR|||lyflausa|||0|90|0||Florealis ehf|Florealis ehf|Devil´s claw dry extrakt ethanolic 60%|||||||1 165019|C05AA0102|Proctosedyl|eþ-smyr|||30|g|1|túpa||C05AA01|01.03.1981||L|0|0|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||0|30|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||||1 165175|N05BA0205|Risolid|filmhtfl|10|mg|100|stk|1|glas||N05BA02|01.03.2012||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|1205|3063|lyfalmen|||2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Klórdíazepoxíð||1205||1205|3063|31.8.2018|1 165306|QN05CM9101|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM91|01.05.2009||R|0|0|0|0|0|0|LAS|1|0|0|100|XEU|5415|10444|vetalmen|||0|10|0||Dýraheilsa ehf|Laboratorios SYVA S.A.|Metetomidinum||5415||5415|10444||2 165507|L01XX1904|Irinotecan Actavis|irþ|20|mg/ml|25|ml|1|hgl|lausn|L01XX19|01.04.2018||R|0|0|0|0|0|1|EHF|0|0|0|100|XEU|6714|10646|lyfsjukr|||2|25|0||Actavis Group PTC hf|Actavis ehf|Írinótekan||6714||6714|10646||1 165603|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|5|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|MEC|0|1|0|100|SEK|129434|167087|lyfsjukr|||1|7,5|0|90,0000|Icepharma hf|Merck AB|Sómatrópín||129434||129434|167087||2 165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|þpakki||R06AE05|01.07.2017||R|1|0|0|0|G|0|GOP|0|0|1|100|SEK|471|2053|lyfalmen|V0904|2053|1|100|0|50,0000|Sofus Regulatory Affairs AB|Gen. Orph|Meklózín||471||471|2053||1 165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|þpakki||R06AE05|01.12.1972||R|1|0|0|0|G|0|GOP|0|0|1|100|SEK|136|1592|lyfalmen|V0505|1592|1|25|0|12,5000|Sofus Regulatory Affairs AB|Gen. Orph|Meklózín||136||136|1592||1 165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.12.1972||L|1|0|0|0|0|0|GOP|0|0|1|100|IKR|||lyflausa|||0|10|0|5,0000|Sofus Regulatory Affairs AB|Gen. Orph|Meklózín|||||||1 165799|C02KX0501|Adempas|filmhtfl|2|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|159018|203881|lyfsjukr|||1|42|0|18,6700|Vistor hf|Bayer AG|Riociguatum||159018||159018|203881||1 165859|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3275|5913|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||3275||3275|5913||1 165903|QA03DB0401|Spasmium vet.|stl|504|mg/ml|100|ml|1|hgl|500 mg/ml+4 mg/ml, lausn|QA03DB04|01.02.2016||R|0|0|0|0|0|0|RPG|1|0|0|100|XEU|4685|9059|vetalmen|||0|100|0||Icepharma hf|Richter Pharma AG|Butylscopolamine og metamizolum||||4685|9059||2 166008|QJ51RC2202|Nafpenzal vet.|spenalyf|||3|g|20|spr||QJ51RC22|01.02.2010||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|3664|7122|vetalmen|||0|60|0||Vistor hf|Intervet International BV|||||3664|7122||1 166029|G04BE0309|Vizarsin|munndr.t|50|mg|24|stk|1|þpakki||G04BE03|01.01.2018||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|8916|5947|lyfalmen|||2|24|0|24,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||3300||3300|5947||2 166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|þpakki||P01BA02|01.12.1972||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|1235|3105|lyfalmen|||1|100|0|38,7597|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||1235||1235|3105||1 166165|H01CA0201|Synarela|nefúði|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|0|0|0|1|G|0|PLS|0|0|0|100|DKK|12216|18219|lyfalmen|||1|8|0|30,0000|Icepharma hf|Pfizer ApS|Nafarelín||12216||12216|18219||1 166204|J07BB0205|Influvac|stl|||0,5|ml|10|áfspr||J07BB02|01.11.2017||R|0|0|0|0|0|0|PGB|0|0|0|100|DKK|6817|10788|lyfalmen|||1|5|0||Icepharma hf|BGP Products ApS|Inflúensa, hreinsaðir mótefnavakar||||6817|10788||2 166277|C10AA0508|Lipistad|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|2665|2713|lyfalmen|V0113|2713|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||950||950|2713||2 166351|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1490|3456|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Naproxen||1490||1490|3456||2 166362|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|2820|5286|lyfalmen|V0428|5286|2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||2820||2820|5286||2 166628|L04AB0401|Humira|stl|40|mg/penna|0,4|ml|2|áfpen|áfylltur penni|L04AB04|01.11.2016||R|0|1|0|1|0|1|ABD|0|1|0|100|DKK|116026|150411|lyfsjukr|||1|0,8|0|27,5900|Vistor hf|AbbVie Deutschland GmbH & Co. KG|Adalimumab||116026||116026|150411||1 166869|N02BA0110|Aspirin Actavis|töflur|300|mg|100|stk|1|glas||N02BA01|01.11.2010||L|0|0|0|0|0|0|UAK|0|0|1|100|IKR|||lyflausa|||0|100|0|10,0000|Actavis Group hf|Actavis UK Ltd.|Acetýlsalicýlsýra|||||||1 167366|C01CA1702|Midodrin Evolan|töflur|2,5|mg|50|stk|1|þpakki||C01CA17|01.05.2018||R|1|0|0|0|0|0|EVO|0|0|0|100|IKR|8346|12892|lyfalmen|||2|50|0|4,1666|LYFIS ehf|Evolan Pharma AB|midodrine||8346||8346|12892||2 167588|B02BD0208|Afstyla|sts|500|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|0|1|0|1|CSB|0|1|0|100|SEK|33632|45608|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||33632||33632|45608||2 167753|M01AH0504|Etoricoxib Krka|filmhtfl|90|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|2588|2988|lyfalmen|V0826|2988|2|30|0|45,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1150||1150|2988||2 167905|A02BC0508|Esomeprazol Actavis|sþ-tfl|40|mg|28|stk|1|þpakki||A02BC05|01.01.2015||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|1405|2766|lyfalmen|V0005|1953|2|28|0|37,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||989||989|2766||1 168038|J05AR0901|Stribild|filmhtfl|745|mg|30|stk|1|glas|150+150+200+245 mg|J05AR09|01.11.2013||R|0|1|0|1|0|1|GEI|0|0|0|100|DKK|138454|178305|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Sciences Ireland|Emtrícítabín,tenófóvír disóproxíl,elvítegravír og kóbísistat||138454||138454|178305||2 168083|L02BB0305|Bicalutamide Alvogen|filmhtfl|50|mg|90|stk|1|þpakki||L02BB03|01.11.2016||R|0|0|0|0|G|0|GOV|0|0|0|100|IKR|19158|10076|lyfalmen|V0420|10076|2|90|0|90,0000|Alvogen|Alvogen ehf|Bíkalútamíð||6300||6300|10076||2 168275|M04AA0104|Allopurinol|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.06.2009||R|1|0|0|0|G|0|UAK|0|0|0|100|GBP|349|1885|lyfalmen|V0119|1885|2|100|0|25,0000|Actavis Group hf|Actavis UK Ltd.|Allópúrinol||||349|1885||1 168309|A02BC0306|Lanser|sþ-hylki|30|mg|98|stk|1|þpakki||A02BC03|01.08.2009||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|3952|6844|lyfalmen|V0007|6222|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lansóprazól||3952||3952|6844||1 168423|R06AX2701|Aerius|filmhtfl|5|mg|90|stk|1|þpakki||R06AX27|01.10.2015||R|1|0|0|0|G|0|MBV|0|0|1|100|DKK|2685|5101|lyfalmen|V0458|2380|1|90|0|90,0000|Vistor hf|Merck Sharp & Dohme B.V.|Deslóratadín||2685||2685|5101||1 168589|N02CC0402|Maxalt Smelt|frþ.tfl|10|mg|6|stk|1|þpakki||N02CC04|01.11.2013|30.06.2018|R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|2165|4385|lyfalmen|||1|6|0|6,0000|Vistor hf|M.S.D.|Rizatriptan||2165||2165|4385||1 168640|L04AX0307|Metoject|stl|50|mg/ml|0,3|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|1953|4093|lyfalmen|||1|0,3|0|6,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||1953||1953|4093||2 168662|L04AX0307|Metoject|stl|50|mg/ml|0,5|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2325|4605|lyfalmen|||1|0,5|0|10,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2325||2325|4605||2 168740|N03AF0105|Tegretol Retard|forðatfl|200|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2390|4695|lyfalmen|V0240|4693|1|200|0|40,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||2390||2390|4695||1 168778|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|21,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 168971|N03AF0105|Tegretol Retard|forðatfl|400|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|4411|7476|lyfalmen|V0433|7475|1|200|0|80,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||4411||4411|7476||1 168997|L01CA0401|Navelbine|irþ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|0|0|0|0|0|1|PFP|0|0|0|100|SEK|20782|29355|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||20782||20782|29355||1 169175|N03AX1603|Pregabalin Krka|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|7196|4598|lyfalmen|V0688|4598|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||2320||2320|4598||2 169287|M05BA0606|Ibandronic acid WH|filmhtfl|50|mg|84|stk|1|þpakki||M05BA06|01.01.2018||R|1|1|0|0|0|0|WEH|0|0|0|100|IKR|54874|72475|lyfalmen|||2|84|0|840,0000|Williams & Halls efh|Williams & Halls ehf|Íbandrónsýra||54874||54874|72475||2 169433|L01CA0401|Navelbine|irþ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|0|0|0|0|0|1|PFP|0|0|0|100|SEK|103911|135343|lyfsjukr|||1|50|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||103911||103911|135343||1 169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|0|0|0|0|0|1|ROA|0|0|0|100|DKK|16152|23637|lyfsjukr|||1|5|0|5,0000|Icepharma hf|Roche A.S.|Gancíklóvír||16152||16152|23637||2 169664|J07BK0101|Varilrix|sts|||0,5|ml|1|hgl|þurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|3937|6824|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Hlaupabóla, veikluð veira||3937||3937|6824||1 169751|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|500|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|GOV|0|0|1|100|IKR|1168|3007|lyfalmen|V0411|3007|2|20|0|10,0000|Alvogen|Alvogen ehf|Cíprófloxacín||1164||1164|3007||2 169762|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|500|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|GOV|0|0|1|100|IKR|647|2295|lyfalmen|V0177|2295|2|10|0|5,0000|Alvogen|Alvogen ehf|Cíprófloxacín||647||647|2295||2 169773|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|250|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|GOV|0|0|1|100|IKR|638|2283|lyfalmen|V0418|2283|2|20|0|5,0000|Alvogen|Alvogen ehf|Cíprófloxacín||638||638|2283||2 169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|2118|4320|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín||2118||2118|4320||2 169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|2280|4543|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín||2280||2280|4543||2 169998|S01GA0101|Cleye|augndr|0,12|mg/ml|10|ml|1|glas||S01GA01|01.08.2017||L|0|0|0|0|0|0|CLE|0|0|0|100|IKR|||lyflausa|||1|10|0||LYFIS ehf|Clear Eyes Pharma Ltd.|Nafazólín|||||||2 170062|L04AC0701|RoActemra|irþ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|0|0|1|RRG|0|1|0|100|DKK|16748|24457|lyfsjukr|||1|4|0|4,0000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||||16748|24457||2 170085|L04AC0701|RoActemra|irþ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|0|0|1|RRG|0|1|0|100|DKK|41567|55644|lyfsjukr|||1|10|0|10,0000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||||41567|55644||2 170092|J07BC2001|Twinrix Adult|stl|||1|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GBI|0|0|0|100|DKK|4134|7095|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||4134||4134|7095||1 170107|L04AC0701|RoActemra|irþ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|0|0|1|RRG|0|1|0|100|DKK|82705|107676|lyfsjukr|||1|20|0|20,0000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||82705||82705|107676||2 170309|C10AA0106|Simvastatin Bluefish|filmhtfl|10|mg|100|stk|1|þpakki||C10AA01|01.07.2018||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|743|1994|lyfalmen|V0108|1994|2|100|0|33,3400|Vistor hf|Bluefish Pharmaceuticals AB|Simvastatín||428||428|1994||1 170486|C10AX1401|Praluent|stl|75|mg/ml|1|ml|6|áfpen|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|0|SGB|0|0|0|100|XEU|165321|211720|lyfalmen|||1|6|0|83,3333|Vistor hf|Sanofi-aventis groupe|Alirocumab||165321||165321|211720||1 170505|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|þpakki||J04AB02|01.07.2012||R|1|0|0|0|G|0|HSS|0|0|0|100|DKK|10154|15381|lyfalmen|||1|100|0|50,0000|Artasan ehf|Sandoz GmbH|Rífampicín||10154||10154|15381||1 170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1733|3790|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Mepívakaín í blöndum||1733||1733|3790||2 170628|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|LEM|0|0|0|100|XEU|8955|13731|lyfsjukr|||2|1600|0|6,6700|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||8955||8955|13731||2 170640|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|LEM|0|0|0|100|XEU|21542|30317|lyfsjukr|||2|1600|0|20,0000|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||21542||21542|30317||2 170651|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|LEM|0|0|0|100|XEU|32313|43940|lyfsjukr|||2|2400|0|30,0000|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||32313||32313|43940||2 170672|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2015||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|28016|38505|lyfsjukr|||1|2,5|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||28016|38505||1 170697|M05BA0406|Alendronat Actavis|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.06.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2630|2843|lyfalmen|V0203|2843|2|12|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Alendrónsýra||1045||1045|2843||1 170881|QM01AC0607|Meloxoral|mixtúra|0,5|mg/ml|5|ml|1|glas|handa köttum|QM01AC06|01.12.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|1158|2276|vetalmen|||0|5|0||Dýraheilsa ehf|Le Vet B.V.|Meloxícam||1158||1158|2276||2 170997|L01BC0701|Vidaza|sts|25|mg/ml|4|ml|1|hgl|dreifa|L01BC07|01.09.2009||R|0|0|0|0|0|1|CEE|0|1|0|100|XEU|45071|60076|lyfsjukr|||1|4|0||Celgene Europe ltd|Celgene Europe ltd|Azasitidín||45071||45071|60076||2 171404|QS02CA0102|Canaural|eyrnadr|||25|ml|1|glas|handa hundum|QS02CA01|01.01.2012||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|2144|4214|vetalmen|||0|25|0||Vistor hf|Dechra Veterinary Products A/S|||2144||2144|4214||1 171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|2625|5018|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín í blöndum||2625||2625|5018||2 171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|2651|5054|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín í blöndum||2651||2651|5054||2 171762|A03AA0407|Duspatalin Retard|forðahlk|200|mg|30|stk|1|þpakki||A03AA04|01.11.2016||R|0|0|0|0|G|0|PGB|0|0|0|100|DKK|992|2770|lyfalmen|||1|30|0|20,0000|Icepharma hf|BGP Products ApS|Mebeverín||992||992|2770||2 171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|2105|4302|lyfalmen|V0247|2023|1|60|0|5,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||2105||2105|4302||1 171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|3657|6438|lyfalmen|V0248|3297|1|60|0|10,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||3657||3657|6438||1 172289|L04AX0501|Esbriet|hylki|267|mg|63|stk|1|þpakki|hart|L04AX05|01.02.2016||R|1|1|0|1|0|0|RRG|0|0|0|100|DKK|88667|115216|lyfalmen|V0920|113513|1|63|0|7,0000|Icepharma hf|Roche Registration GmbH|Pírfenidon||||88667|115216||2 172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|6770|10723|lyfalmen|V0249|3727|1|60|0|20,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||6770||6770|10723||1 172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|12321|18364|lyfalmen|||1|60|0|40,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||12321||12321|18364||1 172482|N06DA0303|Nimvastid (Lyfis)|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|27510|37865|lyfalmen|V0355|37865|3|112|0|74,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||27510||27510|37865||2 172592|N06AX2601|Brintellix|filmhtfl|10|mg|98|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LUN|0|0|0|100|DKK|15842|23210|lyfalmen|||1|98|0|98,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||15842||15842|23210||1 172627|C07FB0202|Logimax forte|forðatfl|105|mg|98|stk|1|pakki|þp 10 + 95 mg|C07FB02|01.07.1999||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|7450|11659|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og Felodipin||7450||7450|11659||1 172723|N05AH0410|Quetiapin Actavis|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.07.2013||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2132|2198|lyfalmen|V0284|2167|2|100|0|6,2500|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||576||576|2198||1 172895|H01CB0501|Signifor|stl|0,9|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|479358|602294|lyfalmen|||1|60|0|45,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||479358||479358|602294||1 173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.12.1972||R|1|0|0|0|0|0|MEA|0|0|1|100|DKK|298|1815|lyfalmen|||1|50|0|50,0000|Icepharma hf|Meda AB|Nítrazepam||298||298|1815||2 173284|C10AA0702|Rosuvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.12.2012||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|8337|9462|lyfalmen|V0118|8391|2|98|0|196,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rósuvastatín||5854||5854|9462||1 173310|N05BE0108|Buspiron Mylan|töflur|5|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|2299|4569|lyfalmen|||2|100|0|16,6667|Icepharma hf|Mylan AB|Búspírón hýdróklóríð||2299||2299|4569||2 173344|A06AG1101|Microlax|innhl|||5|ml|12|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|60|0|12,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||3450||1 173518|N05BE0108|Buspiron Mylan|töflur|10|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|3938|6825|lyfalmen|||2|100|0|33,3333|Icepharma hf|Mylan AB|Búspírón hýdróklóríð||3938||3938|6825||2 173750|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|áf.spr|nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|10363|15669|lyfsjukr|||1|1,6|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||10363||10363|15669||1 173895|N05AX1207|Lemilvo|töflur|15|mg|100|stk|1|glas||N05AX12|01.03.2016||R|1|1|0|0|G|0|GPA|0|0|0|100|XEU|14542|7420|lyfalmen|V0684|6763|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||4370||4370|7420||1 173942|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012|31.07.2018|R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|11338|17011|lyfsjukr|||1|1,5|0|7,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||11338||11338|17011||1 173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|0|0|0|0|0|1|GRP|0|0|0|100|DKK|1587|3589|lyfsjukr|||2|20|0|10,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||1587||1587|3589||1 174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|þpakki||J01CE02|01.01.1989||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|446|2019|lyfalmen|||1|14|0|5,6000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||446||446|2019|31.7.2018|2 174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|þpakki||J01CE02|01.01.1989||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|454|2030|lyfalmen|||1|14|0|7,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||454||454|2030||2 174433|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|1124|2952|lyfalmen|||1|5|0|25,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Brímónidín||1124||1124|2952||1 174522|N04BC0505|Oprymea|forðatfl|0,26|mg|30|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|2900|5396|lyfalmen|||2|30|0|4,5000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||2900||2900|5396||2 174615|N05CF0105|Zopiklon Mylan|filmhtfl|7,5|mg|30|stk|1|þpakki||N05CF01|01.01.2017||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|260|1540|lyfalmen|V0312|1540|2|30|0|30,0000|Icepharma hf|Mylan AB|Zópíklón||98||98|1540||2 174626|A10AE0601|Tresiba|stl|200|ae/ml|3|ml|3|áfpen|FlexTouch|A10AE06|01.12.2016||R|0|1|0|0|G|0|NAS|0|0|0|100|DKK|9380|14316|lyfalmen|||1|9|0|45,0000|Vistor hf|Novo-Nordisk A/S|Insulin degludec||9380||9380|14316||1 174664|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|3251|5880|lyfalmen|V0368|4105|1|15|0|75,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Brímónidín||3251||3251|5880||1 174806|J05AE1002|Darunavir Alvogen|filmhtfl|800|mg|30|stk|1|glas||J05AE10|01.07.2017||R|1|0|0|1|0|1|ALO|0|0|0|100|XEU|41994|51564|lyfsjukr|||2|30|0|20,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Darunavír||38341||38341|51564||2 174875|N06AB1007|Escitalopram Bluefish|filmhtfl|10|mg|98|stk|1|þpakki||N06AB10|01.08.2018||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|2143|2644|lyfalmen|V0325|2644|2|98|0|98,0000|Vistor hf|Bluefish Pharmaceuticals AB|Escítalópram||900||900|2644||1 174903|N06BA1201|Elvanse Adult|hylki|70|mg|30|stk|1|glas|hart|N06BA12|01.06.2018||R|1|1|1|0|0|0|SHI|0|0|0|100|DKK|12868|19116|lyfalmen|||1|30|0|70,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|lisdexamfetamine||12868||12868|19116||3 174935|L01XE1301|Giotrif|filmhtfl|20|mg|28|stk|1|þpakki||L01XE13|01.05.2016||R|0|0|0|1|0|1|BOE|0|1|0|100|DKK|232131|294813|lyfsjukr|||1|28|0||Vistor hf|Boehringer Ingelheim International GmbH|Afatiníb||232131||232131|294813||1 175058|N05AH0413|Quetiapin ratiopharm|forðatfl|50|mg|10|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|0|0|0|TVA|0|0|0|100|IKR|1262|3142|lyfalmen|||2|10|0|1,2500|Alvogen|Teva B.V.|Quetíapín||1262||1262|3142||2 175246|B02BD0205|Elocta|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|0|1|0|1|SAB|0|0|0|100|DKK|18584|26984|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||18584|26984||3 175253|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.07.2016||R|0|0|0|0|G|0|NAA|0|0|1|100|DKK|6684|6474|lyfalmen|||1|10|0|1,2500|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||3683||3683|6474||1 175333|QM01AC0603|Rheumocam|mixtúra|15|mg/ml|100|ml|1|glas|handa hestum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|4186|8112|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||4186||4186|8112||2 175370|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.08.2015||R|0|0|0|1|G|0|MBV|0|0|0|100|DKK|12432|18516|lyfalmen|||1|0,36|0|4,0000|Vistor hf|Merck Sharp & Dohme B.V.|Follitrópín beta||||12432|18516||1 175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.10.1996||R|1|0|0|0|G|0|GPH|0|0|1|100|DKK|1872|2322|lyfalmen|V0033|1960|1|10|0|1,6667|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||666||666|2322||1 175868|V03AN0101|Conoxia|lyfjagas|100|%|37|l|1|gashyl|kælt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|37|0||Ísaga ehf|AGA AB|Súrefni|||||||5 176214|N05AH0301|Zyprexa|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.1999||R|1|0|0|0|0|0|NED|0|0|0|100|XEU|3906|6781|lyfalmen|V0278|2674|1|28|0|7,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||3906||3906|6781||2 176472|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.09.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|1161|3003|lyfalmen|||1|100|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón||1161||1161|3003||1 176520|M01AH0105|Cloxabix|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|2079|4266|lyfalmen|V0429|3745|2|100|0|50,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||2079||2079|4266||2 176616|N05CH0101|Circadin|forðatfl|2|mg|30|stk|1|þpakki||N05CH01|01.10.2012||R|0|0|0|0|0|0|RAD|0|0|1|100|DKK|2160|4378|lyfalmen|||2|30|0|30,0000|Vistor hf|RAD Neurim Pharmaceuticals EEC Ltd.|Melatonin||2160||2160|4378||1 176773|R02AA0308|Strepsils Ingefær|sogtfl|||24|stk|1|þpakki||R02AA03|01.08.2018||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 176835|C09CA0106|Losatrix|filmhtfl|25|mg|100|stk|1|þpakki||C09CA01|01.01.2018||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|1832|3926|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Lósartan||1832||1832|3926||2 176889|QP53AC5501|Seresto|hálsband|1,81|g|1|stk|1|poki|1,25 + 0,56 g|QP53AC55|01.06.2016||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|5165|9970|vetalmen|||0|1|0||Icepharma hf|Bayer Animal Health GmbH|Flúmetrín í blöndum||5165||5165|9970||2 176955|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas|+spaði|D01AE16|01.12.2017||R|0|0|0|0|0|0|GAN|0|0|0|100|XEU|1882|3995|lyfalmen|V0655|3995|1|5|0||Icepharma hf|Galderma Nordic AB|Amorolfín||||1882|3995||2 177099|L01XC1901|Blincyto|st/irþ|38,5|mcg/ml|1|hgl|1|pakki|lausn|L01XC19|01.04.2017||R|0|1|0|0|0|1|AEB|0|0|0|100|DKK|337291|425603|lyfsjukr|||1|1|0||Vistor hf|Amgen Europe B.V.|Blinatumomab||337291||337291|425603||1 177176|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6087|9783|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Kolvetni||6087||6087|9783||2 177199|L01XE3301|Ibrance|hylki|125|mg|21|stk|1|þpakki||L01XE33|01.02.2017||R|1|0|0|1|0|1|PHH|0|1|0|100|DKK|435976|548339|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Limited|Palbociclib||435976||435976|548339||1 177454|N02BE0107|Paratabs|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.05.2013||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|603|2235|lyfalmen|V0231|2235|2|300|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól||603||603|2235||1 177627|QH02AB0201|Dexaject|stl|2|mg/ml|100|ml|1|hgl||QH02AB02|01.06.2013||R|0|0|0|0|0|0|DOR|1|0|0|100|XEU|3593|6987|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|Dexamethasón||3593||3593|6987||2 177882|L04AX0501|Esbriet|filmhtfl|801|mg|84|stk|1|þpakki||L04AX05|01.11.2017||R|1|1|0|1|0|0|RRG|0|0|0|100|DKK|297760|376437|lyfalmen|||1|84|0|28,0350|Icepharma hf|Roche Registration GmbH|Pírfenidon||||297760|376437||2 177937|M04AC0102|Colrefuz|töflur|500|mcg|100|stk|1|þpakki||M04AC01|01.10.2015||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|7348|9555|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Kolkisín||5921||5921|9555||1 178223|B01AF0101|Xarelto|filmhtfl|10|mg|100|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|26834|37010|lyfalmen|||1|100|0|50,0000|Icepharma hf|Bayer AG|Rivaoxaban||26834||26834|37010||2 178273|L01XE2501|Mekinist|filmhtfl|2|mg|30|stk|1|glas||L01XE25|01.01.2016||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|696292|872099|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Trametinib||696292||696292|872099||1 178511|B02BD0205|Elocta|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|0|1|0|1|SAB|0|0|0|100|DKK|74339|97094|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||74339|97094||3 178722|N06AB0404|Citalopram Bluefish|filmhtfl|40|mg|100|stk|1|þpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|4998|2781|lyfalmen|V0320|2781|2|100|0|200,0000|Vistor hf|Bluefish Pharmaceuticals AB|Cítalópram||1000||1000|2781||1 179100|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.10.2017||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|114578|148610|lyfsjukr|||1|7,5|0|75,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||114578||114578|148610||1 179157|L04AB0601|Simponi|stl|50|mg|1|spr|1|spr|áfyllt sprauta|L04AB06|01.06.2011||R|0|1|0|1|0|1|JAN|0|1|0|100|DKK|111046|144217|lyfsjukr|||1|1|0|30,1200|Vistor hf|Janssen Biologics B.V.|Golimumab||111046||111046|144217||1 179207|N02BE0122|Dolorin|töflur|500|mg|20|stk|1|þpakki||N02BE01|01.12.2017||L|1|0|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Williams & Halls efh|Williams & Halls ehf|Paracetamól|||||||2 179552|B01AF0101|Xarelto|filmhtfl|15|mg|28|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|7575|11831|lyfalmen|||1|28|0|21,0000|Icepharma hf|Bayer AG|Rivaoxaban||||7575|11831||2 179557|C10BA0501|Atozet|filmhtfl|50|mg|90|stk|1|þpakki|10 mg + 40 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|14010|20688|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||14010||14010|20688||1 180130|L01AX0303|Temomedac|hylki|250|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|1|0|100|XEU|91600|118926|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||91600||91600|118926||2 180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|1|0|0|0|G|0|ATN|0|0|0|100|DKK|3883|6749|lyfalmen|V0953|6749|1|100|0|25,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||3883||3883|6749||1 180500|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|100|stk|1|þpakki|með br. losunarhraða|G04CA02|01.12.2012||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|2191|3359|lyfalmen|V0148|3359|2|100|0|100,0000|Medical ehf|Medical ehf|Tamsúlósín||1420||1420|3359||2 180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|||5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|624|2264|lyfalmen|||1|5|0||Icepharma hf|Pfizer ApS|Hýdrókortisón og sýkingalyf||624||624|2264||1 181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|50|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2 181750|L01BA0108|Methotrexate Pfizer|irþ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|7661|11950|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Metótrexat||7661||7661|11950||1 181890|G03AD0102|Postinor|töflur|1,5|mg|1|stk|1|þpakki||G03AD01|01.11.2016||L|0|0|0|0|0|0|RIC|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Gedeon Ricther Nordics AB|Gedeon Richter Plc.|Levonorgestrel|||||||1 181980|C10BA0201|Inegy|töflur|30|mg|28|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MBV|0|0|0|100|DKK|4795|8005|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb og simvastatín||4795||4795|8005||1 182086|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|3|dropaí||S01XA20|01.09.2014||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|30|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||5507||2 182177|J02AC0106|Fungyn|hylki|150|mg|4|stk|1|þpakki|hart|J02AC01|01.06.2017||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|2031|2189|lyfalmen|V0556|1763|2|4|0|3,0000|Alvogen|Alvogen|Flúkónazól||570||570|2189||2 182307|L04AD0201|Advagraf|forðahlk|0,5|mg|50|stk|1|þpakki||L04AD02|01.11.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|9435|14391|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||9435||9435|14391||1 182502|C01CA0302|Noradrenalin Abcur|irþ|1|mg/ml|5|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|12053|17995|lyfsjukr|||2|50|0|8,3300|Icepharma hf|Abcur AB|Noradrenalín||12053||12053|17995||2 182569|N06BA0902|Atomoxetin Actavis|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017||R|1|1|0|0|0|0|GPA|0|0|0|100|XEU|13483|6498|lyfalmen|V0817|6171|2|28|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||3700||3700|6498||1 182763|QC01CE9001|Vetmedin vet.|tuggutfl|10|mg|100|stk|1|þpakki|fyrir hunda|QC01CE90|01.04.2017||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|12923|24688|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||12923||12923|24688||1 182831|QN51AA0102|Exagon vet.|stl|400|mg/ml|100|ml|5|hgl||QN51AA01|01.09.2014||R|0|0|1|0|0|0|RPG|1|0|0|100|XEU|16193|30892|vetalmen|||0|500|0||Icepharma hf|Richter Pharma AG|Pentobarbital||||16193|30892||2 182893|M05BA0806|Zoledronic Acid Accord|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.07.2016||R|0|1|0|0|0|1|ARD|0|0|0|100|IKR|9983|4740|lyfsjukr|||2|5|0|1,0000|Artasan ehf|Accord Healthcare Limited|Zoledronsýra||2423||2423|4740||1 183093|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2015||R|0|0|0|0|0|0|PLS|0|0|0|100|SEK|2691|5109|lyfalmen|||1|0,25|0||Icepharma hf|Pfizer ApS|Heilabólguveira óvirk, borin með blóðmaur||2691||2691|5109||1 183133|J01DD5201|Zavicefta|st/irþ|||20|ml|10|hgl|2g/0,5g|J01DD52|01.12.2017||R|0|0|0|0|0|1|PIP|0|0|0|100|DKK|139309|179368|lyfsjukr|||1|200|0|3,3333|Icepharma hf|Pfizer Ireland Pharmaceuticals|Ceftazidime og beta-laktamasa hemill||139309||139309|179368||1 183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|4225|8186|vetalmen|||0|50|0||Vistor hf|Intervet International BV|||4225||4225|8186||1 183455|C10AX0903|Ezetimib Krka|töflur|10|mg|30|stk|1|þpakki||C10AX09|01.05.2018||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|3836|6360|lyfalmen|V0612|6360|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Ezetimíb||3600||3600|6360||2 183516|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|þpakki||N02CC01|01.03.2013||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|1494|2444|lyfalmen|V0234|1478|2|6|0|12,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||755||755|2444||1 183660|C01CA2407|Jext|stl|300|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|1|0|0|G|0|ALK|0|0|1|100|DKK|4536|7648|lyfalmen|||1|1|0|0,6000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||4536|7648||1 183825|QP53AC5501|Seresto|hálsband|6,53|g|1|stk|1|poki|4,50 +2,03 g|QP53AC55|01.06.2016||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|5456|10522|vetalmen|||0|1|0||Icepharma hf|Bayer Animal Health GmbH|Flúmetrín í blöndum||5456||5456|10522||2 183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|931|2686|lyfalmen|||1|100|0|100,0000|Icepharma hf|Aspen Pharma Trading Limited|Flúdrókortisón||931||931|2686||2 184046|L01XE2701|IMBRUVICA|filmhtfl|140|mg|90|stk|1|glas||L01XE27|01.02.2016||R|1|0|0|1|0|1|JCI|0|1|0|100|SEK|616849|773294|lyfsjukr|||1|90|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||||616849|773294||1 184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|0|0|0|0|0|0|LDD|0|0|1|100|XEU|609|2243|lyfalmen|||2|100|0|2,5000|Actavis Group hf|LEK Pharmaceuticals d.d|Amoxicillín og beta-laktamasa hemill ||609||609|2243||1 184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|0|0|0|0|0|0|LDD|0|0|1|100|XEU|1540|2659|lyfalmen|||2|100|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d|Amoxicillín og beta-laktamasa hemill ||911||911|2659||1 184205|L04AC0501|Stelara|irþ|130|mg|26|ml|1|hgl|lausn|L04AC05|01.09.2017||R|0|1|0|0|0|1|JCI|0|1|0|100|SEK|275740|349050|lyfsjukr|||1|26|0|240,7407|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||275740||275740|349050||1 184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|0|0|0|0|G|0|TIL|0|0|0|100|SEK|2528|4884|lyfalmen|V0017|4884|1|700|0|4,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||2528|4884||2 184247|V08CA0901|Gadovist|stl|1|mmol/ml|10|ml|5|áfspr|lausn|V08CA09|01.04.2018||R|0|0|0|0|0|1|BAB|0|0|0|100|DKK|34486|46688|lyfsjukr|||1|50|0||Icepharma hf|Bayer AB|Gadóbútról||||34486|46688||2 184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.03.1998||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|39838|53457|lyfalmen|V0185|11710|1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S|Letrózól||39838||39838|53457||1 184341|J01CR0201|Amoksiklav|filmhtfl|625|mg|16|stk|1|þpakki|500+125 mg|J01CR02|01.01.1996||R|0|0|0|0|0|0|LDD|0|0|1|100|XEU|1262|2913|lyfalmen|||2|16|0|8,0000|Actavis Group hf|LEK Pharmaceuticals d.d|Amoxicillín og beta-laktamasa hemill ||1096||1096|2913||1 184418|QB03AC0001|Uniferon|stl|200|mg/ml|100|ml|5|hgl|lausn|QB03AC|01.07.2017||R|0|0|0|0|0|0|PHM|0|0|0|100|XEU|10035|19209|vetalmen|||0|500|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíð||10035||10035|19209||2 184731|N05AX1205|Aripiprazol Krka|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.04.2017||R|1|1|0|0|0|0|KRK|0|0|0|100|IKR|3362|6032|lyfalmen|V0690|6032|2|28|0|9,3300|LYFIS ehf|Krka Sverige AB|Aripiprazól||3362||3362|6032||2 185025|R01AC0102|Glinor|nefúði|5,2|mg/sk|15|ml|1|glas||R01AC01|01.03.2015||L|0|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|15|0|1,9500|Alvogen|ratiopharm GmbH|Krómóglíkatsýra|||||||2 185248|G03AA0707|Microstad|húðuðtfl|||63|stk|1|þpakki|150/30 mcg|G03AA07|01.05.2017||R|0|0|0|0|0|0|ASR|0|0|0|100|IKR|985|1955|lyfalmen|V0545|1955|1|63|0|84,0000|LYFIS ehf|STADA Arzneimittel AG|Levónorgestrel og ethinylestradíól||400||400|1955||2 186026|B02BD0205|Elocta|sts|3000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|0|1|0|1|SAB|0|0|0|100|DKK|223017|283478|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||223017|283478||3 186259|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.02.2016||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|13963|13283|lyfalmen|V0419|12566|2|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Flúkónazól||8630||8630|13283||1 186615|R03AK0706|DuoResp Spiromax|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2018||R|0|0|0|0|G|0|TAB|0|0|0|100|XEU|12751|15311|lyfalmen|||2|360|0|90,0000|Alvogen|Teva Pharma B.V.|Formóteról og budesonide||10103||10103|15311||2 186713|N02AA0506|Oxikodon Depot Actavis|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|744|2429|lyfalmen|V0597|2428|2|28|0|3,7300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||744||744|2429||1 186790|N06DX0106|Memantine ratiopharm|filmhtfl|20|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|9786|4360|lyfalmen|V0607|3049|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Memantín||2147||2147|4360||2 186867|C10BA0501|Atozet|filmhtfl|20|mg|30|stk|1|þpakki|10 mg + 10 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|4882|8125|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||4882||4882|8125||1 187154|N06AX1611|Duofaxin|forðatfl|225|mg|98|stk|1|þpakki||N06AX16|01.07.2015|30.06.2018|R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|3526|5928|lyfalmen|||2|98|0|220,5000|Vistor hf|MediLink A/S|Venlafaxín||3286||3286|5928||1 187191|A10BX0204|Repaglinide Krka|töflur|0,5|mg|120|stk|1|þpakki||A10BX02|01.11.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2459|4789|lyfalmen|V0462|4789|2|120|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2459||2459|4789||2 187399|QP54AA0501|Stronghold|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|4578|7891|vetorma|||0|6|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||4578||4578|7891||2 187595|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MEA|0|0|1|100|DKK|3265|5899|lyfalmen|||1|30|0||Icepharma hf|Meda AB|Pímekrólímus||3265||3265|5899||2 188338|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|1|dropaí||S01XA20|01.09.2014||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||2772||2 188364|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.08.2012||R|0|0|0|0|0|1|PHH|0|0|0|100|DKK|60477|79562|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Pfizer Limited|Tigecýklín||60477||60477|79562||1 188405|N02CC0406|Rizatriptan Alvogen|munndr.t|10|mg|6|stk|1|þpakki||N02CC04|01.09.2013||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|1234|3103|lyfalmen|V0621|1806|2|6|0|6,0000|Alvogen|Alvogen|Rizatriptan||1234||1234|3103||2 188479|N04BD0201|Azilect|töflur|1|mg|28|stk|1|þpakki||N04BD02|01.06.2016||R|0|0|0|0|G|0|TEE|0|0|0|100|NOK|13633|20169|lyfalmen|V0726|6795|1|28|0|28,0000|Actavis Pharmaceuticals Iceland ehf.|Teva. B.V.|Rasagilín||13633||13633|20169||1 188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|0|1|0|0|G|0|DEA|0|0|0|100|XEU|2297|4567|lyfalmen|||1|250|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||2297||2297|4567||1 188827|S01ED5117|DUOKOPT|augndr|25|mg/ml|5|ml|3|glas|5+20 mg/ml, án rotvarnar|S01ED51|01.06.2016||R|0|0|0|0|G|0|LTH|0|0|0|100|SEK|4342|7381|lyfalmen|||1|15|0|75,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||4342||4342|7381||1 188829|R06AX2707|Dasselta|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.09.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|1400|2644|lyfalmen|V0458|2644|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Deslóratadín||900||900|2644||2 188988|H02AB0205|Dexametason Abcur|töflur|4|mg|20|stk|1|þpakki|stakskammtaþynna|H02AB02|01.02.2016||R|1|0|0|0|G|0|ABC|0|0|1|100|IKR|2931|4020|lyfalmen|V0422|3745|2|20|0|53,3300|Icepharma hf|Abcur AB|Dexametasón||1900||1900|4020||2 189052|M05BA0604|Iasibon|irþ|1|mg/ml|2|ml|1|lykja||M05BA06|01.10.2012||R|0|0|0|0|0|1|PSA|0|0|0|100|DKK|7564|11232|lyfsjukr|||2|2|0|0,3400|Alvogen|Pharmathen S.A.|Íbandrónsýra||7140||7140|11232||2 189148|J05AG0501|EDURANT|filmhtfl|25|mg|30|stk|1|glas||J05AG05|01.04.2013||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|32398|44047|lyfsjukr|||1|30|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Rilpívírin||32398||32398|44047||1 189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|5610|9127|lyfsjukr|||1|10|0||Vistor hf|Novartis Healthcare A/S|Deferoxamín||5610||5610|9127||1 189235|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|áfspr||H01CC01|01.12.2015||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|4166|7139|lyfalmen|||1|0,5|0|1,0000|Vistor hf|Merck Sharp & Dohme Limited|Ganirelix||4166||4166|7139||1 189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|2216|4455|lyfalmen|||1|5|0|10,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2216||2216|4455||1 189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|805|2513|lyfalmen|V0413|2513|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||805||805|2513||1 189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|389|1940|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||389||389|1940||1 189627|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.11.2011||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|361|1902|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Metótrexat||361||361|1902||1 190042|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|þpakki||G03CA04|01.11.2015||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|1338|3247|lyfalmen|||1|90|0|45,0000|Icepharma hf|Aspen Pharma Trading Limited|Estríól||1338||1338|3247||2 190320|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.05.2014|31.07.2018|R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|212|1697|lyfalmen|||2|10|0|2,5000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||212||212|1697||1 190425|C08CA0502|Adalat Oros|forðatfl|60|mg|98|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BAB|0|0|0|100|DKK|6051|9734|lyfalmen|||1|98|0|196,0000|Icepharma hf|Bayer AB|Nífedipín||||6051|9734||2 190889|G03XB0201|Esmya|töflur|5|mg|28|stk|1|þpakki||G03XB02|01.05.2016||R|0|1|0|1|G|0|CLP|0|0|0|100|XEU|18573|26969|lyfalmen|||1|28|0|28,0000|Vistor hf|Gedeon Ricther Plc.|Ulipristal||18573||18573|26969||1 191045|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|100|0|10,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||3496||1 191064|B05XC03|Vitalipid Infant|irþ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3026|5570|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||3026||3026|5570||1 191079|C10AA0702|Rosuvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.12.2012||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|5488|5801|lyfalmen|V0117|5154|2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rósuvastatín||3194||3194|5801||1 191247|B05XC02|Vitalipid Adult|irþ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2851|5329|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||2851||2851|5329||1 191251|C09DA0108|Losartan/Hydrochlorothiazide Medical Val|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2017||R|1|0|0|0|G|0|VAL|0|0|0|100|XEU|1944|2494|lyfalmen|V0088|2232|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Lósartan og þvagræsilyf||791||791|2494||2 191254|B05XC01|Soluvit|irs|||10|ml|10|hgl||B05XC|01.10.1985||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2975|5500|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||2975||2975|5500||1 191403|R01AA0503|Nezeril|nefúði|0,25|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|7,5|0|4,6875|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1 191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|408|1966|lyfalmen|V0936|1882|1|4|0||Icepharma hf|Pfizer ApS|Klóramfeníkól||408||408|1966||1 192030|QD06AA0202|Cyclospray vet.|húðúði|78,6|mg/g|200|ml|1|úðaílá||QD06AA02|01.12.2016||R|0|0|0|0|0|0|ERO|0|0|0|100|XEU|897|1763|vetalmen|||0|200|0||Vistor hf|Eurovet Animal Health B.V.|Chlortetracycline||897||897|1763||1 192296|H05BX0103|Cinacalcet Sandoz|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.05.2016||R|1|0|0|0|0|0|SHS|0|0|0|100|DKK|33165|20807|lyfalmen|V0721|11071|2|28|0|28,0000|Artasan ehf|Sandoz A/S|Cinacalcet||14096||14096|20807||1 192400|J05AB1106|Valablis|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.05.2017||L|1|0|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||2|10|0|1,6667|Alvogen|Alvogen|Valacíklóvír|||||||2 192456|N06AX1104|Miron Smelt|munndr.t|15|mg|96|stk|1|þpakki||N06AX11|01.12.2011||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|3002|5537|lyfalmen|||2|96|0|48,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||3002||3002|5537||1 192514|M01AH0106|Celecoxib Actavis|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|2418|4298|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Celekoxíb||2102||2102|4298|31.8.2018|1 192558|R06AE0501|Postafen|töflur|25|mg|100|stk|1|þpakki||R06AE05|01.07.2016||R|1|0|0|0|G|0|GOP|0|0|1|100|SEK|471|2053|lyfalmen|V0904|2053|1|100|0|50,0000|Sofus Regulatory Affairs AB|Gen. Orph|Meklózín||471||471|2053||1 192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|||100|stk|1|glas||C03AB01|01.12.1972||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|1815|3903|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||1815||1815|3903||1 192699|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5328|8738|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||5328||5328|8738||2 192867|S01BA0103|Ozurdex|vefjalyf|700|mcg|1|stk|1|pakki|til ísetningar, vefjalyf|S01BA01|01.10.2012||R|0|1|0|0|0|1|IRE|0|1|0|100|XEU|138206|177997|lyfsjukr|||2|1|0||Actavis ehf|Allergan Pharmaceuticals Ireland|Dexametasón||138206||138206|177997||1 193122|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|12|stk|1|þpakki||N02CC01|01.07.2014||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|2134|2444|lyfalmen|V0233|1946|2|12|0|12,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||755||755|2444||1 193242|A07DA0301|Imodium|filmhtfl|2|mg|100|stk|1|þpakki||A07DA03|01.02.2014||R|1|0|0|0|G|0|MCS|0|0|0|100|SEK|692|2357|lyfalmen|||1|100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíð||692||692|2357||1 193323|C09CA0107|Losartan Medical Valley|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.05.2018||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|1800|2484|lyfalmen|V0069|2456|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Lósartan||784||784|2484||2 193411|H05BX0104|Cinacalcet Mylan|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.11.2016||R|1|0|0|0|0|0|ASD|0|0|0|100|IKR|21696|11315|lyfalmen|V0721|11071|2|28|0|28,0000|Icepharma hf|Mylan S.A.S.|Cinacalcet||7200||7200|11315||2 193432|N03AX2201|Fycompa|filmhtfl|10|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|16623|24285|lyfalmen|||1|28|0|35,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||16623||16623|24285||1 193821|A12AA0601|Calcium-Sandoz|freyðit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|0|0|0|0|0|0|SHS|0|0|0|100|IKR|||lyfalmen|||0|20|0|7,5500|Artasan ehf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2667||1 193999|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|250|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|31775|51221|veteldis|||0|250|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||31775||31775|51221||1 194356|J02AC0102|Candizol|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|2062|2200|lyfalmen|V0556|1763|2|4|0|3,0000|Actavis Group hf|Actavis Group PTC ehf|Flúkónazól||578||578|2200||1 194404|QM01AC0606|Meloxidolor|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.07.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|4289|8308|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Meloxícam||4289||4289|8308||2 194672|A02BC0508|Esomeprazol Actavis|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.02.2015||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|5112|5592|lyfalmen|V0012|5592|2|100|0|133,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||3042||3042|5592||1 195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|G|0|MYL|0|0|0|100|SEK|1231|3099|lyfalmen|||2|250|0|83,3300|Icepharma hf|Mylan AB|Atenólól||1231||1231|3099||2 195104|R01AA0707|Otrivin Junior ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas||R01AA07|01.12.2016||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 195455|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|||100|ml|50|pokar|leysir f.stungulyf|V07AB|01.07.2013||L|0|0|0|0|0|0|BAM|0|0|0|100|IKR|||lyfalmen|||0|5000|0||Icepharma hf|Baxter Medical AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||13227||2 195518|N05AH0206|Clozapin Medical|töflur|100|mg|500|stk|1|glas||N05AH02|01.01.2018||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|23000|28366|lyfalmen|||2|500|0|166,6666|Medical ehf|Medical ehf|Klózapín||20000||20000|28366||2 195583|H01AC0104|Saizen|sts|8|mg/ml|2,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|MEC|0|1|0|100|SEK|43145|57640|lyfsjukr|||1|2,5|0|30,0000|Icepharma hf|Merck AB|Sómatrópín||43145||43145|57640||2 195587|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.06.2011||R|0|1|0|1|0|1|JAN|0|1|0|100|DKK|110141|143092|lyfsjukr|||1|1|0|30,1200|Vistor hf|Janssen Biologics B.V.|Golimumab||110141||110141|143092||1 195618|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|775|2472|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||775||775|2472||1 195669|D01AC2002|Pevisone|krem|||15|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|489|2078|lyfalmen|||1|15|0||Vistor hf|Janssen-Cilag AB|Blöndur||489||489|2078||1 195999|M05BA0606|Ibandronic acid WH|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2018||R|1|1|0|0|G|0|WEH|0|0|0|100|IKR|3842|3869|lyfalmen|V0205|3869|2|3|0|90,0000|Williams & Halls efh|Williams & Halls ehf|Íbandrónsýra||1790||1790|3869||2 196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|G|0|MYL|0|0|0|100|SEK|1573|3570|lyfalmen|||2|250|0|166,6700|Icepharma hf|Mylan AB|Atenólól||1573||1573|3570||2 196106|C10AA0107|Simvastatin LYFIS|filmhtfl|40|mg|100|stk|1|glas||C10AA01|01.12.2016||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|2047|2506|lyfalmen|V0110|2456|2|100|0|133,3333|LYFIS ehf|LYFIS ehf|Simvastatín||800||800|2506||2 196444|M04AA0105|Allonol|töflur|300|mg|100|stk|1|þpakki||M04AA01|01.06.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|1681|3719|lyfalmen|||2|100|0|75,0000|Alvogen|ratiopharm GmbH|Allópúrinol||1681||1681|3719||2 196551|N02BE0114|Pinex|mixtúra|24|mg/ml|100|ml|1|fl||N02BE01|01.07.2012||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyfalmen|||0|100|0|0,8000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||2048||1 196851|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.05.2012||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|5586|9093|lyfalmen|||1|100|0|0,8333|Icepharma hf|Aspen Pharma Trading Limited|Labetalól||5586||5586|9093||2 196889|D07AB0202|Locoid Crelo|húðfl|0,1|%|30|g|1|glas|á húð|D07AB02|01.03.2018||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|484|2071|lyfalmen|V0950|2071|1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||484||484|2071||1 196913|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|17259|25160|lyfsjukr|||1|2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||||17259|25160||1 197160|M04AA0105|Allonol|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.05.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|564|1887|lyfalmen|V0119|1885|2|100|0|25,0000|Alvogen|ratiopharm GmbH|Allópúrinol||350||350|1887||2 197320|L04AB0204|Inflectra|irþ|100|mg|1|hgl|1|pakki||L04AB02|01.01.2015||R|0|1|0|0|0|1|VOG|0|1|0|100|XEU|49675|65899|lyfsjukr|||2|1|0|26,6700|Alvogen HS|Hospira UK Ltd.|Infliximab||49675||49675|65899||2 197554|N07BA0147|Nicorette QuickMist|munnhúði|1|mg/sk|150|skammtar|1|fl|1 x 150 úðaskammtar|N07BA01|01.01.2013||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|150|0|0,4400|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr|án rotvarnarefnis|N01BB02|01.10.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1312|3211|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Lídókaín||1312||1312|3211||2 197927|L01XE3101|Ofev|hylki|100|mg|60|stk|1|þpakki||L01XE31|01.07.2016||R|0|0|0|1|0|0|BOE|0|0|0|100|DKK|204864|260900|lyfalmen|||1|60|0||Vistor hf|Boehringer Ingelheim International GmbH|Nintedanib||204864||204864|260900||1 198334|M02AA1502|Voltaren|hlaup|11,6|mg/g|150|g|1|túpa||M02AA15|01.02.2015||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|150|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 198361|J01FA0904|Clarithromycin Krka|filmhtfl|500|mg|14|stk|1|þpakki||J01FA09|01.09.2018||R|1|0|0|0|0|0|KNM|0|0|1|100|IKR|2990|4433|lyfalmen|V0116|4433|2|14|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Klaritrómýcín||2200||2200|4433||2 198582|C09CA0106|Losatrix|filmhtfl|50|mg|100|stk|1|þpakki||C09CA01|01.01.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|1883|2506|lyfalmen|V0069|2506|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Lósartan||800||800|2506||2 198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|5588|9096|lyfsjukr|||1|200|0||Icepharma hf|Pfizer ApS|Flúóróúracíl||5588||5588|9096||1 198665|H01BA0208|NOCDURNA|frþ.tfl|50|mcg|30|stk|1|þpakki||H01BA02|01.04.2017||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|2923|5428|lyfalmen|||1|30|0|3,7500|Vistor hf|Ferring Lægemidler A/S|Desmópressín||2923||2923|5428||1 199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|28193|38729|lyfalmen|||1|100|0||Icepharma hf|Pfizer ApS|Estramústín||28193||28193|38729||1 199454|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|þpakki||B01AC22|01.11.2016||R|0|1|0|0|G|0|DSA|0|0|0|100|XEU|6549|10419|lyfalmen|||1|28|0|14,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Prasugrel||||6549|10419||2 199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|þpakki||N05CD05|01.11.1981||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|493|2083|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tríazólam||493||493|2083||1 199692|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|73331|95819|lyfsjukr|||1|0,6|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||||73331|95819||1 199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|3636|6410|lyfalmen|V0126|6410|1|8|0|8,0000|Icepharma hf|Pfizer ApS|Kabególín||3636||3636|6410||1 199940|L01XC1101|Yervoy|stþ|5|mg/ml|40|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|0|0|1|BMS|0|1|0|100|DKK|2010375|2506451|lyfsjukr|||1|40|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||2010375||2010375|2506451||1 370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|481|2067|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Roche|Fýtómenadíón||481||481|2067||2 370173|QH01CA9301|Suprelorin|vefjalyf|9,4|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|30586|58198|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||30586||30586|58198||1 370395|J01CA0413|Amoxin|filmhtfl|375|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RTH|0|0|1|100|IKR|1222|3072|lyfalmen|||2|20|0|7,5000|Alvogen|ratiopharm GmbH|Amoxicillín||1211||1211|3072||2 370901|L01XE0302|Varlota|filmhtfl|100|mg|30|stk|1|þpakki||L01XE03|01.07.2017||R|1|1|0|1|0|1|ALO|0|1|0|100|XEU|200032|254891|lyfsjukr|||2|30|0||Alvogen|Alvogen Malta Operations(ROW)Ltd.|Erlótiníb||200032||200032|254891||2 371058|A06AD6501|Moxalole|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.06.2016||L|0|0|0|0|0|0|MEA|0|0|0|100|SEK|||lyfalmen|V0592|5246|0|50|0|25,0000|Icepharma hf|Meda AB|Makrógól 3350|||||5246||2 371583|A06AG1001|Klyx|innhl|||240|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|240|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||||1 371609|A06AG1001|Klyx|innhl|||120|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|120|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||||1 371617|A06AG1001|Klyx|innhl|||120|ml|10|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|DKK|||lyfalmen|||0|1200|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||8408||1 371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|þpakki||A02BA02|01.10.1995||L|1|0|0|0|0|0|TCA|0|0|0|100|IKR|||lyflausa|||0|10|0|5,0000|Actavis Group hf|Actavis hf|Ranitidín|||||||1 371826|L01XE3601|Alecensa|hylki|150|mg|224|stk|1|þpakki|4 x 56|L01XE36|01.06.2017||R|0|0|0|1|0|1|RRG|0|1|0|100|DKK|664620|832708|lyfsjukr|||1|224|0||Icepharma hf|Roche Registration GmbH|Alectinib hydrochloride||664620||664620|832708||2 372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|2905|5403|lyfalmen|||1|90|0|11,2500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||2905||2905|5403||1 372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|0|0|0|0|G|0|ROC|0|0|0|100|DKK|2713|5139|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2713||2713|5139||2 372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|42|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 372180|L01AA0903|Bendamustine medac|st/irþ|2,5|mg/ml|25|mg|1|hgl|lausn|L01AA09|01.03.2018||R|0|0|0|0|0|1|WIL|0|1|0|100|XEU|8750|13448|lyfsjukr|||2|25|0||Williams & Halls efh|medac Gesellschaft|Bendamústín||8750||8750|13448||2 372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|18|0|3,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 372571|G03CA0401|Ovestin|sk-stíll|0,5|mg|15|stk|1|þpakki||G03CA04|01.08.2015||L|0|0|0|0|G|0|AEP|0|0|0|100|DKK|||lyfalmen|||0|15|0|37,5000|Icepharma hf|Aspen Pharma Trading Limited|Estríól|||||2531||2 373184|P01BB5103|Malastad|filmhtfl|350|mg|12|stk|1|þpakki|250 + 100 mg|P01BB51|01.01.2018||R|1|0|0|0|0|0|ASR|0|0|0|100|IKR|3200|5534|lyfalmen|V0934|5534|2|12|0|3,0000|LYFIS ehf|STADA Arzneimittel AG|Prógúaníl í blöndum||3000||3000|5534||2 373205|V04CX0005|Hexvix|duft|85|mg|1|hgl|1|pakki|og leysir|V04CX|01.05.2018||R|0|0|0|0|0|1|CUR|0|0|0|100|XEU|64793|85020|lyfsjukr|||0|1|0||PhotoCure ASA|PhotoCure ASA|Önnur sjúkdómsgreiningarefni||||64793|85020||3 373234|C09AA0211|Enalapril Krka|töflur|10|mg|250|stk|1|glas||C09AA02|01.02.2016||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2770|5218|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2770||2770|5218||2 373239|R03AK0706|DuoResp Spiromax|innönddu|329|mcg/sk|60|skammtar|1|innö.t|320+9 mcg/sk|R03AK07|01.05.2018||R|0|0|0|0|G|0|TAB|0|0|0|100|XEU|4264|6045|lyfalmen|||2|60|0|30,0000|Alvogen|Teva Pharma B.V.|Formóteról og budesonide||3371||3371|6045||2 373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|9902|15034|lyfalmen|||1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||9902||9902|15034||1 373251|L03AB1301|Plegridy|stl|||2|áf-penni|1|pakki|63 og 94 mcg|L03AB13|01.07.2015||R|0|0|0|1|0|1|BNB|0|0|0|100|XEU|75038|97978|lyfsjukr|||1|2|0|17,6400|Icepharma hf|Biogen Netherlands B.V.|Peginterferón beta-1a||75038||75038|97978||2 373252|N05AX1205|Aripiprazol Krka|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.04.2017||R|1|1|0|0|G|0|KRK|0|0|0|100|IKR|3507|5809|lyfalmen|V0204|5809|2|28|0|18,6670|LYFIS ehf|Krka Sverige AB|Aripiprazól||3200||3200|5809||2 373324|R03AK0602|Seretide Diskus|innönddu|150|mcg/sk|60|skammtar|1|pakki|50/100 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|3026|5570|lyfalmen|||1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||3026||3026|5570||1 373340|R03AK0602|Seretide Diskus|innönddu|300|mcg/sk|60|skammtar|1|pakki|50/250 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|3634|6407|lyfalmen|||1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||3634||3634|6407||1 373365|R03AK0602|Seretide Diskus|innönddu|550|mcg/sk|60|skammtar|1|pakki|50/500 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|4648|7802|lyfalmen|||1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||4648||4648|7802||1 373581|G03GA1001|REKOVELLE|stl|36|mcg|1,08|ml|1|pakki|+ 6 inndælingarnálar|G03GA10|01.08.2017||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|33708|45704|lyfalmen|||1|1,08|0||Vistor hf|Ferring Lægemidler A/S|Follitrópín delta||||33708|45704||1 373611|J07AL0103|Pneumovax|stl|25|mcg|0,5|ml|1|áfspr|lausn|J07AL01|01.06.2017||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|3304|5953|lyfalmen|||1|0,5|0||Vistor hf|Merck Sharp & Dohme B.V.|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||3304||3304|5953||1 373853|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.06.2012||R|0|0|0|0|G|0|MED|0|0|0|100|XEU|4936|4379|lyfalmen|V0420|3359|2|30|0|30,0000|Medical ehf|Medical ehf|Bíkalútamíð||2161||2161|4379||2 373857|C07AB0309|Atenolol Actavis|töflur|25|mg|100|stk|1|þpakki||C07AB03|01.10.2012||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|346|1788|lyfalmen|V0541|1788|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Atenólól||278||278|1788||1 374036|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.12.2016||R|0|0|0|0|0|1|EUS|0|0|0|100|XEU|6611|10504|lyfsjukr|||1|1|0|0,1354|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||6611||6611|10504||3 374077|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 374143|L01XE1201|Caprelsa|filmhtfl|100|mg|30|stk|1|þpakki||L01XE12|01.07.2012||R|1|1|0|1|0|1|GEB|0|0|0|100|XEU|283402|349921|lyfsjukr|||1|30|0||Vistor hf|Genzyme Europe B.V.|Vandetaníb||276440||276440|349921||1 374194|L01XE2501|Mekinist|filmhtfl|0,5|mg|30|stk|1|glas||L01XE25|01.01.2016||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|174073|222605|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Trametinib||174073||174073|222605||1 374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|þpakki||A10BA02|01.01.1987||R|1|0|0|0|G|0|MCK|0|0|0|100|SEK|379|1927|lyfalmen|V0500|1873|1|100|0|25,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||379||379|1927||2 374251|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|4555|7674|lyfsjukr|||1|7500|0||Vistor hf|Fresenius Kabi AB|Kolvetni||4555||4555|7674||1 374348|G04CA0201|Omnic|hylki|0,4|mg|30|stk|1|þpakki|með br.losunarhraða|G04CA02|01.08.1998||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|2988|5518|lyfalmen|V0926|3847|1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||2988||2988|5518||1 374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|þpakki||J05AB11|01.01.2003||R|1|0|0|0|G|0|GPH|0|0|1|100|DKK|8440|13022|lyfalmen|||1|60|0|5,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||8440||8440|13022||1 374450|L01XE3301|Ibrance|hylki|100|mg|21|stk|1|þpakki||L01XE33|01.02.2017||R|1|0|0|1|0|1|PHH|0|1|0|100|DKK|435976|548339|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Limited|Palbociclib||435976||435976|548339||1 374504|G01AF0502|Pevaryl Depot|krem/sti|||15|g|1|sett|kr.+1sk-stíll m.forðaverkun|G01AF05|01.01.1997||L|0|0|0|0|0|0|TRI|0|0|0|100|IKR|||lyflausa|||0|15|0|1,5000|Vistor hf|Trimb Healthcare AB|Ekónazól|||||||1 374527|J07CA0602|Pentavac|sts|||0,5|ml|1|hgl|leysir, dreifa|J07CA06|01.04.2015||R|0|0|0|0|0|0|SSS|0|0|0|100|XEU|3547|6287|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||3547||3547|6287||1 374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNP|0|0|1|100|XEU|5453|8910|lyfalmen|||1|6|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||5453||5453|8910||1 374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNP|0|0|1|100|XEU|6436|10263|lyfalmen|||1|8|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||6436||6436|10263||1 374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNP|0|0|1|100|XEU|7537|11779|lyfalmen|||1|10|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||7537||7537|11779||1 374672|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|50|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BFP|0|0|1|100|IKR|8525|13139|lyfalmen|V0383|11714|2|50|0|12,5000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||8525||8525|13139||1 374941|QJ01CA0403|Amoxibactin vet.|töflur|50|mg|100|stk|1|þpakki||QJ01CA04|01.12.2016||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|2720|5331|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||2720||2720|5331||2 375153|C09DA0311|Valsartan/ Hydrochlorothiazide Krka|filmhtfl|92,5|mg|98|stk|1|þpakki|80/12,5 mg|C09DA03|01.08.2018||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|2800|5259|lyfalmen|||2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Valsartan og þvagræsilyf||2800||2800|5259||2 375275|J02AC0304|Voriconazole Accord|filmhtfl|50|mg|30|stk|1|þpakki||J02AC03|01.04.2018||R|1|1|0|0|0|1|ARD|0|0|0|100|XEU|8891|13642|lyfsjukr|||2|30|0|3,7500|Artasan ehf|Accord Healthcare Limited|Voricónazól||||8891|13642||1 375304|N06DX0109|Marbodin|filmhtfl|10|mg|100|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|4000|2781|lyfalmen|V0605|2781|2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||1000||1000|2781||2 376246|B01AC2401|Brilique|filmhtfl|90|mg|168|stk|1|þpakki||B01AC24|01.06.2011||R|1|0|0|0|G|0|AZA|0|0|0|100|SEK|20789|29364|lyfalmen|V0459|29364|1|168|0|84,0000|Vistor hf|AstraZeneca AB|Ticagrelor||20789||20789|29364||1 376387|R03AK1001|Relvar Ellipta|innönddu|206|mcg/sk|30|skammtar|1|pakki|184+22 mcg|R03AK10|01.04.2014||R|0|0|0|0|G|0|RGO|0|0|0|100|DKK|4902|8152|lyfalmen|||1|30|0||Vistor hf|Glaxo Group Limited|Vilanterol og flútícason||4902||4902|8152||1 376509|L04AD0202|Prograf|hylki|1|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|14132|20856|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||14132||14132|20856||1 376510|R06AE0706|Zensitin|filmhtfl|10|mg|10|stk|1|þpakki||R06AE07|01.07.2017||L|1|0|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Williams & Halls efh|Williams & Halls ehf|Cetirizín|||||||2 376533|L04AD0202|Prograf|hylki|5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|72600|94895|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||72600||72600|94895||1 376974|L01XX4301|Erivedge|hylki|150|mg|28|stk|1|glas||L01XX43|01.10.2014||R|1|1|0|1|0|1|RRG|0|0|0|100|DKK|676418|847382|lyfsjukr|||1|28|0||Icepharma hf|Roche Registration GmbH|Vismodegibum||676418||676418|847382||2 377134|QP54AA0105|Noromectin|stl|1|% w/v|250|ml|1|hgl|lausn|QP54AA01|01.03.2014||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|9928|17112|vetorma|||0|250|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||9928||9928|17112||2 377249|C10AX1301|Repatha|stl|140|mg|6|áf-penni|1|pakki||C10AX13|01.10.2016||R|0|0|0|0|0|0|AEB|0|0|0|100|DKK|167698|214676|lyfalmen|||1|6|0|84,0000|Vistor hf|Amgen Europe B.V.|Evolocumab||167698||167698|214676||1 377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|þpakki||J05AB11|01.10.1996||R|1|0|0|0|G|0|GPH|0|0|1|100|DKK|8174|6527|lyfalmen|V0182|3595|1|42|0|7,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||3721||3721|6527||1 377504|G04CB0203|Dutasteride ratiopharm|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.06.2018||R|1|0|0|0|G|0|TVA|0|0|0|100|DKK|1792|3459|lyfalmen|V0909|3447|2|30|0|30,0000|Alvogen|Teva B.V.|Dútasteríð||1492||1492|3459||2 377640|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.10.2017||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|22916|32054|lyfsjukr|||1|1,5|0|15,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||22916||22916|32054||1 378432|L01XX4701|Zydelig|filmhtfl|100|mg|60|stk|1|glas||L01XX47|01.07.2016||R|1|0|0|1|0|1|GSE|0|0|0|100|DKK|443951|558258|lyfsjukr|||1|60|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|Idelalisib||443951||443951|558258||2 378535|D07AC1301|Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1540|3525|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1540||1540|3525||1 378543|N03AX1606|Pregabalin Mylan|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|4999|3625|lyfalmen|V0687|2849|2|56|0|28,0000|Mylan AB|Generics (UK) Ltd.|Pregabalín||1613||1613|3625||2 378686|D11AX1801|Solaraze|hlaup|3|%|100|g|1|túpa||D11AX18|01.08.2012||R|0|0|0|0|0|0|ALM|0|0|0|100|XEU|12761|18969|lyfalmen|||1|100|0||Vistor hf|Almirall S.A.|Önnur húðlyf-Diclofenacum||12761||12761|18969||1 378870|N04BA0210|Sinemet 12,5/50|töflur|62,5|mg|100|stk|1|þpakki|12,5+50 mg|N04BA02|01.02.2018||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|1374|3296|lyfalmen|V0937|3296|1|100|0|8,3300|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||1374||1374|3296||1 379158|R01AD0901|Nasonex|nefúði|50|mcg/sk|140|skammtar|1|úðagl|18 g í pakkn.|R01AD09|01.02.2015||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1083|2896|lyfalmen|V0677|2660|1|140|0|35,0000|Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1083||1083|2896||1 379173|M01AH0504|Etoricoxib Krka|filmhtfl|60|mg|100|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|9400|7184|lyfalmen|V0830|7184|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||4199||4199|7184||2 379419|B02BD0205|Elocta|sts|2000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|0|1|0|1|SAB|0|0|0|100|DKK|148678|191021|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||148678|191021||3 379570|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.03.2012||R|0|1|0|1|0|1|PHH|0|1|0|100|DKK|120100|155478|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Limited|Etanercept||||120100|155478||1 379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|91597|118922|lyfsjukr|||1|2|0|14,2900|Vistor hf|Novartis Healthcare A/S|Oktreótíð||91597||91597|118922||1 379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|102709|133848|lyfsjukr|||1|2|0|28,5700|Vistor hf|Novartis Healthcare A/S|Oktreótíð||102709||102709|133848||1 379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|132642|171077|lyfsjukr|||1|2|0|42,8600|Vistor hf|Novartis Healthcare A/S|Oktreótíð||132642||132642|171077||1 379760|L03AB1001|PegIntron|sts|150|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013|30.06.2018|R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|111530|144819|lyfsjukr|||1|4|0|80,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||111530||111530|144819||1 379796|N04BC0408|Ropinirole Alvogen|forðatfl|2|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|4548|6092|lyfalmen|V0532|6092|2|84|0|28,0000|Alvogen|Alvogen|Rópíníról||3405||3405|6092||2 379875|N05BA0105|Stesolid|eþ-lausn|5|mg/2,5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|GRP|0|0|1|100|DKK|1741|3801|lyfalmen|||2|12,5|0|2,5000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||1741||1741|3801||1 379883|N05BA0105|Stesolid|eþ-lausn|10|mg/2,5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|GRP|0|0|1|100|DKK|2484|4824|lyfalmen|||2|12,5|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||2484||2484|4824||1 379945|N06AB0604|Sertralin Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.09.2017||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|2311|2781|lyfalmen|V0322|2506|2|100|0|100,0000|Vistor hf|Bluefish Pharmaceuticals AB|Sertralín||1000||1000|2781||1 380141|QN03AA0201|Phenoleptil|töflur|25|mg|100|stk|1|þpakki|handa hundum|QN03AA02|01.05.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2057|4043|vetalmen|||1|100|0||Dýraheilsa ehf|Le Vet B.V.|Phenobarbitalum||2057||2057|4043||2 380162|H01BA0201|Minirin|nefúði|0,1|mg/ml|5|ml|3|úðagl||H01BA02|01.09.2013||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|16283|23817|lyfalmen|||1|15|0|60,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||16283||16283|23817||1 380374|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.02.2015||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1266|3147|lyfalmen|||1|30|0||Icepharma hf|Bayer AB|Azelainsýra||1266||1266|3147||2 380466|B01AF0201|Eliquis|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BSM|0|0|0|100|DKK|23021|32187|lyfalmen|V0653|32187|1|168|0|42,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||23021|32187||1 380621|D07AD0101|Dermovat|smyrsli|0,5|mg/g|30|g|1|túpa||D07AD01|01.12.2017||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|468|2049|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||||468|2049||1 380732|C10AA0703|Rosuvastatin Krka|filmhtfl|40|mg|100|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|17988|10076|lyfalmen|V0195|10076|2|100|0|400,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||6300||6300|10076||2 380833|N06DX0106|Memantine ratiopharm|filmhtfl|20|mg|30|stk|1|þpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|4288|4846|lyfalmen|V0902|4846|2|30|0|30,0000|Alvogen|ratiopharm GmbH|Memantín||2500||2500|4846||2 380922|D07AB0201|Locoid|húðlausn|1|mg/ml|30|ml|1|glas||D07AB02|01.09.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|476|2060|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||476||476|2060||1 381120|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 381231|QP54AA0501|Stronghold|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2473|4262|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2473||2473|4262||2 381589|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.06.2015||R|0|0|0|1|G|0|MBV|0|0|0|100|DKK|35025|47370|lyfalmen|||1|1,08|0|12,0000|Vistor hf|Merck Sharp & Dohme B.V.|Follitrópín beta||||35025|47370||1 381794|V03AC0301|Exjade|filmhtfl|360|mg|90|stk|1|þpakki||V03AC03|01.06.2017||R|1|1|0|1|0|0|NEL|0|0|0|100|DKK|258348|327420|lyfalmen|||1|90|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||258348||258348|327420||1 382162|N04BC0406|Ropinirole Portfarma|forðatfl|4|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|6237|8657|lyfalmen|V0533|8657|2|84|0|56,0000|Alvogen|Alvogen|Rópíníról||5269||5269|8657||2 382383|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|kælt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5 382474|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|20|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 382657|B02BD0205|Elocta|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|0|1|0|1|SAB|0|0|0|100|DKK|111509|144793|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||111509|144793||3 382764|R03AK0705|Bufomix Easyhaler|innönddu|164,5|mcg/sk|120|skammtar|1|innö.t|160+4,5 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|3930|6814|lyfalmen|||2|120|0|30,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||3930||3930|6814||1 383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|4574|7701|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Bambúteról||4574||4574|7701||1 383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|þpakki|230+20 mg|QP52AA51|01.06.2000||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1002|1701|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|||987||987|1701||2 383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|60|0||Actavis Group hf|Actavis Group PTC ehf|Ketókónazól|||||||1 383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|120|0||Actavis Group hf|Actavis Group PTC ehf|Ketókónazól|||||||1 383428|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.04.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1113|2937|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||1113||1113|2937||1 383445|J05AG0101|Viramune|forðatfl|400|mg|30|stk|1|þpakki||J05AG01|01.03.2013||R|1|0|0|1|0|1|BII|0|0|0|100|DKK|30879|42126|lyfsjukr|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Nevírapín||30879||30879|42126||1 384064|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|56|stk|1|þpakki|hart|A02BC01|01.06.2015||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|2373|1955|lyfalmen|V0006|1149|2|56|0|56,0000|Alvogen|ratiopharm GmbH|Ómeprazól||400||400|1955||2 384125|A10BK0301|Jardiance|filmhtfl|10|mg|30|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|5630|9154|lyfalmen|||1|30|0|17,1400|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||5630||5630|9154||1 384716|D01AE1504|Terbinafin Actavis|krem|10|mg/g|15|g|1|túpa||D01AE15|01.09.2015||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||0|15|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Terbínafín|||||||1 385238|C10BA0201|Inegy|töflur|50|mg|28|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MBV|0|0|0|100|DKK|5913|9544|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb og simvastatín||5913||5913|9544||1 386133|H01CB0501|Signifor|sts|60|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|0|1|NEL|0|0|0|100|DKK|329839|416334|lyfsjukr|||1|1|0|50,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||329839||329839|416334||1 386959|C03DA0406|Eplerenon Alvogen|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2014||R|1|0|0|0|0|0|POF|0|0|0|100|DKK|11960|9606|lyfalmen|V0111|8211|2|100|0|100,0000|Alvogen|Alvogen|Eplerenón||5958||5958|9606||2 387012|S01EC5401|Simbrinza|augndr|12|mg/ml|5|ml|3|glas|10 + 2 mg/ml|S01EC54|01.01.2015||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|6750|10696|lyfalmen|||1|15|0||Vistor hf|Novartis Europharm Ltd|Brimoníð og brinzolamið||6750||6750|10696||1 387263|L01BA0402|Pemetrexed W&H|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.06.2016||R|0|0|0|0|0|1|WEH|0|1|0|100|XEU|116072|150468|lyfsjukr|||2|1|0||Williams & Halls efh|Williams & Halls ehf|Pemetrexed||116072||116072|150468||2 387579|N05BA1206|Alprazolam Krka|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|0|100|XEU|724|2331|lyfalmen|V0308|2331|2|60|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||673||673|2331||2 387759|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.04.2013|30.06.2018|R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|89917|116797|lyfsjukr|||1|4|0|64,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||89917||89917|116797||1 387854|QM01AE9103|Carprofelican|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|4496|8700|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||4496||4496|8700||2 387884|C01CA0701|Dobutamin Medical|irþ|12,5|mg/ml|20|ml|5|lykjur||C01CA07|01.10.2016||R|0|0|0|0|0|1|DIC|0|0|0|100|IKR|6709|10639|lyfsjukr|||2|100|0|2,5000|LYFIS ehf|Medical ehf|Dobutamin||6709||6709|10639||2 387991|R03DC0304|Montelukast Teva|tuggutfl|5|mg|98|stk|1|þpakki||R03DC03|01.01.2013||R|1|0|0|0|G|0|TSA|0|0|0|100|XEU|5245|8624|lyfalmen|||2|98|0|49,0000|Alvogen|Teva Sweden AB|Montelúkast||5245||5245|8624||2 388068|A07DA0601|Truberzi|filmhtfl|100|mg|56|stk|1|þpakki||A07DA06|01.08.2017||R|1|0|0|1|0|0|AIP|0|0|0|100|XEU|13842|20457|lyfalmen|||2|56|0||Actavis ehf|Allergan Pharmaceuticals Ltd.|Eluksadólín||||13842|20457||1 388198|L01XE0901|Torisel|irþ|30|mg|1|hgl|1|pakki||L01XE09|01.09.2012||R|0|0|0|0|0|1|PHH|0|0|0|100|DKK|117316|152015|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Limited|Temsirolímus||117316||117316|152015||1 388256|N01BB2001|Emla|krem|||5|g|5|túpa|+12 umbúð.|N01BB20|01.01.1987||R|0|0|0|0|0|0|MAR|0|0|0|100|DKK|2233|4478|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma|Blöndur||2233||2233|4478||2 388264|N01BB2001|Emla|krem|||30|g|1|túpa||N01BB20|01.01.1987||R|0|0|0|0|0|0|MAR|0|0|0|100|DKK|2437|4759|lyfalmen|||1|30|0||Icepharma hf|Aspen Pharma|Blöndur||2437||2437|4759||2 388272|N01BB2001|Emla|plástur|||2|stk|1|pakki||N01BB20|01.04.1994||L|0|0|0|0|0|0|MAR|0|0|0|100|IKR|||lyflausa|||0|2|0||Icepharma hf|Aspen Pharma|Blöndur|||||||2 388278|N01AH0601|Remifentanil Actavis|sts/irs|5|mg|5|hgl|1|pakki|þykkni,lausn|N01AH06|01.01.2017||R|0|0|1|0|0|1|GPA|0|0|0|100|XEU|9257|14146|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||9257||9257|14146||1 388280|N01BB2001|Emla|plástur|||20|stk|1|pakki||N01BB20|01.04.1994||R|0|0|0|0|0|0|MAR|0|0|0|100|DKK|4387|7443|lyfalmen|||1|20|0||Icepharma hf|Aspen Pharma|Blöndur||4387||4387|7443||2 388836|H05BX0102|Cinacalcet WH|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|52683|18969|lyfalmen|V0722|18969|2|28|0|42,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||12761||12761|18969||2 388898|S01ED5116|Taptiqom|augndr|||0,3|ml|90|Sk-ílá|15mcg/ml + 5mg/ml|S01ED51|01.07.2015||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|7635|11914|lyfalmen|||1|27|0|90,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||7635||7635|11914||2 389095|A04AA0108|Cinveron|stl|2|mg/ml|4|ml|5|lykjur|lausn|A04AA01|01.07.2018||R|0|0|0|0|0|1|WEH|0|0|0|100|IKR|6370|10173|lyfsjukr|||2|20|0|2,5000|Williams & Halls efh|Williams & Halls ehf|Ondansetrón||6370||6370|10173||2 389106|G03FA0103|Femanor|töflur|||84|stk|1|pakki|þp 2+1 mg |G03FA01|01.08.1998||R|0|0|0|0|G|0|MEA|0|0|0|100|DKK|1997|4154|lyfalmen|V0410|4154|1|84|0|84,0000|Icepharma hf|Meda AB|Noretísterón og östrógen||1997||1997|4154||2 389122|G03FB0503|Femasekvens|töflur|||84|stk|1|pakki|þp samsett pk. |G03FB05|01.08.1998||R|0|0|0|0|G|0|MEA|0|0|0|100|DKK|1408|3343|lyfalmen|||1|84|0|84,0000|Icepharma hf|Meda AB|Noretísterón og östrógen||1408||1408|3343|30.6.2018|2 389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|0|0|0|0|G|0|MEA|0|0|0|100|DKK|626|2267|lyfalmen|V0128|2267|1|84|0|84,0000|Icepharma hf|Meda AB|Estradíól||626||626|2267||2 389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|0|0|0|0|G|0|MEA|0|0|0|100|DKK|433|2001|lyfalmen|||1|84|0|42,0000|Icepharma hf|Meda AB|Estradíól||433||433|2001||2 389330|L01BC5901|Lonsurf|filmhtfl|28,19|mg|60|stk|1|þpakki|20 mg + 8,19 mg|L01BC59|01.09.2016||R|0|0|0|1|0|1|LLS|0|1|0|100|DKK|346790|437417|lyfsjukr|||1|60|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||346790|437417||2 389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|629|2271|lyfalmen|||1|3|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||629||629|2271||1 389404|N06DA0405|Galantamin STADA|forðahlk|24|mg|84|stk|1|þpakki|Hart forðahylki|N06DA04|01.04.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|16000|23427|lyfalmen|||2|84|0|126,0000|LYFIS ehf|STADA Arzneimittel AG|Galantamín||16000||16000|23427||2 389443|N04BC0504|Oprymea (Lyfis)|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|2554|3625|lyfalmen|V0267|2988|3|100|0|10,0000|LYFIS ehf|LYFIS ehf|Pramipexól||1613||1613|3625||2 389453|J01CE0207|Fenoximetylpenicillin EQL Pharma|filmhtfl|800|mg|14|stk|1|þpakki||J01CE02|01.01.2018||R|0|0|0|0|0|0|EQL|0|0|1|100|IKR|450|2024|lyfalmen|||2|14|0|5,6000|LYFIS ehf|EQL Pharma AB|Fenoxýmetýlpenicillín||450||450|2024||2 389637|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg)|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|33369|45275|lyfalmen|||1|1,5|0|12,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||||33369|45275||2 389944|L04AD0201|Advagraf|forðahlk|1|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|13429|19889|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||13429||13429|19889||1 390699|N05CM1801|Dexdor|irþ|100|mcg/ml|2|ml|25|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|0|0|1|ORC|0|0|0|100|DKK|64150|84207|lyfsjukr|||1|50|0|5,0000|Vistor hf|Orion Corporation|Dexmedetómid||64150||64150|84207||1 390878|N06BA0202|Attentin|töflur|20|mg|30|stk|1|þpakki||N06BA02|01.08.2017||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|12127|18097|lyfalmen|||1|30|0|40,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Dexamfetamine ||||12127|18097||2 390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|5075|8390|lyfalmen|V0429|3745|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Celekoxíb||5075||5075|8390||1 390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|2162|4381|lyfalmen|V0037|2231|1|20|0|20,0000|Icepharma hf|Pfizer ApS|Celekoxíb||2162||2162|4381||1 391010|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg)|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|17376|25321|lyfalmen|||1|0,75|0|6,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||||17376|25321||2 391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|8709|13392|lyfalmen|V0196|4708|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Celekoxíb||8709||8709|13392||1 391354|B02BX0501|Revolade|filmhtfl|50|mg|28|stk|1|þpakki||B02BX05|01.08.2016||R|1|1|0|1|0|1|NEL|0|1|0|100|DKK|209050|266107|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Eltrombópag||209050||209050|266107||1 391653|L01XE0102|Imatinib Accord|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.11.2013||R|0|0|0|1|0|1|ARD|0|1|0|100|XEU|210466|96437|lyfsjukr|||2|30|0||Artasan ehf|Accord Healthcare Limited|Imatiníb||73819||73819|96437||1 391954|N07BC0202|Metadon Abcur|töflur|20|mg|20|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|1625|3642|lyfalmen|||1|20|0|20,0000|Icepharma hf|Abcur AB|Metadón||1625||1625|3642||2 392000|G03AA0706|Erlibelle|töflur|||63|stk|1|þpakki||G03AA07|01.08.2014||R|0|0|0|0|0|0|GRP|0|0|0|100|XEU|436|2005|lyfalmen|V0545|1955|2|63|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Levónorgestrel og ethinylestradíól||436||436|2005||1 392024|G04BE0311|Revastad|filmhtfl|20|mg|100|stk|1|þpakki||G04BE03|01.11.2017||R|0|0|0|1|0|1|ASR|0|0|0|100|IKR|45000|59986|lyfsjukr|||2|100|0|40,0000|LYFIS ehf|STADA Arzneimittel AG|Síldenafíl||45000||45000|59986||2 392390|S01XA1802|Ikervis|augndr|1|mg/ml|0,3|ml|30|sk-ílá|fleyti, stakskammtar|S01XA18|01.02.2016||R|0|0|0|1|0|0|SAO|0|0|0|100|XEU|11326|16994|lyfalmen|||1|9|0||Icepharma hf|Santen Oy|Ciclosporin||11326||11326|16994||2 392402|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|3534|5211|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||2765||2765|5211|30.6.2018|1 392438|N07XX0901|Tecfidera|hylki|120|mg|14|stk|1|þpakki||N07XX09|01.12.2014||R|0|0|0|1|0|1|BIB|0|1|0|100|XEU|21868|30729|lyfsjukr|||1|14|0|3,5000|Icepharma hf|Biogen Idec Ltd|Dimethyl fumarate||21868||21868|30729||2 393248|C10AA0107|Simvastatin LYFIS|filmhtfl|20|mg|100|stk|1|glas||C10AA01|01.12.2016||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|2250|2368|lyfalmen|V0109|2123|2|100|0|66,6700|LYFIS ehf|LYFIS ehf|Simvastatín||700||700|2368||2 393642|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||10|ml|20|plastl|fyrir stungulyf|V07AB|01.06.2015||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3381||1 393735|H02AB0908|Plenadren|töflur|20|mg|50|stk|1|glas|með breyttan losunarhraða|H02AB09|01.01.2013||R|1|0|0|0|G|0|BVB|0|0|1|100|DKK|55921|73799|lyfalmen|||1|50|0|33,3300|Lyfjaver ehf|Shire Services BVBA|Hýdrókortisón||55921||55921|73799||3 393939|S01EE0403|Travoprost Portfarma|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.01.2015||R|0|0|0|0|G|0|POF|0|0|0|100|USD|1753|3658|lyfalmen|V0669|3658|2|2,5|0|25,0000|Alvogen|Alvogen|Travóprost||1637||1637|3658||2 394139|D01BA0207|Terbinafin Medical Valley|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.08.2017||R|1|0|0|0|0|0|VAL|0|0|0|100|XEU|1629|3134|lyfalmen|V0123|3134|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Terbínafín||1256||1256|3134||2 394364|J01DB0402|Cefazolina Normon|sts|1|g|100|stk|1|hgl|í vöðva|J01DB04|01.06.2018||R|0|0|0|0|0|1|LNA|0|0|0|100|SEK|43644|58271|lyfsjukr|||2|100|0|33,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Cefazólín||43644||43644|58271||2 395077|V03AC0301|Exjade|filmhtfl|90|mg|90|stk|1|þpakki||V03AC03|01.06.2017||R|1|1|0|1|0|0|NEL|0|0|0|100|DKK|64608|84786|lyfalmen|||1|90|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||64608||64608|84786||1 395175|A10BJ0202|Saxenda|stl|6|mg/ml|3|ml|5|lyfjap|lausn,áfylltur lyfjapenni|A10BJ02|01.09.2017||R|0|0|0|0|0|0|NAS|0|0|0|100|DKK|31348|42719|lyfalmen|||1|15|0|75,0000|Vistor hf|Novo-Nordisk A/S|Liraglutide||31348||31348|42719||1 395522|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|áf.spr|nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|116299|149851|lyfsjukr|||1|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||115576||115576|149851||1 395539|C10BA0501|Atozet|filmhtfl|50|mg|30|stk|1|þpakki|10 mg + 40 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|5003|8291|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||5003||5003|8291||1 395732|C09CA0305|Valsartan ratiopharm|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.02.2015||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|3710|2781|lyfalmen|||2|98|0|196,0000|Alvogen|ratiopharm GmbH|Valsartan||1000||1000|2781|31.8.2018|2 395886|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|0|G|0|LVR|0|0|0|100|NOK|14403|21229|lyfalmen|V0356|20823|3|360|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||14403||14403|21229||3 396120|R03AK0705|Bufomix Easyhaler|innönddu|329|mcg/sk|60|skammtar|1|innö.t|320+9 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|3872|6734|lyfalmen|||2|60|0|30,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||3872||3872|6734||1 396318|R06AX2201|Kestine|filmhtfl|10|mg|100|stk|1|þpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|3168|5765|lyfalmen|||1|100|0|100,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||3168||3168|5765||1 396319|QN01BA0201|Procamidor vet.|stl|20|mg/ml|100|ml|10|hgl||QN01BA02|01.03.2014||R|0|0|0|0|0|0|RPG|1|0|0|100|DKK|16660|31778|vetalmen|||0|1000|0||Icepharma hf|Richter Pharma AG|Procaine Hydrochlorid||16660||16660|31778||2 396841|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|56|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|2300|1955|lyfalmen|V0006|1149|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||400||400|1955||2 396865|QN03AX9001|Pexion|töflur|100|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|4400|8518|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||4400||4400|8518||1 397353|N03AX1603|Pregabalin Krka|hylki|75|mg|100|stk|1|glas||N03AX16|01.04.2017||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|4186|3745|lyfalmen|V0686|3719|2|100|0|25,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1700||1700|3745||2 397458|N03AX1209|Gabapentin Sandoz|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.12.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|1968|2474|lyfalmen|V0250|2031|2|100|0|16,6667|Artasan ehf|Sandoz A/S|Gabapentín||777||777|2474||1 397494|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.12.2011||R|0|0|0|0|0|1|MKA|0|1|0|100|SEK|20093|28484|lyfsjukr|||1|20|0||Icepharma hf|Merck KgaA|Cetúxímab||20093||20093|28484||2 397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|þpakki||L01BC06|01.01.2002|31.07.2018|R|0|0|0|1|0|1|RRG|0|0|0|100|DKK|4277|7292|lyfsjukr|||1|60|0||Icepharma hf|Roche Registration GmbH|Capecitabín||4277||4277|7292||2 397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|þpakki||L01BC06|01.01.2002||R|0|0|0|1|0|1|RRG|0|0|0|100|DKK|24538|34106|lyfsjukr|||1|120|0||Icepharma hf|Roche Registration GmbH|Capecitabín||24538||24538|34106||2 397796|A06AB5801|Picoprep|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.10.2011||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyfalmen|||0|2|0||Vistor hf|Ferring Lægemidler A/S|Natríumpicosúlfat|||||5735||1 398565|N06AA0907|Amitriptylin Abcur|filmhtfl|10|mg|100|stk|1|glas||N06AA09|01.12.2017||R|1|0|0|0|G|0|ABC|0|0|0|100|SEK|586|2053|lyfalmen|V0923|2053|2|100|0|13,3333|Icepharma hf|Abcur AB|Amitriptýlín||471||471|2053||2 398759|N06BA0404|Methylphenidate Sandoz|forðatfl|54|mg|90|stk|1|glas||N06BA04|01.11.2016||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|15904|13860|lyfalmen|||2|90|0|162,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||9049||9049|13860||1 399039|R03DX0901|Nucala|sts|100|mg|1|hgl|1|pakki||R03DX09|01.06.2016||R|0|0|0|1|0|1|GSD|0|1|0|100|DKK|146883|188788|lyfsjukr|||1|1|0|27,7700|Vistor hf|GlaxoSmithKline Trading Services Ltd.|Mepolizumab||146883||146883|188788||1 399309|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.08.2015||R|0|0|0|1|G|0|MBV|0|0|0|100|DKK|24689|34297|lyfalmen|||1|0,72|0|8,0000|Vistor hf|Merck Sharp & Dohme B.V.|Follitrópín beta||||24689|34297||1 399482|B02BD0101|Octaplex|irs|1000|ae|1|hgl|1|hgl|+leysir,lausn|B02BD01|01.02.2018||R|0|0|0|1|0|1|OCT|0|0|0|100|DKK|64575|84745|lyfsjukr|||1|1|0||Vistor hf|Octapharma AB|Storkuþættir lX,ll,Vll,X||64575||64575|84745||1 399510|N02AX0204|Tradolan|filmhtfl|50|mg|100|stk|1|þpakki||N02AX02|01.05.2012||R|1|0|1|0|G|0|GLP|0|0|1|100|DKK|471|2053|lyfalmen|V0225|1958|1|100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||471||471|2053||1 399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|2113|2675|lyfalmen|V0244|2344|1|56|0|9,3333|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||923||923|2675||1 399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|áf.spr|7500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.1993||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|7058|11120|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||7058||7058|11120||1 399825|L01XE3301|Ibrance|hylki|75|mg|21|stk|1|þpakki||L01XE33|01.02.2017||R|1|0|0|1|0|1|PHH|0|1|0|100|DKK|435976|548339|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Limited|Palbociclib||435976||435976|548339||1 399904|M01AH0502|Coxient|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|ALO|0|0|1|100|IKR|2440|2946|lyfalmen|V0824|2789|2|28|0|14,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Etoríkoxíb||1120||1120|2946||2 400044|S03CA0102|Sofradex|aug.eydr|||8|ml|1|glas||S03CA01|01.03.1980||R|0|0|0|0|G|0|SNP|0|0|1|100|XEU|963|2730|lyfalmen|||1|8|0||Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||963||963|2730||1 400134|J05AR2201|Symtuza|filmhtfl|30|mg|30|stk|1|glas|800+150+200+10 mg|J05AR22|01.03.2018||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|94923|123129|lyfsjukr|||1|30|0||Vistor hf|Janssen-Cilag International N.V.|Darunavir, Kobicistat, Emtricitabin, Tenofoviralafenamid||94923||94923|123129||1 400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|þpakki||C10AB04|01.04.1988||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|2114|4315|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||2114||2114|4315||1 400244|B03AC0005|Ferinject|irl|50|mg/ml|20|ml|1|hgl||B03AC|01.08.2016||R|0|1|0|0|G|0|VIF|0|0|1|100|CHF|43194|57702|lyfalmen|||1|20|0|10,0000|Vistor hf|Vifor France SA|Járn, stungulyf||43194||43194|57702||1 400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|175|1646|lyfalmen|||1|25|0|12,5000|Icepharma hf|Pfizer ApS|Oxazepam||175||175|1646||1 400422|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.09.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|455|2031|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||455||455|2031||1 400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|301|1819|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Oxazepam||301||301|1819||1 400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|151|1613|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Oxazepam||151||151|1613||1 400508|N02AE0104|Buprenorphine ratiopharm|forðapl|5|mcg/klst|4|stk|1|skpoki||N02AE01|01.06.2018||R|0|0|1|0|G|0|RTH|0|0|0|100|SEK||2659|lyfalmen|V0943|2644|2|4|0|2,8000|Alvogen|ratiopharm GmbH|Búprenorfín||911||911|2659||2 400573|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|þpakki||C10AX09|01.07.2013||R|1|0|0|0|0|0|MBV|0|0|0|100|DKK|4217|7209|lyfalmen|V0612|5936|1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb||4217||4217|7209||1 400574|N07XX0901|Tecfidera|hylki|240|mg|56|stk|1|þpakki||N07XX09|01.12.2014||R|0|0|0|1|0|1|BIB|0|1|0|100|XEU|147654|189747|lyfsjukr|||1|56|0|28,0000|Icepharma hf|Biogen Idec Ltd|Dimethyl fumarate||147654||147654|189747||2 401084|M01AH0105|Cloxabix|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|1827|2784|lyfalmen|V0037|2231|2|20|0|20,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||1002||1002|2784||2 401403|J01FA1007|Azithromycin STADA|filmhtfl|500|mg|2|stk|1|þpakki||J01FA10|01.06.2017||R|1|0|0|0|0|0|ASR|0|0|1|100|IKR|702|2038|lyfalmen|V0173|2038|2|2|0|3,3300|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||460||460|2038||2 401801|B01AC2401|Brilique|filmhtfl|90|mg|56|stk|1|þpakki||B01AC24|01.06.2011||R|1|0|0|0|G|0|AZA|0|0|0|100|SEK|7182|11290|lyfalmen|V0459|9788|1|56|0|28,0000|Vistor hf|AstraZeneca AB|Ticagrelor||7182||7182|11290||1 401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|645|2293|lyfalmen|||1|100|0|13,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||645||645|2293||1 401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|946|2707|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||946||946|2707||1 402038|N06AB0313|Fluoxetin WH|hylki|20|mg|28|stk|1|þpakki|Hart|N06AB03|01.07.2017||R|0|0|0|0|G|0|WEH|0|0|0|100|IKR|457|1907|lyfalmen|V0038|1907|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Flúoxetín||365||365|1907||2 402203|D07AC1302|Ovixan|húðlausn|0,1|%|100|ml|1|dropaí||D07AC13|01.08.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|1051|2852|lyfalmen|V0952|2852|2|100|0||Vistor hf|Galenica AB|Mómetasón||1051||1051|2852||1 402673|N06BX1301|Raxone|filmhtfl|150|mg|180|stk|1|glas||N06BX13|01.05.2016||R|1|0|0|1|0|1|SPD|0|0|0|100|DKK|712177|891856|lyfsjukr|||1|180|0|30,0000|Vistor hf|Santhera Pharmaceuticals GmbH|Idebenone||712177||712177|891856||1 402743|QJ01RA0102|Streptocillin, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.11.1979||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|1555|3056|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|||1555||1555|3056||1 402873|N06DA0302|Exelon (Lyfjaver)|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|DKK|11014|16565|lyfalmen|V0349|15949|3|30|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||11014||11014|16565||3 402988|J02AC0102|Candizol|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|4052|3515|lyfalmen|V0552|3483|2|30|0|7,5000|Actavis Group hf|Actavis Group PTC ehf|Flúkónazól||1533||1533|3515||1 403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|5119|9882|vetalmen|||0|20|0||Vistor hf|Intervet International BV|||5119||5119|9882||1 403856|L01BA0108|Methotrexate Pfizer|irþ|100|mg/ml|50|ml|1|hgl||L01BA01|01.10.2011||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|28920|39648|lyfsjukr|||1|50|0||Icepharma hf|Pfizer ApS|Metótrexat||||28920|39648||1 403915|A07EB0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|dropaí||A07EB01|01.09.2018||R|0|0|0|0|G|0|SNP|0|0|0|100|XEU|829|2546|lyfalmen|||0|13,5|0||Vistor hf|Sanofi-aventis Norge AS|cromoglicic acid ||||829|2546||1 403966|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|10|áf.spr||B01AX05|01.11.2015||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|14503|21367|lyfalmen|||1|6|0|30,0000|Icepharma hf|Aspen Pharma Trading Limited|Fondaparinux||14503||14503|21367||2 404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||2411||2 404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|51647|68393|lyfsjukr|||1|1|0|0,5000|Vistor hf|Boehringer Ingelheim|Alteplasi||51647||51647|68393||1 404818|C03AA0305|Hydromed|töflur|25|mg|100|stk|1|þpakki||C03AA03|01.06.2013||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|941|2700|lyfalmen|||2|100|0|100,0000|Vistor hf|MediLink A/S|hýdróklórtíazíð||941||941|2700||1 404832|R02AA0306|Strepsils Jordbær Sukkerfri|sogtfl|||36|stk|1|þpakki||R02AA03|01.03.2014||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|535|2141|lyfsjukr|||1|5|0|2,5000|Icepharma hf|Roche|Fýtómenadíón||535||535|2141||2 404997|A10BJ0301|Lyxumia|stl|||3|ml|2|áfpen|10 mcg/sk og 20 mcg/sk|A10BJ03|01.10.2013||R|0|0|0|0|0|0|SGB|0|0|0|100|XEU|8153|12627|lyfalmen|||1|6|0|21,0000|Vistor hf|Sanofi-aventis groupe|Lixisenatide||8153||8153|12627||1 405076|C03EA0114|Diuramin mite|töflur|27,5|mg|100|stk|1|þpakki|2,5+25 mg|C03EA01|01.05.2013||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|1398|3329|lyfalmen|||2|100|0|100,0000|Alvogen|ratiopharm GmbH|Hýdróklórtíazíð og kalíumsparandi lyf||1398||1398|3329||2 405129|QP54AA0501|Stronghold|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|DKK|2475|4266|vetorma|||0|2,25|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2475||2475|4266||2 405168|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.06.2015||L|0|0|0|0|0|0|FKA|0|0|0|100|DKK|||lyfalmen|||0|400|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||2294||1 405220|A02BC0403|Rabeprazol Krka|sþ-tfl|10|mg|98|stk|1|þpakki||A02BC04|01.04.2017||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|2436|2988|lyfalmen|V0467|2988|2|98|0|49,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1150||1150|2988||2 405491|V08CA0901|Gadovist|stl|1|mmol/ml|7,5|ml|5|áfspr|lausn|V08CA09|01.04.2018||R|0|0|0|0|0|1|BAB|0|0|0|100|DKK|25865|35784|lyfsjukr|||1|37,5|0||Icepharma hf|Bayer AB|Gadóbútról||||25865|35784||2 405597|J07BD5203|Priorix|sts|||0,5|ml|10|hgl||J07BD52|01.11.2001||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|14444|21286|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Pharma A/S|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||14444||14444|21286|30.6.2018|1 405677|J01DD0401|Rocephalin|irþ|2|g|1|hgl|1|pakki|lausn|J01DD04|01.03.2013||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|2855|5335|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Roche|Ceftríaxón||2855||2855|5335||2 405823|C10BA0501|Atozet|filmhtfl|90|mg|90|stk|1|þpakki|10 mg + 80 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|14357|21166|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||14357||14357|21166||1 405998|A10BA0202|Metformin Actavis|filmhtfl|1000|mg|60|stk|1|þpakki||A10BA02|01.11.2014||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|384|1933|lyfalmen|V0502|1933|2|60|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||384||384|1933||1 406106|C10AX1401|Praluent|stl|150|mg/ml|1|ml|6|áfpen|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|0|SGB|0|0|0|100|XEU|165321|211720|lyfalmen|||1|6|0|166,6667|Vistor hf|Sanofi-aventis groupe|Alirocumab||165321||165321|211720||1 406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|15512|22756|lyfalmen|||1|100|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||15512||15512|22756||1 406356|L01XX4601|Lynparza|hylki|50|mg|448|stk|1|pakki|4 x 112 hylki|L01XX46|01.07.2016||R|0|0|0|1|0|0|AZA|0|1|0|100|SEK|551645|692199|lyfalmen|||1|448|0||Vistor hf|AstraZeneca AB|Olaparib||551645||551645|692199||1 406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|46783|62241|lyfalmen|||1|100|0|75,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||46783||46783|62241||1 406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|53920|71268|lyfalmen|||1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||53920||53920|71268||1 406678|N04BA0210|Sinemet 12,5/50|töflur|62,5|mg|100|stk|1|glas|12,5+50 mg|N04BA02|01.10.2015||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|1374|3296|lyfalmen|V0937|3296|1|100|0|8,3300|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||1374||1374|3296||1 407043|B03BA0102|Betolvex|filmhtfl|1|mg|100|stk|1|glas||B03BA01|01.10.2016||L|1|0|0|0|G|0|GRP|0|0|1|100|XEU|||lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Cyanocobalamin|||||3882||1 407423|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|10|hgl|1|pakki|+leysir 30 ml x 10 hgl, dreifa|QJ01CE90|01.02.2016||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|14456|27596|vetalmen|||0|10|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|||||14456|27596||2 407933|QP54AA5401|BROADLINE|bl.lausn|||0,9|ml|3|sk-ílá||QP54AA54|01.04.2018||R|0|0|0|0|0|0|MER|0|0|0|100|XEU|2223|3832|vetorma|||0|2,7|0||Vistor hf|Merial|Praziquantelum ,Fipronil, s-Methoprene ,Eprinomectinum||2223||2223|3832||1 407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|131|1585|lyfalmen|||1|25|0|5,0000|Icepharma hf|Pfizer ApS|Oxazepam||131||131|1585||1 407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|270|1777|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Oxazepam||270||270|1777||1 408102|B01AF0301|Lixiana|filmhtfl|60|mg|100|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|0|G|0|OPE|0|0|0|100|DKK|26807|36976|lyfalmen|||1|100|0|100,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||26807||26807|36976||1 408145|B01AF0101|Xarelto|filmhtfl|2,5|mg|100|stk|1|þpakki|stakskammtaþynna|B01AF01|01.04.2015||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|13312|19728|lyfalmen|||1|100|0|12,5000|Icepharma hf|Bayer AG|Rivaoxaban||13312||13312|19728||2 408266|N05BA1206|Alprazolam Krka|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|0|100|XEU|1530|3156|lyfalmen|V0310|3156|2|60|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1272||1272|3156||2 408675|D10AD5301|Epiduo|hlaup|||60|g|1|túpa|0,1% / 2,5%|D10AD53|01.07.2017||R|0|0|0|0|0|0|GAN|0|0|0|100|XEU|3733|6543|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíð||3733||3733|6543||2 408909|N06BA0903|Atomoxetin Medical Valley|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|0|VAL|0|0|0|100|XEU|8351|5218|lyfalmen|V0813|5218|2|28|0|6,3000|Acare ehf|Medical Valley Invest AB|Atomoxetín||2770||2770|5218||2 408927|N03AX1408|Levetiracetam STADA|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.08.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|2688|3607|lyfalmen|V0515|3607|2|100|0|16,6700|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||1600||1600|3607||2 409019|QP54AA0501|Stronghold|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2569|4428|vetorma|||0|1,5|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2569||2569|4428||2 409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|0|0|0|0|0|0|PLS|0|0|1|100|DKK|3012|5551|lyfalmen|||1|35|0|1,7500|Icepharma hf|Pfizer ApS|Flúkónazól||3012||3012|5551||1 409425|R01AD0502|Rhinocort Turbuhaler|nefúðad|100|mcg/sk|200|skammtar|1|stauk||R01AD05|01.01.1992|31.08.2018|R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|2760|5204|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2760||2760|5204||1 409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|7319|11479|lyfalmen|||1|98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||7319||7319|11479||1 409547|C09DX0401|Entresto|filmhtfl|200|mg|168|stk|1|þpakki|97 + 103 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|49846|66115|lyfalmen|V0728|66115|1|168|0|84,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||49846||49846|66115||1 409720|A10BG0302|Pioglitazone Actavis|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.04.2017||R|1|1|0|0|G|0|GRP|0|0|0|100|XEU|13505|16146|lyfalmen|||2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||10710||10710|16146||1 409745|N05AX1302|Xeplion|stl|100|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|46544|61939|lyfalmen|||1|1|0|40,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||46544||46544|61939||1 409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|5933|9571|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||5933||5933|9571||1 409809|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|18|stk|1|þpakki||N02CC01|01.12.2015||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|5650|4433|lyfalmen|V0234|4433|2|18|0|36,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||2200||2200|4433||1 409927|G04BD1201|Betmiga|forðatfl|50|mg|90|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|13524|20019|lyfalmen|V0651|20019|1|90|0|90,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||13524||13524|20019||1 409975|M01AH0105|Cloxabix|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|3039|5588|lyfalmen|V0196|4708|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||3039||3039|5588||2 410077|N02CC0402|Maxalt Smelt|frþ.tfl|5|mg|6|stk|1|þpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|2653|5057|lyfalmen|V0620|4761|1|6|0|3,0000|Vistor hf|M.S.D.|Rizatriptan||2653||2653|5057||1 410382|C03DA0103|Spiron|töflur|100|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|2898|4845|lyfalmen|||2|100|0|133,3300|Vistor hf|Orion Corporation|Spírónólaktón||2499||2499|4845||1 410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|þpakki||P01BA01|01.08.2005||R|1|0|0|0|0|0|REP|0|0|0|100|SEK|1303|3198|lyfalmen|||1|20|0|6,2000|Vistor hf|Recip AB|Klórókín||1303||1303|3198||1 410649|C09CA0305|Valsartan ratiopharm|filmhtfl|40|mg|14|stk|1|þpakki||C09CA03|01.02.2015||R|1|0|0|0|0|0|RTH|0|0|0|100|IKR|672|2330|lyfalmen|||2|14|0|7,0000|Alvogen|ratiopharm GmbH|Valsartan||672||672|2330|31.7.2018|2 411033|M03BX0105|Baklofen Mylan|töflur|10|mg|50|stk|1|þpakki||M03BX01|01.01.1990||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|455|2031|lyfalmen|||2|50|0|10,0000|Icepharma hf|Mylan AB|Baklófen||455||455|2031||2 411034|N06AA0907|Amitriptylin Abcur|filmhtfl|25|mg|100|stk|1|glas||N06AA09|01.12.2017||R|1|0|0|0|G|0|ABC|0|0|0|100|SEK|798|2280|lyfalmen|V0510|2280|2|100|0|33,3333|Icepharma hf|Abcur AB|Amitriptýlín||636||636|2280||2 411076|N05AD0301|Buronil|húðuðtfl|25|mg|100|stk|1|glas||N05AD03|01.12.2014||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|1191|3044|lyfalmen|||1|100|0|8,3333|Vistor hf|MediLink A/S|Melperón||1191||1191|3044||1 411184|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|100|stk|1|glas||N02BE01|01.10.2013||R|1|0|0|0|0|0|RTH|0|0|1|100|XEU|342|1849|lyfalmen|V0230|1848|2|100|0|16,6667|Alvogen|ratiopharm GmbH|Paracetamól||323||323|1849||2 411324|N06AX2107|Duloxetine Mylan|sþ-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|1253|2359|lyfalmen|V0692|2275|2|28|0|14,0000|Mylan AB|Generics (UK) Ltd.|Duloxetín||693||693|2359||2 411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|5074|8389|lyfsjukr|||1|50|0|16,6667|Icepharma hf|Roche|Mídazólam||5074||5074|8389||2 411466|N04BA0303|Levodopa+Carbidopa+Entacapona WH|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|0|100|IKR|8924|12671|lyfalmen|V0829|12671|2|100|0|22,2200|Williams & Halls efh|Williams & Halls ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||8185||8185|12671||2 411616|N06BA0404|Methylphenidate Sandoz|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.11.2013||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|4204|4759|lyfalmen|V0624|4759|2|30|0|36,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||2437||2437|4759||1 411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|1|0|0|1|0|1|VIH|0|0|0|100|DKK|18616|27028|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare UK Ltd|Lamívúdín||18616||18616|27028||1 411859|J02AC0102|Candizol|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.02.2014||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyfalmen|V0554|1823|2|1|0|0,7500|Actavis Group hf|Actavis Group PTC ehf|Flúkónazól|||||2199||1 411918|N02CC0101|Imigran|nefúði|20|mg/sk|6|skammtar|1|pakki||N02CC01|01.07.2000||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|4854|8086|lyfalmen|||1|6|0|6,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||4854||4854|8086||1 412049|L02AE0301|Zoladex|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.01.1990||R|0|0|0|1|G|0|AZA|0|0|0|100|SEK|14661|20736|lyfalmen|V0183|16193|1|1|0|27,9070|Vistor hf|AstraZeneca AB|Góserelín||14045||14045|20736||1 412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|með rotv.|B01AB05|01.02.1999||R|0|0|0|0|0|1|SNP|0|0|0|100|XEU|2415|4729|lyfsjukr|||1|3|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||2415||2415|4729||1 412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|0|0|0|0|0|0|MER|1|0|0|100|XEU|2432|4780|vetalmen|||0|100|0||Vistor hf|Merial|Ketóprófen||2432||2432|4780||1 412468|QM01AC0606|Meloxidolor|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.07.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|3859|7492|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Meloxícam||3859||3859|7492||2 412547|L03AB0701|Avonex|stl|30|mcg/pen|0,5|ml|4|spr|lausn,áfylltur lyfjapenni|L03AB07|01.11.2011||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|80634|105056|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||80634||80634|105056||2 412555|N04BD0201|Azilect|töflur|1|mg|112|stk|1|þpakki||N04BD02|01.06.2016||R|0|0|0|0|G|0|TEE|0|0|0|100|NOK|41161|55131|lyfalmen|V0711|15907|1|112|0|112,0000|Actavis Pharmaceuticals Iceland ehf.|Teva. B.V.|Rasagilín||41161||41161|55131||1 412581|N05AX1302|Xeplion|stl|75|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|39739|53332|lyfalmen|||1|1|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||39739||39739|53332||1 412662|C09DA0311|Valsartan/ Hydrochlorothiazide Krka|filmhtfl|172,5|mg|98|stk|1|þpakki|160/12,5 mg|C09DA03|01.08.2018||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|4100|7048|lyfalmen|||2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Valsartan og þvagræsilyf||4100||4100|7048||2 412825|L02BA0107|Tamoxifen Mylan|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|2288|4554|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Tamoxífen||2288||2288|4554||2 412924|L02BA0107|Tamoxifen Mylan|töflur|20|mg|100|stk|1|glas||L02BA01|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2361|4655|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Tamoxífen||2361||2361|4655||2 413116|N02BE0122|Dolorin|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.12.2017||L|1|0|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Williams & Halls efh|Williams & Halls ehf|Paracetamól|||||||2 413220|V03AB1703|Methylthioninium chloride Proveblue|stl|5|mg/ml|10|ml|5|lykjur||V03AB17|01.05.2015||R|0|0|0|0|0|1|ROP|0|0|0|100|DKK|26340|36385|lyfsjukr|||1|50|0||Williams & Halls efh|Provepharm SAS|Metýltíónín||26340||26340|36385||2 413988|N02BE0107|Paratabs|filmhtfl|500|mg|20|stk|1|þpakki||N02BE01|01.03.2013||L|1|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 414424|N06AA0907|Amitriptylin Abcur|filmhtfl|50|mg|100|stk|1|glas||N06AA09|01.10.2017||R|1|0|0|0|G|0|ABC|0|0|0|100|SEK|1160|3002|lyfalmen|||2|100|0|66,6666|Icepharma hf|Abcur AB|Amitriptýlín||1160||1160|3002||2 414592|L03AX1301|Copaxone|stl|40|mg/spr|12|áf.spr|1|pakki||L03AX13|01.11.2015||R|0|0|0|1|0|1|TEI|0|0|0|100|NOK|101401|132221|lyfsjukr|||1|12|0|24,0000|Actavis Pharmaceuticals Iceland ehf.|Teva Pharmaceuticals Limited|Glatíramer acetat||101401||101401|132221||1 414661|L01DC0302|Mitomycin medac|duft|40|mg|1|hgl|1|pakki|+ leysir fyrir þvagblöðrulausn|L01DC03|01.03.2017||R|0|0|0|0|0|1|WIL|0|0|0|100|XEU|32611|44317|lyfsjukr|||1|1|0||Williams & Halls efh|medac Gesellschaft|Mitomycin||32611||32611|44317||2 414680|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|90|stk|1|þpakki||C03BA11|01.03.1999||R|1|0|0|0|G|0|SEV|0|0|0|100|DKK|999|2780|lyfalmen|||1|90|0|54,0000|Icepharma hf|Servier|Indapamíð||999||999|2780||2 414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|958|2724|lyfalmen|||1|300|0|6,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||958||958|2724||1 415338|N05AA0201|Nozinan|filmhtfl|25|mg|100|stk|1|þpakki||N05AA02|01.11.2012||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|1613|3625|lyfalmen|||1|100|0|8,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||1613||1613|3625||1 415368|C02KX0501|Adempas|filmhtfl|2,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|159018|203881|lyfsjukr|||1|42|0|23,3300|Vistor hf|Bayer AG|Riociguatum||159018||159018|203881||1 415635|N05AX1303|TREVICTA|stl|263|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|104512|136091|lyfalmen|||1|1|0|105,2000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||104512||104512|136091||1 415946|N03AX1405|Matever|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.02.2012||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|6373|6125|lyfalmen|V0253|5534|2|100|0|33,3300|Alvogen|Pharmathen S.A.|Levetíracetam||3429||3429|6125||2 416371|QM01AE9001|Quadrisol|hlaup|100|mg/ml|30|ml|1|spr|f. hesta|QM01AE90|01.04.2015||R|0|0|0|0|0|0|VCL|0|0|0|100|DKK|1485|2919|vetalmen|||0|30|0||Icepharma hf|VETCOOL BV.|Vedaprófen||1485||1485|2919||2 416446|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|7425|8144|lyfalmen|V0088|2232|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||4896||4896|8144||1 416589|N03AX1604|Brieka|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|3950|2328|lyfalmen|V0686|2083|2|56|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||671||671|2328||1 416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.03.2013||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|3394|6076|lyfalmen|||1|300|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Ranitidín||3394||3394|6076||1 416859|A01AA0101|Duraphat|tanndrei|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|0|0|0|0|G|0|GOG|0|0|1|100|XEU|2262|4518|lyfalmen|||1|10|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||2262||2262|4518||2 416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|790|2492|lyfalmen|||1|30|0||Icepharma hf|Bayer AB|Azelainsýra||790||790|2492||2 417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|þpakki||J05AF06|01.07.2005||R|1|1|0|1|0|1|VIH|0|0|0|100|DKK|30470|41609|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare UK Ltd|Abacavír||30470||30470|41609||1 417880|B02BD0901|BeneFIX|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD09|01.07.2012||R|0|0|0|1|0|1|PHH|0|1|0|100|DKK|77721|101372|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Limited|Storkuþáttur IX||77721||77721|101372||1 418043|B01AE0701|Pradaxa|hylki|150|mg|180|stk|1|þpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|25202|34946|lyfalmen|V0460|34946|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||25202|34946||1 418119|N05AX1207|Lemilvo|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.10.2015||R|1|1|0|0|G|0|GPA|0|0|0|100|XEU|4333|3843|lyfalmen|V0682|3787|2|56|0|18,6670|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||1771||1771|3843||1 418592|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|áf.spr||L04AC03|01.06.2012||R|0|1|0|1|0|1|BIO|0|0|0|100|DKK|105321|137097|lyfsjukr|||1|18,76|0|28,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||105321||105321|137097||3 418731|A07EC0201|Mesasal|eþ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|0|0|0|0|G|0|SNP|0|0|0|100|XEU|4745|7936|lyfalmen|V0014|7206|1|60|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||4745||4745|7936||1 419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|2159|4377|lyfalmen|||1|100|0|25,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||2159||2159|4377||1 419294|J01DD0403|Rocephalin IV|sts|1|g|1|stk|1|hgl|+ leysir, lausn|J01DD04|01.09.2018||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|2139|4349|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Roche|Ceftríaxón||||2139|4349||2 419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|7224|11348|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||7224||7224|11348||1 419385|J01FA0901|Klacid|filmhtfl|500|mg|14|stk|1|þpakki||J01FA09|01.03.2017||R|1|0|0|0|0|0|DUT|0|0|1|100|DKK|3473|6064|lyfalmen|||1|14|0|14,0000|Icepharma hf|BGP Products AB|Klaritrómýcín||3385||3385|6064|31.8.2018|1 419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|38926|52304|lyfsjukr|||1|180|0|30,0000|Vistor hf|M.S.D.|Indínavír||38926||38926|52304||1 419828|N06BA0406|Medikinet CR|hylki|5|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|2854|5333|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||2854||2854|5333||2 419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|1|0|0|1|0|0|ORP|0|0|0|100|XEU|31224|42562|lyfalmen|||1|100|0|7,5000|Swedish Orphan International AB|Orphan Europe (S)|Mecaptamín||31224||31224|42562||3 419937|A16AA0401|Cystagon|hylki|50|mg|100|stk|1|glas||A16AA04|01.10.2016||R|1|0|0|1|0|0|ORP|0|0|0|100|XEU|10735|16181|lyfalmen|||1|100|0|2,5000|Swedish Orphan International AB|Orphan Europe (S)|Mecaptamín||10735||10735|16181||3 419945|D07AD0101|Dermovat|húðlausn|0,5|mg/ml|25|ml|1|glas|í hársvörð|D07AD01|01.09.1982||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|530|2134|lyfalmen|||1|25|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||530||530|2134||1 420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|9431|14386|lyfalmen|||1|10|0|40,0000|Icepharma hf|Pfizer ApS|Dalteparín||9431||9431|14386||1 420176|J05AR1801|Genvoya|filmhtfl|||30|stk|1|glas|150mg+150mg+200mg+10mg|J05AR18|01.07.2016||R|0|0|0|1|0|1|GEI|0|0|0|100|DKK|124777|161295|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Sciences Ireland|Elvitegravír, kóbísistat, emtrícítabín og tenófóvír alafenam||124777||124777|161295||2 420209|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|100|stk|1|þpakki|hart|A02BC01|01.08.2015||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|4359|2093|lyfalmen|V0006|2052|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Ómeprazól||500||500|2093||2 420471|B01AB0401|Fragmin|stl|12500|ae/ml|0,2|ml|10|áf.spr|2.500 a.e. anti-Xa/ml/sprautu|B01AB04|01.05.2018||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|2927|5434|lyfalmen|||1|2|0|10,0000|Icepharma hf|Pfizer Aps|Dalteparín||2927||2927|5434||1 420497|B01AB0401|Fragmin|stl|25000|ae/ml|0,2|ml|10|áf.spr|5.000 a.e. anti-Xa/ml/sprautu|B01AB04|01.05.2018||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|4175|7151|lyfalmen|||1|2|0|20,0000|Icepharma hf|Pfizer Aps|Dalteparín||4175||4175|7151||1 420510|J01CA0413|Amoxin|mixtduft|100|mg/ml|60|ml|1|glas||J01CA04|01.01.2016||R|0|0|0|0|0|0|RTH|0|0|1|100|IKR|2242|2644|lyfalmen|V0479|2644|2|60|0|6,0000|Alvogen|ratiopharm GmbH|Amoxicillín||900||900|2644||2 421120|C10AA0704|Rosuvastatin Xiromed|filmhtfl|5|mg|100|stk|1|þpakki||C10AA07|01.04.2018||R|0|0|0|0|0|0|VAL|0|0|0|100|IKR|2280|4543|lyfalmen|V0214|4543|2|100|0|50,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||2280||2280|4543||2 421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.07.1989||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|1009|2794|lyfalmen|V0036|2445|1|30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1009||1009|2794||1 421434|C10AA0509|Atorvastatin Xiromed|filmhtfl|40|mg|98|stk|1|þpakki||C10AA05|01.07.2018||R|1|0|0|0|G|0|MVX|0|0|0|100|IKR|2000|2686|lyfalmen|V0114|2659|2|98|0|196,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||931||931|2686||2 421729|N06BA0407|Metylfenidat Actavis|forðatfl|36|mg|100|stk|1|glas||N06BA04|01.07.2017||R|1|1|1|0|0|0|GPA|0|0|0|100|XEU|12918|11849|lyfalmen|V0959|11849|2|100|0|120,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||7588||7588|11849||1 421816|QN04BC0201|Prascend|töflur|1|mg|160|stk|1|þpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|26467|50384|vetalmen|||0|160|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||26467||26467|50384||1 421938|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.09.2013||R|1|0|0|0|G|0|TVA|0|0|1|100|XEU|1751|2901|lyfalmen|V0458|2644|2|100|0|100,0000|Alvogen|Teva B.V.|Deslóratadín||1087||1087|2901||2 421962|A06AB0202|Toilax|sþ-tfl|5|mg|25|stk|1|glas||A06AB02|01.12.2016||L|1|0|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||0|25|0|12,5000|Vistor hf|Orion Pharma|Bisakódýl|||||||1 422022|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.11.2017||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|1031|2824|lyfalmen|||1|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Metóprólól||1031||1031|2824||1 422115|N02AA0506|Oxikodon Depot Actavis|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|474|2057|lyfalmen|V0596|2057|2|28|0|1,8600|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||474||474|2057||1 422246|C07AB0206|Seloken ZOC|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2279|4542|lyfalmen|V0049|2861|1|98|0|62,0700|Vistor hf|AstraZeneca A/S DK|Metóprólól||2279||2279|4542||1 422337|C07AB0206|Seloken ZOC|forðatfl|190|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|3747|6562|lyfalmen|V0054|3535|1|98|0|124,1300|Vistor hf|AstraZeneca A/S DK|Metóprólól||3747||3747|6562||1 422474|B02BB0101|Riastap|sts/irs|1|g|1|hgl|1|pakki|lausn|B02BB01|01.12.2011||R|0|0|0|0|0|1|CSB|0|0|0|100|SEK|47735|63445|lyfsjukr|||1|1|0|0,2000|Icepharma hf|CSL Behring GmbH|Manna Fíbrínógen||47735||47735|63445||2 422545|B02BD0205|Elocta|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|0|1|0|1|SAB|0|0|0|100|DKK|37170|50083|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||37170|50083||3 422738|G03GA0503|Bemfola|stl|75|ae|0,125|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|2305|4578|lyfalmen|||1|0,125|0|1,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||2305||2305|4578||3 422937|B01AF0101|Xarelto|filmhtfl|2,5|mg|56|stk|1|þpakki||B01AF01|01.04.2015||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|7472|11689|lyfalmen|||1|56|0|7,0000|Icepharma hf|Bayer AG|Rivaoxaban||7472||7472|11689||2 423361|G03AA1201|Yasmin|filmhtfl|||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.01.2014||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|2523|4878|lyfalmen|||1|63|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||||2523|4878||2 423414|R01AA0705|Otrivin Menthol ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.11.2016||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 423737|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|10|fl||J01GB03|01.07.2012||R|0|0|0|0|0|1|LEM|0|0|0|100|XEU|17117|24965|lyfsjukr|||2|1200|0|15,0000|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||17117||17117|24965||2 423859|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.09.2015||R|0|0|0|0|G|0|SAO|0|0|0|100|DKK|4597|7732|lyfalmen|V0373|4233|1|15|0|75,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||4597||4597|7732||2 424477|N06BA1201|Elvanse Adult|hylki|30|mg|30|stk|1|glas|hart|N06BA12|01.06.2018||R|1|1|1|0|0|0|SHI|0|0|0|100|DKK|9149|13998|lyfalmen|||1|30|0|30,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|lisdexamfetamine||9149||9149|13998||3 424811|L01BB0503|Fludarabin Actavis|stl/irþ|25|mg/ml|2|ml|1|hgl|lausn|L01BB05|01.03.2018||R|0|0|0|0|0|1|GPA|0|0|0|100|XEU|15244|22387|lyfsjukr|||2|2|0||Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||15244||15244|22387||1 424973|R03BB0404|Braltus|innönddu|10|mcg|30|stk|3|glas|hart hylki|R03BB04|01.09.2018||R|0|0|0|0|G|0|TVA|0|0|0|100|DKK|11793|17637|lyfalmen|||2|90|0|90,0000|Alvogen|Teva B.V.|Tíótrópíumbrómíð||11793||11793|17637||2 425181|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|1|0|1|0|0|0|MYL|0|0|0|100|SEK|348|1884|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Flúnítrazepam||348||348|1884||2 425282|L01XE0102|Imatinib Accord|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.09.2017||R|0|0|0|1|0|1|ARD|0|1|0|100|XEU|114991|55811|lyfsjukr|||2|60|0||Artasan ehf|Accord Healthcare Limited|Imatiníb||41699||41699|55811||1 425939|C09CA0102|Lopress|töflur|12,5|mg|100|stk|1|glas||C09CA01|01.06.2012||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1290|3180|lyfalmen|V0213|3180|2|100|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Lósartan||1290||1290|3180||1 425943|A07EA0601|Entocort|forðahlk|3|mg|100|stk|1|glas||A07EA06|01.06.2016||R|1|0|0|0|G|0|TTT|0|0|0|100|SEK|11852|17718|lyfalmen|||1|100|0|33,3300|Icepharma hf|Tillotts Pharma GmbH|Búdesóníð||11852||11852|17718||2 426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|479|2064|lyfalmen|||1|20|0|5,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||479||479|2064||2 426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|862|2591|lyfalmen|||1|30|0|7,5000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||862||862|2591|31.7.2018|2 427030|J05AR0602|Padviram|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.03.2018||R|1|1|0|1|0|1|SHS|0|0|0|100|DKK|93085|120804|lyfsjukr|||2|30|0|30,0000|Artasan ehf|Sandoz A/S|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||||93085|120804||1 427075|M01AE0115|Alvofen Express|hylki|400|mg|50|stk|1|þpakki||M01AE01|01.04.2014||L|1|0|0|0|0|0|IPC|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Alvogen|Alvogen IPco S.á.r.l.|Íbúprófen|||||||2 427186|C10BA0201|Inegy|töflur|90|mg|28|stk|1|þpakki|10 mg + 80 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MBV|0|0|0|100|DKK|6648|10555|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb og simvastatín||6648||6648|10555||1 427308|J01AA0212|Doxycyklin EQL Pharma|töflur|100|mg|10|stk|1|þpakki||J01AA02|01.03.2018||R|1|0|0|0|0|0|LYF|0|0|1|100|IKR|817|2529|lyfalmen|||2|10|0|10,0000|LYFIS ehf|LYFIS ehf|Doxýcýklín||817||817|2529|31.7.2018|2 427321|S01EE0402|IZBA|augndr|30|mcg/ml|2,5|ml|3|glös||S01EE04|01.10.2014||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|5620|9140|lyfalmen|||1|7,5|0|75,0000|Vistor hf|Novartis Europharm Ltd|Travóprost||5620||5620|9140||1 427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|0|0|0|0|0|0|SNP|0|0|0|100|IKR|||lyfalmen|||0|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Natríum pícósúlfat|||||3175||1 428018|R06AX2201|Kestine|filmhtfl|10|mg|10|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1 428089|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||2169||1 428828|N06DA0303|Nimvastid (Lyfis)|hylki|3|mg|112|stk|1|þpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|25104|34822|lyfalmen|V0345|34822|3|112|0|37,3300|LYFIS ehf|LYFIS ehf|Rívastigmín||25104||25104|34822||2 429093|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|skammtar|1|glas|með skammtadælu|G03CA03|01.06.2016||R|0|0|0|0|G|0|TAT|0|0|0|100|DKK|950|2713|lyfalmen|V0129|2713|2|64|0||Vistor hf|Takeda Oy|Estradíól||950||950|2713||1 429098|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2649|5051|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||2649||2649|5051||2 429358|R03BB0404|Braltus|innönddu|10|mcg|30|stk|1|glas|hart hylki|R03BB04|01.09.2018||R|0|0|0|0|G|0|TVA|0|0|0|100|DKK|3975|6876|lyfalmen|||2|30|0|30,0000|Alvogen|Teva B.V.|Tíótrópíumbrómíð||3975||3975|6876||2 429503|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|glas||J02AC04|01.07.2014||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|75528|98598|lyfsjukr|||1|105|0|14,0000|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||75528||75528|98598||1 429584|N06BA0902|Atomoxetin Actavis|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017||R|1|1|0|0|0|0|GPA|0|0|0|100|XEU|10062|5456|lyfalmen|V0812|5218|2|28|0|3,5000|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||2943||2943|5456||1 429815|N02AJ0602|Parkodin forte|filmhtfl|530|mg|200|stk|1|tfílát|30+500 mg|N02AJ06|01.02.2018||R|2|0|1|0|0|0|GPA|0|0|1|100|XEU|3124|5705|lyfalmen|||2|200|0|66,6667|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||3124||3124|5705||1 429875|G03GA0503|Bemfola|stl|225|ae|0,375|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|7616|11888|lyfalmen|||1|0,375|0|3,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||7616||7616|11888||3 430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|4467|8645|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||4467||4467|8645||1 430232|L03AB1001|PegIntron|sts|100|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013|30.06.2018|R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|74979|97904|lyfsjukr|||1|4|0|53,3300|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||74979||74979|97904||1 430281|L02BG0303|Astrozol|filmhtfl|1|mg|98|stk|1|þpakki||L02BG03|01.08.2011||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|15509|5285|lyfalmen|V0184|5285|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Anastrózól||2819||2819|5285||2 430458|M01AH0503|Coxerit|filmhtfl|90|mg|98|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|1|100|IKR|8900|7735|lyfalmen|V0831|7580|2|98|0|147,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||4599||4599|7735||2 430507|A07EA0601|Entocort|endaþ.dr|2|mg|7|stk|1|þpakki|samsett pk|A07EA06|01.06.2016||R|0|0|0|0|G|0|TTT|0|0|0|100|SEK|4637|7787|lyfalmen|||1|7|0|7,0000|Icepharma hf|Tillotts Pharma GmbH|Búdesóníð||4637||4637|7787||2 430729|A11DA0101|Tiacur|stl|50|mg/ml|2|ml|5|lykjur||A11DA01|01.09.2015||R|0|0|0|0|0|0|ABC|0|0|0|100|SEK|17154|25016|lyfalmen|||1|10|0|10,0000|Icepharma hf|Abcur AB|Thiamine (vit B1)||||17154|25016||2 430839|M01AE0116|Ibuprofen Bril|filmhtfl|400|mg|50|stk|1|þpakki||M01AE01|01.11.2016||L|1|0|0|0|0|0|BLL|0|0|1|100|IKR|||lyflausa|||2|50|0|16,6600|Williams & Halls efh|Bristol Laboratories Limited|Íbúprófen|||||||2 430862|J01FA1005|Azithromycin Actavis|filmhtfl|500|mg|2|stk|1|þpakki||J01FA10|01.05.2013||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|777|2060|lyfalmen|V0173|2038|2|2|0|3,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Azitrómýcín||476||476|2060||1 431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|927|2681|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||927||927|2681||1 431154|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.11.2013||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|4|0||Vistor hf|McNeil Sweden AB|Levókabastín|||||||1 431193|N02AB0306|Instanyl|nefúði|100|mcg|6|sk-ílát|1|pakki||N02AB03|01.08.2014||R|0|1|1|1|0|0|TPA|0|0|0|100|DKK|7666|11956|lyfalmen|||1|6|0|1,0000|Vistor hf|Takeda Pharma A/S|Fentanýl||7666||7666|11956||1 431759|M01AB5503|Arthrotec Forte|töflur|75,2|mg|20|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|1106|2927|lyfalmen|||1|20|0|15,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||||1106|2927||1 431783|M01AB5503|Arthrotec Forte|töflur|75,2|mg|100|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|2871|5357|lyfalmen|||1|100|0|75,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||2871||2871|5357||1 431930|N06BA0406|Medikinet CR|hylki|60|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|11696|17503|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||11696||11696|17503||2 431978|L04AA3301|Entyvio|irþ|300|mg|1|hgl|1|pakki||L04AA33|01.07.2016||R|0|1|0|0|0|1|TPA|0|1|0|100|DKK|290053|366852|lyfsjukr|||1|1|0|55,5600|Vistor hf|Takeda Pharma A/S|Vedolizumab||290053||290053|366852||1 431985|D07XC0101|Diprosalic|húðlausn|||100|ml|1|glas|0,5 mg/ml+20 mg/ml|D07XC01|01.04.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1622|3637|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||1622||1622|3637||1 432220|QM01AC0603|Rheumocam|stl|20|mg/ml|100|ml|1|hgl|handa nautg, svínum og hestum|QM01AC06|01.06.2018||R|0|0|0|0|0|0|CHP|1|0|0|100|IKR|6850|13166|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||||6850|13166||2 432410|N06AX2105|Duloxetin Krka|sþ-hylki|60|mg|30|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|0|0|KNM|0|0|0|100|IKR|4900|3332|lyfalmen|V0693|3332|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||1400||1400|3332||2 432482|N03AX1211|Gabapentin PCD|hylki|400|mg|120|stk|1|þpakki|hart|N03AX12|01.07.2017||R|1|1|0|0|G|0|PDA|0|0|0|100|IKR|2200|2547|lyfalmen|V0251|2547|2|120|0|26,0000|LYFIS ehf|PharmaCoDane ApS|Gabapentín||830||830|2547||2 432665|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dælur|einnota dælur plast|M09AX01|01.10.2011||R|0|0|0|0|G|0|NDR|0|0|0|100|DKK|29148|39937|lyfalmen|||1|12,5|0|34,7222|Vistor hf|Nordic Drugs AB|Natríumhýalúrónat||||29148|39937||1 432972|QJ01CR0201|Combisyn|töflur|50|mg|100|stk|1|pakki||QJ01CR02|01.02.2012||R|0|0|0|0|0|0|NOB|0|0|0|100|IKR|2490|4265|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og beta-laktamasa hemill||2170||2170|4265||2 433126|N02BE0102|Panodil Brus|freyðit|500|mg|20|stk|1|þpakki||N02BE01|01.05.2014||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyfalmen|||0|20|0|3,3300|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||2083||1 433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|9315|14226|lyfalmen|||1|100|0|20,0000|Vistor hf|Orion Corporation|Entakapón||9315||9315|14226||1 433292|N02AA0106|Contalgin Uno|forðahlk|30|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|1963|4107|lyfalmen|||1|28|0|8,4000|Icepharma hf|Pfizer ApS|Morfín||1963||1963|4107||1 433318|N02AA0106|Contalgin Uno|forðahlk|90|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|4313|7341|lyfalmen|||1|28|0|25,2000|Icepharma hf|Pfizer ApS|Morfín||4313||4313|7341||1 433666|J02AC0401|Noxafil|sþ-tfl|100|mg|96|stk|1|þpakki||J02AC04|01.11.2015||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|364698|459689|lyfsjukr|||1|96|0|32,0000|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||364698||364698|459689||1 434088|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.03.2013||R|0|0|0|0|0|1|BAB|0|0|0|100|DKK|135539|174680|lyfsjukr|||1|150|0||Icepharma hf|Bayer AB|Gadóbútról||135539||135539|174680||2 434169|R03DC0304|Montelukast Teva|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.01.2013||R|1|0|0|0|G|0|TAB|0|0|0|100|XEU|4418|2419|lyfalmen|V0490|2419|2|98|0|98,0000|Alvogen|Teva Pharma B.V.|Montelúkast||737||737|2419||2 434261|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|1000|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|NOK|59942|91736|veteldis|||0|1000|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||56908||56908|91736||1 434353|QM01AE9104|Canicaral vet|töflur|160|mg|100|stk|1|þpakki||QM01AE91|01.09.2016||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|15098|28814|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||15098||15098|28814||2 434366|G03GA1001|REKOVELLE|stl|12|mcg|0,36|ml|1|áfpen|+ 3 inndælingarnálar|G03GA10|01.08.2018||R|0|0|0|1|G|0|FEP|0|0|0|100|DKK|11573|17334|lyfalmen|||1|0,36|0||Vistor hf|Ferring Pharmaceuticals A/S|Follitrópín delta||11573||11573|17334||1 434461|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|þpakki||N03AX15|01.03.2014||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|6281|10050|lyfalmen|||1|56|0|14,0000|Vistor hf|Eisai Ltd|Zonisamíð||6281||6281|10050||1 434576|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|3272|3882|lyfalmen|V0010|3814|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1800||1800|3882||2 434670|D01AC2001|Daktacort|krem|||50|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|MCS|0|0|1|100|SEK|601|2232|lyfalmen|||1|50|0||Vistor hf|McNeil Sweden AB|Blöndur||601||601|2232||1 434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|1|0|0|G|0|MEA|0|0|1|100|DKK|4552|7670|lyfalmen|||1|1|0|0,6000|Icepharma hf|Meda AB|Adrenalín tartrat||4552||4552|7670||2 434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|1|0|0|G|0|MEA|0|0|1|100|DKK|5234|8609|lyfalmen|||1|1|0|0,3000|Icepharma hf|Meda AB|Adrenalín tartrat||5234||5234|8609||2 434852|N06AB0302|Fontex|dreifit.|20|mg|100|stk|1|pakki|þp (10x10 stk)|N06AB03|01.06.1998||R|0|0|0|0|0|0|DAN|0|0|0|100|XEU|8041|12473|lyfalmen|V0315|5200|1|100|0|100,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||8041||8041|12473||2 434967|A16AX1401|Galafold|hylki|123|mg|14|stk|1|þpakki|Hart|A16AX14|01.05.2017||R|0|0|0|1|0|1|AMI|0|0|0|100|DKK|1964395|2449264|lyfsjukr|||1|14|0|28,0000|Vistor hf|Amicus Therapeuticks UK Ltd.|Migalastat||1964395||1964395|2449264||1 435072|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.10.2017||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|11312|16975|lyfsjukr|||1|1,5|0|7,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||11312||11312|16975||1 435151|R06AX2706|Flynise|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.10.2015||L|1|0|0|0|G|0|GRP|0|0|1|100|IKR|||lyfalmen|V0458|2644|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín|||||3754||1 436010|L01AA0901|Levact|irþ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|0|0|1|AST|0|1|0|100|DKK|170360|217987|lyfsjukr|||1|500|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||170360||170360|217987||2 436044|N02AJ0601|Parkodin|filmhtfl|510|mg|10|stk|1|þpakki|10+500 mg|N02AJ06|01.07.2018||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|205|1687|lyfalmen|V0962|1687|2|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||205||205|1687||1 436147|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|20|stk|1|þpakki||M01AE02|01.07.1993||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2 436394|H01BA0202|Octostim|nefúði|0,15|mg/sk|2,5|ml|1|úðagl||H01BA02|01.01.2013||R|0|0|0|1|0|1|FEL|0|0|0|100|DKK|33733|45736|lyfsjukr|||1|2,5|0|150,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||33733||33733|45736||1 436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|874|2608|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||874||874|2608||1 436647|A16AA0402|Procysbi|hylki|25|mg|60|stk|1|glas||A16AA04|01.04.2016||R|0|1|0|1|0|1|CFS|0|0|0|100|XEU|57391|75658|lyfsjukr|||1|60|0|0,7500|Chiesi Pharma AB|Chiesi Farmaceutici S.p.A|Mecaptamín||57391||57391|75658||3 436669|J02AC0106|Fungyn|hylki|150|mg|2|stk|1|þpakki|hart|J02AC01|01.06.2017||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|523|2125|lyfalmen|V0555|2125|2|2|0|1,5000|Alvogen|Alvogen|Flúkónazól||523||523|2125||2 436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|607|2240|lyfalmen|||1|100|0|12,5000|Vistor hf|Janssen-Cilag AB|Halóperídól||607||607|2240||1 437223|V10XX0301|Xofigo|stl|1100|kBq/ml|6|ml|1|hgl||V10XX03|01.06.2015||R|0|0|0|0|0|1|FIN|0|1|0|100|DKK|502299|630826|lyfsjukr|||1|6|0||Icepharma hf|Bayer AG|radium-223 dichloride||502299||502299|630826||2 437427|R06AX2704|Desloratadine ratiopharm|munndr.t|5|mg|10|stk|1|þpakki||R06AX27|01.04.2014||L|0|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||2|10|0|10,0000|Alvogen|ratiopharm GmbH|Deslóratadín|||||||2 437763|A10BD2001|Synjardy|filmhtfl|1005|mg|180|stk|1|þpakki|5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|17140|24996|lyfalmen|V0712|24996|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||17140||17140|24996||1 437767|N03AG0102|Orfiril|sþ-tfl|150|mg|100|stk|1|glas||N03AG01|01.08.2015||R|1|1|0|0|G|0|DEA|0|0|0|100|XEU|922|2674|lyfalmen|||1|100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||922||922|2674||1 437935|L01AA0901|Levact|irþ|2,5|mg/ml|25|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|0|0|1|AST|0|1|0|100|DKK|48978|65018|lyfsjukr|||1|125|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||48978||48978|65018||2 438084|QM05BA0201|Osphos|stl|51|mg/ml|1|hgl|1|pakki|handa hestum|QM05BA02|01.12.2016||R|0|0|0|0|0|0|HRA|1|0|0|100|XEU|18589|35438|vetalmen|||0|1|0||Vistor hf|Dechra Limited|Clodronic acid||18589||18589|35438||1 438353|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1707|3754|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||1707||1707|3754||1 438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|||10|ml|1|dropaí|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|0|0|0|0|G|0|HES|0|0|1|100|DKK|1719|3771|lyfalmen|||1|10|0||Vistor hf|Novartis Healthcare A/S|Hýdrókortisón og sýkingalyf||1719||1719|3771||1 438428|N02AE0101|Bupremyl|forðapl|5|mcg/klst|4|stk|1|skpoki||N02AE01|01.03.2018||R|0|0|1|0|G|0|MYL|0|0|0|100|IKR|1062|2644|lyfalmen|V0943|2644|2|4|0|2,8000|Icepharma hf|Mylan AB|Búprenorfín||900||900|2644||2 438591|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.06.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|1411|3347|lyfalmen|||1|100|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||1411||1411|3347||1 438639|N06DX0107|Zalatine|filmhtfl|10|mg|98|stk|1|þpakki||N06DX01|01.03.2014||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|5211|2740|lyfalmen|V0605|2725|2|98|0|49,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||970||970|2740||2 438759|L01XE1501|Zelboraf|filmhtfl|240|mg|56|stk|1|þpakki||L01XE15|01.08.2012||R|0|0|0|1|0|1|RRG|0|1|0|100|DKK|189130|241332|lyfsjukr|||1|56|0||Icepharma hf|Roche Registration GmbH|Vemurafeníb||189130||189130|241332||2 438806|B03XA0201|Aranesp|stl|130|mcg/spr|0,65|ml|4|áf.spr|nálavörn|B03XA02|01.12.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|128691|166163|lyfsjukr|||1|2,6|0|115,5600|Vistor hf|Amgen|Darbepóetín alfa||128691||128691|166163||1 439089|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.11.2016||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 439489|C07FB0201|Logimax|forðatfl|55|mg|98|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|4179|7157|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og Felodipin||4179||4179|7157||1 439548|L01XE0104|Imatinib Mylan|filmhtfl|100|mg|120|stk|1|þpakki||L01XE01|01.02.2017||R|1|0|0|1|0|1|MYL|0|1|0|100|SEK|129051|56666|lyfsjukr|||2|120|0||Icepharma hf|Mylan AB|Imatiníb||42375||42375|56666||2 439594|C10BA0201|Inegy|töflur|50|mg|98|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MBV|0|0|0|100|DKK|16725|24425|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb og simvastatín||16725||16725|24425||1 439672|N06AX2106|Duloxetin W&H|sþ-hylki|30|mg|500|stk|1|glas||N06AX21|01.01.2016||R|2|0|0|0|G|0|WEH|0|0|0|100|XEU|44694|13133|lyfalmen|||2|500|0|250,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||8521||8521|13133||2 439680|A10BJ0101|Byetta|stl|10|mcg/sk|60|skammtar|1|penni|lausn|A10BJ01|01.10.2015||R|0|0|0|0|0|0|AZA|0|0|0|100|SEK|11464|17184|lyfalmen|||1|60|0|40,0000|Vistor hf|AstraZeneca AB|Exenatide||11464||11464|17184||1 439719|S01EE0402|IZBA|augndr|30|mcg/ml|2,5|ml|1|glas||S01EE04|01.10.2014||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|1887|4002|lyfalmen|||1|2,5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Travóprost||1887||1887|4002||1 439766|N06BA0902|Atomoxetin Actavis|hylki|100|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017||R|1|1|0|0|0|0|GPA|0|0|0|100|XEU|14087|18128|lyfalmen|V0818|18128|2|28|0|35,0000|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||12150||12150|18128||1 440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|0|0|0|0|0|0|GPH|0|0|1|100|DKK|1099|2679|lyfalmen|V0163|2434|1|70|0|5,6000|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill ||926||926|2679||1 440410|N05AX1303|TREVICTA|stl|350|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|135173|174224|lyfalmen|||1|1|0|140,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||135173||135173|174224||1 440652|C09AA0211|Enalapril Krka|töflur|20|mg|250|stk|1|glas||C09AA02|01.02.2016||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|3115|5692|lyfalmen|||2|250|0|500,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||3115||3115|5692||2 440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|GRP|0|0|0|100|DKK|1102|2922|lyfsjukr|||2|10|0|1,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Benzýlpenicillín||1102||1102|2922||1 440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|GRP|0|0|0|100|DKK|1738|3797|lyfsjukr|||2|10|0|3,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Benzýlpenicillín||1738||1738|3797||1 441191|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|80|stk|1|pakki|4 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|80|0|5,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 441279|D01AC2002|Pevisone|krem|||30|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|846|2569|lyfalmen|||1|30|0||Vistor hf|Janssen-Cilag AB|Blöndur||846||846|2569||1 441312|N07BA0151|Nicorette Cooldrops|munnstfl|4|mg|80|stk|1|pakki|4 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|80|0|10,6700|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 441341|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|822|2536|lyfalmen|V0046|2167|2|100|0|33,3333|Vistor hf|Takeda Pharma A/S|Spírónólaktón||822||822|2536||1 441619|J05AR0801|Eviplera|filmhtfl|470|mg|30|stk|1|glas|200+25+245 mg|J05AR08|01.05.2012||R|0|0|0|1|0|1|GEI|0|0|0|100|DKK|94571|122684|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Sciences Ireland|Emtrícítabín, rilpívírin og tenófóvír||94571||94571|122684||2 441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|þpakki||G03DC02|01.12.1972||R|0|0|0|0|G|0|BAB|0|0|0|100|DKK|820|2534|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer AB|Noretísterón||820||820|2534||2 442407|N05AH0312|Zalasta|töflur|15|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|2085|2853|lyfalmen|V0283|2853|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1052||1052|2853||2 442586|N03AX1608|Pregabalina Tecnigen|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|1634|1818|lyfalmen|V0685|1500|2|56|0|4,6667|Williams & Halls efh|Williams & Halls ehf|Pregabalín||300||300|1818||2 442678|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|61913|81378|lyfsjukr|||1|1|0||Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||61913||61913|81378||3 442705|B01AE0701|Pradaxa|hylki|150|mg|60|stk|1|þpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|8929|13695|lyfalmen|V0460|11649|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||8929|13695||1 443122|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.01.2018||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1129|2959|lyfalmen|V0560|2929|1|100|0||Icepharma hf|Aspen Pharma|Lídókaín||1129||1129|2959||2 443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|hgl|1|pakki|dæla|H04AA01|01.01.1989||R|0|0|0|0|G|0|NAS|0|0|1|100|DKK|2624|5017|lyfalmen|||1|1|0|1,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||2624||2624|5017||1 443325|H04AA0103|GlucaGen|sts|1|mg|10|hgl|1|pakki|leysir, lausn|H04AA01|01.07.2016||R|0|0|0|0|G|0|NAS|0|0|1|100|DKK|20827|29412|lyfalmen|||1|10|0|10,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||20827||20827|29412||1 443358|N02AA0101|Contalgin|forðatfl|200|mg|90|stk|1|þpakki||N02AA01|01.04.1993||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|19223|27863|lyfalmen|||1|90|0|180,0000|Icepharma hf|Pfizer ApS|Morfín||19223||19223|27863||1 443586|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.12.2016||R|0|0|0|0|0|1|EUS|0|0|0|100|XEU|19834|28704|lyfsjukr|||1|1|0|0,5417|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||19834||19834|28704||3 443861|N06AB0311|Fluoxetin Mylan|hylki|20|mg|30|stk|1|glas||N06AB03|01.11.2015||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|788|2334|lyfalmen|V0038|2043|2|30|0|30,0000|Icepharma hf|Mylan AB|Flúoxetín||675||675|2334||2 443903|N06AB0311|Fluoxetin Mylan|hylki|20|mg|100|stk|1|glas||N06AB03|01.11.2015||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1461|3043|lyfalmen|V0039|2978|2|100|0|100,0000|Icepharma hf|Mylan AB|Flúoxetín||1190||1190|3043||2 443904|J01FA0902|Clarithromycin ratiopharm|filmhtfl|500|mg|14|stk|1|þpakki||J01FA09|01.06.2014||R|1|0|0|0|0|0|TSA|0|0|1|100|IKR|2475|4812|lyfalmen|V0116|4433|2|14|0|14,0000|Alvogen|Teva Sweden AB|Klaritrómýcín||2475||2475|4812||2 444041|N05AH0501|Sycrest|tungur.t|10|mg|20|stk|1|þpakki||N05AH05|01.10.2011|30.06.2018|R|0|0|0|0|0|0|NVO|0|0|0|100|DKK|6260|10021|lyfalmen|||1|20|0|10,0000|Vistor hf|N.V. Organon|Asenapíne||6260||6260|10021||1 444098|L04AX0306|Metojectpen|stl|15|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2408|4719|lyfalmen|||1|1|0|6,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2408||2408|4719||2 444102|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|60|stk|1|þpakki||A06AB06|01.10.2012||R|1|0|0|0|0|0|FMV|0|0|0|100|GBP|727|2406|lyfalmen|||3|60|0||Icepharma hf|Icepharma hf|Senna||727||727|2406||2 444260|L04AC0801|Ilaris|stl|150|mg/ml|1|ml|1|hgl|lausn|L04AC08|01.04.2018||R|0|1|0|1|0|1|NEP|0|0|0|100|DKK|1244257|1553614|lyfsjukr|||1|1|0||Vistor hf|Novartis Europharm Limited|Canakinumab||1244257||1244257|1553614||1 444285|J01CF0104|Dicloxacillin Bluefish|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.01.2017||R|0|0|0|0|0|0|BFP|0|0|1|100|IKR|1686|3470|lyfalmen|V0337|3470|2|30|0|7,5000|Vistor hf|Bluefish Pharmaceuticals AB|Díkloxacillín||1500||1500|3470||1 444315|N06AB0302|Fontex|dreifit.|20|mg|30|stk|1|pakki|þp (2 x 15 stk)|N06AB03|01.06.1998||R|0|0|0|0|0|0|DAN|0|0|0|100|DKK|2444|4769|lyfalmen|V0061|2978|1|30|0|30,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||2444||2444|4769||2 444362|N01AF0302|Pentocur|sts|1|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|17093|24932|lyfsjukr|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||17093||17093|24932||2 444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|0|0|0|0|G|0|ROC|0|0|0|100|DKK|1685|3724|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1685||1685|3724||2 444574|N07CA0102|Betahistin ratiopharm|töflur|8|mg|100|stk|1|þpakki||N07CA01|01.12.2013||R|1|0|0|0|G|0|RHA|0|0|0|100|IKR|2018|4182|lyfalmen|||2|100|0|33,3300|Alvogen|ratiopharm Oy|Betahistín||2018||2018|4182||2 444765|A05AA0207|Ursochol|hylki|250|mg|100|stk|1|þpakki||A05AA02|01.11.2014||R|1|0|0|0|G|0|IRO|0|0|0|100|XEU|4309|7336|lyfalmen|||2|100|0|33,3300|Artasan ehf|Orifarm Generics A/S|Úrsódeoxýkól sýra||4309||4309|7336||1 444932|B02BD0208|Afstyla|sts|2000|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|0|1|0|1|CSB|0|1|0|100|SEK|131304|169412|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||131304||131304|169412||2 445022|A10BD1101|Jentadueto|filmhtfl|1002,5|mg|180|stk|1|þpakki|2,5mg/1000mg|A10BD11|01.11.2015||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|15393|22592|lyfalmen|V0705|22592|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og linagliptinum||15393||15393|22592||1 445149|R03AK1001|Relvar Ellipta|innönddu|114|mcg/sk|30|skammtar|1|pakki|92+22 mcg|R03AK10|01.04.2014||R|0|0|0|0|G|0|RGO|0|0|0|100|DKK|3933|6818|lyfalmen|||1|30|0||Vistor hf|Glaxo Group Limited|Vilanterol og flútícason||3933||3933|6818||1 445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|0|0|0|0|G|0|LEO|0|0|1|100|DKK|1605|3614|lyfalmen|||1|30|0||Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1605||1605|3614||1 445418|N05AX1210|Aripiprazol Medical Valley|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.10.2016||R|1|1|0|0|G|0|VAL|0|0|0|100|IKR|7019|3869|lyfalmen|V0684|3787|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Aripiprazól||1790||1790|3869||2 445580|H05BX0105|Cinacalcet Accord|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.02.2018||R|1|0|0|0|0|0|ARD|0|0|0|100|XEU|42113|19955|lyfalmen|V0722|18969|2|28|0|42,0000|Artasan ehf|Accord Healthcare Limited|Cinacalcet||13477||13477|19955||1 445705|A10AE0406|Toujeo [SoloStar]|stl|300|ein/ml|1,5|ml|3|pennar|áfylltir lyfjapennar|A10AE04|01.10.2015||R|0|1|0|0|G|0|SDH|0|0|0|100|XEU|5031|8330|lyfalmen|||1|4,5|0|33,7500|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||5031||5031|8330||1 446268|C08CA0502|Adalat Oros|forðatfl|20|mg|98|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BAB|0|0|0|100|DKK|3948|6839|lyfalmen|||1|98|0|65,3333|Icepharma hf|Bayer AB|Nífedipín||||3948|6839|30.6.2018|2 446618|N03AF0301|Inovelon|mixtúra|40|mg/ml|460|ml|1|fl||N03AF03|01.09.2012||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|12956|19238|lyfalmen|||1|460|0|13,1400|Vistor hf|Eisai Ltd|Rúfínamíð||12956||12956|19238||1 447040|N06AX2105|Duloxetin Krka|sþ-hylki|60|mg|100|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|9820|5809|lyfalmen|V0694|5258|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||3200||3200|5809||2 447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|18000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|9423|14375|lyfalmen|||1|3,6|0|36,0000|Icepharma hf|Pfizer ApS|Dalteparín||9423||9423|14375||1 447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|10000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|5405|8844|lyfalmen|||1|2|0|20,0000|Icepharma hf|Pfizer ApS|Dalteparín||5405||5405|8844||1 447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|12500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|6637|10540|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Dalteparín||6637||6637|10540||1 447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|15000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|8204|12697|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||8204||8204|12697||1 447596|C07AG0205|Carveratio|töflur|25|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|0|G|0|RTH|0|0|0|100|IKR|2887|4708|lyfalmen|V0948|3882|2|100|0|66,6700|Alvogen|ratiopharm GmbH|Carvedílól||2400||2400|4708||2 448125|C08CA0501|Adalat|töflur|10|mg|100|stk|1|þpakki||C08CA05|01.03.2013|30.06.2018|R|1|0|0|0|G|0|BAB|0|0|0|100|DKK|1921|4049|lyfalmen|||1|100|0|33,3333|Icepharma hf|Bayer AB|Nífedipín||||1921|4049||2 448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.12.1972||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|1628|3646|lyfalmen|V0202|3152|1|50|0|25,0000|Vistor hf|Novartis Healthcare A/S|Baklófen||1628||1628|3646||1 448821|C10AA0703|Rosuvastatin Krka|filmhtfl|5|mg|100|stk|1|þpakki||C10AA07|01.02.2017||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|6031|4543|lyfalmen|V0214|4543|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||2280||2280|4543||2 448897|C09DX0401|Entresto|filmhtfl|100|mg|168|stk|1|þpakki|49 + 51 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|49846|66115|lyfalmen|V0727|66115|1|168|0|84,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||49846||49846|66115||1 449470|B05BB0120|Natriumhydrogenkarbonat B.Braun|irl|500|mmól/l|0,25|l|1|fl|lausn|B05BB01|01.02.2012||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|897|2640|lyfsjukr|||2|0,25|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||897||897|2640||2 449485|N03AX1603|Pregabalin Krka|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|3435|2492|lyfalmen|V0686|2083|2|56|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||790||790|2492||2 449611|C07AB0311|Atenolol Mylan|töflur|100|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|772|2468|lyfalmen|||2|98|0|130,6667|Icepharma hf|Mylan AB|Atenólól||772||772|2468||2 449647|N05AH0414|Quetiapin Hexal|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.09.2017||R|1|1|0|0|G|0|SSA|0|0|0|100|DKK|3803|5957|lyfalmen|V0275|5259|2|100|0|12,5000|Artasan ehf|Hexal A/S|Quetíapín||3307||3307|5957||1 449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|GRP|0|0|0|100|DKK|4120|7076|lyfsjukr|||2|10|0|8,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Benzýlpenicillín||4120||4120|7076||1 449868|B01AF0101|Xarelto|filmhtfl|10|mg|10|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|2705|5128|lyfalmen|||1|10|0|5,0000|Icepharma hf|Bayer AG|Rivaoxaban||2705||2705|5128||2 450009|QN51AA0101|Euthasol vet.|stl|400|mg/ml|100|ml|1|fl||QN51AA01|01.07.2012||R|0|0|1|0|0|0|LEV|1|0|0|100|XEU|3798|7376|vetalmen|||0|100|0||Le Vet B.V.|Le Vet B.V.|Pentobarbital||3798||3798|7376||2 450054|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|þpakki||G03CA04|01.12.2014||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|962|2729|lyfalmen|||1|30|0|30,0000|Icepharma hf|Aspen Pharma Trading Limited|Estríól||962||962|2729||2 450201|V03AB3501|Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.07.2014||R|0|0|0|0|0|1|MLD|0|0|0|100|DKK|105499|137318|lyfsjukr|||1|20|0||Vistor hf|Merck Sharp & Dohme Limited|Sugammadex||105499||105499|137318||1 450413|V03AB3701|Praxbind|stl/irl|2,5|g|50|ml|2|hgl||V03AB37|01.05.2016||R|0|0|0|0|0|1|BOE|0|0|0|100|DKK|333973|421476|lyfsjukr|||1|100|0||Vistor hf|Boehringer Ingelheim International GmbH|Idarucizumab||333973||333973|421476||1 450508|N02AE0104|Buprenorphine ratiopharm|forðapl|5|mcg/klst|4|stk|1|skpoki||N02AE01|01.06.2018||R|0|0|1|0|G|0|RTH|0|0|0|100|SEK|896|2638|lyfalmen|||2|4|0|2,8000|Alvogen|ratiopharm GmbH|Búprenorfín||896||896|2638|30.6.2018|2 450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.10.1992||R|1|0|0|0|0|0|SNP|0|0|0|100|XEU|1965|3425|lyfalmen|V0313|2704|1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||1468||1468|3425||1 450979|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|6869|11839|vetorma|||0|2,5|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||6869||6869|11839||2 450993|R07AX0101|INOmax|innö.gas|800|ppm|10|l|1|gashyl||R07AX01|01.09.2014||R|0|1|0|0|0|1|LIN|0|0|0|100|XEU|16728|24429|lyfsjukr|||1|10|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíð||||16728|24429||5 451293|N05AX1204|ABILIFY MAINTENA|sts|400|mg|1|hgl|1|pakki||N05AX12|01.07.2014||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|38115|51278|lyfalmen|||1|1|0|30,0800|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||38115||38115|51278||1 451378|H02AB0607|Prednisolon Actavis|töflur|10|mg|25|stk|1|glas||H02AB06|01.12.2016||R|1|0|0|0|G|0|APC|0|0|1|100|XEU|585|2210|lyfalmen|||2|25|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Prednisólón||585||585|2210||1 451655|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.09.2018||L|0|0|0|0|0|0|CON|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Terbínafín|||||||1 451751|N05AE0403|Ziprasidon Actavis|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.07.2016||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|7115|11198|lyfalmen|V0610|11198|2|56|0|42,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||7115||7115|11198||1 451761|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2013||R|0|0|0|1|G|0|AEP|0|0|0|100|DKK|35616|48117|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma Trading Limited|Búsúlfan||35616||35616|48117||2 452022|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|fl||D01AC08|01.01.2012||L|0|0|0|0|0|0|TRI|0|0|1|100|IKR|||lyflausa|||0|120|0||Vistor hf|Trimb Healthcare AB|Ketókónazól|||||||1 452215|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.12.2016||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0||Vistor hf|Omega Pharma Nordic AB|Pencíklóvír|||||||1 452258|R03AK1101|Flutiform|innúðal|260|mcg/sk|120|skammtar|1|pakki|250+10 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|MUP|0|0|0|100|DKK|6436|10263|lyfalmen|||1|120|0|60,0000|Icepharma hf|Mundipharma A/S|Formóteról og flútikasón||6436||6436|10263||2 452467|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.03.2011|30.06.2018|R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|8652|14913|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||8652||8652|14913||2 452482|V07AB0009|Sterilt Vann B. Braun|leysir|||100|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|2000|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||5720||2 452500|L01XE3801|Cotellic|filmhtfl|20|mg|63|stk|1|þpakki|3 x 21|L01XE38|01.02.2016||R|1|0|0|1|0|1|RRG|0|1|0|100|DKK|757884|948702|lyfsjukr|||1|63|0||Icepharma hf|Roche Registration GmbH|Cobimetinib||||757884|948702||2 452594|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|3500|2781|lyfalmen|V0010|2179|2|56|0|56,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1000||1000|2781||2 452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|7518|11753|lyfalmen|||1|3000|0||Icepharma hf|Meda AB|Imikvímóð||7518||7518|11753||2 452866|B05AA0114|Albuman|irl|200|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SPP|0|0|0|100|XEU|6450|10283|lyfsjukr|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|Albúmín||6450||6450|10283||2 452904|N02AA0501|Oxycontin|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|1086|2900|lyfalmen|V0597|2428|1|28|0|3,7300|Icepharma hf|Norpharma |Oxýcódon||1086||1086|2900||2 452920|N02AA0501|Oxycontin|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|3259|5891|lyfalmen|V0598|4569|1|98|0|13,0700|Icepharma hf|Norpharma |Oxýcódon||3259||3259|5891||2 452995|N02AA0501|Oxycontin|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|2075|4261|lyfalmen|V0584|3110|1|28|0|7,4700|Icepharma hf|Norpharma |Oxýcódon||2075||2075|4261||2 453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dæl||QP54AA01|01.01.1991||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|1154|1989|vetorma|||0|6,4|0||Vistor hf|Merial (MSD)|Ivermectinum||1154||1154|1989||1 453175|N02AA0501|Oxycontin|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|6254|10013|lyfalmen|V0585|6575|1|98|0|26,1300|Icepharma hf|Norpharma |Oxýcódon||6254||6254|10013||2 453498|N02AA0501|Oxycontin|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|3492|6211|lyfalmen|V0586|4649|1|28|0|14,9300|Icepharma hf|Norpharma |Oxýcódon||3492||3492|6211||2 453515|N03AX1211|Gabapentin PCD|hylki|300|mg|120|stk|1|þpakki|hart|N03AX12|01.07.2017||R|1|1|0|0|G|0|PDA|0|0|0|100|IKR|1800|2437|lyfalmen|V0250|2437|2|120|0|20,0000|LYFIS ehf|PharmaCoDane ApS|Gabapentín||750||750|2437||2 453559|N03AX1604|Brieka|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|1694|1903|lyfalmen|V0685|1500|2|56|0|4,6667|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||362||362|1903||1 453560|L04AX0501|Esbriet|filmhtfl|267|mg|63|stk|1|þpakki||L04AX05|01.11.2017||R|1|1|0|1|0|0|RRG|0|0|0|100|DKK|87320|113513|lyfalmen|V0920|113513|1|63|0|7,0000|Icepharma hf|Roche Registration GmbH|Pírfenidon||||87320|113513||2 453571|N02AA0501|Oxycontin|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|11665|17461|lyfalmen|V0587|11524|1|98|0|52,2700|Icepharma hf|Norpharma|Oxýcódon||11665||11665|17461||2 453731|N06AX1613|Venlafaxin Medical Valley|forðatfl|225|mg|100|stk|1|glas||N06AX16|01.10.2017||R|0|0|0|0|G|0|VAL|0|0|0|100|IKR|3500|5672|lyfalmen|||2|100|0|225,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||3100||3100|5672||2 453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|2153|4368|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer ApS|Ziprasidon||2153||2153|4368||1 454442|QH01BB0204|Oxytobel|stl|10|ae/ml|50|ml|12|hgl||QH01BB02|01.11.2015||R|0|0|0|0|0|0|Bel|1|0|0|100|DKK|4153|8050|vetalmen|||0|600|0||Icepharma hf|Bela-Pharma GmbH & CO KG|Oxytocin||4153||4153|8050||2 454650|D05AX5204|Enstilar|húðfroða|||60|g|1|ílát|50 mcg/g+0,5 mg/g|D05AX52|01.06.2018||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|6385|10193|lyfalmen|||1|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||6385||6385|10193||1 454659|N05AH0414|Quetiapin Hexal|forðatfl|150|mg|100|stk|1|þpakki||N05AH04|01.09.2017||R|1|1|0|0|G|0|SSA|0|0|0|100|DKK|5720|8411|lyfalmen|V0910|8012|2|100|0|37,5000|Artasan ehf|Hexal A/S|Quetíapín||5090||5090|8411||1 454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|8848|13583|lyfalmen|||1|28|0|37,3333|Icepharma hf|Pfizer ApS|Dónepezíl||8848||8848|13583||1 454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|30166|35300|lyfalmen|V0342|6631|1|98|0|130,6667|Icepharma hf|Pfizer ApS|Dónepezíl||25482||25482|35300||1 454819|N02BE0115|Paracet|eþ-stíll|60|mg|10|stk|1|pakki||N02BE01|01.07.2011||L|0|0|0|0|0|0|WAS|0|0|1|100|IKR|||lyflausa|||0|10|0|0,2000|Actavis Group PTC ehf|Weifa AS|Paracetamól|||||||1 454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|0|0|0|0|0|1|OPH|0|0|0|100|DKK|43884|58575|lyfsjukr|||1|1|0||Artasan ehf|Novartis Europharm Ltd|Tópótecan||43884||43884|58575||1 454882|A16AX0701|Kuvan|lausnart|100|mg|120|stk|1|glas||A16AX07|01.05.2017||R|0|0|0|1|0|0|MSE|0|0|0|100|SEK|312153|394338|lyfalmen|||1|120|0||Icepharma hf|Merck Serono Europe Ltd|Saprópterín||312153||312153|394338||2 454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|898|1765|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|||898||898|1765||1 454973|J01FA1007|Azithromycin STADA|filmhtfl|500|mg|3|stk|1|þpakki||J01FA10|01.06.2017||R|1|0|0|0|0|0|ASR|0|0|1|100|IKR|800|2506|lyfalmen|V0174|2506|2|3|0|5,0000|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||800||800|2506||2 455171|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3792|6624|lyfsjukr|||1|4000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||3792||3792|6624||1 455223|J05AR0303|Emtricitabine/Tenofovir disoproxil Krka|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.08.2017||R|0|1|0|1|0|1|KNM|0|1|0|100|IKR|50000|66310|lyfsjukr|||2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Tenófóvír dísóproxíl og emtrícítabín||||50000|66310||2 455266|A10BD2001|Synjardy|filmhtfl|1012,5|mg|60|stk|1|þpakki|12,5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|6085|9780|lyfalmen|V0713|8682|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||6085||6085|9780||1 455325|L04AX0601|Imnovid|hylki|2|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|0|1|0|1|CEE|0|1|0|100|XEU|1075925|1344256|lyfsjukr|||1|21|0|14,0000|Celgene Europe ltd|Celgene Europe ltd|Pomalidómide||1075925||1075925|1344256||2 455492|G04BE0310|Sildenafil LYFIS|filmhtfl|50|mg|24|stk|1|þpakki||G04BE03|01.09.2016||R|0|0|0|0|0|0|LYF|0|0|0|100|IKR|8916|8287|lyfalmen|V0143|6840|2|24|0|24,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||5000||5000|8287||2 455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|þpakki||J01AA02|01.10.2008||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|657|2309|lyfalmen|||2|10|0|10,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Doxýcýklín||657||657|2309||1 455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|þpakki||J01AA02|01.01.2009||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|720|2396|lyfalmen|||2|15|0|15,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Doxýcýklín||720||720|2396||1 455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|þpakki||J01AA02|01.10.2008||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|1437|3383|lyfalmen|||2|30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Doxýcýklín||1437||1437|3383||1 456171|L01XE0302|Varlota|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.08.2017|30.06.2018|R|1|1|0|1|0|1|ALO|0|1|0|100|XEU|217268|266314|lyfsjukr|||2|30|0||Alvogen|Alvogen Malta Operations(ROW)Ltd.|Erlótiníb||209217||209217|266314||2 456734|C07AB0704|Bisbetol|filmhtfl|10|mg|100|stk|1|þpakki||C07AB07|01.01.2017||R|0|0|0|0|G|0|WEH|0|0|0|100|IKR|2740|5176|lyfalmen|||2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|bisoprolol||2740||2740|5176||2 456895|N05AH0206|Clozapin Medical|töflur|100|mg|100|stk|1|þpakki||N05AH02|01.06.2015||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|5264|4846|lyfalmen|V0277|4840|2|100|0|33,3300|Medical ehf|Medical ehf|Klózapín||2500||2500|4846||2 457112|N06BA0902|Atomoxetin Actavis|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017||R|1|1|0|0|0|0|GPA|0|0|0|100|XEU|10077|5392|lyfalmen|V0816|5218|2|28|0|21,0000|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||2897||2897|5392||1 457204|L02AE0307|Reseligo|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.05.2016||R|0|0|0|1|G|0|IPC|0|0|0|100|SEK|40007|44152|lyfalmen|V0451|44152|2|1|0|83,7200|Alvogen|Alvogen IPco S.á.r.l.|Góserelín||32481||32481|44152||2 457232|A07DA0601|Truberzi|filmhtfl|75|mg|56|stk|1|þpakki||A07DA06|01.08.2017||R|1|0|0|1|0|0|AIP|0|0|0|100|XEU|13842|20457|lyfalmen|||2|56|0||Actavis ehf|Allergan Pharmaceuticals Ltd.|Eluksadólín||||13842|20457||1 457359|N01BB0204|Lidokain Mylan|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.09.2016||R|0|0|0|0|0|0|MLT|0|0|1|100|XEU|1238|3109|lyfalmen|V0561|3109|2|100|0||BGP Products AsP|Mylan Ireland Limited|Lídókaín||1238||1238|3109||2 457508|J07AH0801|Nimenrix|sts|5|mcg|0,5|ml|1|hgl|+áfyllt sprauta|J07AH08|01.07.2013||R|0|0|0|0|0|0|PHH|0|0|0|100|DKK|5436|8887|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Limited|Hreinsaðir fjórgildi A,C,Y,W-135 og fl.||5436||5436|8887||1 457692|L04AX0307|Metoject|stl|50|mg/ml|0,45|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2338|4623|lyfalmen|||1|0,45|0|9,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2338||2338|4623||2 457726|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2011||R|0|0|0|0|0|0|GRP|0|0|0|100|XEU|2129|2147|lyfalmen|V0003|2107|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||539||539|2147||1 457991|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.08.2016||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|8733|15052|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||8733||8733|15052||2 458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|1|0|0|0|0|0|CHE|0|0|1|100|DKK|895|2637|lyfalmen|||1|25|0|5,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Clómetíazól||895||895|2637||1 458149|L01XE2101|Stivarga|filmhtfl|40|mg|84|stk|1|glas|3 x 28|L01XE21|01.06.2014||R|0|0|0|1|0|1|FIN|0|1|0|100|DKK|317102|400493|lyfsjukr|||1|84|0||Icepharma hf|Bayer AG|Regorafenib||317102||317102|400493||2 458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|þpakki||J01CA08|01.12.1980||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|1032|2825|lyfalmen|V0577|2473|1|20|0|6,6667|Vistor hf|LEO Pharma A/S|Pívmecillínam||1032||1032|2825||1 458491|C05AA0801|Doloproct|eþ-krem|||30|g|1|túpa||C05AA08|01.02.2015||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1068|2875|lyfalmen|||1|30|0||Icepharma hf|Bayer AB|Flúókortólón||1068||1068|2875||2 458666|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|0|1|0|1|BAL|0|1|0|100|SEK|94719|122871|lyfsjukr|||1|1|0||Lyfjaver ehf|Baxter Medical AB (L)|Storkuþáttur VIII||||94719|122871||3 458805|B01AF0201|Eliquis|filmhtfl|2,5|mg|60|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BSM|0|0|0|100|DKK|8231|11722|lyfalmen|V0653|11495|1|60|0|15,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||7496||7496|11722||1 459037|L01XE2301|Tafinlar|hylki|75|mg|120|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|765238|957849|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||765238||765238|957849||1 459242|L03AB1301|Plegridy|stl|||2|áf.spr|1|pakki|63 og 94 mcg|L03AB13|01.07.2015||R|0|0|0|1|0|1|BNB|0|0|0|100|XEU|75038|97978|lyfsjukr|||1|2|0|17,6400|Icepharma hf|Biogen Netherlands B.V.|Peginterferón beta-1a||75038||75038|97978||2 459324|V08CA0901|Gadovist|stl|1|mmol/ml|5|ml|5|áfspr|lausn|V08CA09|01.04.2018||R|0|0|0|0|0|1|BAB|0|0|0|100|DKK|17243|25138|lyfsjukr|||1|25|0||Icepharma hf|Bayer AB|Gadóbútról||||17243|25138||2 459342|N05AX1304|Paliperidon Krka|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.08.2018||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|11123|15857|lyfalmen|V0964|15857|2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Paliperídón||10500||10500|15857||2 459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|670|2327|lyfsjukr|||1|2|0|0,1667|Icepharma hf|Pfizer ApS|Klindamýcín||670||670|2327||1 459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|1228|3095|lyfsjukr|||1|4|0|0,3333|Icepharma hf|Pfizer ApS|Klindamýcín||1228||1228|3095||1 459447|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|16597|31658|vetalmen|||0|10|0||Icepharma hf|Zoetis Belgium S.A.|||16597||16597|31658||2 459812|N05AH0411|Quetiapine Teva|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.09.2014||R|1|0|0|0|G|0|TSA|0|0|0|100|IKR|2267|2194|lyfalmen|V0284|2167|2|100|0|6,2500|Alvogen|Teva Sweden AB|Quetíapín||573||573|2194||2 459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|þpakki||B02AA02|01.04.1989||R|1|0|0|0|G|0|MEA|0|0|1|100|DKK|1265|3146|lyfalmen|||1|30|0|7,5000|Icepharma hf|Meda AB|Tranexamsýra||1265||1265|3146||2 460062|L01AA0902|Bendamustine Accord|st/irþ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.01.2016||R|0|0|0|0|0|1|ACC|0|1|0|100|XEU|111724|145060|lyfsjukr|||2|500|0||Artasan ehf|Accord Healthcare Limited|Bendamústín||111724||111724|145060||1 460293|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|þpakki||J04AB02|01.09.2012||R|1|0|0|0|G|0|HSS|0|0|0|100|DKK|7406|11599|lyfalmen|||1|100|0|25,0000|Artasan ehf|Sandoz GmbH|Rífampicín||7406||7406|11599||1 460339|L01XC0301|Herceptin|stl|600|mg/hgl|5|ml|1|hgl||L01XC03|01.12.2013||R|0|0|0|0|0|1|RRG|0|1|0|100|DKK|191862|244730|lyfsjukr|||1|5|0||Icepharma hf|Roche Registration GmbH|Trastuzumab||191862||191862|244730||2 460632|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.03.2017||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|5898|4013|lyfalmen|V0144|3906|2|12|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||1895||1895|4013||1 460826|QJ01CR0201|Combisyn|töflur|250|mg|100|stk|1|pakki||QJ01CR02|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|IKR|4422|8560|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og beta-laktamasa hemill||4422||4422|8560||2 461035|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|3847|6575|lyfalmen|V0585|6575|2|98|0|26,1300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||3756||3756|6575||1 461107|L03AB1001|PegIntron|sts|80|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013|30.06.2018|R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|67648|88631|lyfsjukr|||1|4|0|42,6700|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||67648||67648|88631||1 461113|L01XE1801|Jakavi|töflur|20|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|437222|549889|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||437222||437222|549889||1 461206|J02AC0104|Fluconazol ratiopharm|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.08.2013||L|1|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyfalmen|V0554|1823|2|1|0|0,7500|Alvogen|ratiopharm GmbH|Flúkónazól|||||1823||2 461441|L04AX0601|Imnovid|hylki|4|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|0|1|0|1|CEE|0|1|0|100|XEU|1109195|1385635|lyfsjukr|||1|21|0|28,0000|Celgene Europe ltd|Celgene Europe ltd|Pomalidómide||1109195||1109195|1385635||2 461641|V03AB3501|Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.09.2015||R|0|0|0|0|0|1|MLD|0|0|0|100|DKK|263747|334134|lyfsjukr|||1|50|0||Vistor hf|Merck Sharp & Dohme Limited|Sugammadex||263747||263747|334134||1 461731|N02AJ0601|Parkodin|töflur|510|mg|10|stk|1|þpakki|10+500 mg|N02AJ06|01.01.1989||R|1|0|0|0|0|0|GPA|0|0|1|100|IKR|232|1724|lyfalmen|V0962|1687|2|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||232||232|1724||1 461917|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|31,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 462049|C08CA0501|Adalat|töflur|20|mg|100|stk|1|þpakki||C08CA05|01.03.2013|30.06.2018|R|1|0|0|0|G|0|BAB|0|0|0|100|DKK|2227|4470|lyfalmen|||1|100|0|66,6667|Icepharma hf|Bayer AB|Nífedipín||||2227|4470||2 462070|A10BK0101|Forxiga|filmhtfl|10|mg|98|stk|1|þpakki||A10BK01|01.09.2015||R|1|0|0|0|G|0|BRI|0|0|0|100|SEK|14794|21767|lyfalmen|||1|98|0|98,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Dapagliflozin||14794||14794|21767||1 462302|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|þpakki|2+0,5 mg|N07BC51|01.07.2016||R|0|0|1|1|0|1|IND|0|0|0|100|DKK|3410|6098|lyfsjukr|||1|28|0|7,0000|Vistor hf|Indivior Europe Limited|Búprenorfín í blöndum||3410||3410|6098||1 462849|C09DA0311|Valsartan/ Hydrochlorothiazide Krka|filmhtfl|185|mg|98|stk|1|þpakki|160/25 mg|C09DA03|01.08.2018||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|4100|7048|lyfalmen|||2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Valsartan og þvagræsilyf||4100||4100|7048||2 463251|N06DX0106|Memantine ratiopharm|filmhtfl|10|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|4634|3336|lyfalmen|V0605|2781|2|100|0|50,0000|Alvogen|ratiopharm GmbH|Memantín||1403||1403|3336||2 463654|J05AE1001|Prezista|filmhtfl|800|mg|30|stk|1|plglas||J05AE10|01.08.2013||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|40630|54459|lyfsjukr|||1|30|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||||40630|54459||1 463744|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|tfílát||G02CB03|01.07.1993||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|3636|6410|lyfalmen|V0126|6410|1|8|0|8,0000|Icepharma hf|Pfizer Aps|Kabególín||||3636|6410||1 463861|D07AC1301|Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1706|3753|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1706||1706|3753||1 463941|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|þpakki||M01AX05|01.11.2012||L|1|0|0|0|0|0|LEX|0|0|1|100|IKR|||lyflausa|||0|60|0|52,8000|Icepharma hf|Laboratoires Expanscience|Glúkósamín|||||||2 463956|R02AX0102|Strefen Orange Sukkerfri|sogtfl|8,75|mg|16|stk|1|þpakki||R02AX01|01.11.2016||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|16|0|3,1800|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Flurbiprofen|||||||1 464078|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|150 mg/30 mg|QP54AB51|01.04.2018||R|0|0|0|0|0|0|MER|0|0|0|100|XEU|2746|4733|vetorma|||0|3|0||Vistor hf|Merial|Milbemycin oxime í blöndum||2746||2746|4733||1 464164|N02BE0101|Panodil|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.04.1992||L|1|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 464226|C07AG0205|Carveratio|töflur|12,5|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|0|G|0|RTH|0|0|0|100|IKR|2478|4158|lyfalmen|V0947|3332|2|100|0|33,3300|Alvogen|ratiopharm GmbH|Carvedílól||2000||2000|4158||2 464326|L01XX1905|Onivyde|irþ|5|mg/ml|10|ml|1|hgl||L01XX19|01.04.2017||R|0|0|0|0|0|1|ALT|0|0|0|100|DKK|83334|108471|lyfsjukr|||1|10|0||Lyfjaver ehf|Baxalta Innovations GmbH|Írinótekan||83334||83334|108471||3 464335|N05AE0403|Ziprasidon Actavis|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.11.2016||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|13177|19542|lyfalmen|V0718|19542|2|56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||13177||13177|19542||1 464545|L01XX0502|Hydroxyurea medac|hylki|500|mg|100|stk|1|þpakki||L01XX05|01.01.2016||R|0|0|0|1|G|0|WIL|0|0|0|100|XEU|7474|11692|lyfalmen|||1|100|0||Williams & Halls efh|medac Gesellschaft|Hýdroxýkarbamíð||7474||7474|11692||2 464591|J01FA0902|Clarithromycin ratiopharm|filmhtfl|250|mg|14|stk|1|þpakki||J01FA09|01.06.2014||R|1|0|0|0|0|0|TSA|0|0|1|100|IKR|1713|3763|lyfalmen|V0967|3607|2|14|0|7,0000|Alvogen|Teva Sweden AB|Klaritrómýcín||1713||1713|3763||2 464751|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|3,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 464762|R01AD0904|Mometasone Actavis|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.12.2016||L|0|0|0|0|G|0|GPA|0|0|1|100|XEU|||lyfalmen|V0677|2660|2|140|0|35,0000|Actavis Group hf|Actavis Group PTC ehf|Mómetasón|||||2660||1 465065|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|2,5|ml|3|glös||S01EE01|01.10.2011||R|0|0|0|0|G|0|GRP|0|0|0|100|DKK|1427|3369|lyfalmen|V0376|2659|2|7,5|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||1427||1427|3369||1 465203|QJ01RA0103|Depomycine, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.12.1982||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|929|1826|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||||929|1826||1 465307|C08DA0103|Isoptin retard|forðatfl|120|mg|98|stk|1|þpakki||C08DA01|01.01.2016||R|1|0|0|0|G|0|PGB|0|0|0|100|DKK|1517|3493|lyfalmen|||1|98|0|49,0000|Icepharma hf|BGP Products ApS|Verapamíl||1517||1517|3493||2 465333|L04AX0307|Metoject|stl|50|mg/ml|0,6|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2591|4971|lyfalmen|||1|0,6|0|12,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2591||2591|4971||2 465848|A07DA0303|Immex|töflur|2|mg|100|stk|1|þpakki||A07DA03|01.05.2018||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|812|2272|lyfalmen|||2|100|0|20,0000|Alvogen|Alvogen|Lóperamíð||630||630|2272|31.8.2018|2 466029|N06AB0310|Seromex|hylki|20|mg|100|stk|1|þpakki||N06AB03|01.02.2013||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|2763|2981|lyfalmen|V0039|2978|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Flúoxetín||1145||1145|2981||2 466086|N02AA0101|Contalgin|forðatfl|10|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|490|2079|lyfalmen|||1|25|0|2,5000|Icepharma hf|Pfizer ApS|Morfín||490||490|2079||1 466094|N02AA0101|Contalgin|forðatfl|10|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|1525|3504|lyfalmen|||1|100|0|10,0000|Icepharma hf|Pfizer ApS|Morfín||1525||1525|3504||1 466122|G03AA0702|Microgyn|töflur|||63|stk|1|þpakki||G03AA07|01.08.2013||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1011|2796|lyfalmen|V0545|1955|1|63|0|84,0000|Icepharma hf|Bayer AB|Levónorgestrel og ethinylestradíól||||1011|2796||2 466169|N02AA0101|Contalgin|forðatfl|30|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|1156|2996|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Morfín||1156||1156|2996||1 466219|N02AA0101|Contalgin|forðatfl|30|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|4007|6920|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Morfín||4007||4007|6920||1 466278|L01XC1401|Kadcyla|irþ|100|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|0|0|1|RRG|0|1|0|100|DKK|221308|281352|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration GmbH|Trastuzumab emtansine||221308||221308|281352||2 466394|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|þpakki||N03AX15|01.03.2014||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|14730|21679|lyfalmen|||1|98|0|49,0000|Vistor hf|Eisai Ltd|Zonisamíð||14730||14730|21679||1 466466|N02AA0101|Contalgin|forðatfl|60|mg|25|stk|1|þpakki||N02AA01|01.10.1995||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|2150|4364|lyfalmen|||1|25|0|15,0000|Icepharma hf|Pfizer ApS|Morfín||2150||2150|4364||1 466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|5848|9454|lyfalmen|||1|50|0|5,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||5848||5848|9454||1 466588|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.02.2017||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 466610|N02BE0120|Paracetamol Sandoz|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.03.2016||L|1|0|0|0|0|0|SHS|0|0|1|100|IKR|||lyflausa|||2|30|0|5,0000|Artasan ehf|Sandoz A/S|Paracetamól|||||||1 466680|N02AA0101|Contalgin|forðatfl|100|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|3537|6273|lyfalmen|||1|25|0|25,0000|Icepharma hf|Pfizer ApS|Morfín||3537||3537|6273||1 466723|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|2,5|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|2,5|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 466739|C09DX0401|Entresto|filmhtfl|200|mg|56|stk|1|þpakki|97 + 103 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|16615|24274|lyfalmen|V0728|22038|1|56|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||16615||16615|24274||1 466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|þpakki||N06AG02|01.10.1990||R|1|0|0|0|G|0|MEA|0|0|0|100|DKK|2591|4971|lyfalmen|V0063|4311|1|100|0|50,0000|Icepharma hf|Meda AB|Móklóbemíð||2591||2591|4971||2 466902|N02BE0122|Dolorin|töflur|500|mg|100|stk|1|þpakki||N02BE01|01.12.2017||R|1|0|0|0|0|0|WEH|0|0|1|100|IKR|325|1852|lyfalmen|||2|100|0|16,6666|Williams & Halls efh|Williams & Halls ehf|Paracetamól||325||325|1852||2 467189|N06BA0407|Metylfenidat Actavis|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|1|0|0|0|GPA|0|0|0|100|XEU|5524|5409|lyfalmen|V0622|4241|2|30|0|54,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||2909||2909|5409||1 467437|QP51AJ0103|Baycoxine vet|mixtúra|50|mg/ml|250|ml|1|glas||QP51AJ01|01.08.2018||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4691|8085|vetorma|||0|250|0||Icepharma hf|Bayer Animal Health GmbH|Toltrazuril||4691||4691|8085||2 467459|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4823|8043|lyfsjukr|||1|2500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||4823||4823|8043||2 467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|11347|17023|lyfalmen|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||11347||11347|17023||1 467699|G03FA1701|Angemin|töflur|||84|stk|1|þpakki|2+1 mg|G03FA17|01.10.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|4860|8094|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og östrogen||4860||4860|8094||2 467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|21593|30381|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||21593||21593|30381||1 467756|A10BJ0301|Lyxumia|stl|20|mcg/sk|3|ml|2|áfpen||A10BJ03|01.10.2013||R|0|0|0|0|0|0|SGB|0|0|0|100|XEU|8153|12627|lyfalmen|||1|6|0|28,0000|Vistor hf|Sanofi-aventis groupe|Lixisenatide||8153||8153|12627||1 467810|J01DI0201|Zinforo|irþ|600|mg|10|hgl|1|pakki|lausn|J01DI02|01.04.2013||R|0|0|0|0|0|1|PIP|0|0|0|100|SEK|63169|82966|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Pfizer Ireland Pharmaceuticals|Ceftarólin||63169||63169|82966||1 467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|0|0|0|0|0|1|JAS|0|0|0|100|SEK|324|1851|lyfsjukr|||1|5|0|3,1250|Vistor hf|Janssen-Cilag AB|Halóperídól||324||324|1851||1 468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|4830|5871|lyfalmen|V0317|2781|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3245||3245|5871||1 468103|H05BX0104|Cinacalcet Mylan|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.11.2016||R|1|0|0|0|0|0|ASD|0|0|0|100|SEK|11960|9432|lyfalmen|V0720|9432|2|28|0|14,0000|Icepharma hf|Mylan S.A.S.|Cinacalcet||5832||5832|9432|| 468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|5880|5848|lyfalmen|V0318|3470|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3228||3228|5848||1 468537|QP54AA0501|Stronghold|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|1839|3170|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||1839||1839|3170||2 468825|QM01AC0603|Rheumocam|stl|20|mg/ml|50|ml|1|hgl|handa nautg, svínum og hestum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|4878|9425|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||4878||4878|9425||2 468932|B05BB0115|Ringer-acetat Fresenius Kabi|irl|||500|ml|20|plpok|Freeflex umbúðir|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|5726|9286|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||5726||5726|9286||1 468996|A02BC0402|Rabeprazol Actavis|sþ-tfl|10|mg|100|stk|1|glas||A02BC04|01.01.2012||R|0|0|0|0|G|0|GRP|0|0|0|100|XEU|2702|5124|lyfalmen|V0467|3049|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||2702||2702|5124||1 469086|A10BD2001|Synjardy|filmhtfl|1005|mg|60|stk|1|þpakki|5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|5830|9429|lyfalmen|V0712|8332|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||5830||5830|9429||1 469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|þpakki||C10AB04|01.07.1991||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|2545|4908|lyfalmen|||1|98|0|49,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||2545||2545|4908||1 469422|G03AB0501|Gracial|töflur|||66|stk|1|þpakki|Þp 3 * (15+7 stk)|G03AB05|01.08.2015||R|0|0|0|0|0|0|AEP|0|0|0|100|DKK|1953|4093|lyfalmen|||1|66|0|66,0000|Icepharma hf|Aspen Pharma Trading Limited|Desógestrel og ethinylestradíól||1953||1953|4093||2 469480|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|6054|9738|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||6054||6054|9738||1 469817|N02AX0206|Nobligan Retard|forðatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000|30.06.2018|R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|4411|7476|lyfalmen|||1|100|0|66,6667|Icepharma hf|Grunenthal|Tramadól||4411||4411|7476||2 469847|M01AH0106|Celecoxib Actavis|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|1968|2618|lyfalmen|V0037|2231|2|20|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Celekoxíb||881||881|2618||1 469874|N02AX0206|Nobligan Retard|forðatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000|30.06.2018|R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|3618|6385|lyfalmen|||1|100|0|50,0000|Icepharma hf|Grunenthal|Tramadól||3618||3618|6385||2 469932|N02AX0206|Nobligan Retard|forðatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000|30.06.2018|R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|2222|4463|lyfalmen|||1|100|0|33,3333|Icepharma hf|Grunenthal|Tramadól||2222||2222|4463||2 470148|N06BA0404|Methylphenidate Sandoz|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.09.2013||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|5488|5406|lyfalmen|V0622|4241|2|30|0|54,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||2907||2907|5406||1 470202|R03AK0706|DuoResp Spiromax|innönddu|329|mcg/sk|60|skammtar|3|innö.t|320+9 mcg/sk|R03AK07|01.05.2018||R|0|0|0|0|G|0|TAB|0|0|0|100|XEU|12310|15099|lyfalmen|||2|180|0|90,0000|Alvogen|Teva Pharma B.V.|Formóteról og budesonide||9949||9949|15099||2 470315|J05AF0703|Virofob|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.01.2017||R|1|1|0|1|0|1|IPC|0|0|0|100|DKK|39952|46864|lyfsjukr|||2|30|0|30,0000|Alvogen|Alvogen IPco S.á.r.l.|Tenófóvír dísóproxíl||34625||34625|46864||2 470385|R03BA0501|Flixotide|innúðal|250|mcg/sk|120|skammtar|1|stauk||R03BA05|01.04.1995||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|3232|5853|lyfalmen|||1|120|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||3232||3232|5853||1 470397|N05CM1801|Dexdor|irþ|100|mcg/ml|4|ml|4|hgl|lausn|N05CM18|01.03.2012||R|0|0|0|0|0|1|ORC|0|0|0|100|DKK|21258|29957|lyfsjukr|||1|16|0|1,6000|Vistor hf|Orion Corporation|Dexmedetómid||21258||21258|29957||1 470471|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|10|áf.spr||B01AX05|01.01.2016||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|4854|8086|lyfalmen|||1|5|0|10,0000|Icepharma hf|Aspen Pharma Trading Limited|Fondaparinux||4854||4854|8086||2 471550|R01BA0101|Rinexin|forðatfl|50|mg|30|stk|1|þpakki||R01BA01|01.10.2017||R|1|0|0|0|G|0|MEA|0|0|1|100|SEK|656|2308|lyfalmen|||1|30|0|15,0000|Icepharma hf|Meda AB|Fenýlprópanólamín||656||656|2308||2 471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|0|0|0|0|0|0|ORC|1|0|0|100|DKK|3724|7236|vetalmen|||0|10|0||Vistor hf|Orion Corporation|Atipamesól||3724||3724|7236||1 472092|C07AB0206|Seloken ZOC|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.07.1989||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1404|3337|lyfalmen|V0048|2254|1|98|0|31,0300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1404||1404|3337||1 472099|R02AA0307|Strepsils Warm|sogtfl|||24|stk|1|þpakki||R02AA03|01.08.2011||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 472332|J07BC0201|Havrix|stl|1440|ein/ml|0,5|ml|1|dæla|einnota dæla|J07BC02|01.10.1995||R|0|0|0|0|0|0|GPH|0|0|0|100|NOK|3186|5790|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3186||3186|5790|31.7.2018|1 472338|S01AA2701|APROKAM|sts|50|mg|10|hgl|1|pakki|lausn|S01AA27|01.04.2013||R|0|0|0|0|0|1|TEA|0|0|0|100|SEK|7249|11382|lyfsjukr|||1|10|0||Vistor hf|Laboratories THEA|Cefuroxím||7249||7249|11382||1 472984|S01EC5401|Simbrinza|augndr|12|mg/ml|5|ml|1|glas|10 + 2 mg/ml|S01EC54|01.01.2015||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|2294|4562|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Brimoníð og brinzolamið||2294||2294|4562||1 473213|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.07.2016||R|0|0|0|0|G|0|ATN|0|0|1|100|DKK|1134|2966|lyfalmen|||1|5|0|5,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Ketórólak||1134||1134|2966||2 473957|L04AB0102|Benepali|stl|50|mg|4|áf-penni|1|pakki|lausn|L04AB01|01.10.2017||R|0|1|0|1|0|1|SAM|0|1|0|100|XEU|105952|137882|lyfsjukr|||2|4|0|28,5800|Biogen Idec Ltd.|Samsung Bioepis UK Ltd.|Etanercept||105952||105952|137882||2 473968|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.11.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|3899|6772|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Takrólímus||3899||3899|6772||1 474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|0|0|0|0|0|1|MEA|0|0|0|100|DKK|8700|13380|lyfsjukr|||1|400|0||Icepharma hf|Meda AB|Dextran||8700||8700|13380||2 474043|N01AH0601|Remifentanil Actavis|sts/irs|2|mg|5|hgl|1|pakki|þykkni,lausn|N01AH06|01.06.2012||R|0|0|1|0|0|1|GPA|0|0|0|100|XEU|5958|9606|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||5958||5958|9606||1 474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|0|0|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||||2 474120|N03AX1604|Brieka|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|6566|3022|lyfalmen|V0687|2849|2|56|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||1175||1175|3022||1 474608|QB03AC0001|Uniferon|stl|200|mg/ml|100|ml|12|hgl|lausn|QB03AC|01.08.2011||R|0|0|0|0|0|0|PHM|0|0|0|100|DKK|23783|45292|vetalmen|||0|1200|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíð||23783||23783|45292||2 474657|N04BC0504|Oprymea (Lyfis)|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|625|2265|lyfalmen|V0266|1997|3|30|0|1,5000|LYFIS ehf|LYFIS ehf|Pramipexól||625||625|2265||2 474855|N07BC0202|Metadon Abcur|töflur|10|mg|20|stk|1|þpakki||N07BC02|01.03.2016||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|812|2523|lyfalmen|||1|20|0|8,0000|Icepharma hf|Abcur AB|Metadón||812||812|2523||2 475338|QI09AL0101|Eryseng Parvo|stl|||50|ml|1|hgl|dreifa|QI09AL01|01.10.2014||R|0|0|0|0|0|0|LHS|0|0|0|100|IKR|9978|17198|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Porcine parvovirus + erysipelothrix||9978||9978|17198||2 475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|1|0|0|0|G|0|GRP|0|0|0|100|IKR|1100|2919|lyfalmen|||2|100|0|26,6667|Actavis Group PTC ehf|Actavis Group PTC ehf|Warfarín||1100||1100|2919||1 475491|N02AJ0602|Parkodin forte|töflur|530|mg|20|stk|1|þpakki|30+500 mg|N02AJ06|01.04.1992|31.07.2018|R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|505|2100|lyfalmen|||2|20|0|6,6667|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||505||505|2100||1 475669|N03AX1603|Pregabalin Krka|hylki|50|mg|56|stk|1|þpakki||N03AX16|01.01.2018||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|2904|3607|lyfalmen|||2|56|0|9,3333|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1600||1600|3607||2 475705|QN02AF0104|Torphadine vet.|stl|10|mg/ml|10|ml|1|hgl|lausn|QN02AF01|01.03.2018||R|0|0|0|0|0|0|VEB|1|0|0|100|IKR|5789|11153|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Bútorfanóltartrat||||5789|11153||2 475862|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|28|stk|1|þpakki|hart|A02BC01|01.04.2015||L|1|0|0|0|0|0|RTH|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Alvogen|ratiopharm GmbH|Ómeprazól|||||||2 476249|QJ01CA0403|Amoxibactin vet.|töflur|250|mg|100|stk|1|þpakki||QJ01CA04|01.12.2016||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|5695|10975|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||5695||5695|10975||2 476434|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|51779|68560|lyfsjukr|||1|1,2|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||||51779|68560||1 476580|R03AC0206|Ventoline|lausn|2|mg/ml|20|lykjur|1|pakki|fyrir eimgjafa|R03AC02|01.04.1992||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|990|2768|lyfalmen|||1|20|0|10,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||990||990|2768||1 476873|B05BA0314|Glucos Baxter Viaflo|irl|100|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3483|6199|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||||3483|6199||2 477017|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.07.2013||R|1|0|0|0|0|0|MBV|0|0|0|100|DKK|13781|20373|lyfalmen|V0954|12185|1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb||13781||13781|20373||1 477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|þpakki|250 + 100 mg|P01BB51|01.02.2006||R|1|0|0|0|0|0|GPH|0|0|0|100|DKK|3564|6310|lyfalmen|V0934|5534|1|12|0|3,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Prógúaníl í blöndum||3564||3564|6310||1 477099|L04AA3201|Otezla|filmhtfl|||27|stk|1|þpakki|10+20+30 mg upphafs.pkn|L04AA32|01.05.2016||R|1|0|0|1|0|1|CLC|0|1|0|100|XEU|46336|61676|lyfsjukr|||1|27|0||Celgene AB|Celgene Europe Limited|Apremilast||46336||46336|61676||2 477201|L04AB0102|Benepali|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.10.2017||R|0|1|0|1|0|1|SAM|0|1|0|100|XEU|105952|137882|lyfsjukr|||2|4|0|28,5800|Biogen Idec Ltd.|Samsung Bioepis UK Ltd.|Etanercept||105952||105952|137882||2 477295|N05AH0413|Quetiapin ratiopharm|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|0|G|0|TAB|0|0|0|100|IKR|28055|9801|lyfalmen|V0272|9388|2|100|0|75,0000|Alvogen|Teva Pharma B.V.|Quetíapín||6100||6100|9801||2 477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||20|ml|10|hgl|fyrir stungulyf|V07AB|01.02.2007||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3307||2 477631|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|lykja|dreifa|H02AB01|01.10.2013||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|575|2196|lyfalmen|||1|1|0|4,6700|Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||575||575|2196||1 477752|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3307||1 478119|A10BA0202|Metformin Actavis|filmhtfl|500|mg|100|stk|1|glas||A10BA02|01.12.2011||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|419|1873|lyfalmen|V0500|1873|2|100|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||340||340|1873||1 478163|D05AX5204|Enstilar|húðfroða|||60|g|2|ílát|50 mcg/g+0,5 mg/g|D05AX52|01.06.2018||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|12771|18983|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||12771||12771|18983||1 478360|QM01AC0603|Rheumocam|stl|5|mg/ml|20|ml|1|hgl|handa hundum og köttum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|5940|11440|vetalmen|||0|20|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||5940||5940|11440||2 478993|M01AH0502|Coxient|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|ALO|0|0|1|100|IKR|1954|2864|lyfalmen|V0825|2789|2|28|0|28,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Etoríkoxíb||1060||1060|2864||2 479127|C10AA0509|Atorvastatin Xiromed|filmhtfl|80|mg|98|stk|1|þpakki||C10AA05|01.04.2018||R|1|0|0|0|0|0|MVX|0|0|0|100|IKR|4900|8012|lyfalmen|V0115|7986|2|98|0|392,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||4800||4800|8012||2 479407|L04AA1302|Leflunomide medac|filmhtfl|20|mg|100|stk|1|glas||L04AA13|01.07.2011||R|0|1|0|1|G|0|WIL|0|0|0|100|XEU|20286|28728|lyfalmen|||2|100|0|100,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíð||20286||20286|28728||2 479703|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.07.2017||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|783|2483|lyfsjukr|||1|50|0||Vistor hf|Janssen-Cilag AB|Fentanýl||783||783|2483||1 479904|L01XE1401|Bosulif|filmhtfl|100|mg|28|stk|1|þpakki||L01XE14|01.09.2014||R|1|0|0|1|0|1|PIZ|0|1|0|100|DKK|95728|124147|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Ltd|Bósútíníb||95728||95728|124147||1 480454|QN05CM1802|Sileo|munnh.hl|0,1|mg/ml|3|ml|1|spr||QN05CM18|01.01.2017||R|0|0|0|0|0|0|OCO|0|0|0|100|DKK|2578|5061|vetalmen|||0|3|0||Icepharma hf|Orion Corporation (I)|||2578||2578|5061||2 480519|C09CA0604|Kairasec|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.2017||R|1|0|0|0|0|0|VAL|0|0|0|100|XEU|3760|5215|lyfalmen|V0080|5215|2|98|0|196,0000|Acare ehf|Medical Valley Invest AB|Candesartan||2768||2768|5215||2 481176|N06AX1201|Zyban|forðatfl|150|mg|100|stk|1|þpakki||N06AX12|01.09.2000||R|1|0|0|0|0|0|GPH|0|0|0|100|DKK|10256|15521|lyfalmen|||1|100|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||10256||10256|15521||1 481208|D07AC1302|Ovixan|krem|0,1|%|30|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|555|2169|lyfalmen|||2|30|0||Vistor hf|Galenica AB|Mómetasón||555||555|2169||1 481345|N06DA0304|Nimvastid|hylki|3|mg|112|stk|1|þpakki||N06DA03|01.04.2018||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|25104|34822|lyfalmen|V0345|34822|2|112|0|37,3300|LYFIS ehf|Krka d.d. Novo mesto|Rívastigmín||25104||25104|34822||2 481375|R03AC1901|Striverdi Respimat|innöndl|2,5|mcg|60|skammtar|1|rörlyk||R03AC19|01.08.2014||R|0|0|0|0|G|0|BII|0|0|1|100|DKK|3703|6502|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Olodaterol||3703||3703|6502||1 481506|N06BA0407|Metylfenidat Actavis|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|1|0|0|0|GPA|0|0|0|100|XEU|5711|6364|lyfalmen|V0681|6343|2|30|0|27,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||3603||3603|6364||1 481534|N02AX0204|Tradolan|filmhtfl|50|mg|20|stk|1|þpakki||N02AX02|01.05.2012||R|1|0|1|0|G|0|GLP|0|0|1|100|DKK|204|1686|lyfalmen|V0055|1686|1|20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||204||204|1686||1 482183|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|hgl||G03BA03|01.05.2014||R|0|0|0|0|G|0|BAB|0|0|0|100|DKK|12743|18944|lyfalmen|||1|4|0|55,5600|Icepharma hf|Bayer AB|Testósterón||12743||12743|18944||2 482457|N02BA5102|Treo|freyðit|||20|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|0|MEA|0|0|1|100|DKK|||lyflausa|||0|20|0|3,3333|Icepharma hf|Meda AB|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||2 482751|QJ01DB0101|Cefabactin vet.|töflur|500|mg|100|stk|1|þpakki||QJ01DB01|01.03.2018||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|6458|12423|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Cefalexin||||6458|12423||2 483104|L01XC0801|Vectibix|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.03.2013||R|0|1|0|0|0|1|AEB|0|1|0|100|DKK|53759|71065|lyfsjukr|||1|5|0||Vistor hf|Amgen Europe B.V.|Panitúmúmab||53759||53759|71065||1 483217|B01AF0101|Xarelto|filmhtfl|20|mg|98|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|25955|35898|lyfalmen|||1|98|0|98,0000|Icepharma hf|Bayer AG|Rivaoxaban||||25955|35898||2 483371|B05AA0114|Albuman|irl|40|g/líter|400|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SPP|0|0|0|100|XEU|5161|8509|lyfsjukr|||1|400|0||Williams & Halls efh|Sanquin Plasma Product|Albúmín||5161||5161|8509||2 483485|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|15|ml|10|áfspr|lausn,áf.spr.|V08CA02|01.10.2017||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|44691|59595|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||44691||44691|59595||2 483540|A10AC0110|Humulin NPH KwikPen|stl|100|ae/ml|3|ml|5|pennar|áfylltur penni|A10AC01|01.01.2017||R|0|0|0|0|G|0|DAN|0|0|0|100|XEU|3993|6901|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||3993||3993|6901||2 483556|S01EA0502|Brimonidin Bluefish|augndr|2|mg/ml|5|ml|3|glös|lausn|S01EA05|01.04.2018||R|0|0|0|0|G|0|BFP|0|0|0|100|XEU|1962|4105|lyfalmen|V0368|4105|2|15|0|75,0000|Vistor hf|Bluefish Pharmaceuticals AB|Brímónidín||1962||1962|4105||1 483663|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|3|lykja||B03BA03|01.07.2012||R|0|0|0|0|G|0|SHS|0|0|1|100|DKK|5314|8719|lyfalmen|||1|3|0|150,0000|Artasan ehf|Sandoz A/S|Hýdroxókóbalamín||5314||5314|8719||1 483711|S01ED5114|Latanoprost/Timolol Alvogen|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml|S01ED51|01.01.2012||R|0|0|0|0|G|0|POF|0|0|0|100|DKK|1555|3545|lyfalmen|V0374|3545|2|2,5|0|25,0000|Alvogen|Alvogen|Tímólól í blöndum||1555||1555|3545||2 483903|N06DX0109|Marbodin|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|2486|4827|lyfalmen|V0902|4523|2|28|0|28,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||2486||2486|4827||2 483968|C03AA0305|Hydromed|töflur|12,5|mg|100|stk|1|þpakki||C03AA03|01.06.2013||R|0|0|0|0|G|0|MEV|0|0|0|100|DKK|795|2499|lyfalmen|||2|100|0|50,0000|Vistor hf|MediLink A/S|hýdróklórtíazíð||795||795|2499||1 483996|N02AX0212|Tramadol Actavis|hylki|50|mg|20|stk|1|þpakki||N02AX02|01.09.2011||R|1|0|1|0|G|0|GPA|0|0|1|100|XEU|228|1713|lyfalmen|V0055|1686|2|20|0|3,3300|Actavis Group hf|Actavis Group PTC ehf|Tramadól||224||224|1713||1 484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|þpakki||D11AX10|01.08.1999||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|4308|7334|lyfalmen|V0961|6301|1|28|0|28,0000|Vistor hf|M.S.D.|Fínasteríð||4308||4308|7334||1 484271|L01XE3101|Ofev|hylki|150|mg|60|stk|1|þpakki||L01XE31|01.07.2016||R|0|0|0|1|0|0|BOE|0|0|0|100|DKK|322570|407294|lyfalmen|||1|60|0||Vistor hf|Boehringer Ingelheim International GmbH|Nintedanib||322570||322570|407294||1 484327|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|nálavörn|L03AA13|01.11.2010||R|0|0|0|1|0|1|AEB|0|0|0|100|DKK|105584|137424|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||105584||105584|137424||1 484618|A01AD0201|Andolex|munnskol|1,5|mg/ml|300|ml|1|glas|lausn|A01AD02|01.01.1996||R|0|0|0|0|G|0|MEA|0|0|1|100|DKK|978|2751|lyfalmen|||1|300|0|50,0000|Icepharma hf|Meda AB|Benzýdamín||978||978|2751||2 484658|B01AF0101|Xarelto|filmhtfl|10|mg|30|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|8116|12576|lyfalmen|||1|30|0|15,0000|Icepharma hf|Bayer AG|Rivaoxaban||8116||8116|12576||2 484721|L04AD0201|Advagraf|forðahlk|3|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|39770|53371|lyfalmen|||1|50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||39770||39770|53371||1 484846|A10AE0601|Tresiba|stl|100|ae/ml|3|ml|5|áfpen|FlexTouch|A10AE06|01.12.2016||R|0|1|0|0|G|0|NAS|0|0|0|100|DKK|7817|12164|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulin degludec||7817||7817|12164||1 485006|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.01.2012||R|0|0|0|0|G|0|ANS|0|0|1|100|XEU|1121|2948|lyfalmen|||1|5|0||Anstalt zur gewerblichen Produktion|Anstalt zur gewerblichen Produktion|Prednisólón||1121||1121|2948||2 485067|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.01.2016||R|1|0|0|0|G|0|ATN|0|0|0|100|DKK|8220|12719|lyfalmen|V0714|12719|1|100|0|50,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||8220||8220|12719||2 485304|C02KX0501|Adempas|filmhtfl|2|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|320328|404505|lyfsjukr|||1|84|0|37,3300|Vistor hf|Bayer AG|Riociguatum||320328||320328|404505||1 485549|R03AK0705|Bufomix Easyhaler|innönddu|329|mcg/sk|60|skammtar|3|innö.t|320+9 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|11410|17110|lyfalmen|||2|180|0|90,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||11410||11410|17110||1 485593|J01FA0904|Clarithromycin Krka|filmhtfl|500|mg|21|stk|1|þpakki||J01FA09|01.09.2018||R|1|0|0|0|0|0|KNM|0|0|1|100|IKR|4800|8012|lyfalmen|V0116|6650|2|21|0|21,0000|LYFIS ehf|Krka d.d. Novo mesto|Klaritrómýcín||4800||4800|8012||2 485764|J05AX1201|Tivicay|filmhtfl|50|mg|30|stk|1|glas||J05AX12|01.04.2014||R|1|0|0|1|0|1|VIC|0|0|0|100|DKK|64146|84202|lyfsjukr|||1|30|0|30,0000|Vistor hf|ViiV Healthcare BV|Dolutegravír||64146||64146|84202||1 486750|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.09.2017||L|0|0|0|0|0|0|OEL|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón|||||||1 486779|M01AE0218|Naproxen Mylan|töflur|250|mg|20|stk|1|þpakki||M01AE02|01.04.1995||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2 486821|N06BA0404|Methylphenidate Sandoz|forðatfl|18|mg|90|stk|1|glas||N06BA04|01.11.2016||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|10225|12164|lyfalmen|V0958|11637|2|90|0|54,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||7817||7817|12164||1 486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|0|0|0|0|G|0|HES|0|0|1|100|DKK|430|1997|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Dexametasón||430||430|1997||1 486886|S01CA0101|Maxitrol|augndr|||5|ml|1|glas||S01CA01|01.07.1990||R|0|0|0|0|G|0|HES|0|0|1|100|DKK|474|2057|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Dexametasón||474||474|2057||1 487105|L01XE2801|Zykadia|hylki|150|mg|150|stk|1|þpakki|3 x 50|L01XE28|01.05.2017||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|654403|820001|lyfsjukr|||1|150|0||Vistor hf|Novartis Europharm Ltd|Ceritinib||654403||654403|820001||1 487361|H02AB0910|Hydrokortison Orion|töflur|10|mg|100|stk|1|þpakki||H02AB09|01.11.2015||R|0|0|0|0|G|0|ARN|0|0|1|100|DKK|2087|4277|lyfalmen|||2|100|0|33,3300|Vistor hf|Orion Corporation|Hýdrókortisón||2087||2087|4277||1 487650|N04BD0204|Rasagiline Mylan|töflur|1|mg|112|stk|1|þpakki||N04BD02|01.11.2016||R|0|0|0|0|G|0|ASD|0|0|0|100|SEK|20882|13008|lyfalmen|||2|112|0|112,0000|Icepharma hf|Mylan S.A.S.|Rasagilín||8430||8430|13008|31.8.2018|2 487692|L04AB0101|Enbrel|sts|10|mg|4|hgl|1|pakki|+ leysir, lausn|L04AB01|01.12.2012||R|0|1|0|1|0|1|PHH|0|1|0|100|DKK|25846|35760|lyfsjukr|||1|4|0|5,7200|Icepharma hf|Pfizer Limited|Etanercept||25846||25846|35760||1 487725|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|43375|57931|lyfsjukr|||1|1,2|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||43375||43375|57931||1 487796|L04AA1302|Leflunomide medac|töflur|10|mg|100|stk|1|glas||L04AA13|01.07.2011||R|0|1|0|1|G|0|WIL|0|0|0|100|XEU|23173|29866|lyfalmen|V0453|29866|2|100|0|50,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíð||21186||21186|29866||2 487827|M01AB0517|Diclomex|sþ-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.04.2013||R|1|0|0|0|G|0|RTH|0|0|1|100|IKR|1033|2231|lyfalmen|V0469|2231|2|100|0|50,0000|Alvogen|ratiopharm GmbH|Díklófenak||600||600|2231||2 487961|QC01CE9001|Vetmedin vet.|tuggutfl|5|mg|100|stk|1|þpakki|fyrir hunda|QC01CE90|01.04.2017||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|7175|13783|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||7175||7175|13783||1 488152|G04BE0807|Tadalafil Mylan|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.01.2018||R|1|0|0|0|0|0|GEN|0|0|0|100|IKR|3273|3676|lyfalmen|V0924|3221|2|4|0|4,0000|Icepharma hf|Generics UK Ltd|Tadalafíl||1650||1650|3676||2 488468|L01XE1801|Jakavi|töflur|5|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|219852|279541|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||219852||219852|279541||1 488730|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|1|1|0|1|G|0|GRP|0|0|0|100|DKK|5480|8948|lyfalmen|||1|50|0|14,2857|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||5480||5480|8948||1 488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|1|1|0|1|G|0|GRP|0|0|0|100|DKK|8768|13473|lyfalmen|||1|50|0|35,7143|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||8768||8768|13473||1 488813|N07BA0106|Nicotinell|forðapl|21|mg/sólh|7|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|10,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 489085|N06BA0407|Metylfenidat Actavis|forðatfl|27|mg|100|stk|1|glas||N06BA04|01.08.2017||R|1|1|1|0|0|0|GPA|0|0|0|100|XEU|13989|18511|lyfalmen|||2|100|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||12428||12428|18511||1 489149|G03GA0503|Bemfola|stl|150|ae|0,25|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|4972|8248|lyfalmen|||1|0,25|0|2,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||4972||4972|8248||3 489259|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|70648|92426|lyfsjukr|||1|1,6|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||||70648|92426||1 489264|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.09.2017||L|0|0|0|0|0|0|OEL|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón|||||||1 489662|A10AE5401|Suliqua|stl|||3|ml|5|áfpen|100 ein/ml + 33 mcg/ml|A10AE54|01.05.2018||R|0|1|0|0|0|0|SGB|0|0|0|100|XEU|16319|23866|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi-aventis groupe|Insulin glargine og lixisenatide||16319||16319|23866||1 490198|N03AX1606|Pregabalin Mylan|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|5297|4591|lyfalmen|||2|56|0|42,0000|Mylan AB|Generics (UK) Ltd.|Pregabalín||2315||2315|4591|30.6.2018|2 490417|G03FB0504|Evorel Sequi|forðapl|||8|stk|1|pakki||G03FB05|01.08.1999||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|1580|3580|lyfalmen|||1|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1580||1580|3580||1 490425|G03FA0104|Evorel Conti|forðapl|||8|stk|1|pakki||G03FA01|01.08.1999||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|1464|3420|lyfalmen|||1|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1464||1464|3420||1 490510|G03CX0103|Tibolon Orifarm|töflur|2,5|mg|84|stk|1|þpakki|3 x 28 stk|G03CX01|01.11.2014||R|0|0|0|0|G|0|IRO|0|0|0|100|XEU|3820|6663|lyfalmen|V0133|6663|2|84|0|84,0000|Artasan ehf|Orifarm Generics A/S|Tíbólón||3820||3820|6663||1 490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|3285|5926|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Atorvastatín||3285||3285|5926||1 490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|8469|8960|lyfalmen|V0112|2713|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Atorvastatín||5489||5489|8960||1 490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|10338|11925|lyfalmen|V0113|2713|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Atorvastatín||7643||7643|11925||1 490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|12139|14679|lyfalmen|V0114|2713|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Atorvastatín||9644||9644|14679||1 491230|J05AP5501|Epclusa|filmhtfl|500|mg|28|stk|1|glas|400 mg + 100 mg|J05AP55|01.10.2016||R|0|0|0|1|0|1|GSE|0|0|0|100|DKK|2031231|2532390|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|Sofosbuvír og Velpatasvír||2031231||2031231|2532390||2 491237|L02BX0301|Zytiga|filmhtfl|500|mg|56|stk|1|þpakki||L02BX03|01.12.2017||R|0|0|0|0|0|1|JCI|0|1|0|100|SEK|288087|364407|lyfsjukr|||1|56|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Abírateron||288087||288087|364407||1 491321|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.08.2013||R|0|1|0|1|0|1|PHH|0|1|0|100|DKK|105940|137867|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Limited|Etanercept||||105940|137867||1 491593|M05BX0402|XGEVA|stl|120|mg|1,7|ml|1|hgl|lausn|M05BX04|01.01.2018||R|0|1|0|0|0|1|AEB|0|0|0|100|DKK|35630|48135|lyfsjukr|||1|1,7|0|363,6364|Vistor hf|Amgen Europe B.V.|Denosúmab||35630||35630|48135||1 491695|N06AX2107|Duloxetine Mylan|sþ-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.10.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|1820|3202|lyfalmen|V0693|3110|2|28|0|28,0000|Mylan AB|Generics (UK) Ltd.|Duloxetín||1306||1306|3202||2 491753|C10AC0103|Questran Loc|mixtduft|4|g|50|skpokar|1|pakki||C10AC01|01.12.2014||R|0|0|0|0|0|0|BBB|0|0|0|100|DKK|2939|5450|lyfalmen|||1|50|0|14,2800|Vistor hf|Bristol-Myers Squibb AB|Kólestýramín||||2939|5450||1 492114|J07BB0205|Influvac|stl|||0,5|ml|1|áfspr|með nál|J07BB02|01.08.2017||R|0|0|0|0|0|0|PGB|0|0|0|100|DKK|682|2344|lyfalmen|||1|0,5|0||Icepharma hf|BGP Products ApS|Inflúensa, hreinsaðir mótefnavakar||682||682|2344||2 492377|L01XE1401|Bosulif|filmhtfl|500|mg|28|stk|1|þpakki||L01XE14|01.09.2014||R|1|0|0|1|0|1|PIZ|0|1|0|100|DKK|430776|541872|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Ltd|Bósútíníb||430776||430776|541872||1 492405|N04BA0202|Madopar Depot|forðahlk|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.01.1991||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|2365|4660|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2365||2365|4660||2 492507|S01BA0201|Softacort|augndr|3,35|mg/ml|0,4|ml|30|sk-ílá|lausn í staksk.íláti|S01BA02|01.05.2018||R|0|0|0|0|G|0|TEA|0|0|1|100|SEK|1241|3113|lyfalmen|||1|12|0||Vistor hf|Laboratories THEA|Hydrocortisone||1241||1241|3113||1 492512|A02BC0102|Losec|sh-tfl|10|mg|14|stk|1|þpakki||A02BC01|01.09.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1 492520|A02BC0102|Losec|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5195|8555|lyfalmen|V0002|5837|1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||5195||5195|8555||1 492546|A02BC0102|Losec|sh-tfl|20|mg|14|stk|1|þpakki||A02BC01|01.05.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1 492815|C10BA0501|Atozet|filmhtfl|20|mg|90|stk|1|þpakki|10 mg + 10 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|13647|20189|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||13647||13647|20189||1 492917|QD07XB0201|Dermanolon|húðúði|19,47|mg/ml|75|ml|1|úðaílá|1,77+17,7 mg/ml|QD07XB02|01.11.2017||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|2758|5403|vetalmen|||0|75|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Triamcinolon||||2758|5403||2 493113|R02AA0306|Strepsils Jordbær Sukkerfri|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.2011||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 493143|QN02AE0102|Bupredine vet|stl|0,3|mg/ml|10|ml|1|hgl||QN02AE01|01.06.2018||R|0|0|1|0|0|0|VEB|1|0|0|100|IKR|3725|7238|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Buprenorphinhýdróklóríð||||3725|7238||2 493173|N06BA0902|Atomoxetin Actavis|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017||R|1|1|0|0|0|0|GPA|0|0|0|100|XEU|10069|5456|lyfalmen|V0813|5218|2|28|0|6,3000|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||2943||2943|5456||1 493218|B03AC0001|Monofer|irl|100|mg/ml|5|ml|1|hgl||B03AC|01.07.2013||R|0|1|0|0|G|0|PAC|0|0|1|100|DKK|21849|30705|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||21849||21849|30705||1 493226|A02BC0113|Omeprazol Sandoz|sþ-hylki|20|mg|14|stk|1|þpakki||A02BC01|01.10.2015|31.07.2018|L|1|0|0|0|0|0|SHS|0|0|0|100|IKR|||lyflausa|||2|14|0|14,0000|Artasan ehf|Sandoz A/S|Ómeprazól|||||||1 493496|N05AX1303|TREVICTA|stl|175|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|73244|95709|lyfalmen|||1|1|0|70,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||73244||73244|95709||1 493534|L01XC2401|Darzalex|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC24|01.06.2017||R|0|1|0|0|0|1|JCI|0|1|0|100|SEK|54542|72055|lyfsjukr|||1|5|0||Vistor hf|Janssen-Cilag International N.V.|Daratumumab||54542||54542|72055||1 493888|C09CA0107|Losartan Medical Valley|filmhtfl|12,5|mg|98|stk|1|þpakki||C09CA01|01.10.2017||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|1455|3408|lyfalmen|V0213|3116|2|98|0|24,5000|Acare ehf|Medical Valley Invest AB|Lósartan||1455||1455|3408||2 493896|C10AA0509|Atorvastatin Xiromed|filmhtfl|20|mg|98|stk|1|þpakki||C10AA05|01.04.2018||R|1|0|0|0|G|0|MVX|0|0|0|100|IKR|1960|2686|lyfalmen|V0113|2659|2|98|0|98,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||931||931|2686||2 494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|937|2695|lyfalmen|||1|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||937||937|2695||1 494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|þpakki||N02CX01|01.04.1974||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2694|5113|lyfalmen|||1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S|Pízótífen||2694||2694|5113||1 494237|L01XC0201|MabThera|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|0|1|0|0|0|1|RRG|0|1|0|100|DKK|58037|76475|lyfsjukr|||1|20|0||Icepharma hf|Roche Registration GmbH|Rítúxímab||58037||58037|76475||2 494286|L01XC0201|MabThera|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|0|1|0|0|0|1|RRG|0|1|0|100|DKK|145092|186561|lyfsjukr|||1|50|0||Icepharma hf|Roche Registration GmbH|Rítúxímab||145092||145092|186561||2 494474|J02AC0106|Fungyn|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.10.2017||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|1250|2066|lyfalmen|V0551|2024|2|7|0|1,7500|Alvogen|Alvogen|Flúkónazól||480||480|2066||2 494533|G04BE0807|Tadalafil Mylan|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.01.2018||R|1|0|0|0|0|0|GEN|0|0|0|100|IKR|7287|5809|lyfalmen|V0145|5609|2|8|0|16,0000|Icepharma hf|Generics UK Ltd|Tadalafíl||3200||3200|5809||2 494559|D10AF0101|Dalacin|húðfl|10|mg/ml|60|ml|1|glas|fleyti|D10AF01|01.10.1995||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|1770|3841|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||1770||1770|3841||1 494578|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|14|stk|1|þpakki||A02BC05|01.10.2015||L|1|0|0|0|0|0|GRP|0|0|0|100|IKR|||lyflausa|||2|14|0|9,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól|||||||1 494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|1767|3837|lyfalmen|V0128|2267|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||1767||1767|3837||1 494724|G03FA0102|Kliogest|töflur|||84|stk|1|skífup||G03FA01|01.10.1986||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2568|4940|lyfalmen|V0410|4154|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2568||2568|4940||1 494740|QA12CC0203|Sedaman vet|irl|200|mg/ml|100|ml|1|hgl||QA12CC02|01.04.2014||R|0|0|0|0|0|0|OOR|0|0|0|100|DKK|2149|4224|vetalmen|||0|100|0||Icepharma hf|Orion Corporation|Magnesíum súlfat||2149||2149|4224||2 494831|B01AC0702|Persantin retard|forðahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|2274|4535|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||2274||2274|4535||1 494885|A16AA0402|Procysbi|hylki|75|mg|250|stk|1|glas||A16AA04|01.04.2016||R|0|1|0|1|0|1|CFS|0|0|0|100|XEU|717387|898336|lyfsjukr|||1|250|0|9,3700|Chiesi Pharma AB|Chiesi Farmaceutici S.p.A|Mecaptamín||717387||717387|898336||3 495256|A02BC0404|Rabeprazol Medical Valley|sþ-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.09.2018||R|0|0|0|0|G|0|VAL|0|0|0|100|IKR|3000|3814|lyfalmen|V0010|3814|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Rabeprazól||1750||1750|3814||2 495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|þpakki||A04AA01|01.01.1991||R|1|0|0|0|G|0|NAA|0|0|1|100|DKK|17186|6353|lyfalmen|V0384|4488|1|15|0|7,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||3595||3595|6353||1 495637|J02AC0304|Voriconazole Accord|filmhtfl|200|mg|30|stk|1|þpakki||J02AC03|01.04.2018||R|1|1|0|0|0|1|ARD|0|0|0|100|XEU|70623|92394|lyfsjukr|||2|30|0|15,0000|Artasan ehf|Accord Healthcare Limited|Voricónazól||70623||70623|92394||1 495692|N05AX1211|Aripiprazole Mylan Pharma|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.05.2017||R|1|1|0|0|G|0|MAT|0|0|0|100|IKR|7772|3869|lyfalmen|V0683|3787|2|56|0|37,3300|Icepharma hf|Pharmathen S.A.|Aripiprazól||1790||1790|3869||2 495757|N06AX2601|Brintellix|filmhtfl|10|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LUN|0|0|0|100|DKK|4776|7979|lyfalmen|||1|28|0|28,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||4776||4776|7979||1 496040|N06DA0303|Nimvastid (Lyfis)|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|27510|37865|lyfalmen|V0346|37865|3|112|0|56,0000|LYFIS ehf|LYFIS ehf|Rívastigmín||27510||27510|37865||2 496174|QJ01MA9001|Baytril vet.|töflur|150|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3579|6961|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||3579||3579|6961||2 496935|N02AG0201|Ketogan|eþ-stíll|||10|stk|1|pakki|10 + 50 mg|N02AG02|01.07.1994||R|0|0|1|0|G|0|PLS|0|0|0|100|DKK|367|1910|lyfalmen|||1|10|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||367||367|1910||1 496950|N02AG0201|Ketogan|töflur|||20|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|662|2316|lyfalmen|||1|20|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||662||662|2316||1 497003|L01XE0103|Mylaukim|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.09.2014||R|0|0|0|1|0|1|WEH|0|1|0|100|XEU|154342|97380|lyfsjukr|||2|30|0||Williams & Halls efh|Williams & Halls ehf|Imatiníb||74565||74565|97380||2 497012|A07AA1201|Dificlir|filmhtfl|200|mg|20|stk|1|þpakki||A07AA12|01.08.2012||R|1|0|0|0|0|1|APE|0|0|0|100|XEU|193759|247089|lyfsjukr|||1|20|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Fidaxomicin||193759||193759|247089||1 497099|N02AG0201|Ketogan|töflur|||100|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|2524|4879|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||2524||2524|4879||1 497286|C08CA0105|Amlodipin Bluefish|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.12.2014||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|1153|2320|lyfalmen|V0056|2320|2|100|0|100,0000|Vistor hf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|2320||1 497290|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.01.2016||R|1|0|0|0|0|0|GRP|0|0|0|100|NOK|5204|4054|lyfalmen|||1|12|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rísedrónsýru||1925||1925|4054||1 497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|485|2072|lyfalmen|V0448|2072|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Enalapríl||485||485|2072||1 497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|968|2737|lyfalmen|V0449|2737|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Enalapríl||968||968|2737||1 497995|S01EC0303|Dorzolamide Portfarma|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.10.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|1202|3059|lyfalmen|||2|5|0|16,6667|Alvogen|Alvogen|Dorzólamíð||1202||1202|3059||2 498051|A10BX0204|Repaglinide Krka|töflur|2|mg|120|stk|1|þpakki||A10BX02|01.11.2014||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2300|4571|lyfalmen|V0472|4571|2|120|0|60,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2300||2300|4571||2 498481|N05AX1210|Aripiprazol Medical Valley|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.10.2016||R|1|1|0|0|G|0|VAL|0|0|0|100|IKR|12534|3869|lyfalmen|V0683|3787|2|56|0|37,3300|Acare ehf|Medical Valley Invest AB|Aripiprazól||1790||1790|3869||2 498552|QN01AX9401|AQUI-S vet.|baðþ|540|g/líter|1000|ml|1|glas||QN01AX94|01.06.2016||R|0|0|0|0|0|0|SAS|0|0|0|100|NOK|61493|99127|veteldis|||0|1000|0||Vistor hf|Scan Aqua AS|Isoeugenol||61493||61493|99127||1 499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|15139|22242|lyfalmen|V0610|11198|1|56|0|42,0000|Icepharma hf|Pfizer ApS|Ziprasidon||15139||15139|22242||1 499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|19540|28300|lyfalmen|V0718|19542|1|56|0|56,0000|Icepharma hf|Pfizer ApS|Ziprasidon||19540||19540|28300||1 499273|B01AF0101|Xarelto|filmhtfl|20|mg|28|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|7575|11831|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer AG|Rivaoxaban||||7575|11831||2 499436|R03AK1101|Flutiform|innúðal|130|mcg/sk|120|skammtar|1|pakki|125+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|MUP|0|0|0|100|DKK|4906|8158|lyfalmen|||1|120|0|30,0000|Icepharma hf|Mundipharma A/S|Formóteról og flútikasón||4906||4906|8158||2 499462|M05BA0606|Ibandronic acid WH|irþ|2|mg|2|ml|1|hgl|lausn|M05BA06|01.03.2018||R|0|1|0|0|0|1|WEH|0|0|0|100|IKR|7722|11360|lyfsjukr|||2|2|0|0,3333|Williams & Halls efh|Williams & Halls ehf|Íbandrónsýra||7233||7233|11360||2 499920|N06AX2601|Brintellix|filmhtfl|20|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LUN|0|0|0|100|DKK|8918|13680|lyfalmen|||1|28|0|56,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||8918||8918|13680||1 500402|C07AB0214|Bloxazoc|forðatfl|25|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|900|2079|lyfalmen|V0050|2079|2|100|0|15,8300|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||490||490|2079||2 500476|L01XE3901|Rydapt|hylki|25|mg|112|stk|1|þpakki|4 x 28|L01XE39|01.04.2018||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|1582549|1974355|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Midostaurin||1582549||1582549|1974355||1 500481|J05AR1701|Descovy|filmhtfl|210|mg|30|stk|1|glas|200+10 mg|J05AR17|01.10.2016||R|0|0|0|1|0|1|GSE|0|0|0|100|DKK|57473|75762|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|emtricitabine og tenofovir alafenamide||57473||57473|75762||2 501225|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|185|mg|98|stk|1|þpakki|160/25 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|4087|4189|lyfalmen|||2|98|0|98,0000|Alvogen|ratiopharm GmbH|Valsartan og þvagræsilyf||2023||2023|4189|31.8.2018|2 501278|G04BD1201|Betmiga|forðatfl|25|mg|30|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|4634|7783|lyfalmen|||1|30|0|15,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||4634||4634|7783||1 501364|N06BA0403|Ritalin Uno|hylki|60|mg|30|stk|1|glas||N06BA04|01.11.2015||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|11405|17103|lyfalmen|||1|30|0|60,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||11405||11405|17103||1 501660|B01AF0101|Xarelto|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF01|01.04.2015||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|22076|30992|lyfalmen|||1|168|0|21,0000|Icepharma hf|Bayer AG|Rivaoxaban||22076||22076|30992||2 501735|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|2222|4463|lyfalmen|V0434|4094|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2222||2222|4463||2 502349|G04BE0313|Sildenafil Medical Valley|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.03.2018||R|1|0|0|0|0|0|VAL|0|0|0|100|XEU|2906|3420|lyfalmen|V0143|3420|2|12|0|12,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||1464||1464|3420||2 502647|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|30|stk|1|þpakki|með br. losunarhraða|G04CA02|01.12.2017||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|1774|3847|lyfalmen|V0926|3847|2|30|0|30,0000|Medical ehf|Medical ehf|Tamsúlósín||1774||1774|3847||2 502761|QP51AA0101|Metrobactin vet|töflur|250|mg|100|stk|1|þpakki||QP51AA01|01.04.2018||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|3285|5662|vetorma|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Metronidazolum||||3285|5662||2 502888|N07BC0202|Metadon Abcur|töflur|10|mg|100|stk|1|þpakki||N07BC02|01.03.2016||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|3369|6042|lyfalmen|||1|100|0|40,0000|Icepharma hf|Abcur AB|Metadón||3369||3369|6042||2 502904|A10BK0101|Forxiga|filmhtfl|10|mg|28|stk|1|þpakki||A10BK01|01.11.2015||R|1|0|0|0|G|0|BRI|0|0|0|100|SEK|4578|7706|lyfalmen|||1|28|0|28,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Dapagliflozin||4578||4578|7706||1 502956|A11DA0101|Tiacur|stl|25|mg/ml|2|ml|5|lykjur||A11DA01|01.09.2015||R|0|0|0|0|0|0|ABC|0|0|0|100|SEK|10769|16227|lyfalmen|||1|10|0|5,0000|Icepharma hf|Abcur AB|Thiamine (vit B1)||||10769|16227||2 503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|16370|23937|lyfsjukr|||1|1|0|37,5000|Vistor hf|Ferring|Triptórelín||16370||16370|23937||1 503266|N03AX2201|Fycompa|filmhtfl|6|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|16623|24285|lyfalmen|||1|28|0|21,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||16623||16623|24285||1 503406|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|1|innö.t||R03BB05|01.12.2015||R|0|0|0|0|G|0|ZEN|0|0|0|100|SEK|3923|6805|lyfalmen|||1|60|0|30,0000|Vistor hf|AstraZeneca AB|Aclídínumbrómíð||3923||3923|6805||1 503491|N06DA0303|Nimvastid (Lyfis)|hylki|1,5|mg|28|stk|1|þpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|6070|9760|lyfalmen|V0344|9760|3|28|0|4,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||6070||6070|9760||2 504020|B05AA0114|Albuman|irl|40|g/líter|250|ml|1|hgl|lausn|B05AA01|01.04.2013||R|0|0|0|0|0|1|SPP|0|0|0|100|XEU|3364|6035|lyfsjukr|||1|250|0||Williams & Halls efh|Sanquin Plasma Product|Albúmín||3364||3364|6035||2 504119|A10BB1202|Glimeryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.11.2011||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|1294|2421|lyfalmen|V0494|2093|2|90|0|180,0000|Actavis Group hf|Actavis hf|Glímepíríð||738||738|2421||1 504120|R03AL0301|ANORO|innönddu|77|mcg/sk|30|skammtar|1|innö.t|55+22 mcg|R03AL03|01.11.2014||R|0|0|0|0|G|0|RGO|0|0|0|100|DKK|5599|9111|lyfalmen|||1|30|0||Vistor hf|Glaxo Group Limited|Vilanterol og umeclidinium bromide||5599||5599|9111||1 504169|G04BE0302|Revatio|mixtduft|10|mg/ml|112|ml|1|glas||G04BE03|01.04.2016||R|0|0|0|1|0|1|PHH|0|0|0|100|DKK|29677|40606|lyfsjukr|||1|112|0|22,4000|Icepharma hf|Pfizer Limited|Síldenafíl||29677||29677|40606||1 504502|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.09.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|474|2057|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||474||474|2057||1 504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|þpakki||N05BA08|01.01.1987||R|1|0|0|0|0|0|ROC|0|0|1|100|DKK|908|2655|lyfalmen|||1|100|0|30,0000|Icepharma hf|Roche|Brómazepam||908||908|2655||2 504923|QN04BC0201|Prascend|töflur|1|mg|60|stk|1|þpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|10950|20945|vetalmen|||0|60|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||10950||10950|20945||1 505095|N06AX1613|Venlafaxin Medical Valley|forðatfl|150|mg|100|stk|1|glas||N06AX16|01.10.2017||R|0|0|0|0|G|0|VAL|0|0|0|100|IKR|3100|2781|lyfalmen|V0335|2781|2|100|0|150,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||1000||1000|2781||2 505647|N07BA0147|Nicorette QuickMist|munnhúði|1|mg/sk|300|skammtar|1|fl|2 x 150 úðaskammtar|N07BA01|01.11.2012||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|300|0|0,8800|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|2818|5284|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Doxórúbicín||2818||2818|5284||1 505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|6432|10258|lyfsjukr|||1|25|0||Icepharma hf|Pfizer ApS|Doxórúbicín||6432||6432|10258||1 506036|N03AX2201|Fycompa|filmhtfl|4|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|16623|24285|lyfalmen|||1|28|0|14,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||16623||16623|24285||1 506176|N07BC0202|Metadon Abcur|töflur|5|mg|100|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|1908|4031|lyfalmen|||1|100|0|25,0000|Icepharma hf|Abcur AB|Metadón||1908||1908|4031||2 506276|A02BC0404|Rabeprazol Medical Valley|sþ-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.09.2018||R|0|0|0|0|0|0|VAL|0|0|0|100|IKR|1390|3318|lyfalmen|V0467|1707|2|56|0|28,0000|Acare ehf|Medical Valley Invest AB|Rabeprazól||1390||1390|3318||2 506431|G04BE0808|Tadalafil Sandoz|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.01.2018||R|1|0|0|0|0|0|SHS|0|0|0|100|DKK|3911|4564|lyfalmen|V0145|2805|2|4|0|8,0000|Artasan ehf|Sandoz A/S|Tadalafíl||2295||2295|4564||1 506756|M01AH0504|Etoricoxib Krka|filmhtfl|90|mg|100|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|12000|7735|lyfalmen|V0831|7735|2|100|0|150,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||4599||4599|7735||2 506809|N05AX1207|Lemilvo|töflur|5|mg|100|stk|1|glas||N05AX12|01.03.2016||R|1|1|0|0|G|0|GPA|0|0|0|100|XEU|8598|7420|lyfalmen|V0682|6763|2|100|0|33,3300|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||4370||4370|7420||1 506963|C01EB2101|Rapiscan|stl|400|mcg|5|ml|1|hgl||C01EB21|01.01.2018||R|0|0|0|0|0|1|RAS|0|0|0|100|NOK|6454|10288|lyfsjukr|||1|5|0||Icepharma hf|Rapidscan Pharma Solutions EU Ltd.|Regadenoson||6454||6454|10288||2 506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|1927|4057|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Doxepín||1927||1927|4057||1 507315|L03AB1001|PegIntron|sts|120|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013|30.06.2018|R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|100074|130571|lyfsjukr|||1|4|0|64,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||100074||100074|130571||1 507834|N07CA0102|Betahistin ratiopharm|töflur|16|mg|100|stk|1|þpakki||N07CA01|01.12.2013||R|1|0|0|0|G|0|RHA|0|0|0|100|IKR|3105|5679|lyfalmen|||2|100|0|66,6700|Alvogen|ratiopharm Oy|Betahistín||3105||3105|5679||2 507915|C03DA0103|Spiron|töflur|50|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|1526|3505|lyfalmen|V0092|3505|2|100|0|66,6600|Vistor hf|Orion Corporation|Spírónólaktón||1526||1526|3505||1 507916|S01AA1301|Fucithalmic|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.08.2015||R|0|0|0|0|G|0|AML|0|0|1|100|SEK|699|2367|lyfalmen|||1|5|0||Abcur AB|Amdipharm Limited|Fúsidínsýra||699||699|2367||2 508350|N03AX1603|Pregabalin Krka|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|5662|3022|lyfalmen|V0687|2849|2|56|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1175||1175|3022||2 508589|J02AC0102|Candizol|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.02.2015||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|621|2136|lyfalmen|V0555|2125|2|2|0|1,5000|Actavis Group hf|Actavis Group PTC ehf|Flúkónazól||531||531|2136||1 508634|J07BM0301|Gardasil 9|stl|||0,5|ml|1|áf.spr|dreifa + 2 nálar|J07BM03|01.04.2018||R|0|0|0|0|0|0|MVA|0|0|0|100|DKK|16028|23466|lyfalmen|||1|0,5|0||Vistor hf|MSD VACCINS|Papillomavírus (mannagerð 6, 11, 16, 18, 31, 33, 45, 52, 58)||16028||16028|23466||1 508671|QJ01MA9001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3996|7752|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||3996|7752||2 508689|QJ01MA9001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3600|7000|vetalmen|||0|50|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||3600||3600|7000||2 508705|QJ01MA9001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|10666|20406|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||10666||10666|20406||2 508921|L01CD0401|Jevtana|irþ|60|mg|1|hgl|1|pakki|+ leysir|L01CD04|01.08.2011||R|0|0|0|0|0|1|SGB|0|1|0|100|XEU|463864|583024|lyfsjukr|||1|1|0||Vistor hf|Sanofi-aventis groupe|Cabazitaxel||463864||463864|583024||1 509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|7465|11680|lyfalmen|||1|10|0|133,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||7465||7465|11680||1 509127|QG02CB0301|Finilac|mixtúra|50|mcg/ml|15|ml|1|glas||QG02CB03|01.03.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|5425|10463|vetalmen|||0|15|0||Dýraheilsa ehf|Le Vet B.V.|Kabergólín||5425||5425|10463||2 509359|N06AX1611|Duofaxin|forðatfl|75|mg|28|stk|1|þpakki||N06AX16|01.07.2015|30.06.2018|R|1|0|0|0|0|0|MEV|0|0|0|100|DKK|854|2452|lyfalmen|||2|28|0|21,0000|Vistor hf|MediLink A/S|Venlafaxín||761||761|2452||1 509504|QJ51CR0201|Clavubactin vet.|töflur|312,5|mg|100|stk|1|þpakki|250 mg+ 62,5 mg|QJ51CR02|01.03.2015||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|5785|11146|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Amoxillinum og ensim hemill||5785||5785|11146||2 509577|G03HB0102|Diane mite|töflur|||63|stk|1|þpakki||G03HB01|01.06.2013||R|0|1|0|0|0|0|BAB|0|0|0|100|DKK|1721|3774|lyfalmen|V0134|3091|1|63|0|84,0000|Icepharma hf|Bayer AB|Cýpróterón og östrógen||1721||1721|3774||2 509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|þpakki|150+300 mg|J05AR01|01.05.2004||R|1|0|0|1|0|1|VIH|0|0|0|100|DKK|35362|47796|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare UK Ltd|Zídóvúdín og lamívúdín||35362||35362|47796||1 510200|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAR|0|1|0|100|SEK|64183|84249|lyfsjukr|||1|1|0||Icepharma hf|Bayer AG|Storkuþáttur VIII||||64183|84249||2 510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|RRG|0|0|0|100|DKK|13012|19315|lyfsjukr|||1|1,8|0|12,0000|Icepharma hf|Roche Registration GmbH|Epóetín||13012||13012|19315||2 510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|RRG|0|0|0|100|DKK|19477|28213|lyfsjukr|||1|1,8|0|18,0000|Icepharma hf|Roche Registration GmbH|Epóetín||19477||19477|28213||2 510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|RRG|0|0|0|100|DKK|31949|43479|lyfsjukr|||1|1,8|0|30,0000|Icepharma hf|Roche Registration GmbH|Epóetín||31949||31949|43479||2 510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|RRG|0|0|0|100|DKK|49380|65526|lyfsjukr|||1|3,6|0|60,0000|Icepharma hf|Roche Registration GmbH|Epóetín||49380||49380|65526||2 510553|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|376|1922|lyfalmen|V0601|1756|2|100|0|100,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||376||376|1922||1 510810|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|129046|166604|lyfsjukr|||1|1,2|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||||129046|166604||1 510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|3261|4450|lyfalmen|V0445|3872|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Fínasteríð||2212||2212|4450||1 511263|N02AJ0602|Parkodin forte|filmhtfl|530|mg|30|stk|1|þpakki|30+500 mg|N02AJ06|01.12.2017||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|637|2282|lyfalmen|||2|30|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||637||637|2282||1 511303|G03FB0501|Trisekvens|töflur|||84|stk|1|skífup||G03FB05|01.12.1980||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2105|4302|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2105||2105|4302||1 511506|L01DB0106|Doxorubicin medac|irþ|2|mg/ml|25|ml|1|hgl|lausn|L01DB01|01.08.2017||R|0|0|0|0|0|1|WIL|0|0|0|100|XEU|2069|4253|lyfsjukr|||2|25|0||Williams & Halls efh|medac Gesellschaft|Doxórúbicín||||2069|4253||2 511560|G03GA1001|REKOVELLE|stl|36|mcg|1,08|ml|1|áfpen|+ 6 inndælingarnálar|G03GA10|01.08.2018||R|0|0|0|1|G|0|FEP|0|0|0|100|DKK|34719|46983|lyfalmen|||1|1,08|0||Vistor hf|Ferring Pharmaceuticals A/S|Follitrópín delta||34719||34719|46983||1 511688|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 511932|G02BA0303|Jaydess|leginnle|13,5|mg|1|stk|1|þpakki||G02BA03|01.01.2014||R|0|1|0|0|0|0|BAB|0|0|0|100|DKK|12695|18878|lyfalmen|||1|1|0||Icepharma hf|Bayer AB|Plast lyfjalykkja (IUD) með prógestógen||12695||12695|18878||2 512608|B05XA3101|Peditrace|irþ|||10|ml|10|hgl||B05XA31|01.07.1993||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|4109|7061|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með öðrum efnum||4109||4109|7061||1 512918|M01AH0504|Etoricoxib Krka|filmhtfl|120|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|3400|3057|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1200||1200|3057||2 513133|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.2015||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|1826|2320|lyfalmen|V0057|2320|2|100|0|200,0000|Vistor hf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|2320||1 513195|C10AA0106|Simvastatin Bluefish|filmhtfl|20|mg|100|stk|1|þpakki||C10AA01|01.02.2014||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|836|2123|lyfalmen|V0109|2123|2|100|0|66,6700|Vistor hf|Bluefish Pharmaceuticals AB|Simvastatín||522||522|2123||1 513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|0|0|0|0|0|0|MAR|0|0|1|100|IKR|||lyflausa|||0|35|0||Icepharma hf|Aspen Pharma|Lídókaín|||||||2 513312|A02BC0510|Eradizol|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC05|01.06.2017||L|1|0|0|0|0|0|POF|0|0|0|100|IKR|||lyflausa|||2|28|0|18,6600|Alvogen|Alvogen|Esómeprazól|||||||2 513391|QJ51CR0201|Clavubactin vet.|töflur|62,5|mg|100|stk|1|þpakki|50 mg + 12,5 mg|QJ51CR02|01.03.2015||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2789|5462|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Amoxillinum og ensim hemill||2789||2789|5462||2 513474|N05AH0501|Sycrest|tungur.t|5|mg|60|stk|1|þpakki||N05AH05|01.10.2011|30.06.2018|R|0|0|0|0|0|0|NVO|0|0|0|100|DKK|21431|30176|lyfalmen|||1|60|0|15,0000|Vistor hf|N.V. Organon|Asenapíne||21431||21431|30176||1 513494|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|2104|4135|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||2104||2104|4135||2 513758|QJ01CR0201|Combisyn|stl|175|mg/ml|100|ml|1|hgl|140+35 mg/ml|QJ01CR02|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|1658|3259|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og beta-laktamasa hemill||1658||1658|3259||2 514090|C09AA0211|Enalapril Krka|töflur|5|mg|250|stk|1|glas||C09AA02|01.06.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2000|4158|lyfalmen|||2|250|0|125,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2000||2000|4158||2 514105|N05AH0415|Quetiapin Krka|forðatfl|150|mg|100|stk|1|þpakki||N05AH04|01.04.2018||R|0|1|0|0|G|0|KRK|0|0|0|100|IKR|6000|8012|lyfalmen|V0910|8012|2|100|0|37,5000|LYFIS ehf|Krka Sverige AB|Quetíapín||4800||4800|8012||2 514265|R03AC0302|Bricanyl Turbuhaler|innönddu|0,25|mg/sk|200|skammtar|1|stauk||R03AC03|01.07.1993||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|1228|3095|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||1228||1228|3095||1 514840|N06BA0901|Strattera|hylki|100|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2013||R|1|1|0|0|0|0|DAN|0|0|0|100|XEU|14295|21081|lyfalmen|V0818|18128|1|28|0|35,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||||14295|21081||2 514870|N06AX2105|Duloxetin Krka|sþ-hylki|30|mg|30|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|2131|2437|lyfalmen|V0692|2437|2|30|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||750||750|2437||2 515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|þpakki||N06AX18|01.06.2000||R|1|0|0|0|G|0|PLS|0|0|0|100|IKR|3507|4668|lyfalmen|||1|60|0|30,0000|Icepharma hf|Pfizer ApS|Reboxetin||2371||2371|4668||1 515094|QR06AB0401|Histodine|stl|10|mg/ml|100|ml|1|hgl|lausn|QR06AB04|01.03.2018||R|0|0|0|0|0|0|VEB|1|0|0|100|IKR|2756|5399|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Chlorphenamine maleate||||2756|5399||2 515399|G03GA0503|Bemfola|stl|300|ae|0,5|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|10007|15179|lyfalmen|||1|0,5|0|4,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||10007||10007|15179||3 516182|L01BC5901|Lonsurf|filmhtfl|28,19|mg|20|stk|1|þpakki|20 mg + 8,19 mg|L01BC59|01.09.2016||R|0|0|0|1|0|1|LLS|0|1|0|100|DKK|115597|149877|lyfsjukr|||1|20|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||115597|149877||2 516219|J01FA1006|Azithromycin Eberth|irs|500|mg|10|ml|1|hgl||J01FA10|01.12.2012||R|0|0|0|0|0|1|FRI|0|0|0|100|DKK|4202|6387|lyfsjukr|||1|10|0|1,0000|Alvogen|Dr. Friedrich Eberth Arzneimittel GmbH|Azitrómýcín||3620||3620|6387||2 516630|D06BX0201|Picato|hlaup|500|mcg/g|0,47|g|2|túpur||D06BX02|01.02.2016||R|0|0|0|0|G|0|LBB|0|0|1|100|DKK|14912|21930|lyfalmen|||1|0,94|0||Vistor hf|LEO Laboratories Ltd.|Ingenol mebutate||||14912|21930||1 516972|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|30|stk|1|þpakki||A04AA01|01.12.2015||R|1|0|0|0|G|0|BFP|0|0|1|100|IKR|7836|8975|lyfalmen|V0384|8975|2|30|0|15,0000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||5500||5500|8975||1 517693|N05AH0413|Quetiapin ratiopharm|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|0|G|0|TAB|0|0|0|100|IKR|18600|8012|lyfalmen|V0273|7736|2|100|0|50,0000|Alvogen|Teva Pharma B.V.|Quetíapín||4800||4800|8012||2 517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2310|4584|lyfalmen|V0462|3592|1|90|0|11,2500|Vistor hf|Novo-Nordisk A/S|Repaglíníð||2310||2310|4584||1 517728|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|24512|34073|lyfalmen|||1|100|0|28,5700|Vistor hf|Eisai Ltd|Rúfínamíð||24512||24512|34073||1 517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2515|4867|lyfalmen|V0471|3653|1|90|0|22,5000|Vistor hf|Novo-Nordisk A/S|Repaglíníð||2515||2515|4867||1 517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2705|5128|lyfalmen|V0472|3428|1|90|0|45,0000|Vistor hf|Novo-Nordisk A/S|Repaglíníð||2705||2705|5128||1 517824|C01CA0302|Noradrenalin Abcur|irþ|1|mg/ml|10|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|24107|33561|lyfsjukr|||2|100|0|16,6600|Icepharma hf|Abcur AB|Noradrenalín||24107||24107|33561||2 517914|QI09AL0001|Suvaxyn Circo+MH RTU|stl|||100|ml|1|hgl|fleyti|QI09AL|01.01.2017||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|8046|13868|vetorma|||0|100|0||Icepharma hf|Zoetis Belgium S.A.|Mycoplasma hyopneumoniae, Recombinat Porcine Circovirus||8046||8046|13868||2 518224|N04BD0202|Rasagilin Krka|töflur|1|mg|112|stk|1|þpakki||N04BD02|01.01.2016||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|23524|15995|lyfalmen|V0711|15907|2|112|0|112,0000|LYFIS ehf|Krka d.d. Novo mesto|Rasagilín||10600||10600|15995||2 518241|M01AB0509|Modifenac|forðahlk|75|mg|20|stk|1|þpakki||M01AB05|01.11.2000||R|1|0|0|0|G|0|GRP|0|0|1|100|DKK|874|2608|lyfalmen|||1|20|0|15,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díklófenak||874||874|2608||1 518258|M01AB0509|Modifenac|forðahlk|75|mg|100|stk|1|þpakki|með breyttan losunarhraða|M01AB05|01.11.2000||R|1|0|0|0|G|0|GRP|0|0|1|100|DKK|3608|6371|lyfalmen|||1|100|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díklófenak||3608||3608|6371||1 518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2001||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|1630|3648|lyfalmen|V0590|2929|1|84|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Desógestrel||1630||1630|3648||1 518341|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 518750|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC05|01.01.2015||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|991|2769|lyfalmen|V0004|2769|2|28|0|18,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||991||991|2769||1 518897|A10BH0501|Trajenta|filmhtfl|5|mg|90|stk|1|þpakki||A10BH05|01.12.2012||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|15059|22132|lyfalmen|||1|90|0|90,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||15059||15059|22132||1 518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|785|2485|lyfalmen|||1|125|0|3,1250|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||785||785|2485||2 519061|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.07.2016||L|1|0|0|0|G|0|BAB|0|0|1|100|IKR|||lyfalmen|V0362|1858|1|100|0|100,0000|Icepharma hf|Bayer AB|Lóratadín|||||8646||2 519070|M01AE0116|Ibuprofen Bril|filmhtfl|600|mg|100|stk|1|þpakki||M01AE01|01.11.2016||R|1|0|0|0|G|0|BLL|0|0|1|100|IKR|792|2121|lyfalmen|V0564|2053|2|100|0|50,0000|Williams & Halls efh|Bristol Laboratories Limited|Íbúprófen||520||520|2121||2 519112|QJ01EW1002|Equibactin vet.|pasta|400|mg|45|g|1|áfspr|333,3 + 66,7 mg|QJ01EW10|01.03.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2463|4841|vetalmen|||0|45|0||Dýraheilsa ehf|Le Vet B.V.|||||2463|4841||2 519450|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.05.2014|31.07.2018|R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|3131|5714|lyfalmen|||2|125|0|31,2500|Vistor hf|Takeda Pharma A/S|Fúrósemíð||3131||3131|5714||1 519463|J01EE0108|Eusaprim|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.07.2011||R|0|0|0|0|0|0|AEP|0|0|1|100|DKK|1175|3022|lyfalmen|||1|100|0|2,5000|Icepharma hf|Aspen Pharma Trading Limited|Súlfametoxazól og trímetóprím||1175||1175|3022||2 520029|N03AX1404|Levetiracetam Actavis|filmhtfl|250|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|4473|3929|lyfalmen|V0515|3607|2|100|0|16,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||1834||1834|3929||1 520104|C07BB0701|Bisbetol Plus|filmhtfl|17,5|mg|100|stk|1|þpakki|5+12,5 mg|C07BB07|01.01.2017||R|0|0|0|0|G|0|WEH|0|0|0|100|IKR|2136|4345|lyfalmen|||2|100|0||Williams & Halls efh|Williams & Halls ehf|Bisoprolol og Thiazides||2136||2136|4345||2 520160|J01XA0108|Vancomycin Actavis|st/irþ|500|mg/hgl|1|hgl|1|pakki||J01XA01|01.03.2016||R|0|0|0|0|0|1|GPA|0|0|0|100|XEU|703|1925|lyfsjukr|||2|1|0|0,2500|Actavis Group hf|Actavis Group PTC ehf|Vankómýcín||378||378|1925||1 520186|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|17520|25519|lyfalmen|||1|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||||17520|25519||1 520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|14009|20687|lyfalmen|V0143|3420|1|12|0|12,0000|Icepharma hf|Pfizer ApS|Síldenafíl||14009||14009|20687||1 520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|4558|7679|lyfalmen|V0144|1302|1|4|0|8,0000|Icepharma hf|Pfizer ApS|Síldenafíl||4558||4558|7679||1 520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|12613|18765|lyfalmen|V0144|3906|1|12|0|24,0000|Icepharma hf|Pfizer ApS|Síldenafíl||12613||12613|18765||1 520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1244|2384|lyfalmen|V0056|2320|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Amlódipín||711||711|2384||1 520546|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|þpakki|8+2 mg|N07BC51|01.07.2016||R|0|0|1|1|0|1|IND|0|0|0|100|DKK|9607|14628|lyfsjukr|||1|28|0|28,0000|Vistor hf|Indivior Europe Limited|Búprenorfín í blöndum||9607||9607|14628||1 520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2196|2384|lyfalmen|V0057|2320|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Amlódipín||711||711|2384||1 520759|M03BC5101|Norgesic|töflur|||30|stk|1|þpakki||M03BC51|01.03.1981||R|1|0|0|0|G|0|MEA|0|0|1|100|SEK|242|1738|lyfalmen|||1|30|0|7,5000|Icepharma hf|Meda AB|Orfenadrín í blöndum||242||242|1738||2 520903|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.07.2016||L|1|0|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|10|0|10,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2 522003|QJ51RC2302|Streptocillin, vet.|spenalyf|||8|g|40|spr||QJ51RC23|01.12.1982||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|7566|14525|vetalmen|||0|320|0||Vistor hf|Boehringer Ingelheim Danmark|Prókaínpenicillín í blöndum með öðrum sýklalyfjum||7566||7566|14525||1 522327|N03AX1604|Brieka|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|7196|4598|lyfalmen|V0688|4598|2|56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||2320||2320|4598||1 522427|L03AB1301|Plegridy|stl|125|mcg|2|áf-penni|1|pakki||L03AB13|01.07.2015||R|0|0|0|1|0|1|BNB|0|0|0|100|XEU|95877|124335|lyfsjukr|||1|2|0|28,0900|Icepharma hf|Biogen Netherlands B.V.|Peginterferón beta-1a||95877||95877|124335||2 522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|0|0|0|0|0|1|NEL|0|0|0|100|DKK|136345|175682|lyfsjukr|||1|1|0|0,5000|Vistor hf|Novartis Europharm Ltd|Basiliximab||136345||136345|175682||1 522985|D01AE1603|Amorolfin Apofri|lakk|5|%|3|ml|1|glas||D01AE16|01.05.2018||L|0|0|0|0|0|0|APO|0|0|1|100|IKR|||lyflausa|||2|3|0||LYFIS ehf|Apofri AB|Amorolfín|||||||2 523043|N02AJ0602|Parkodin forte|töflur|530|mg|40|stk|1|þpakki|30+500 mg|N02AJ06|01.11.1998|31.07.2018|R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|999|2780|lyfalmen|||2|40|0|13,3333|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||999||999|2780||1 523151|N05AH0410|Quetiapin Actavis|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.08.2013||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|3984|3551|lyfalmen|V0285|3470|2|100|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||1559||1559|3551||1 523274|S01XA2008|Artelac|augndr|||10|ml|1|plglas||S01XA20|01.05.1998||L|0|0|0|0|G|0|HEG|0|0|0|100|IKR|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar samsetningar|||||1823||1 523350|B02BD0801|NovoSeven|sts|2|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|149304|191799|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||149304||149304|191799||1 523355|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.09.2017||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|1336|2506|lyfalmen|V0144|1302|2|4|0|8,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||800||800|2506||1 523758|L01XE0801|Tasigna|hylki|150|mg|112|stk|1|þpakki||L01XE08|01.03.2013||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|256847|325553|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||256847||256847|325553||1 523773|QD06AA0201|Animed vet.|húðúði|2,45|% w/w|211|ml|1|úðaílá||QD06AA02|01.06.2016||R|0|0|0|0|0|0|ANI|0|0|0|100|IKR|1098|2158|vetalmen|||0|211|0||Dýraheilsa ehf|aniMedica GmbH|Chlortetracycline||1098||1098|2158||2 523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|þpakki||R06AD02|01.10.1995||R|1|0|0|0|G|0|SNP|0|0|1|100|XEU|1221|3086|lyfalmen|V0903|2743|1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1221||1221|3086||1 523937|C10AX0903|Ezetimib Krka|töflur|10|mg|100|stk|1|þpakki||C10AX09|01.05.2018||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|10498|12994|lyfalmen|V0954|12434|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Ezetimíb||8420||8420|12994||2 523967|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|1239|3110|lyfalmen|V0584|3110|2|28|0|7,4700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||1239||1239|3110||1 524215|C01DA1401|Imdur|forðatfl|30|mg|28|stk|1|þpakki||C01DA14|01.07.1993||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|277|1786|lyfalmen|||1|28|0|21,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||277||277|1786||1 524223|C01DA1401|Imdur|forðatfl|30|mg|98|stk|1|þpakki||C01DA14|01.07.1993||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1632|3651|lyfalmen|||1|98|0|73,5000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||1632||1632|3651||1 524257|L02BB0401|Xtandi|hylki|40|mg|112|stk|1|þpakki||L02BB04|01.07.2014||R|1|0|0|0|0|1|APE|0|1|0|100|XEU|382305|481587|lyfsjukr|||1|112|0||Vistor hf|Astellas Phama Europe B.V.|Enzalutamid||382305||382305|481587||1 524276|A02BC0401|Pariet|sh-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|7643|6408|lyfalmen|V0010|3814|1|98|0|98,0000|Vistor hf|Eisai Ltd|Rabeprazól||3635||3635|6408||1 524351|L01XX2401|Oncaspar|stl/irl|750|ein/ml|5|ml|1|hgl||L01XX24|01.10.2016||R|0|0|0|0|0|1|ALT|0|0|0|100|SEK|176038|225049|lyfsjukr|||1|5|0||Lyfjaver ehf|Baxalta Innovations GmbH|Pegaspargase||176038||176038|225049||3 524367|N06AB0313|Fluoxetin WH|hylki|20|mg|98|stk|1|þpakki|Hart|N06AB03|01.07.2017||R|0|0|0|0|G|0|WEH|0|0|0|100|IKR|1122|2918|lyfalmen|V0039|2918|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Flúoxetín||1099||1099|2918||2 524981|D11AX2101|Mirvaso|hlaup|3|mg/g|30|g|1|túpa||D11AX21|01.03.2016||R|0|0|0|0|0|0|GAL|0|0|0|100|XEU|5945|9588|lyfalmen|||1|30|0||Icepharma hf|Galderma International|Brimonidine||5945||5945|9588||2 525014|M03BC5101|Norgesic|töflur|||100|stk|1|þpakki||M03BC51|01.06.1981||R|1|0|0|0|G|0|MEA|0|0|1|100|DKK|554|2167|lyfalmen|||1|100|0|25,0000|Icepharma hf|Meda AB|Orfenadrín í blöndum||554||554|2167|31.8.2018|2 525219|QG03XA9101|Improvac|stl|300|mcg|20|ml|12|fl||QG03XA91|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|11016|21070|vetalmen|||0|240|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||11016||11016|21070||2 525418|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||500|ml|20|pokar|lausn|B05BB01|01.07.2018||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3690|6484|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||3690||3690|6484||2 525720|B01AF0101|Xarelto|filmhtfl|20|mg|100|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|26834|37010|lyfalmen|||1|100|0|100,0000|Icepharma hf|Bayer AG|Rivaoxaban||||26834|37010||2 525857|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA01|01.09.2010||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|4241|7242|lyfsjukr|||2|1000|0||Actavis Group hf|B.Braun Melsungen AG|Kalíumklóríð||4241||4241|7242||2 525865|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA03|01.09.2010||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|3862|6721|lyfsjukr|||2|1000|0||Actavis Group hf|B.Braun Melsungen AG|Natríumklóríð||3862||3862|6721||2 525945|J01MA0205|Ciprofloxacin Villerton|irl|2|mg/ml|100|ml|10|pokar||J01MA02|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|2017|4181|lyfsjukr|||2|1000|0|4,0000|Icepharma hf|Villerton Invest SA|Cíprófloxacín||||2017|4181||2 525998|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|1000|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||4770||2 526004|V07AB0009|Sterilt Vann B. Braun|leysir|||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|1000|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||4832||2 526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|3184|5787|lyfalmen|V0435|5787|1|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3184||3184|5787||2 526376|N03AG0103|Orfiril Retard|forðatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|1|0|0|G|0|DEA|0|0|0|100|XEU|4864|8100|lyfalmen|||1|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||4864||4864|8100||1 526396|N03AX1408|Levetiracetam STADA|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.08.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|9168|5259|lyfalmen|V0516|5259|2|100|0|66,6700|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||2800||2800|5259||2 526496|H02AB0207|Dexamethasone Krka|töflur|4|mg|100|stk|1|þpakki|stakskammtaþynna|H02AB02|01.04.2018||R|0|0|0|0|G|0|KNM|0|0|1|100|IKR|15000|14756|lyfalmen|V0423|14756|2|100|0|266,6666|LYFIS ehf|Krka d.d. Novo mesto|Dexametasón||9700||9700|14756||2 526521|C03DA0404|Kalspar|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|11984|8211|lyfalmen|V0111|8211|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Eplerenón||4945||4945|8211||2 526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|1|0|0|G|0|DEA|0|0|0|100|XEU|3082|5647|lyfalmen|||1|100|0|40,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3082||3082|5647||1 527112|N02BE0116|Pinex Smelt|munndr.t|250|mg|20|stk|1|þpakki||N02BE01|01.09.2011||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyfalmen|||0|20|0|1,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||1961||1 527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|0|0|0|0|0|1|SNP|0|0|0|100|XEU|9832|14938|lyfsjukr|||1|2000|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||9832||9832|14938||1 527453|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|12183|5655|lyfalmen|V0516|5259|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||3088||3088|5655||1 527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|1156|2996|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Emedastín||1156||1156|2996||1 527632|A10AB0505|Fiasp|stl|100|ein/ml|3|ml|5|áfpen|FlexTouch|A10AB05|01.07.2018||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4228|7224|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||4228||4228|7224||1 527685|M01AH0503|Coxerit|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|1|100|IKR|3000|2849|lyfalmen|V0825|2789|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||1049||1049|2849||2 527714|N05AX1303|TREVICTA|stl|525|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|197619|251890|lyfalmen|||1|1|0|210,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||197619||197619|251890||1 527914|QS02CA0103|Saniotic vet.|eyrnadr|||20|ml|1|glas|fyrir hundi og ketti|QS02CA01|01.08.2015||R|0|0|0|0|0|0|RPG|0|0|0|100|XEU|1427|2805|vetalmen|||0|20|0||Icepharma hf|Richter Pharma AG|||1427||1427|2805||2 528055|C03DA0103|Spiron|töflur|25|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|784|2167|lyfalmen|V0046|2167|2|100|0|33,3333|Vistor hf|Orion Corporation|Spírónólaktón||554||554|2167||1 528076|D11AX1002|Finasterid STADA|filmhtfl|1|mg|30|stk|1|þpakki||D11AX10|01.07.2018||R|1|0|0|0|0|0|ASR|0|0|0|100|IKR|3884|6751|lyfalmen|V0961|6751|2|30|0|30,0000|LYFIS ehf|STADA Arzneimittel AG|Fínasteríð||3884||3884|6751||2 528214|N04BC0505|Oprymea|forðatfl|0,52|mg|100|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|8816|13539|lyfalmen|||2|100|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||8816||8816|13539||2 528241|A04AD0101|Scopoderm|forðapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.12.2016||L|0|0|0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen|||0|2|0|2,0000|Artasan ehf|Novartis Healthcare A/S|Skópólamín|||||2739||1 528267|A02BC0501|Nexium|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2013||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|8083|5533|lyfalmen|V0011|4733|1|100|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||2999||2999|5533||1 528311|M01AE0116|Ibuprofen Bril|filmhtfl|400|mg|100|stk|1|þpakki||M01AE01|01.11.2016||R|1|0|0|0|G|0|BLL|0|0|1|100|IKR|590|1954|lyfalmen|V0562|1954|2|100|0|33,3300|Williams & Halls efh|Bristol Laboratories Limited|Íbúprófen||399||399|1954||2 528418|D07AC1302|Ovixan|krem|0,1|%|100|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|1595|3600|lyfalmen|||2|100|0||Vistor hf|Galenica AB|Mómetasón||1595||1595|3600||1 528584|A07EC0202|Pentasa|forðatfl|1|g|60|stk|1|þpakki|6 x 10 stk|A07EC02|01.06.2012||R|1|0|0|0|G|0|FEL|0|0|0|100|DKK|5372|8799|lyfalmen|||1|60|0|40,0000|Vistor hf|Ferring Lægemidler A/S|Mesalazín (5-amínósalicýlsýra)||5372||5372|8799||1 528874|N02CC0405|Rizatriptan ratiopharm|munndr.t|10|mg|18|stk|1|þpakki||N02CC04|01.02.2018||R|0|0|0|0|G|0|RTH|0|0|0|100|XEU|3657|5417|lyfalmen|V0621|5417|2|18|0|18,0000|Alvogen|ratiopharm GmbH|Rizatriptan||2915||2915|5417||2 529352|N05AX1304|Paliperidon Krka|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.08.2018||R|0|0|0|0|0|0|KNM|0|0|0|100|IKR|11088|15857|lyfalmen|V0963|15857|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Paliperídón||10500||10500|15857||2 529735|N03AB0501|Pro-Epanutin|irþ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|53584|70843|lyfsjukr|||1|100|0|11,1000|Icepharma hf|Pfizer ApS|Fosfenýtóín||53584||53584|70843||1 529787|L01XC1801|KEYTRUDA|irþ|50|mg|1|hgl|1|pakki||L01XC18|01.10.2015||R|0|1|0|0|0|1|MBV|0|1|0|100|DKK|221885|282070|lyfsjukr|||1|1|0||Vistor hf|Merck Sharp & Dohme B.V.|Pembrolizumab||221885||221885|282070||1 530109|C10AA0703|Rosuvastatin Krka|filmhtfl|40|mg|30|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|6500|10352|lyfalmen|||2|30|0|120,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||6500||6500|10352||2 530162|A06AD6502|Movicol|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.07.2014||L|0|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|8|0||Artasan ehf|Norgine A/S|Makrógól 3350|||||||1 530172|J05AP0901|Exviera|filmhtfl|250|mg|56|stk|1|þpakki||J05AP09|01.10.2015||R|1|0|0|1|0|1|ABD|0|1|0|100|DKK|133982|172743|lyfsjukr|||1|56|0|28,0000|Vistor hf|AbbVie Deutschland GmbH & Co. KG|Dasabuvir||133982||133982|172743||1 530188|A06AD6502|Movicol|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|XEU|||lyfalmen|V0592|5246|0|50|0|25,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||6021||1 530255|M01AH0504|Etoricoxib Krka|filmhtfl|30|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|2488|2988|lyfalmen|V0824|2988|2|30|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1150||1150|2988||2 530322|B01AC0602|Hjarta-Aspirín|sþ-tfl|75|mg|100|stk|1|glas||B01AC06|01.02.2014||L|1|0|0|0|0|0|LYF|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|LYFIS ehf|LYFIS ehf|Asetýlsalicýlsýra|||||||2 530701|QN05CM9204|Nerfasin vet.|stl|20|mg/ml|25|ml|1|hgl|nautg. hestar,hundar og kettir|QN05CM92|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|1275|2506|vetalmen|||0|25|0||Dýraheilsa ehf|Le Vet B.V.|||1275||1275|2506||2 530741|G03FA0105|Activelle|töflur|||84|stk|1|pakki|þp 1+0,5 mg|G03FA01|01.03.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2231|4476|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2231||2231|4476||1 530828|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|4968|8243|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||4968||4968|8243||1 531611|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.04.2015||R|0|0|0|0|0|1|STI|0|0|0|100|NOK|3559|6304|lyfsjukr|||1|5|0|3,3333|Lyfjaver ehf|Sigma-Tau Industrie Farmaceutiche|Oxýtócín||3559||3559|6304||3 532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|502|2096|lyfalmen|||1|30|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||502||502|2096||1 532707|N04BD0203|Rasagilin WH|töflur|1|mg|100|stk|1|þpakki||N04BD02|01.05.2016||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|36242|14203|lyfalmen|V0711|14203|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Rasagilín||9298||9298|14203||2 532821|L01XX3203|Bortezomib W&H|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.02.2016||R|0|1|0|0|0|1|WEH|0|1|0|100|XEU|92099|119557|lyfsjukr|||2|1|0||Williams & Halls efh|Williams & Halls ehf|Bortezomíb||92099||92099|119557||2 532869|QP51AJ0103|Baycoxine vet|mixtúra|50|mg/ml|1000|ml|1|glas||QP51AJ01|01.08.2018||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|20783|35822|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|Toltrazuril||20783||20783|35822||2 532881|C07BB0701|Bisbetol Plus|filmhtfl|35|mg|100|stk|1|þpakki|10+25 mg|C07BB07|01.01.2017||R|0|0|0|0|G|0|WEH|0|0|0|100|IKR|3843|6694|lyfalmen|||2|100|0||Williams & Halls efh|Williams & Halls ehf|Bisoprolol og Thiazides||3843||3843|6694||2 532983|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1544|3530|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||1544||1544|3530||2 532984|N02AJ0601|Parkodin|filmhtfl|510|mg|100|stk|1|þpakki|10+500 mg|N02AJ06|01.06.2018||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|1058|2861|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||1058||1058|2861||1 533048|N06BA0407|Metylfenidat Actavis|forðatfl|54|mg|100|stk|1|glas||N06BA04|01.07.2017||R|1|1|1|0|0|0|GPA|0|0|0|100|XEU|15823|14137|lyfalmen|V0622|14137|2|100|0|180,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||9250||9250|14137||1 533147|B02BD0208|Afstyla|sts|3000|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|0|1|0|1|CSB|0|1|0|100|SEK|196957|251066|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||196957||196957|251066||2 533363|L04AA3601|Ocrevus|irþ|300|mg|10|ml|1|hgl|lausn|L04AA36|01.04.2018||R|0|0|0|0|0|1|RRG|0|0|0|100|DKK|632380|792611|lyfsjukr|||1|10|0||Icepharma hf|Roche Registration GmbH|Ocrelizumab||||632380|792611||2 533779|A02BC0111|Omeprazol Pensa|sþ-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.12.2012||L|1|0|0|0|0|0|PEN|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Lyfjaver ehf|Pensa Pharma AB|Ómeprazól|||||||3 534141|A02BC0113|Omeprazol Sandoz|sþ-hylki|20|mg|100|stk|1|glas||A02BC01|01.10.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|2188|2052|lyfalmen|V0006|2052|2|100|0|100,0000|Artasan ehf|Sandoz A/S|Ómeprazól||470||470|2052||1 534166|N05AB0302|Trilafon Dekanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.04.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|17676|25734|lyfalmen|||1|10|0|154,5714|Vistor hf|Orion Corporation|Perfenazín||17676||17676|25734||1 534471|L04AA1001|Rapamune|filmhtfl|1|mg|100|stk|1|þpakki||L04AA10|01.06.2012||R|0|0|0|1|G|0|PHH|0|0|0|100|DKK|45865|61080|lyfalmen|||1|100|0|33,3300|Icepharma hf|Pfizer Limited|Sirolimus||45865||45865|61080||1 534497|QJ01CA0402|Vetrimoxin L.A.|stl|150|mg/ml|100|ml|1|hgl||QJ01CA04|01.11.2014||R|0|0|0|0|0|0|CES|0|0|0|100|XEU|2348|4615|vetalmen|||0|100|0||Icepharma hf|Ceva Sante Animale|||2348||2348|4615||2 534512|C10AA0703|Rosuvastatin Krka|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|7576|5259|lyfalmen|V0117|5259|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||2800||2800|5259||2 534885|L01AA0601|Holoxan|sts/irs|1000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4138|7100|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||4138||4138|7100||2 535265|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|1755|3821|lyfalmen|V0092|3505|2|100|0|66,6667|Vistor hf|Takeda Pharma A/S|Spírónólaktón||1755||1755|3821||1 535453|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|19 mg/4 mg|QP54AB51|01.04.2018||R|0|0|0|0|0|0|MER|0|0|0|100|XEU|1962|3382|vetorma|||0|3|0||Vistor hf|Merial|Milbemycin oxime í blöndum||1962||1962|3382||1 535685|M01AH0503|Coxerit|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|1|100|IKR|3200|2849|lyfalmen|V0826|2789|2|28|0|42,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||1049||1049|2849||2 535773|P03AA5401|Tenutex|áburður|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|Bioglan AB|Dísúlfíram í blöndum|||||||2 535777|N06AX2108|Aritavi|sþ-hylki|30|mg|28|stk|1|glas||N06AX21|01.12.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|1327|2366|lyfalmen|V0692|2275|2|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Duloxetín||698||698|2366||1 536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|313|1836|lyfalmen|||1|10|0|25,0000|Vistor hf|Novartis Healthcare A/S|Pílókarpín||313||313|1836||1 536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|326|1854|lyfalmen|||1|10|0|25,0000|Vistor hf|Novartis Healthcare A/S|Pílókarpín||326||326|1854||1 536289|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|23322|32568|lyfsjukr|||1|1,2|0|15,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||23322||23322|32568||1 536384|N03AX1609|Pregabalin Sandoz GmbH|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.02.2016|31.07.2018|R|1|0|0|0|0|0|SDG|0|0|0|100|DKK|5315|6299|lyfalmen|||2|56|0|28,0000|Artasan ehf|Sandoz GmbH (Kundl)|Pregabalín||3556||3556|6299||1 536385|C10AA0509|Atorvastatin Xiromed|filmhtfl|10|mg|98|stk|1|þpakki||C10AA05|01.04.2018||R|1|0|0|0|G|0|MVX|0|0|0|100|IKR|1960|2686|lyfalmen|V0112|2659|2|98|0|49,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||931||931|2686||2 536460|N05AX1302|Xeplion|stl|150|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|72384|94622|lyfalmen|||1|1|0|60,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||72384||72384|94622||1 536682|J02AC0106|Fungyn|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.01.2018||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|11524|12324|lyfalmen|V0419|11728|2|28|0|28,0000|Alvogen|Alvogen|Flúkónazól||7933||7933|12324||2 536745|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2069|4253|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||2069||2069|4253||2 536875|N05AE0403|Ziprasidon Actavis|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.07.2016||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|6912|10919|lyfalmen|||2|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||6912||6912|10919||1 536963|D06BX0201|Picato|hlaup|150|mcg/g|0,47|g|3|túpur||D06BX02|01.02.2016||R|0|0|0|0|G|0|LBB|0|0|1|100|DKK|14749|21705|lyfalmen|||1|1,41|0||Vistor hf|LEO Laboratories Ltd.|Ingenol mebutate||||14749|21705||1 537029|N06BA0404|Methylphenidate Sandoz|forðatfl|36|mg|90|stk|1|glas||N06BA04|01.11.2016||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|13438|11494|lyfalmen|V0959|10664|2|90|0|108,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||7330||7330|11494||1 537111|J05AR1701|Descovy|filmhtfl|225|mg|30|stk|1|glas|200+25 mg|J05AR17|01.10.2016||R|0|0|0|1|0|1|GSE|0|0|0|100|DKK|57473|75762|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|emtricitabine og tenofovir alafenamide||57473||57473|75762||2 537465|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|4840|8067|lyfsjukr|||1|7500|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||4840||4840|8067||1 537600|C07AG0207|Carvedilol STADA|töflur|3,125|mg|30|stk|1|þpakki||C07AG02|01.03.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|1500|3470|lyfalmen|||2|30|0|2,5000|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||1500||1500|3470||2 537842|N05AH0206|Clozapin Medical|töflur|25|mg|500|stk|1|glas||N05AH02|01.12.2017||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|14000|13380|lyfalmen|||2|500|0|41,6666|Medical ehf|Medical ehf|Klózapín||8700||8700|13380||2 537866|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|25|0|2,5000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||2156||1 537873|N05CM0901|Sefitude|húðuðtfl|445|mg|60|stk|1|þpakki||N05CM09|01.06.2018||L|1|0|0|0|0|0|FLO|0|0|0|100|IKR|||lyfalmen|||1|60|0||Florealis ehf|Florealis ehf|Valerianae radix|||||||1 538138|N05AE0403|Ziprasidon Actavis|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.11.2015||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|5450|8906|lyfalmen|||2|56|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||5450||5450|8906||1 538181|A02AD0106|Rennie|sog/tugg|||24|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|24|0|2,4000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2 538199|A02AD0106|Rennie|sog/tugg|||48|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|48|0|4,8000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2 538207|A02AD0106|Rennie|sog/tugg|||96|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|96|0|9,6000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2 538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|0|0|0|1|0|1|MRP|0|0|0|100|SEK|82750|107732|lyfsjukr|||1|6|0|61,3953|Icepharma hf|Merck Europe B.V.|Interferón beta-1a||82750||82750|107732||2 538555|L04AX0306|Metojectpen|stl|12,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2332|4615|lyfalmen|||1|1|0|5,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2332||2332|4615||2 538696|C09CA0305|Valsartan ratiopharm|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.02.2015||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|2682|2781|lyfalmen|||2|98|0|98,0000|Alvogen|ratiopharm GmbH|Valsartan||1000||1000|2781|31.8.2018|2 538713|R03BB0701|Incruse|innönddu|55|mcg|30|skammtar|1|innö.t|afmældir skammtar|R03BB07|01.10.2015||R|0|0|0|0|G|0|RGO|0|0|0|100|DKK|4044|6971|lyfalmen|||1|30|0|30,0000|Vistor hf|Glaxo Group Limited|Umeclidiniumbrómið||4044||4044|6971||1 539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|þpakki||N03AG04|01.10.1992||R|1|0|0|1|G|0|SNP|0|0|0|100|XEU|7274|11417|lyfalmen|||1|100|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||7274||7274|11417||1 539310|A10AB0505|Fiasp|stl|100|ein/ml|3|ml|5|rörlyk|Penfill|A10AB05|01.07.2018||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4008|6922|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||4008||4008|6922||1 539385|L01XC1701|OPDIVO|irþ|10|mg/ml|4|ml|1|hgl||L01XC17|01.06.2016||R|0|1|0|0|0|1|BMS|0|1|0|100|DKK|67963|89030|lyfsjukr|||1|4|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Nivolumab||67963||67963|89030||1 539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|GRP|0|0|1|100|DKK|613|2249|lyfalmen|||2|25|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||613||613|2249||1 539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|GRP|0|0|0|100|DKK|642|2289|lyfalmen|||2|100|0|20,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||642||642|2289||1 539783|D01AC2001|Daktacort|krem|||15|g|1|túpa||D01AC20|01.04.1986||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|McNeil Sweden AB|Blöndur|||||||1 539906|N06BA0903|Atomoxetin Medical Valley|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|0|VAL|0|0|0|100|XEU|8351|5218|lyfalmen|V0816|5218|2|28|0|21,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||2770||2770|5218||2 539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|1403|3336|lyfalmen|||1|40|0|8,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1403||1403|3336||1 540009|B05BA1021|SmofKabiven|irl|550|kcal|493|ml|6|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|17135|24990|lyfsjukr|||1|2958|0||Vistor hf|Fresenius Kabi AB|Blöndur||17135||17135|24990||1 540133|H05BX0102|Cinacalcet WH|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|35812|11071|lyfalmen|V0721|11071|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||7023||7023|11071||2 540220|S01FA5601|MYDRANE|stl|||20|lykjur|1|pakki|0,2+3,1+10 mg/ml|S01FA56|01.10.2017||R|0|0|0|0|0|1|TEA|0|0|0|100|SEK|17672|25729|lyfsjukr|||1|20|0||Vistor hf|Laboratories THEA|Tropikamid í blöndum||17672||17672|25729||1 540648|N05AX1207|Lemilvo|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.10.2015||R|1|1|0|0|G|0|GPA|0|0|0|100|XEU|7290|3843|lyfalmen|V0684|3787|2|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||1771||1771|3843||1 540709|N04BD0204|Rasagiline Mylan|töflur|1|mg|28|stk|1|þpakki||N04BD02|01.11.2016||R|0|0|0|0|G|0|ASD|0|0|0|100|SEK|5440|6795|lyfalmen|V0726|6795|2|28|0|28,0000|Icepharma hf|Mylan S.A.S.|Rasagilín||3916||3916|6795||2 540958|L04AX0401|Revlimid|hylki|2,5|mg|21|stk|1|þpakki|hart|L04AX04|01.09.2015||R|1|1|0|1|0|1|CPV|0|1|0|100|XEU|570832|716062|lyfsjukr|||1|21|0|5,2500|Celgene Europe ltd|Celgene Europe B.V.|Lenalídómíd||||570832|716062||2 541169|R02AA0302|Strepsils med honning og citron|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.1982||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 541846|C02KX0501|Adempas|filmhtfl|0,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|159018|203881|lyfsjukr|||1|42|0|4,6700|Vistor hf|Bayer AG|Riociguatum||159018||159018|203881||1 542216|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|LEM|0|0|0|100|XEU|4594|7728|lyfsjukr|||2|800|0|3,3300|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||4594||4594|7728||2 542434|N05AX1208|Aripiprazol W&H|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|0|1|0|0|G|0|WEH|0|0|0|100|XEU|4333|3787|lyfalmen|V0682|3787|2|56|0|18,6670|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||1731||1731|3787||2 542474|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|skammtar|1|túpa|með skammtadælu|G03CA03|01.03.2017||R|0|0|0|0|G|0|TAT|0|0|0|100|DKK|950|2713|lyfalmen|V0129|2713|2|64|0||Vistor hf|Takeda Oy|Estradíól||950||950|2713||1 542634|N05AX1207|Lemilvo|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.10.2015||R|1|1|0|0|G|0|GPA|0|0|0|100|XEU|6042|4004|lyfalmen|V0683|3787|2|56|0|37,3300|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||1888||1888|4004||1 542744|B05BB0214|Plasmalyte Glucos|irl|50|mg/ml|1000|ml|10|pokar||B05BB02|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5653|9186|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar í blöndum með kol­vetnum||||5653|9186||2 542893|H05BX0106|Cinacalcet ratiopharm|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.07.2018||R|1|0|0|0|0|0|RTH|0|0|0|100|XEU|14398|9644|lyfalmen|V0720|9432|2|28|0|14,0000|Alvogen|ratiopharm GmbH|Cinacalcet||5986||5986|9644||2 543236|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|þpakki||N05AA02|01.10.2012||R|1|0|0|0|0|0|SNP|0|0|0|100|XEU|743|2428|lyfalmen|||1|100|0|1,6667|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||743||743|2428||1 543274|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|12310|18348|lyfalmen|||1|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||||12310|18348||1 543320|M05BA0409|Alendronat Bluefish|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.09.2014||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|2972|2845|lyfalmen|V0203|2843|2|12|0|84,0000|Vistor hf|Bluefish Pharmaceuticals AB|Alendrónsýra||1046||1046|2845||1 543374|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamid 20mg/ml|S01ED51|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|880|2616|lyfalmen|||2|5|0|25,0000|Alvogen|Alvogen|Tímólól í blöndum||880||880|2616||2 543592|N01AB0701|Suprane|innönd.l|||240|ml|6|glas||N01AB07|01.09.2014||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|63182|82983|lyfsjukr|||1|1440|0||Icepharma hf|Baxter Medical AB|Desflúran||63182||63182|82983||2 543663|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|20|stk|1|pakki||N07BA01|01.07.2016||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|20|0|1,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|0|0|0|0|0|0|MEA|0|0|0|100|DKK|||lyflausa|||0|250|0|21,7857|Icepharma hf|Meda AB|Semen psyllii (ispaghula)|||||||2 543744|R01AA0503|Nezeril|nefúði|0,5|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|7,5|0|9,3750|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1 544186|G04BE0307|Sildenafil Mylan|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|2804|3439|lyfalmen|V0143|3420|2|12|0|12,0000|Icepharma hf|Mylan AB|Síldenafíl||1478||1478|3439||2 544374|L01XX4701|Zydelig|filmhtfl|150|mg|60|stk|1|glas||L01XX47|01.07.2016||R|1|0|0|1|0|1|GSE|0|0|0|100|DKK|443951|558258|lyfsjukr|||1|60|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|Idelalisib||443951||443951|558258||2 544385|J06BA0208|Privigen|irl|100|mg/ml|400|ml|1|hgl||J06BA02|01.02.2014||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|200648|255657|lyfsjukr|||1|400|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||200648||200648|255657||2 544429|L04AD0202|Prograf|hylki|0,5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|10168|15400|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||10168||10168|15400||1 544571|G04BE0808|Tadalafil Sandoz|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.01.2018||R|1|0|0|0|0|0|SHS|0|0|0|100|DKK|6826|8603|lyfalmen|V0145|5609|2|8|0|16,0000|Artasan ehf|Sandoz A/S|Tadalafíl||5230||5230|8603||1 545090|N04BC0505|Oprymea|forðatfl|2,1|mg|100|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|27126|37379|lyfalmen|V0636|37379|2|100|0|120,0000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||27126||27126|37379||2 545104|L01XC0201|MabThera|stl|1400|mg|11,7|ml|1|hgl|lausn|L01XC02|01.10.2014||R|0|1|0|0|0|1|RRG|0|1|0|100|DKK|206140|262487|lyfsjukr|||1|11,7|0||Icepharma hf|Roche Registration GmbH|Rítúxímab||206140||206140|262487||2 545176|G03HB0103|Cypretyl|töflur|||63|stk|1|þpakki||G03HB01|01.10.2012||R|0|1|0|0|0|0|RTH|0|0|0|100|XEU|1321|3091|lyfalmen|V0134|3091|2|63|0|84,0000|Alvogen|ratiopharm GmbH|Cýpróterón og östrógen||1225||1225|3091||2 545554|M01AE0116|Ibuprofen Bril|filmhtfl|200|mg|20|stk|1|þpakki||M01AE01|01.11.2016||L|1|0|0|0|0|0|BLL|0|0|1|100|IKR|||lyflausa|||2|20|0|3,3333|Williams & Halls efh|Bristol Laboratories Limited|Íbúprófen|||||||2 545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|0|0|0|0|0|0|GPH|0|0|1|100|DKK|720|2396|lyfalmen|||1|15|0||Vistor hf|GlaxoSmithKline Pharma A/S|Múpírócín||720||720|2396||1 545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|684|2346|lyfalmen|||1|100|0|6,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||684||684|2346||1 545827|R06AD0203|Prometazin Actavis|filmhtfl|25|mg|100|stk|1|þpakki||R06AD02|01.07.2017||R|1|1|0|0|G|0|VBA|0|0|1|100|XEU|1036|2743|lyfalmen|V0903|2743|2|100|0|100,0000|Actavis Group PTC ehf|Actavis BV|Prómetazín||972||972|2743||1 545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1669|3702|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||1669||1669|3702||1 545996|V01AA0507|Alutard SQ, birkifrjo|stl|||5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|23622|32947|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|trjáfrjó||23622||23622|32947||1 546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|19046|27620|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|trjáfrjó||19046||19046|27620||1 546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|||5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|23761|33123|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|grasfrjó||23761||23761|33123||1 546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|20187|28603|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|grasfrjó||20187||20187|28603||1 546151|A02BC0510|Eradizol|sþ-tfl|20|mg|14|stk|1|þpakki||A02BC05|01.10.2015||L|1|0|0|0|0|0|POF|0|0|0|100|IKR|||lyflausa|||2|14|0|9,3300|Alvogen|Alvogen|Esómeprazól|||||||2 546722|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|92,5|mg|98|stk|1|þpakki|80/12,5 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|3218|2713|lyfalmen|||2|98|0|98,0000|Alvogen|ratiopharm GmbH|Valsartan og þvagræsilyf||950||950|2713|31.8.2018|2 546844|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|100|stk|1|glas||A02BC04|01.10.2012||R|0|0|0|0|G|0|GRP|0|0|0|100|XEU|3389|4100|lyfalmen|V0010|3892|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1958||1958|4100||1 546947|N05AX1211|Aripiprazole Mylan Pharma|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.05.2017||R|1|1|0|0|G|0|MAT|0|0|0|100|IKR|7772|3869|lyfalmen|V0682|3787|2|56|0|18,6600|Icepharma hf|Pharmathen S.A.|Aripiprazól||1790||1790|3869||2 547054|A07EC0203|Pentasa Sachet|forðakyr|4|g|30|pokar|1|pakki||A07EC02|01.04.2017||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|11774|17611|lyfalmen|||1|30|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||11774||11774|17611||1 547094|B05BB0122|Natriumklorid B. Braun|irl|9|mg/ml|100|ml|20|glös|lausn|B05BB01|01.01.2018||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|2735|5169|lyfsjukr|||2|2000|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||2735||2735|5169||2 547519|N03AX1209|Gabapentin Sandoz|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.12.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|2582|2832|lyfalmen|V0251|2123|2|100|0|22,2200|Artasan ehf|Sandoz A/S|Gabapentín||1037||1037|2832||1 547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|þpakki||A02BX02|01.01.1986||L|1|0|0|0|0|0|ORC|0|0|0|100|IKR|||lyfalmen|||0|60|0|15,0000|Vistor hf|Orion Corporation|Súkralfat|||||5241||1 547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|0|0|0|0|0|1|RGO|0|0|0|100|DKK|7551|11798|lyfsjukr|||1|100|0|0,3800|Vistor hf|Glaxo Group Limited|Eptifibatíð||7551||7551|11798||1 547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|0|0|0|0|0|1|RGO|0|0|0|100|DKK|2428|4747|lyfsjukr|||1|10|0|0,1000|Vistor hf|Glaxo Group Limited|Eptifibatíð||2428||2428|4747||1 547925|B05BB0214|Plasmalyte Glucos|irl|50|mg/ml|500|ml|20|pokar||B05BB02|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7862|12226|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar í blöndum með kol­vetnum||||7862|12226||2 548121|L03AB0801|Betaferon|sts|250|mcg/ml|15|spr|1|pakki|+leysir|L03AB08|01.07.2013||R|0|0|0|1|0|1|FIN|0|0|0|100|DKK|83413|108571|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Bayer AG|Interferón beta-1b||83413||83413|108571||2 548136|C07AB0704|Bisbetol|filmhtfl|5|mg|100|stk|1|þpakki||C07AB07|01.01.2017||R|0|0|0|0|G|0|WEH|0|0|0|100|IKR|1370|3291|lyfalmen|||2|100|0|50,0000|Williams & Halls efh|Williams & Halls ehf|bisoprolol||1370||1370|3291||2 548326|M01AE0112|ibuxin rapid|filmhtfl|400|mg|10|stk|1|þpakki||M01AE01|01.09.2012||L|0|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|Alvogen|ratiopharm GmbH|Íbúprófen|||||||2 548506|D07AC1301|Elocon|húðlausn|0,1|%|30|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|432|2000|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||432||432|2000||1 548563|S01XA2011|Oculac|augndr|50|mg/ml|10|ml|1|glas|með rotvörn|S01XA20|01.11.2013||L|0|0|0|0|G|0|HES|0|0|0|100|DKK|||lyfalmen|||0|10|0||Vistor hf|Novartis Healthcare A/S|Gervitár og aðrar óvirkar samsetningar|||||1951||1 548722|N06AX2107|Duloxetine Mylan|sþ-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.10.2015||R|0|0|0|0|G|0|GGE|0|0|0|100|SEK|6558|7063|lyfalmen|V0694|5153|2|98|0|98,0000|Mylan AB|Generics (UK) Ltd.|Duloxetín||4111||4111|7063||2 548894|B02BC3002|TISSEEL|vefjalím|||2|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|118576|153582|lyfsjukr|||1|20|0||Icepharma hf|Baxter Medical AB|Blöndur||118576||118576|153582||2 549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|6024|9696|lyfalmen|||1|5|0|151,5152|Vistor hf|Janssen-Cilag AB|Halóperídól||6024||6024|9696||1 549442|C10AA0704|Rosuvastatin Xiromed|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.04.2018||R|0|0|0|0|0|0|VAL|0|0|0|100|IKR|4950|5259|lyfalmen|V0117|5259|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||2800||2800|5259||2 549674|B01AF0101|Xarelto|filmhtfl|15|mg|98|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|25955|35898|lyfalmen|||1|98|0|73,5000|Icepharma hf|Bayer AG|Rivaoxaban||||25955|35898||2 550111|S01AA0102|Oftan Chlora|augnsm|10|mg/g|3,5|g|1|túpa||S01AA01|01.02.2018||R|0|0|0|0|G|0|SAO|0|0|1|100|XEU|409|1647|lyfalmen|V0936|1647|2|3,5|0||Icepharma hf|Santen Oy|Klóramfeníkól||176||176|1647||2 550256|J02AC0102|Candizol|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|1269|2077|lyfalmen|V0551|2024|2|7|0|1,7500|Actavis Group hf|Actavis Group PTC ehf|Flúkónazól||488||488|2077||1 550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|60|0|0,4800|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 550803|A10BX0204|Repaglinide Krka|töflur|1|mg|120|stk|1|þpakki||A10BX02|01.11.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2518|4871|lyfalmen|V0471|4871|2|120|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2518||2518|4871||2 551043|B01AC0701|Persantin|húðuðtfl|100|mg|100|stk|1|þpakki||B01AC07|01.05.2014||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|1348|3260|lyfalmen|||1|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||1348||1348|3260||1 551328|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.06.2013||L|0|0|0|0|0|0|TEA|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Laboratories THEA|Ketotifen|||||||1 551388|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.08.2012||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6073|9764|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Mannitól||6073||6073|9764||2 551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|þpakki||N02CC03|01.05.2001|31.08.2018|R|0|0|0|0|G|0|AZA|0|0|0|100|SEK|3722|6528|lyfalmen|||1|12|0|12,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||3722||3722|6528||1 551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|0|0|0|0|G|0|MEA|0|0|1|100|DKK|1298|3191|lyfalmen|||1|1|0|2,6667|Icepharma hf|Meda AB|Tríamcínólón||1298||1298|3191||2 551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|þpakki||M01AX01|01.04.1995||R|1|0|0|0|G|0|MEA|0|0|1|100|DKK|2078|4265|lyfalmen|||1|100|0|50,0000|Icepharma hf|Meda AB|Nabúmeton||2078||2078|4265||2 551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|1812|2183|lyfalmen|V0466|2183|1|28|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|2183||1 551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|2691|3873|lyfalmen|V0467|1707|1|56|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3873||1 551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|þpakki||A02BC04|01.11.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|1355|1434|lyfalmen|V0003|1054|1|14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||21||21|1434||1 551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|2821|2183|lyfalmen|V0003|2107|1|28|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|2183||1 551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|5587|3873|lyfalmen|V0010|2179|1|56|0|56,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3873||1 551969|S01EE0106|Latanoprost Mylan|augndr|50|mcg/ml|2,5|ml|3|glös||S01EE01|01.04.2017||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|1290|2659|lyfalmen|V0376|2659|2|7,5|0|75,0000|Icepharma hf|Mylan AB|Latanóprost||911||911|2659||2 552328|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1302|3197|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1302||1302|3197||2 552377|M01AE0102|Ibufen|filmhtfl|400|mg|50|stk|1|glas||M01AE01|01.11.2012||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1 552481|R06AE0501|Postafen|töflur|25|mg|20|stk|1|þpakki||R06AE05|01.05.2018||R|1|0|0|0|G|0|GOP|0|0|1|100|DKK|143|1602|lyfalmen|V0505|1274|1|20|0|10,0000|Sofus Regulatory Affairs AB|Gen. Orph|Meklózín||143||143|1602||1 552764|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|100|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|12813|20655|veteldis|||0|100|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||12813||12813|20655||1 552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|þpakki||N03AF02|01.10.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2514|4865|lyfalmen|||1|100|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||2514||2514|4865||1 553076|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|50|ml|10|glas|lausn|V08CA02|01.10.2017||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|148967|191380|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||148967||148967|191380||2 553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|þpakki||N02CC06|01.08.2009||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|8433|13012|lyfalmen|V0237|13012|1|18|0|18,0000|Icepharma hf|Pfizer ApS|Eletriptan||||8433|13012||1 553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|þpakki||N02CC06|01.10.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|2711|5136|lyfalmen|V0237|4337|1|6|0|6,0000|Icepharma hf|Pfizer ApS|Eletriptan||2711||2711|5136||1 553382|R06AD0102|Alimemazin Evolan|hylki|20|mg|100|stk|1|glas|hart|R06AD01|01.09.2018||R|1|0|0|0|G|0|EVO|0|0|1|100|IKR|5000|8287|lyfalmen|||2|100|0|66,6666|LYFIS ehf|Evolan Pharma AB|Alímemazín||5000||5000|8287||2 553684|N06BA0904|Atomoxetine Sandoz|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.10.2017||R|1|1|0|0|0|0|SHS|0|0|0|100|DKK|9052|5406|lyfalmen|V0812|5218|2|28|0|3,5000|Artasan ehf|Sandoz A/S|Atomoxetín||2907||2907|5406||1 553720|L01XE1801|Jakavi|töflur|15|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|437222|549889|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||437222||437222|549889||1 553923|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAR|0|1|0|100|SEK|32295|43917|lyfsjukr|||1|1|0||Icepharma hf|Bayer AG|Storkuþáttur VIII||||32295|43917||2 554154|QA12CE9902|Selevitan, vet.|stl|||100|ml|5|hgl||QA12CE99|01.05.1983||R|0|0|0|0|0|0|BID|1|0|0|100|DKK|7539|14473|vetalmen|||0|500|0||Vistor hf|Boehringer Ingelheim Danmark|Selen blöndur||7539||7539|14473||1 554582|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|100|stk|1|glas||B01AC04|01.11.2013||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|5195|5701|lyfalmen|V0029|5669|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||3121||3121|5701||1 554720|L04AX0601|Imnovid|hylki|3|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|0|1|0|1|CEE|0|1|0|100|XEU|1092622|1365023|lyfsjukr|||1|21|0|21,0000|Celgene Europe ltd|Celgene Europe ltd|Pomalidómide||1092622||1092622|1365023||2 554721|J01XA0108|Vancomycin Actavis|st/irþ|1000|mg/hgl|1|hgl|1|pakki||J01XA01|01.07.2016||R|0|0|0|0|0|1|GPA|0|0|0|100|XEU|1221|2316|lyfsjukr|||2|1|0|0,5000|Actavis Group hf|Actavis Group PTC ehf|Vankómýcín||662||662|2316||1 555196|L04AC1001|Cosentyx|stl|150|mg|2|áf-penni|1|pakki||L04AC10|01.07.2015||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|127837|165100|lyfsjukr|||1|2|0|30,0000|Vistor hf|Novartis Europharm Ltd|Secukinumab||127837||127837|165100||1 555235|N05AB0303|Peratsin|húðuðtfl|4|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|1397|3328|lyfalmen|||2|100|0|13,3300|Vistor hf|Orion Corporation|Perfenazín||1397||1397|3328||1 555268|N05AB0303|Peratsin|húðuðtfl|8|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|1944|4081|lyfalmen|||2|100|0|26,6700|Vistor hf|Orion Corporation|Perfenazín||1944||1944|4081||1 555292|N05AB0303|Peratsin|húðuðtfl|2|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|994|2773|lyfalmen|||2|100|0|6,6700|Vistor hf|Orion Corporation|Perfenazín||994||994|2773||1 555572|S01XA2201|JETREA|stþ|0,5|mg/hgl|0,2|ml|1|hgl||S01XA22|01.12.2014||R|0|1|0|0|0|1|THO|0|0|0|100|USD|383262|482778|lyfsjukr|||1|0,2|0||Vistor hf|ThromboGenics NV|Ocriplasmínum||383262||383262|482778||1 556242|QD07XB0202|Recicort|eyrnadr|||20|ml|1|dropaí|1,77+17,7 mg/ml|QD07XB02|01.12.2017||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|1328|2610|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet B.V.|Triamcinolon||||1328|2610||2 556377|R01AD0903|Mometason Evolan|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.06.2016||L|0|0|0|0|G|0|EVO|0|0|1|100|IKR|||lyfalmen|||2|140|0|35,0000|LYFIS ehf|Evolan Pharma AB|Mómetasón|||||2304|31.7.2018|2 556694|C10AX1401|Praluent|stl|150|mg/ml|1|ml|2|áfpen|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|0|SGB|0|0|0|100|XEU|57404|75675|lyfalmen|||1|2|0|55,5556|Vistor hf|Sanofi-aventis groupe|Alirocumab||57404||57404|75675||1 556903|C10AX0904|Ezetimib Medical Valley|töflur|10|mg|100|stk|1|þpakki||C10AX09|01.07.2018||R|0|0|0|0|0|0|VAL|0|0|0|100|DKK|9252|12434|lyfalmen|V0954|12434|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Ezetimíb||8013||8013|12434||2 556921|H01AC0104|Saizen|sts|5,83|mg/ml|1,03|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|MEC|0|1|0|100|SEK|15248|22392|lyfsjukr|||1|1,03|0|9,0000|Icepharma hf|Merck AB|Sómatrópín||15248||15248|22392||2 556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|3810|6649|lyfalmen|||1|100|0|30,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||3810||3810|6649||1 556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|7429|11630|lyfalmen|||1|100|0|60,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||7429||7429|11630||1 557073|N06BA0903|Atomoxetin Medical Valley|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|0|VAL|0|0|0|100|XEU|8351|5218|lyfalmen|V0814|5218|2|28|0|8,7500|Acare ehf|Medical Valley Invest AB|Atomoxetín||2770||2770|5218||2 557907|N02BE0109|Panodil Hot|mixtduft|500|mg|10|skammtar|1|pakki||N02BE01|01.10.2014||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|10|0|1,6700|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 557980|M01AH0105|Cloxabix|hylki|100|mg|20|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|2245|4282|lyfalmen|||2|20|0|10,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||2090||2090|4282||2 558770|L04AA2701|Gilenya|hylki|0,5|mg|28|stk|1|þpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|191788|244638|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||191788|244638||1 558892|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|160|stk|1|pakki|8 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|160|0|10,6700|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 558954|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.01.2017||R|0|0|0|0|0|1|BBV|0|0|0|100|SEK|38910|52284|lyfsjukr|||1|5|0|0,4000|Vistor hf|Janssen-Biologics B.V.|Abciximab||38910||38910|52284||1 559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||||2 559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995|31.08.2018|R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1177|3025|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1177||1177|3025||2 559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||||2 559618|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|3649|6427|lyfalmen|||1|1|0|90,0000|Icepharma hf|Pfizer ApS|Estradíól||3649||3649|6427||1 560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|0|0|0|0|G|0|HEG|0|0|0|100|XEU|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar samsetningar|||||1753||1 560085|L01CD0105|Abraxane|irs|5|mg/ml|100|mg|1|hgl||L01CD01|01.05.2016||R|0|0|0|0|0|1|CLC|0|1|0|100|XEU|38228|51421|lyfsjukr|||1|100|0||Celgene AB|Celgene Europe Limited|Paklítaxel||38228||38228|51421||2 560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|2|0||Artasan ehf|GlaxoSmithKline CH A/S|Acíklóvír|||||||1 560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|1120|2946|lyfalmen|||1|4,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||1120||1120|2946||1 560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|4212|7202|lyfalmen|||1|100|0|2,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||4212||4212|7202||1 560435|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.05.2017||L|1|0|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|30|0|30,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2 560490|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|0|0|0|0|0|1|ORC|0|0|0|100|DKK|76717|100102|lyfsjukr|||1|5|0|1,1400|Vistor hf|Orion Corporation|Levosimendan||76717||76717|100102||1 560557|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|0|0|0|0|0|1|ORC|0|0|0|100|DKK|352897|445012|lyfsjukr|||1|20|0|4,5500|Vistor hf|Orion Corporation|Levosimendan||352897||352897|445012||1 560682|L01XE0102|Imatinib Accord|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.09.2017||R|0|0|0|1|0|1|ARD|0|1|0|100|XEU|210466|96437|lyfsjukr|||2|30|0||Artasan ehf|Accord Healthcare Limited|Imatiníb||73819||73819|96437||1 560695|L01XE0102|Imatinib Accord|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.11.2013||R|0|0|0|1|0|1|ARD|0|1|0|100|XEU|114991|55811|lyfsjukr|||2|60|0||Artasan ehf|Accord Healthcare Limited|Imatiníb||41699||41699|55811||1 561022|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1274|3158|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1274||1274|3158||2 561780|C02KX0501|Adempas|filmhtfl|1,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|159018|203881|lyfsjukr|||1|42|0|14,0000|Vistor hf|Bayer AG|Riociguatum||159018||159018|203881||1 562176|B02BD0901|BeneFIX|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD09|01.02.2013||R|0|0|0|1|0|1|PHH|0|0|0|100|DKK|38917|52292|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Limited|Storkuþáttur IX||38917||38917|52292||1 562254|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|90|sk-hyl|án rotvarnarefnis|S01EE01|01.03.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|3329|5987|lyfalmen|||1|18|0|90,0000|Vistor hf|Laboratories THEA|Latanóprost||3329||3329|5987||1 562577|J06BA0207|Kiovig|irl|100|mg/ml|300|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BXG|0|1|0|100|SEK|199305|253987|lyfsjukr|||1|300|0||Shire Sweden AB |BaxterAG*|Immúnóglóbúlín, normal, manna, gefin í æð||199305||199305|253987||3 562668|L04AA2601|Benlysta|irs|400|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|0|0|1|RGO|0|1|0|100|DKK|67272|88156|lyfsjukr|||1|1|0|16,0000|Vistor hf|Glaxo Group Limited|Belimumab||67272||67272|88156||1 563184|A10BD1101|Jentadueto|filmhtfl|1002,5|mg|60|stk|1|þpakki|2,5mg/1000mg|A10BD11|01.11.2015||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|5083|8401|lyfalmen|V0705|7531|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og linagliptinum||5083||5083|8401||1 563192|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|10|ml|10|áfspr|lausn,áf.spr.|V08CA02|01.10.2017||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|29793|40752|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||29793||29793|40752||2 563213|D07AC1702|Flutivate|krem|0,05|%|100|g|1|túpa||D07AC17|01.12.2017||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|1771|3843|lyfalmen|||1|100|0||Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1771||1771|3843||1 563285|N06BA0904|Atomoxetine Sandoz|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.10.2017||R|1|1|0|0|0|0|SHS|0|0|0|100|DKK|9052|5406|lyfalmen|V0813|5218|2|28|0|6,3000|Artasan ehf|Sandoz A/S|Atomoxetín||2907||2907|5406||1 563502|N02AA0101|Contalgin|forðatfl|5|mg|100|stk|1|þpakki||N02AA01|01.10.1993||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|1079|2890|lyfalmen|||1|100|0|5,0000|Icepharma hf|Pfizer ApS|Morfín||1079||1079|2890||1 563527|H05BX0102|Cinacalcet WH|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|19560|10435|lyfalmen|V0720|9432|2|28|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||6561||6561|10435||2 563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995|31.08.2018|R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|2729|5161|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||2729||2729|5161||2 563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|2798|5256|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||2798||2798|5256||2 563653|A10BB1203|Glimepirid Bluefish|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.12.2016||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|1326|2093|lyfalmen|V0494|2093|2|90|0|180,0000|Vistor hf|Bluefish Pharmaceuticals AB|Glímepíríð||500||500|2093||1 563730|QJ01CE9003|Penethaone vet.|sts|5|m.ae/hgl|1|hgl|1|pakki|+leysir|QJ01CE90|01.03.2016||R|0|0|0|0|0|0|DIV|0|0|0|100|IKR|1398|2748|vetalmen|||0|1|0||Dýraheilsa ehf|Divasa-Farmavic S.A.|||||1398|2748||2 563756|H01CB0501|Signifor|stl|0,3|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|362738|457252|lyfalmen|||1|60|0|15,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||362738||362738|457252||1 563799|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.03.2018||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|1428|3370|lyfalmen|V0949|3370|1|100|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||1428||1428|3370||1 563899|QP54AA0105|Noromectin|áhella|0,5|% w/v|1000|ml|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|IKR|10463|18034|vetorma|||0|1000|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||10463||10463|18034||2 563905|J02AC0106|Fungyn|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.01.2017||L|1|0|0|0|0|0|GOV|0|0|1|100|IKR|||lyflausa|||2|1|0|0,7500|Alvogen|Alvogen ehf|Flúkónazól|||||||2 563918|N02AA0505|Oxycodone ratiopharm|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RTH|0|0|0|100|XEU|524|2126|lyfalmen|V0596|2057|2|28|0|1,8600|Alvogen|ratiopharm GmbH|Oxýcódon||524||524|2126||2 564124|N06DA0405|Galantamin STADA|forðahlk|8|mg|30|stk|1|þpakki|Hart forðahylki|N06DA04|01.04.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|3200|4571|lyfalmen|V0348|4571|2|30|0|15,0000|LYFIS ehf|STADA Arzneimittel AG|Galantamín||2300||2300|4571||2 564270|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|16664|24341|lyfsjukr|||1|1|0||Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||16664||16664|24341||3 564441|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|glas||R06AX27|01.11.2012||R|1|0|0|0|G|0|MBV|0|0|1|100|DKK|806|2514|lyfalmen|||1|120|0|12,0000|Vistor hf|Merck Sharp & Dohme B.V.|Deslóratadín||806||806|2514||1 564827|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|9 mg/2 mg|QP54AB51|01.04.2018||R|0|0|0|0|0|0|MER|0|0|0|100|XEU|1871|3225|vetorma|||0|3|0||Vistor hf|Merial|Milbemycin oxime í blöndum||1871||1871|3225||1 564918|A02BC0113|Omeprazol Sandoz|sþ-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.10.2015||L|1|0|0|0|0|0|SHS|0|0|0|100|IKR|||lyflausa|||2|28|0|28,0000|Artasan ehf|Sandoz A/S|Ómeprazól|||||||1 565046|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2063|4244|lyfsjukr|||1|5000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||2063||2063|4244||1 565306|A02BX1302|Galieve Cool Mint|mixtúra|||300|ml|1|glerfl|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|300|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 565400|N05AH0411|Quetiapine Teva|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2014||R|1|0|0|0|G|0|TSA|0|0|0|100|IKR|7600|6068|lyfalmen|V0286|6068|2|100|0|50,0000|Alvogen|Teva Sweden AB|Quetíapín||3388||3388|6068||2 565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|1|0|0|0|G|0|ATN|0|0|0|100|DKK|8220|12719|lyfalmen|V0714|12719|1|100|0|50,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||8220||8220|12719||1 565625|M01AE0102|Ibufen|mixtúra|20|mg/ml|100|ml|1|glas||M01AE01|01.08.2016||L|0|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|100|0|1,6700|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1 565685|QA04AD9001|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|6765|13005|vetalmen|||0|20|0||Icepharma hf|Zoetis Belgium S.A.|||||6765|13005||2 565982|H01BA0401|Glypressin|stl|0,1|mg/ml|8,5|ml|5|lykjur|lausn|H01BA04|01.08.2012||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|19175|27797|lyfsjukr|||1|42,5|0|0,3600|Vistor hf|Ferring Lægemidler A/S|Terlípressín||19175||19175|27797||1 566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|1291|3182|lyfalmen|V0444|2713|1|5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Brinzólamíð||1291||1291|3182||1 566853|D11AH0101|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AH01|01.10.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|1603|3611|lyfalmen|||1|10|0||Vistor hf|LEO Pharma A/S|Takrólímus||1603||1603|3611||1 566873|N05BB0102|Allerzine|filmhtfl|25|mg|100|stk|1|þpakki||N05BB01|01.09.2017||R|1|0|0|0|0|0|IPC|0|0|1|100|SEK|825|2267|lyfalmen|V0907|2267|2|100|0|33,3333|Alvogen|Alvogen IPco S.á.r.l.|Hýdroxýzín||626||626|2267||2 566924|R03AK0705|Bufomix Easyhaler|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|11573|17334|lyfalmen|||2|360|0|90,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||11573||11573|17334||1 567028|L01XE0701|Tyverb|filmhtfl|250|mg|84|stk|1|glas||L01XE07|01.02.2012||R|1|0|0|1|0|1|NEL|0|0|0|100|DKK|146752|188625|lyfsjukr|||1|84|0||Vistor hf|Novartis Europharm Ltd|Labatinibum||146752||146752|188625||1 567332|C10AA0508|Lipistad|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|3587|2713|lyfalmen|V0114|2713|2|100|0|200,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||950||950|2713||2 567338|G04BD1201|Betmiga|forðatfl|50|mg|90|stk|1|glas||G04BD12|01.07.2014||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|13524|20019|lyfalmen|V0651|20019|1|90|0|90,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||13524||13524|20019||1 567400|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.06.2015||L|0|0|0|0|G|0|AEP|0|0|0|100|DKK|||lyfalmen|||0|15|0|75,0000|Icepharma hf|Aspen Pharma Trading Limited|Estríól|||||2854||2 567460|C01CA2407|Jext|stl|150|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|1|0|0|G|0|ALK|0|0|1|100|DKK|4536|7648|lyfalmen|||1|1|0|0,3000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||4536|7648||1 567461|D07AC1702|Flutivate|smyrsli|0,005|%|100|g|1|túpa||D07AC17|01.12.2017||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|1685|3724|lyfalmen|||1|100|0||Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1685||1685|3724||1 567503|N05AX0801|Risperdal|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|2039|4211|lyfalmen|V0291|2231|1|60|0|12,0000|Vistor hf|Janssen-Cilag AB|Risperídón||2039||2039|4211||1 567510|C07AG0101|Trandate|filmhtfl|200|mg|100|stk|1|glas||C07AG01|01.06.2013||R|1|0|0|0|G|0|AEP|0|0|0|100|DKK|2153|4368|lyfalmen|||1|100|0|33,3333|Icepharma hf|Aspen Pharma Trading Limited|Labetalól||2153||2153|4368||2 567511|N05AX0801|Risperdal|filmhtfl|2|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|3949|6840|lyfalmen|V0292|3057|1|60|0|24,0000|Vistor hf|Janssen-Cilag AB|Risperídón||3949||3949|6840||1 567545|R01AC0201|Livostin|nefúði|0,5|mg/úðask|15|ml|1|glas||R01AC02|01.06.1998||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0|12,5000|Vistor hf|McNeil Sweden AB|Levókabastín|||||||1 567802|L04AX0501|Esbriet|filmhtfl|267|mg|252|stk|1|þpakki||L04AX05|01.11.2017||R|1|1|0|1|0|0|RRG|0|0|0|100|DKK|297760|376437|lyfalmen|V0919|376437|1|252|0|28,0300|Icepharma hf|Roche Registration GmbH|Pírfenidon||||297760|376437||2 567805|M01AE0116|Ibuprofen Bril|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.11.2016||L|1|0|0|0|0|0|BLL|0|0|1|100|IKR|||lyflausa|||2|30|0|10,0000|Williams & Halls efh|Bristol Laboratories Limited|Íbúprófen|||||||2 567837|G04BE0808|Tadalafil Sandoz|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.01.2018||R|1|0|0|0|0|0|SHS|0|0|0|100|DKK|8151|12624|lyfalmen|V0935|12624|2|28|0|14,0000|Artasan ehf|Sandoz A/S|Tadalafíl||8151||8151|12624||1 567980|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 568478|M01AH0502|Coxient|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|ALO|0|0|1|100|IKR|2191|2946|lyfalmen|V0826|2789|2|28|0|42,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Etoríkoxíb||1120||1120|2946||2 568708|N06AX1613|Venlafaxin Medical Valley|forðatfl|75|mg|100|stk|1|glas||N06AX16|01.10.2017||R|0|0|0|0|G|0|VAL|0|0|0|100|IKR|2800|2781|lyfalmen|V0334|2781|2|100|0|75,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||1000||1000|2781||2 568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|0|0|0|0|0|0|GPH|0|0|1|100|DKK|805|2513|lyfalmen|||1|3|0||Vistor hf|GlaxoSmithKline Pharma A/S|Mupirocin||805||805|2513||1 568812|N03AX2201|Fycompa|filmhtfl|2|mg|7|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|4156|7125|lyfalmen|||1|7|0|1,7500|Vistor hf|Eisai Europe Ltd.|Perampanel||4156||4156|7125||1 568840|C08CA0201|Feldil|forðatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2273|2794|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Felódipín||1009||1009|2794|31.7.2018|1 568865|C08CA0201|Feldil|forðatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|3060|3529|lyfalmen|V0059|3057|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Felódipín||1543||1543|3529||1 569174|M01AH0503|Coxerit|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|1|100|IKR|850|1885|lyfalmen|V0827|1680|2|7|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||349||349|1885||2 569257|J05AR1301|Triumeq|filmhtfl|950|mg|30|stk|1|glas|50+600+300 mg|J05AR13|01.12.2014||R|0|1|0|1|0|1|VIH|0|0|0|100|DKK|104416|135971|lyfsjukr|||1|30|0||Vistor hf|ViiV Healthcare UK Ltd|Abacavír, dolutegravír og lamivudín||104416||104416|135971||1 569378|L01AA0601|Holoxan|sts/irs|2000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|8302|12832|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||8302||8302|12832||2 569422|A02BC0114|Omeprazol Medical Valley|sþ-hylki|40|mg|100|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|4800|2781|lyfalmen|V0001|2781|2|100|0|200,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||1000||1000|2781||2 569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|12024|17955|lyfsjukr|||1|5|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||12024||12024|17955||1 569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|13828|20438|lyfsjukr|||1|20|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||13828||13828|20438||1 569514|N06AX2105|Duloxetin Krka|sþ-hylki|30|mg|100|stk|1|þpakki||N06AX21|01.02.2017||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|4602|7186|lyfalmen|||2|100|0|50,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||4200||4200|7186||2 570258|N06BA0702|Modafinil Bluefish|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.11.2015||R|1|0|0|1|0|0|BFP|0|0|0|100|XEU|5208|7857|lyfalmen|V0657|7857|2|30|0|10,0000|Vistor hf|Bluefish Pharmaceuticals AB|Modafinil||4688||4688|7857||1 570272|C10AA0104|Simvastatin Alvogen|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.07.2017||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|1780|2653|lyfalmen|V0110|2456|2|100|0|133,3333|Alvogen|Alvogen ehf|Simvastatín||907||907|2653||2 570421|L04AX0306|Metojectpen|stl|10|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2235|4481|lyfalmen|||1|1|0|4,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2235||2235|4481||2 570649|N04BA0207|Sinemet depot mite|forðatfl|125|mg|100|stk|1|þpakki|25+100 mg|N04BA02|01.02.2018||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|1624|3640|lyfalmen|V0938|3640|1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||1624||1624|3640||1 570775|M01AH0108|Celecoxib Medical|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.05.2018||R|1|0|0|0|G|0|DIC|0|0|1|100|IKR|3584|4708|lyfalmen|V0196|4708|2|100|0|100,0000|LYFIS ehf|Medical ehf|Celekoxíb||2400||2400|4708||2 571030|QM01AA9001|Danilon equidos|kyrni|1,5|g|10|g|18|pokar||QM01AA90|01.07.2014||R|0|0|0|0|0|0|EST|0|0|0|100|DKK|2650|5198|vetalmen|||0|180|0||Vistor hf|Laboratorios Dr. ESTEVE S.A.|Suxibuzone||2650||2650|5198||1 571063|R06AX2707|Dasselta|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.09.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|650|1680|lyfalmen|V0908|1680|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Deslóratadín||200||200|1680||2 571158|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|15|stk|1|þpakki||A04AA01|01.12.2015||R|1|0|0|0|G|0|BFP|0|0|1|100|IKR|2770|5218|lyfalmen|V0384|4488|2|15|0|7,5000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||2770||2770|5218||2 571181|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.2015||R|0|0|0|0|0|1|CHI|0|0|0|100|DKK|64695|84896|lyfsjukr|||1|1,5|0|0,7500|Chiesi Farmaceutici SpA|Chiesi Farmaceutici SpA|Náttúrulegir fosfólípíðar||64695||64695|84896||1 571285|L01XE1301|Giotrif|filmhtfl|40|mg|28|stk|1|þpakki||L01XE13|01.05.2016||R|0|0|0|1|0|1|BOE|0|1|0|100|DKK|232131|294813|lyfsjukr|||1|28|0||Vistor hf|Boehringer Ingelheim International GmbH|Afatiníb||232131||232131|294813||1 571358|L01XC1501|Gazyvaro|irþ|1000|mg|1|hgl|1|pakki||L01XC15|01.02.2015||R|0|0|0|0|0|1|RRG|0|1|0|100|DKK|426392|536419|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration GmbH|Obinutuzumab||426392||426392|536419||2 571524|A02BX1303|Galieve Peppermint|tuggutfl|||24|stk|1|þpakki|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|24|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 572062|L01AX0304|Temozolomide Accord|hylki|250|mg|5|stk|1|skpoki|hart|L01AX03|01.04.2018||R|0|0|0|1|0|1|ARD|0|1|0|100|XEU|32505|44183|lyfsjukr|||2|5|0||Artasan ehf|Accord Healthcare Limited|Temozolomid||32505||32505|44183||1 572422|L04AD0201|Advagraf|forðahlk|5|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|62501|82122|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||62501||62501|82122||1 572697|R06AE0706|Zensitin|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.01.2018||L|1|0|0|0|G|0|WEH|0|0|1|100|IKR|||lyfalmen|V0575|1584|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Cetirizín|||||2602||2 572798|A02BX1303|Galieve Peppermint|tuggutfl|||48|stk|1|þpakki|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|48|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 573120|N03AX0903|Lamotrin|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.12.2010||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|5148|3871|lyfalmen|V0245|3804|2|98|0|32,6700|Actavis Group hf|Actavis Group PTC ehf|Lamótrigín||1792||1792|3871||1 573177|S01ED5110|Duotrav|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|2927|5434|lyfalmen|||1|2,5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Tímólól í blöndum||2927||2927|5434||1 573382|J05AP5101|Harvoni|filmhtfl|490|mg|28|stk|1|glas|400 mg + 90 mg|J05AP51|01.09.2015||R|1|0|0|1|0|1|GSE|0|0|0|100|DKK|1970647|2457040|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|Sofosbuvir og ledipasvir||||1970647|2457040||2 573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|0|0|0|0|0|1|RRG|0|1|0|100|DKK|68113|89220|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration GmbH|Trastuzumab||68113||68113|89220||2 573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|10|hgl|1|pakki||J01DH02|01.10.1995||R|0|0|0|0|0|1|PLS|0|0|0|100|SEK|11935|17832|lyfsjukr|||1|10|0|2,5000|Icepharma hf|Pfizer ApS|Meropenem||11935||11935|17832||1 573642|J01DH0201|Meronem|sts/irs|1|g/hgl|10|hgl|1|pakki||J01DH02|01.10.1995||R|0|0|0|0|0|1|PLS|0|0|0|100|SEK|19567|28337|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Pfizer ApS|Meropenem||19567||19567|28337||1 573999|G04BE0307|Sildenafil Mylan|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|4094|3949|lyfalmen|V0144|3906|2|12|0|24,0000|Icepharma hf|Mylan AB|Síldenafíl||1848||1848|3949||2 574086|QI09AL0101|Eryseng Parvo|stl|||50|ml|1|hgl|dreifa|QI09AL01|01.09.2016||R|0|0|0|0|0|0|LHS|0|0|0|100|IKR|9978|17198|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Porcine parvovirus + erysipelothrix||9978||9978|17198||2 574423|L01XC1301|Perjeta|irþ|420|mg|14|ml|1|hgl||L01XC13|01.06.2013||R|0|0|0|0|0|1|RRG|0|1|0|100|DKK|326609|412317|lyfsjukr|||1|14|0||Icepharma hf|Roche Registration GmbH|Pertuzumab||326609||326609|412317||2 574510|A04AA0101|Zofran|mixtúra|0,8|mg/ml|50|ml|1|glas||A04AA01|01.07.2016||R|0|0|0|0|G|0|NAA|0|0|1|100|DKK|8074|12518|lyfalmen|||1|50|0|2,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||8074||8074|12518||1 574597|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.10.1995||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|6023|6086|lyfalmen|V0322|2456|1|98|0|98,0000|Icepharma hf|Pfizer ApS|Sertralín||3401||3401|6086||1 575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|þpakki||N06AB06|01.03.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|3565|2289|lyfalmen|V0152|2289|1|28|0|56,0000|Icepharma hf|Pfizer ApS|Sertralín||642||642|2289||1 575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.03.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|10854|6086|lyfalmen|V0323|3804|1|98|0|196,0000|Icepharma hf|Pfizer ApS|Sertralín||3401||3401|6086||1 575458|A10AE5401|Suliqua|stl|||3|ml|5|áfpen|100 ein/ml + 50 mcg/ml|A10AE54|01.05.2018||R|0|1|0|0|0|0|SGB|0|0|0|100|XEU|19548|28311|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi-aventis groupe|Insulin glargine og lixisenatide||19548||19548|28311||1 575484|L01AA0903|Bendamustine medac|st/irþ|2,5|mg/ml|100|mg|1|hgl|lausn|L01AA09|01.03.2018||R|0|0|0|0|0|1|WIL|0|1|0|100|XEU|31250|42595|lyfsjukr|||2|100|0||Williams & Halls efh|medac Gesellschaft|Bendamústín||31250||31250|42595||2 575504|B02BD0801|NovoSeven|sts|8|mg|1|hgl|1|pakki|+áfyllt sprauta með leysi|B02BD08|01.10.2015||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|673520|843777|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||673520||673520|843777||1 575571|J01CA0413|Amoxin|filmhtfl|500|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RTH|0|0|1|100|IKR|1070|2066|lyfalmen|V0159|2066|2|20|0|10,0000|Alvogen|ratiopharm GmbH|Amoxicillín||480||480|2066||2 575589|J01CA0413|Amoxin|filmhtfl|500|mg|30|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RTH|0|0|1|100|IKR|1285|2368|lyfalmen|V0160|2368|2|30|0|15,0000|Alvogen|ratiopharm GmbH|Amoxicillín||700||700|2368||2 575621|J01CA0413|Amoxin|filmhtfl|750|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RTH|0|0|1|100|IKR|1392|2437|lyfalmen|V0158|2437|2|20|0|15,0000|Alvogen|ratiopharm GmbH|Amoxicillín||750||750|2437||2 575715|G03GA1001|REKOVELLE|stl|72|mcg|2,16|ml|1|áfpen|+ 9 inndælingarnálar|G03GA10|01.08.2018||R|0|0|0|1|G|0|FEP|0|0|0|100|DKK|69438|90895|lyfalmen|||1|2,16|0||Vistor hf|Ferring Pharmaceuticals A/S|Follitrópín delta||69438||69438|90895||1 575919|N04BA0303|Levodopa+Carbidopa+Entacapona WH|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|0|100|IKR|9646|14682|lyfalmen|V0900|14682|2|100|0|33,3300|Williams & Halls efh|Williams & Halls ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||9646||9646|14682||2 576032|N03AX0903|Lamotrin|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.12.2010||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|959|1874|lyfalmen|V0243|1874|2|42|0|3,5000|Actavis Group hf|Actavis Group PTC ehf|Lamótrigín||341||341|1874||1 576123|L04AX0601|Imnovid|hylki|1|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|0|1|0|1|CEE|0|1|0|100|XEU|1059304|1323585|lyfsjukr|||1|21|0|7,0000|Celgene Europe ltd|Celgene Europe ltd|Pomalidómide||1059304||1059304|1323585||2 576518|QN05CM1803|Sedadex|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.03.2017||R|0|0|0|0|0|0|VEB|1|0|0|100|IKR|5680|10947|vetalmen|||2|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||5680||5680|10947||2 576714|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.12.2012||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|7937|12329|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma Trading Limited|Merkaptópúrín||7937||7937|12329||2 576797|V03AE0205|Sevelamercarbonat Stada|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.10.2017||R|1|0|0|0|0|0|ASR|0|0|0|100|IKR|13500|11040|lyfalmen|V0680|10434|2|180|0|22,5000|LYFIS ehf|STADA Arzneimittel AG|Sevelamer||7000||7000|11040||2 577021|N02AJ0601|Parkodin|filmhtfl|510|mg|30|stk|1|þpakki|10+500 mg|N02AJ06|01.06.2018||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|373|1918|lyfalmen|||2|30|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||373||373|1918||1 577135|C09DX0401|Entresto|filmhtfl|100|mg|56|stk|1|þpakki|49 + 51 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|16615|24274|lyfalmen|V0727|22038|1|56|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||16615||16615|24274||1 577682|N06BA0904|Atomoxetine Sandoz|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.10.2017||R|1|1|0|0|0|0|SHS|0|0|0|100|DKK|12485|6445|lyfalmen|V0817|6171|2|28|0|28,0000|Artasan ehf|Sandoz A/S|Atomoxetín||3662||3662|6445||1 577711|C01CA0601|Fenylefrin Abcur|stl|0,05|mg/ml|10|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|8941|13711|lyfsjukr|||2|100|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||8941||8941|13711||2 577921|C10AX0902|Ezetimib Actavis|töflur|10|mg|100|stk|1|þpakki||C10AX09|01.05.2018||R|1|0|0|0|0|0|GPA|0|0|0|100|DKK|9347|12870|lyfalmen|V0954|12434|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Ezetimíb||8330||8330|12870||1 578261|J07AH0703|NeisVac-C|stl|||0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.07.2015||R|0|0|0|0|0|0|PLS|0|0|0|100|USD|3623|6392|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer ApS|Hreinsuð meningókokka C, poly­sakkaríð mótefnavakar||3623||3623|6392||1 578368|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|100|ml|10|glas|lausn|V08CA02|01.10.2017||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|297935|376655|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||297935||297935|376655||2 578654|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|þpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|5481|9447|vetorma|||0|20|0||Icepharma hf|Chanelle Pharmaceuticals|||5481||5481|9447||2 578794|A06AB0202|Toilax|sþ-tfl|5|mg|100|stk|1|glas||A06AB02|01.12.2016||R|1|0|0|0|0|0|ERC|0|0|0|100|DKK|537|2144|lyfalmen|||1|100|0|50,0000|Vistor hf|Orion Pharma|Bisakódýl||537||537|2144||1 579043|H02AB0205|Dexametason Abcur|töflur|4|mg|100|stk|1|þpakki||H02AB02|01.06.2016||R|1|0|0|0|G|0|ABC|0|0|1|100|IKR|14658|15857|lyfalmen|V0423|14756|2|100|0|266,6600|Icepharma hf|Abcur AB|Dexametasón||10500||10500|15857||2 579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|836|2556|lyfalmen|||1|10|0|0,3300|Vistor hf|AstraZeneca A/S DK|Terbútalín||836||836|2556||1 579171|C08DA0103|Isoptin retard|forðatfl|240|mg|98|stk|1|þpakki||C08DA01|01.01.2016||R|1|0|0|0|G|0|PGB|0|0|0|100|DKK|2000|4158|lyfalmen|||1|98|0|98,0000|Icepharma hf|BGP Products ApS|Verapamíl||2000||2000|4158||2 579240|L01XC1701|OPDIVO|irþ|10|mg/ml|10|ml|1|hgl||L01XC17|01.06.2016||R|0|1|0|0|0|1|BMS|0|1|0|100|DKK|169561|216993|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Nivolumab||169561||169561|216993||1 579796|N02AJ0602|Parkodin forte|filmhtfl|530|mg|100|stk|1|þpakki|30+500 mg|N02AJ06|01.02.2018||R|1|0|1|0|0|0|GPA|0|0|1|100|IKR|1572|3569|lyfalmen|||2|100|0|33,3333|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||1572||1572|3569||1 579864|C07AB0214|Bloxazoc|forðatfl|100|mg|30|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|800|2506|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||800||800|2506||2 579911|B01AF0301|Lixiana|filmhtfl|60|mg|30|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|0|G|0|OPE|0|0|0|100|DKK|8042|12474|lyfalmen|||1|30|0|30,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||8042||8042|12474||1 579932|C03DA0406|Eplerenon Alvogen|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.06.2014||R|1|0|0|0|0|0|POF|0|0|0|100|DKK|3092|3231|lyfalmen|V0107|2724|2|30|0|15,0000|Alvogen|Alvogen|Eplerenón||1327||1327|3231||2 579972|C03DA0403|Eplerenon Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.05.2015||R|1|0|0|0|0|0|BFP|0|0|0|100|IKR|11539|8287|lyfalmen|V0111|8211|2|100|0|100,0000|Vistor hf|Bluefish Pharmaceuticals AB|Eplerenón||5000||5000|8287||2 580042|C05AA0801|Doloproct|eþ-stíll|||10|stk|1|þpakki||C05AA08|01.02.2015||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|583|2207|lyfalmen|||1|10|0||Icepharma hf|Bayer AB|Flúókortólón||583||583|2207||2 580104|N07BB0501|Selincro|filmhtfl|18|mg|14|stk|1|þpakki||N07BB05|01.06.2013||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6695|10620|lyfalmen|||1|14|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||6695||6695|10620||1 580144|L01CD0203|Docetaxel Kabi|irþ|20|mg/ml|8|ml|1|hgl|lausn|L01CD02|01.01.2016||R|0|0|0|0|0|1|FKD|0|0|0|100|DKK|5904|9531|lyfsjukr|||1|8|0||Vistor hf|Fresenius Kabi Deutschland GmbH|Docetaxel||5904||5904|9531||2 580699|H01BA0208|NOCDURNA|frþ.tfl|25|mcg|30|stk|1|þpakki||H01BA02|01.04.2017||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|2923|5428|lyfalmen|||1|30|0|1,8750|Vistor hf|Ferring Lægemidler A/S|Desmópressín||2923||2923|5428||1 580960|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1232|3101|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1232||1232|3101||2 581417|S01ED5116|Taptiqom|augndr|||0,3|ml|30|Sk-ílá|15mcg/ml + 5mg/ml|S01ED51|01.07.2015||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|2545|4908|lyfalmen|||1|9|0|30,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||2545||2545|4908||2 581661|N02CC0406|Rizatriptan Alvogen|munndr.t|5|mg|6|stk|1|þpakki||N02CC04|01.01.2015||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|2790|4761|lyfalmen|V0620|4761|2|6|0|3,0000|Alvogen|Alvogen|Rizatriptan||2438||2438|4761||2 581792|L02BB0305|Bicalutamide Alvogen|filmhtfl|150|mg|90|stk|1|þpakki||L02BB03|01.11.2016||R|0|0|0|0|G|0|GOV|0|0|0|100|IKR|33214|15169|lyfalmen|V0421|15169|2|90|0|270,0000|Alvogen|Alvogen ehf|Bíkalútamíð||10000||10000|15169||2 581890|QN02AF0103|Torphasol vet.|stl|10|mg/ml|20|ml|1|hgl||QN02AF01|01.02.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|11253|21520|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||11253||11253|21520||2 581969|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.07.2011||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|1887|4002|lyfalmen|V0669|3658|1|2,5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Travóprost||1887||1887|4002||1 582034|QM01AC0608|Novaquin|mixtúra|15|mg/ml|125|ml|1|glas|dreifa|QM01AC06|01.03.2018||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|4185|8110|vetalmen|||0|125|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Meloxícam||||4185|8110||2 582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989|31.08.2018|R|0|0|0|1|0|1|DAN|0|1|0|100|XEU|17272|25178|lyfsjukr|||1|1|0|9,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||17272||17272|25178||2 582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989|31.08.2018|R|0|0|0|1|0|1|DAN|0|1|0|100|XEU|33800|45820|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||33800||33800|45820||2 582122|G03GA0503|Bemfola|stl|450|ae|0,75|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|13619|20150|lyfalmen|||1|0,75|0|6,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||13619||13619|20150||3 582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989|31.08.2018|R|0|0|0|1|0|1|DAN|0|1|0|100|XEU|67598|88568|lyfsjukr|||1|1|0|36,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||67598||67598|88568||2 582221|V08AB0201|Omnipaque|stl|140|mg J/ml|200|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|19741|28576|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jóhexól||19741||19741|28576||2 582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|22646|31713|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jóhexól||22646||22646|31713||2 582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|51421|68108|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jóhexól||51421||51421|68108||2 582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|20074|28460|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||20074||20074|28460||2 582990|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|MEC|0|1|0|100|SEK|25886|35811|lyfsjukr|||1|1,5|0|18,0000|Icepharma hf|Merck AB|Sómatrópín||25886||25886|35811||2 583105|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.08.2013||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|1595|3600|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Latanóprost||1595||1595|3600||1 583126|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|41009|54938|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||41009||41009|54938||2 583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|737|2419|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Sótalól||737||737|2419||2 583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|69255|90664|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||69255||69255|90664||2 583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|21941|30821|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||21941||21941|30821||2 583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|35106|47472|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||35106||35106|47472||2 583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|65823|86323|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||65823||65823|86323||2 583806|G04BE0310|Sildenafil LYFIS|filmhtfl|100|mg|24|stk|1|þpakki||G04BE03|01.09.2016||R|0|0|0|0|0|0|LYF|0|0|0|100|IKR|10000|9663|lyfalmen|V0144|7812|2|24|0|48,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||6000||6000|9663||2 583916|B05BB0122|Natriumklorid B. Braun|irl|9|mg/ml|250|ml|10|pokar|lausn|B05BB01|01.02.2018||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|1450|3401|lyfsjukr|||2|2500|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||1450||1450|3401||2 584133|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|14460|21308|lyfsjukr|||1|1,2|0|9,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||14460||14460|21308||1 585359|L01XC1801|KEYTRUDA|irþ|25|mg/ml|4|ml|1|hgl||L01XC18|01.07.2017||R|0|1|0|0|0|1|MBV|0|1|0|100|DKK|415364|522704|lyfsjukr|||1|4|0||Vistor hf|Merck Sharp & Dohme B.V.|Pembrolizumab||415364||415364|522704||1 585516|A10BK0301|Jardiance|filmhtfl|25|mg|90|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|17592|25619|lyfalmen|||1|90|0|128,5700|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||17592||17592|25619||1 585661|B01AB0101|Heparin Leo|stl|100|ae/ml|10|ml|10|hgl||B01AB01|01.03.2014||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|4719|7900|lyfalmen|||1|100|0|1,0000|Vistor hf|LEO Pharma A/S|Heparín||4719||4719|7900||1 585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|0|0|0|0|0|1|LEP|0|0|0|100|DKK|3478|6192|lyfsjukr|||1|25|0|12,5000|Vistor hf|LEO Pharma A/S|Heparín||3478||3478|6192||1 585692|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|2500|2059|lyfalmen|V0006|2052|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||475||475|2059||2 585754|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|10|áf.spr||B01AX05|01.09.2017||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|9659|14700|lyfalmen|||1|4|0|20,0000|Icepharma hf|Aspen Pharma Trading Limited|Fondaparinux||9659||9659|14700||2 585869|J07BC0201|Havrix|stl|1440|ein/ml|1|ml|1|dæla|einnota dæla|J07BC02|01.07.1994||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|3295|5940|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3295||3295|5940|31.8.2018|1 586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|24047|33485|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||24047||24047|33485||1 586223|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|LEM|0|0|0|100|XEU|11051|16616|lyfsjukr|||2|800|0|10,0000|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||11051||11051|16616||2 586241|J01GB0101|Tobi Podhaler|innönddu|28|mg|224|stk|1|þpakki|hart hylki+innönd.tæki|J01GB01|01.04.2012||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|295220|373278|lyfsjukr|||1|224|0|56,0000|Vistor hf|Novartis Europharm Ltd|Tobramýcín||295220||295220|373278||1 586312|C10AX1301|Repatha|stl|140|mg|2|áf-penni|1|pakki||C10AX13|01.10.2016||R|0|0|0|0|0|0|AEB|0|0|0|100|DKK|54625|72160|lyfalmen|||1|2|0|28,0000|Vistor hf|Amgen Europe B.V.|Evolocumab||54625||54625|72160||1 586797|N06BA0902|Atomoxetin Actavis|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017||R|1|1|0|0|0|0|GPA|0|0|0|100|XEU|10077|5392|lyfalmen|V0815|5218|2|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||2897||2897|5392||1 586967|B01AF0201|Eliquis|filmhtfl|5|mg|168|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BSM|0|0|0|100|DKK|23021|32187|lyfalmen|V0652|32187|1|168|0|84,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||23021|32187||1 587112|M01AH0106|Celecoxib Actavis|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|3495|5586|lyfalmen|V0196|4708|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Celekoxíb||3038||3038|5586||1 587176|N07BA0150|Nicotinell Spearmint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 587522|L04AB0601|Simponi|stl|100|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.11.2014||R|0|1|0|1|0|1|JAN|0|1|0|100|DKK|124212|160592|lyfsjukr|||1|1|0|60,2400|Vistor hf|Janssen Biologics B.V.|Golimumab||124212||124212|160592||1 587641|C09DA0602|Candpress Comp|töflur|28,5|mg|100|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2012||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|3616|6382|lyfalmen|V0095|6382|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan og þvagræsilyf||3616||3616|6382||1 587658|M05BA0606|Ibandronic acid WH|stl|3|mg|3|ml|1|áfspr||M05BA06|01.05.2018||R|0|1|0|0|0|0|WEH|0|0|0|100|IKR|11132|16366|lyfalmen|V0957|16366|2|3|0|0,5000|Williams & Halls efh|Williams & Halls ehf|Íbandrónsýra||10870||10870|16366||2 587958|C09CA0604|Kairasec|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.2017||R|1|0|0|0|0|0|VAL|0|0|0|100|XEU|3545|5215|lyfalmen|V0081|5215|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Candesartan||2768||2768|5215||2 588195|N05AX1208|Aripiprazol W&H|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|0|1|0|0|G|0|WEH|0|0|0|100|XEU|16151|3787|lyfalmen|V0683|3787|2|56|0|37,3300|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||1731||1731|3787||2 588227|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+30 áf.spr.m.leysi|H01AX01|01.10.2017||R|0|0|0|1|0|1|PIZ|0|0|0|100|DKK|571044|716326|lyfsjukr|||1|30|0|60,0000|Icepharma hf|Pfizer Ltd|Pegvisómant||571044||571044|716326||1 588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.10.1995||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|1516|3492|lyfalmen|||1|20|0|5,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1516||1516|3492||1 588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|þpakki||B01AC05|01.04.1995||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|6165|9890|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Tíklópídín||6165||6165|9890||1 588669|N03AX2201|Fycompa|filmhtfl|12|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|16623|24285|lyfalmen|||1|28|0|42,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||16623||16623|24285||1 588767|A10BB0905|Gliclatim|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.08.2017||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|2000|3194|lyfalmen|||2|90|0|45,0000|LYFIS ehf|LYFIS ehf|Glíklazíð||1300||1300|3194|30.6.2018|2 588911|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|7310|5442|lyfalmen|V0282|5423|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||2933||2933|5442||1 589153|L01XE2301|Tafinlar|hylki|50|mg|120|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|510159|640602|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||510159||510159|640602||1 589888|N01AF0302|Pentocur|sts|0,5|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|8759|13461|lyfsjukr|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||8759||8759|13461||2 590092|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar|áfylltur penni|L04AB04|01.07.2013||R|0|1|0|1|0|1|ABD|0|1|0|100|DKK|113465|147226|lyfsjukr|||1|1,6|0|27,5900|Vistor hf|AbbVie Deutschland GmbH & Co. KG|Adalimumab||113465||113465|147226||1 590135|C10AA0107|Simvastatin LYFIS|filmhtfl|10|mg|100|stk|1|glas||C10AA01|01.12.2016||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|1693|2231|lyfalmen|V0108|1994|2|100|0|33,3400|LYFIS ehf|LYFIS ehf|Simvastatín||600||600|2231||2 590252|G04BE0312|Granpidam|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.01.2018||R|1|0|0|1|0|1|ACC|0|0|0|100|XEU|32561|44253|lyfsjukr|||2|90|0|36,0000|Artasan ehf|Accord Healthcare Limited|Síldenafíl||32561||32561|44253||1 590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|1|100|IKR|||lyflausa|||0|20|0||Icepharma hf|Bayer AB|Klótrímazól|||||||2 590562|C01DA1403|Ismo|forðatfl|60|mg|98|stk|1|glas||C01DA14|01.10.1999||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|2394|3018|lyfalmen|V0041|2951|2|98|0|147,0000|Actavis Group hf|Actavis hf|Ísósorbíð mónónítrat||1172||1172|3018||1 590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|131535|169700|lyfsjukr|||1|1|0|0,7500|Vistor hf|Boehringer Ingelheim|Tenekteplasi||131535||131535|169700||1 590947|H05BX0105|Cinacalcet Accord|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.02.2018||R|1|0|0|0|0|0|ARD|0|0|0|100|XEU|28345|12265|lyfalmen|V0721|11071|2|28|0|28,0000|Artasan ehf|Accord Healthcare Limited|Cinacalcet||7890||7890|12265||1 591260|N06DA0302|Exelon (Lyfjaver)|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|DKK|10106|15315|lyfalmen|V0347|15315|3|30|0|14,5300|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||10106||10106|15315||3 591405|L04AA2901|Xeljanz|filmhtfl|5|mg|56|stk|1|þpakki||L04AA29|01.12.2017||R|0|1|0|1|0|0|PHH|0|1|0|100|DKK|95201|123480|lyfalmen|||1|56|0|28,0000|Icepharma hf|Pfizer Limited|Tofacitinib||95201||95201|123480||2 591418|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.01.2018||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1615|3628|lyfalmen|V0561|3109|1|100|0||Icepharma hf|Aspen Pharma|Lídókaín||1615||1615|3628||2 591540|J01CR0202|Augmentin|töflur|625|mg|21|stk|1|þpakki|500+125 mg|J01CR02|01.09.2015||R|0|0|0|0|0|0|GPH|0|0|1|100|DKK|1188|3040|lyfalmen|V0168|2549|1|21|0|10,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill ||1188||1188|3040||1 592068|J01DD0402|Ceftriaxona Normon|sts|1000|mg|1|stk|1|hgl|+ 1 lykja með leysi.|J01DD04|01.06.2018||R|0|0|0|0|0|1|LNA|0|0|0|100|SEK|2015|4178|lyfsjukr|||2|1|0|0,5000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftríaxón||2015||2015|4178||2 592418|M01AH0504|Etoricoxib Krka|filmhtfl|60|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|2308|2988|lyfalmen|V0825|2988|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1150||1150|2988||2 592498|QC09CA0701|Semintra|mixtúra|4|mg/ml|30|ml|1|glas|fyrir ketti|QC09CA07|01.04.2016||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|2966|5798|vetalmen|||1|30|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Telmisartanum||2966||2966|5798||1 592977|L01XE1201|Caprelsa|filmhtfl|300|mg|30|stk|1|þpakki||L01XE12|01.07.2012||R|1|1|0|1|0|1|GEB|0|0|0|100|XEU|578264|707642|lyfsjukr|||1|30|0||Vistor hf|Genzyme Europe B.V.|Vandetaníb||564062||564062|707642||1 593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978|30.06.2018|R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|399|1954|lyfalmen|||1|50|0|3,1250|Icepharma hf|Roche|Klónazepam||399||399|1954||2 593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|710|2382|lyfalmen|||1|150|0|9,3750|Icepharma hf|Roche|Klónazepam||710||710|2382||2 593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|1039|2835|lyfalmen|||1|100|0|25,0000|Icepharma hf|Roche|Klónazepam||1039||1039|2835||2 593438|N06AX2106|Duloxetin W&H|sþ-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.08.2015||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|6038|6268|lyfalmen|V0694|5153|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||3533||3533|6268||2 594099|A10BB1203|Glimepirid Bluefish|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.12.2016||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|919|2093|lyfalmen|V0023|2093|2|90|0|135,0000|Vistor hf|Bluefish Pharmaceuticals AB|Glímepíríð||500||500|2093||1 594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|0|0|0|0|G|0|MEA|0|0|1|100|DKK|14641|21557|lyfalmen|||1|12|0|32,0000|Icepharma hf|Meda AB|Tríamcínólón||14641||14641|21557||2 594343|N02AE0104|Buprenorphine ratiopharm|forðapl|20|mcg/klst|4|stk|1|skpoki||N02AE01|01.06.2018||R|0|0|1|0|G|0|RTH|0|0|0|100|SEK|3134|5337|lyfalmen|V0945|5259|2|4|0|11,2000|Alvogen|ratiopharm GmbH|Búprenorfín||2857||2857|5337||2 594709|C01CA1702|Midodrin Evolan|töflur|5|mg|50|stk|1|þpakki||C01CA17|01.05.2018||R|1|0|0|0|0|0|EVO|0|0|0|100|IKR|10293|15572|lyfalmen|||2|50|0|8,3333|LYFIS ehf|Evolan Pharma AB|midodrine||10293||10293|15572||2 595198|G04BD1201|Betmiga|forðatfl|25|mg|90|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|13524|20019|lyfalmen|||1|90|0|45,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||13524||13524|20019||1 595653|J01CR0205|Spectracillin|filmhtfl|1000|mg|10|stk|1|þpakki|875+125 mg|J01CR02|01.01.2017||R|0|0|0|0|0|0|WEH|0|0|1|100|IKR|752|1978|lyfalmen|||2|10|0|8,7500|Williams & Halls efh|Williams & Halls ehf|Amoxicillín og beta-laktamasa hemill ||416||416|1978||2 595966|B02BD0207|ReFacto AF|sts|250|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PIZ|0|1|0|100|DKK|18199|26454|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Ltd|Storkuþáttur VIII||18199||18199|26454||1 596085|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|43149|57645|lyfsjukr|||1|2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||||43149|57645||1 596523|QP52AC5501|Drontaste|töflur|344|mg|2|stk|1|þpakki|150+144+50 mg|QP52AC55|01.10.2017||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|862|1486|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|Febantel, Pyrantelembonat,Prazikvantel||862||862|1486||2 596881|N05CM1801|Dexdor|irþ|100|mcg/ml|2|ml|5|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|0|0|1|ORC|0|0|0|100|DKK|13286|19692|lyfsjukr|||1|10|0|1,0000|Vistor hf|Orion Corporation|Dexmedetómid||13286||13286|19692||1 597041|R06AX2702|Aerius (Lyf og heilsa)|filmhtfl|5|mg|90|stk|1|þpakki||R06AX27|01.06.2016||R|1|0|0|0|G|0|HOL|0|0|1|100|NOK|2681|5095|lyfalmen|V0458|2380|3|90|0|90,0000|Lyf og heilsa|Lyf og heilsa|Deslóratadín||2681||2681|5095||2 597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|þpakki||J01FF01|01.06.1979||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|1388|3315|lyfalmen|||1|24|0|3,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1388||1388|3315||1 597433|L01XC1101|Yervoy|stþ|5|mg/ml|10|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|0|0|1|BMS|0|1|0|100|DKK|502594|631193|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||502594||502594|631193||1 597565|L03AB1301|Plegridy|stl|125|mcg|2|áf.spr|1|pakki||L03AB13|01.07.2015||R|0|0|0|1|0|1|BNB|0|0|0|100|XEU|95877|124335|lyfsjukr|||1|2|0|28,0900|Icepharma hf|Biogen Netherlands B.V.|Peginterferón beta-1a||95877||95877|124335||2 597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|0|0|0|0|0|0|TRI|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|Trimb Healthcare AB|Ekónazól|||||||1 597814|C09DA0107|Losartan HCT Bluefish|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.01.2018||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|1953|2492|lyfalmen|V0089|2492|2|98|0|98,0000|Vistor hf|Bluefish Pharmaceuticals AB|Lósartan og þvagræsilyf||790||790|2492||1 598021|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.06.2014||R|1|0|0|0|G|0|MPH|0|0|0|100|SEK|1871|3980|lyfalmen|||1|100|0|33,3333|Icepharma hf|Mercury Pharmaceuticals Ltd.|Acetazólamíð||1871||1871|3980||2 598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|0|0|0|0|0|0|SNP|0|0|1|100|XEU|291|1805|lyfalmen|||1|150|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||291||291|1805||1 598499|M01AE0112|ibuxin rapid|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.09.2012||L|0|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Alvogen|ratiopharm GmbH|Íbúprófen|||||||2 598843|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|tfílát||A07EC03|01.04.2018||R|1|0|0|0|G|0|ATN|0|0|0|100|DKK|3883|6749|lyfalmen|V0953|6749|1|100|0|25,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||3883||3883|6749||2 598908|N07BA0106|Nicotinell|forðapl|7|mg/sólh|21|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|10,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 598925|M01AE0114|Nurofen Apelsin|mixtúra|40|mg/ml|100|ml|1|glas||M01AE01|01.04.2013||L|0|0|0|0|0|0|REC|0|0|1|100|DKK|||lyfalmen|||0|100|0|3,3333|Vistor hf|Reckitt Benckiser Healthcare Ltd|Íbúprófen|||||2004||1 599010|L01XE1701|INLYTA|filmhtfl|5|mg|56|stk|1|þpakki||L01XE17|01.05.2013||R|1|0|0|1|0|1|PIZ|0|1|0|100|DKK|481256|604655|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Ltd|Axitinib||481256||481256|604655||1 599176|L01XA0303|Oxaliplatin Actavis|irþ|5|mg/ml|20|ml|1|hgl|lausn|L01XA03|01.03.2018||R|0|0|0|0|0|1|GRP|0|0|0|100|XEU|4577|7705|lyfsjukr|||2|20|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Oxalíplatín||4577||4577|7705||1 599248|QC01CE9001|Vetmedin vet.|tuggutfl|1,25|mg|100|stk|1|þpakki|fyrir hunda|QC01CE90|01.04.2017||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|2823|5526|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||2823||2823|5526||1 599320|QV03AB9002|Narcostop|stl|5|mg/ml|10|ml|1|hgl|fyrir hunda og ketti|QV03AB90|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|3533|6873|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Atipamesól||3533||3533|6873||2 599460|S01XA2011|Oculac|augndr|50|mg/ml|0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.11.2013||L|0|0|0|0|G|0|CLA|0|0|0|100|DKK|||lyfalmen|||0|8|0||Vistor hf|Alcon Nordic A/S|Gervitár og aðrar óvirkar samsetningar|||||2249||1 599462|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|22713|31798|lyfalmen|||1|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||22713|31798||1 599531|H05BX0105|Cinacalcet Accord|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.02.2018||R|1|0|0|0|0|0|ARD|0|0|0|100|XEU|15333|10620|lyfalmen|V0720|9432|2|28|0|14,0000|Artasan ehf|Accord Healthcare Limited|Cinacalcet||6695||6695|10620||1 599737|N05AX1211|Aripiprazole Mylan Pharma|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.05.2017||R|1|1|0|0|G|0|MAT|0|0|0|100|IKR|7772|3869|lyfalmen|V0684|3787|2|56|0|56,0000|Icepharma hf|Pharmathen S.A.|Aripiprazól||1790||1790|3869||2 599883|N06AX1610|Venlafaxine Bluefish|forðahlk|75|mg|100|stk|1|þpakki|hart|N06AX16|01.05.2015||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|2859|3194|lyfalmen|V0334|2781|2|100|0|75,0000|Vistor hf|Bluefish Pharmaceuticals AB|Venlafaxín||1300||1300|3194||1 954851|V09AB0301|DaTSCAN|stl|74|MBq/ml|5|ml|1|hgl||V09AB03|01.10.2013||R|0|0|0|0|0|1|GEL|0|0|0|100|NOK|99000|128285|lyfsjukr|||1|5|0||Icepharma hf|GE Healthcare Limited|Lofendýlat||99000||99000|128285||2 957657|A12BA0201|Polycítra - forskriftarlyf|mixtúra|||500|ml|1|fl|Potassium citrats 102 mg/g|A12BA02|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|15120|22216|lyfalmen|||0|500|0|12,7500|PharmArctica ehf|PharmArctica - forskriftarlyf|potassium citrate||15120||15120|22216||2 957665|A12BA0102|Kalíum Klórið - forskriftarlyf|mixtúra|33|mg/g|300|ml|1|fl|35,34 mg/ml|A12BA01|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|2996|4997|lyfalmen|||0|300|0|3,5400|PharmArctica ehf|PharmArctica - forskriftarlyf|Kalíumklóríð||2610||2610|4997||2 968365|D07CB0101|TNG-smyrsl - forskriftarlyf|smyrsli|||15|ml|1|dos||D07CB01|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|1598|3604|lyfalmen|||0|15|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Triamcinolonum og sýklalyf||1598||1598|3604||2 968373|V03AB1505|Naloxonhydrochlorid - forskriftarlyf|mixtúra|1|mg/ml|500|ml|1|fl||V03AB15|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|18870|27378|lyfalmen|||0|500|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Naloxón||18870||18870|27378||2 968399|A03AA0704|Dicykloverine hydrochloride-forsk.lyf|mixtúra|2|mg/ml|100|ml|1|fl||A03AA07|01.04.2014||R|0|0|0|1|0|0|PAR|0|0|0|100|IKR|7066|11131|lyfalmen|||0|100|0|2,5000|PharmArctica ehf|PharmArctica - forskriftarlyf|Dícýklóverín||7066||7066|11131||2 968406|D05AA0001|Tjara 26 / ASVEP - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|2929|5436|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||2929||2929|5436||2 968414|D05AA0002|Koltjörusmyrsl - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|3650|6429|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||3650||3650|6429||2 970013|A01AD1102|Magical Mouthwash - forskriftarlyf|mixtúra|||100|ml|1|fl||A01AD11|01.04.2015||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|3988|6894|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Ýmis lyf||3988||3988|6894||2 970039|C09AA0106|Captopril mixtúra - forskriftarlyf|lausn|1|mg/ml|100|ml|1|fl||C09AA01|01.02.2017||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|15995|23420|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Kaptópríl||15995||15995|23420||2 970063|N07BB0401|Naltrexone Hydrochloride-forskriftarlyf|lausn|1|mg/ml|100|ml|1|fl||N07BB04|01.03.2017||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|1995|4151|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Naltrexone||||1995|4151||2 974784|A01AC0001|Clobetasol propionate - forskriftarlyf|munnskol|0,5|mg/ml|300|ml|1|fl||A01AC|01.02.2018||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|3375|6050|lyfalmen|||0|300|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Corticosteroids for local oral treatment||||3375|6050||2 974792|C09AA0106|Captopril mixtúra - forskriftarlyf|lausn|2,5|mg/ml|100|ml|1|fl||C09AA01|01.07.2018||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|23568|32879|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Kaptópríl||23568||23568|32879||2 980005|C07AA0513|Propranolol hydrochloride-forskriftarlyf|mixtúra|2|mg/ml|100|ml|1|fl||C07AA05|01.12.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|4995|8280|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Própranólól||4995||4995|8280||2 980071|D07AD0102|Clobetazol in Dermazink - forskriftarlyf|lausn|50|mg|120|ml|1|fl||D07AD01|01.02.2017||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|16998|24801|lyfalmen|||0|120|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Klóbetasól||16998||16998|24801||2